Use these links to rapidly review the document
TABLE OF CONTENTS
INDEX TO FINANCIAL STATEMENTS
As filed with the Securities and Exchange Commission on October 7, 2013
Registration No. 333 191213
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
AMENDMENT NO. 1
TO
FORM F-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
voxeljet AG
(Exact name of Registrant as specified in its charter)
Not Applicable
(Translation of Registrant's name into English)
Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement.
If any of the securities being registered on this Form are offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, please check the following box. o
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o
CALCULATION OF REGISTRATION FEE
|
||||||||
Title of each class of
securities to be registered (1) |
Amount to be
registered (2) |
Proposed maximum
offering price per ordinary share |
Proposed maximum
aggregate offering price (3) |
Amount of
registration fee |
||||
---|---|---|---|---|---|---|---|---|
Ordinary shares, €1.00 nominal value per share |
1,495,000 | $75.00 | $112,125,000 | $15,202 (4) | ||||
|
The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to Section 8(a), may determine.
The information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the Registration Statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to Completion, dated October 7, 2013
6,500,000 American Depositary Shares
Representing 1,300,000 Ordinary Shares
voxeljet AG |
|
$ per American Depositary Share
This investment involves risk. See "Risk Factors" beginning on page 13.
|
|||||||
|
|
Per ADS |
|
Total |
|
||
---|---|---|---|---|---|---|---|
Public offering price |
$ | $ | |||||
Underwriting discounts (1) |
$ | $ | |||||
Proceeds, before expenses, to voxeljet AG |
$ | $ | |||||
Proceeds, before expenses, to the selling shareholders |
$ | $ | |||||
|
The underwriters have a 30-day option to purchase up to 975,000 additional ADSs from the selling shareholders to cover over-allotments, if any .
We are an "emerging growth company" as that term is defined in the Jumpstart Our Business Startups Act and, as such, will be subject to reduced public company reporting requirements for future filings. See "Prospectus Summary Implications of Being an Emerging Growth Company."
Neither the Securities and Exchange Commission nor any state securities commission has approved of anyone's investment in these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
Delivery of the ADSs will be made against payment in New York, New York on or about , 2013.
Piper Jaffray | Citigroup | |
Cowen and Company |
|
Stephens Inc. |
The date of this prospectus is , 2013
You should rely only on the information contained in this prospectus or contained in any free writing prospectus we file with the Securities and Exchange Commission, or the SEC. Neither we nor the underwriters have authorized anyone to provide you with additional information or information different from that contained in this prospectus or in any free writing prospectus filed with the SEC. We are offering to sell, and seeking offers to buy, our ADSs only in jurisdictions where offers and sales of these securities are legally permitted. The information contained in this prospectus or in any free writing prospectus we file is accurate only as of its date, regardless of the time of delivery of this prospectus or of any sale of our ADSs. Our business, financial condition, results of operation and prospects may have changed since that date.
Until 25 days after the date of this prospectus, federal securities laws may require all dealers that buy, sell, or trade the ADSs, whether or not participating in this offering, to deliver a prospectus. This requirement is in addition to the dealers' obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.
All references in this prospectus to "U.S. dollars" or "$" are to the legal currency of the United States and all references to "€" or "euro" are to the currency introduced at the start of the third stage of the European economic and monetary union pursuant to the treaty establishing the European Community, as amended. Solely for the convenience of the reader, unless otherwise indicated, all amounts in U.S. dollars have been converted from euros to U.S. dollars at an exchange rate of $1.3010 per euro, the exchange rate on June 30, 2013. These conversions should not be considered representations that any such amounts have been, could have been or could be converted into U.S. dollars at that or any other exchange rate at that or any other date.
i
This summary highlights information contained elsewhere in this prospectus. This summary does not contain all of the information that you should consider in making your investment decision. Before investing in our ADSs, you should read this entire prospectus carefully, including the sections entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" and Voxeljet Technology GmbH's financial statements and related notes, for a more complete understanding of our business and this offering. Except as otherwise required by the context, references to "voxeljet," "Company," "we," "us" and "our" are to voxeljet AG and its legal predecessor Voxeljet Technology GmbH.
Our Company
We are a leading provider of high-speed, large-format 3D printers and on-demand parts services to industrial and commercial customers. Our 3D printers employ a powder binding, additive manufacturing technology to produce parts using various material sets, which consist of particulate materials and proprietary chemical binding agents. We offer our customers the highest volumetric output rate in the industry due to the combination of our large build boxes and print speeds. We provide our 3D printers and on-demand parts services to industrial and commercial customers serving the automotive, aerospace, film and entertainment, art and architecture, engineering and consumer product end markets.
We currently offer five different 3D printer platforms, and plan to offer a sixth prior to the end of 2013, with build boxes that range from 300 × 200 × 150 millimeters to 4,000 × 2,000 × 1,000 millimeters, with various print speeds, which produce volumetric output rates ranging from 0.7 liters per hour to 123.0 liters per hour. All of our platforms support our commercialized material sets, sand and plastics, along with their respective proprietary chemical binding agents. We develop our material sets according to the needs of our industrial and commercial customers, and we are currently in varying stages of developing new material sets, including shell molding and chromite sands, PMMA-based plastics, ceramics, silicon carbide, tungsten carbide, wood powder and cement.
We believe that our recent innovations in 3D printers will continue to increase customer adoption of our additive manufacturing technology in industrial and commercial applications. Recent key innovations include:
1
Our business is divided into two principal segments: Systems and Services.
In our Systems segment, we focus on the sale, production and development of 3D printers. We also provide consumables, including particulate materials and proprietary chemical binding agents, maintenance contracts and spare parts to our customers.
In our Services segment, we print on-demand parts for our customers. At our service center, which we believe is one of the largest additive manufacturing service centers in Europe, we create parts, molds, cores and models based on designs produced using 3D computer-aided design, or CAD, software.
Our legal predecessor was founded in 1999 as Generis GmbH. We sold our first 3D printer in 2002 and commenced our on-demand parts services business in 2003. As of June 30, 2013, we had an installed base of 52 printers worldwide, and we operated one service center with approximately 16,000 square feet of production space.
Our revenues have grown to €8.7 million in 2012 from €4.8 million in 2010, representing a 35% compound annual growth rate.
Our total backlog of 3D printer orders at June 30, 2013 was €4.4 million. Our backlog has grown steadily as we continue to experience growing demand for our 3D printers. For the years ended December 31, 2012, 2011 and 2010, our backlog was €3.7 million, €1.7 million and €0.1 million, respectively. Our backlog, which consisted of six 3D printers as of June 30, 2013, represents 3D printers for which a customer has signed a purchase order, but which we have not shipped yet. We estimate that the vast majority of systems in our backlog will ship prior to December 31, 2013, with the remainder expected to ship prior to June 30, 2014.
Our Industry
Additive manufacturing, which is often referred to as 3D printing, is a process in which 3D printers produce parts designed with CAD software through the successive addition of thin layers of material until a three-dimensional shape is created. Additive manufacturing has traditionally been used for prototyping and concept modeling, but is now also increasingly being used in tooling, casting and direct part production. Many industrial and commercial customers have realized cost and time savings through the incorporation of additive manufacturing into their existing workflows, either complementing or replacing traditional manufacturing methods. Additive manufacturing processes do not require tooling, an integral part of traditional manufacturing, which allows for quicker turnaround times and minimal setup costs relative to traditional manufacturing. As additive manufacturing technologies continue to improve, particularly with respect to print speed and materials, we believe the addressable market for additive manufacturing solutions will continue to expand.
We believe that additive manufacturing provides several advantages over traditional design and manufacturing processes, including:
2
There are a number of available additive manufacturing technologies, including powder binding, inkjet, fused deposition modeling, stereolithography and selective laser sintering. The technologies differ on the basis of accuracy, surface quality, variety and properties of consumables, capacity, speed, color variety, transparency and the ability to print multiple materials, among other factors. Our 3D printers employ a powder binding technology to produce parts using various material sets. Powder binding is a process in which layers of powder are bonded by a liquid agent that is deposited through a printhead. We believe this process has the fastest build speeds and the lowest materials cost relative to other additive manufacturing technologies.
The worldwide market for additive manufacturing products and services has grown from $1.3 billion in 2010 to $2.2 billion in 2012, representing a 29% compound annual growth rate, according to the Wohlers Report 2013. The Wohlers Report 2013 projects the worldwide additive manufacturing products and services market to reach approximately $6.0 billion by 2017 and $10.8 billion by 2021, representing 2012-2017 and 2012-2021 compound annual growth rates of 22% and 19%, respectively. Much of the recent growth has been driven by the demand for production parts.
We believe that our addressable market is larger than the worldwide market for additive manufacturing products detailed in the Wohlers Report 2013. For example, the global market for machine tools totaled $93.2 billion in 2012, according to the 2013 World Machine Tool Output & Consumption Survey. In addition, according to the American Foundry Society, 90% of all manufactured goods contain some metal castings, with the global metal casting industry producing 98.6 million metric tons of metal castings in 2011 and the United States shipping $32.4 billion in metal castings in 2012. We believe these markets represent significant short and long-term revenue opportunities due to the advantages offered by our technology and the early adoption of additive manufacturing technologies in these markets.
3
Our Competitive Strengths
We believe that our competitive strengths include:
Build box size. The size of the build box is important to many industrial and commercial customers, who may want to produce either large-scale industrial parts or large quantities of discrete parts in one batch. We currently offer five 3D printer platforms with varying build box sizes, ranging from 300 × 200 × 150 millimeters to 4,000 × 2,000 × 1,000 millimeters. Among our systems, the VX4000 system offers a build box of 4,000 × 2,000 × 1,000 millimeters, representing a volume that is more than six times the volume of the next largest commercially available 3D printer.
Volumetric output rate. Due to our build box sizes and print speeds, we believe that our 3D printers provide among the highest output efficiency, as measured by the rate of volume output per hour, relative to competing additive manufacturing technologies. For example, our VX4000 machine features a volumetric output rate of 123.0 liters per hour, which we believe is the highest in the industry. Our industry leading volumetric output rates enable us to produce parts meeting the specifications of our customers at a cost and speed that is attractive relative to traditional manufacturing alternatives, which effectively expands our addressable market.
Material sets. Our 3D printers can utilize various material sets, which include the combination of a particulate material, including sand or plastic, and our proprietary chemical binding agents. We believe that our currently commercialized material sets and technology can more readily address industrial and commercial applications than other additive manufacturing technologies because our materials meet or exceed the desired performance characteristics for a wide range of industrial and commercial applications or are already commonly used in traditional manufacturing processes. To meet our customer requirements, we are in varying stages of development of new material sets which include:
Track record of innovation. Our technology portfolio reflects our continued investments in a range of disciplines, including physics, chemistry, mechanical and electrical engineering and software development. We believe that we have a strong base of technology know-how, backed by our portfolio of intellectual property featuring patents and trade secrets covering processes, materials and equipment. As of June 30, 2013, we owned or co-owned 20 issued U.S. patents and 13 pending U.S. patent applications. In addition, we own or co-own patent rights in Europe, Asia and Canada. In total, as of June 30, 2013 our patent portfolio consisted of over 170 U.S. and international patents and patent applications. We also exchange information between our Services and our Systems segments to ensure that our development efforts are aligned with our customers' needs. We believe that we have a culture
4
of innovation, and we expect to continue to enhance our solutions both to drive further market adoption of 3D printing and to broaden our market reach.
Strong customer relationships. We are an early entrant in the market for additive manufacturing industrial part production, and we are one of the few providers of additive manufacturing solutions to commercial and industrial customers within the foundry, automotive, heavy equipment, power fluid handling and aerospace industries. We believe we have a reputation for providing high-quality systems and services in the marketplace and have relationships with a number of leading multinational customers, including Daimler AG, BMW AG, Ford Motor Company, Hyundai Motor Company, Liebherr Group, Alphaform AG, 3D Systems Corporation, 3M Company, Volkswagen AG and Porsche SE, as well as with other key users of additive manufacturing in the film and entertainment industry, such as Propshop Modelmakers Ltd., or Propshop, and technical universities, such as the University of Rostock, the Technical University of Munich and the Vaal University of Technology. Many of our customers, including Daimler AG, BMW AG, Ford Motor Company, Propshop and the Technical University of Munich, are customers of both our Systems and Services segments. We pride ourselves on our ability to retain customers over time, as Daimler AG, BMW AG, Ford Motor Company, Volkswagen AG, Porsche SE and the Technical University of Munich have all been customers for over a decade. We also collaborate on research and development projects with a number of our automotive and technical university customers, including Daimler AG, BMW AG, Ford Motor Company, Volkswagen AG and the Technical University of Munich. Together, these relationships provide us with significant insights into our customers' needs and help us to direct our research and development efforts.
Extensive global sales agent network. In addition to our direct sales force, we have built an extensive global network of over 25 sales agents in Europe, the Americas, the Middle East, Africa, Asia and Australia. We will continue to invest in expanding our distribution footprint to further penetrate our existing markets and to reach attractive new geographies. We currently print parts on demand for our customers from our service center in Europe, and we plan to expand our services footprint to include service centers in North America and Asia that are in closer proximity to our sales agents and end customers.
Our Business Strategies
The principal elements of our growth strategy include:
Enable adoption of our additive manufacturing technology. Our business model facilitates the adoption of our additive manufacturing technology by providing customers the ability to utilize our technology, either through our on-demand parts services or through the purchase of our 3D printers. Our customer relationships typically begin with the customer's purchase of parts, which we print in our on-demand parts service center. As our parts customers embrace additive manufacturing and our technology, they typically either increase the volume of their on-demand parts orders or purchase one of our 3D printers, or both depending on their needs.
Expand capacity via the development of high-volume service centers in key geographic locations. Our on-demand parts business plays an integral role in the sale of our 3D printers, as a majority of our 3D printer sales have been generated from customers of our on-demand parts business. We believe that the establishment of large-scale service centers will allow us to take advantage of significant economies of scale and will maximize our return on investment in our on-demand parts business. We are in the process of expanding our existing European service center from approximately 16,000 square feet to over 40,000 square feet of production space, and, with a portion of the proceeds from this offering, we plan to establish new service centers in North America and Asia.
5
Invest in research and development. We seek to identify ways we can apply our technology and expertise to meet a wider range of customer needs for both 3D printers and services. We have successfully introduced five printer platforms since 2007, including the VXC800 in 2012, which we believe is the only continuous build 3D printer currently on the market, and the VX4000 in 2011, which offers the largest commercially available 3D printer build box, and we anticipate introducing a sixth printer platform in the fourth quarter of 2013. We continuously work with our customers to develop new material sets that will facilitate the adoption of our technology. In 2012, 2011 and 2010, we spent 18%, 18% and 23% of our revenues, respectively, on research and development investment.
Expand our sales and marketing presence. We plan to increase our market awareness by adding sales agents and increasing marketing efforts in order to increase sales of 3D printers and on-demand parts. We plan to expand our direct sales force and our network of over 25 sales agents throughout Europe, the Americas, the Middle East, Africa, Asia and Australia. We currently market our brand and our services at industry conferences, trade shows, and across various forms of digital and traditional media, and we will increasingly expand our marketing efforts in North America and Asia in conjunction with our geographic expansion to those regions.
Further penetrate our targeted industry verticals. We continue to actively pursue opportunities in our targeted verticals, which utilize larger scale parts that require customization, complexity and short lead times. We believe our planned service center expansions, our continued investment in research and development and expanded sales and marketing capabilities will help us further penetrate these verticals. We serve our targeted industry verticals both directly and indirectly through foundries and service bureaus. Our targeted industry verticals include:
Company History / Corporate Information
The legal predecessor of our company was founded as Generis GmbH on May 5, 1999. On January 7, 2004, Generis GmbH changed its name to Voxeljet Technology GmbH.
On July 2, 2013, the shareholders of Voxeljet Technology GmbH incorporated VXLT 2013 AG, which was registered in the commercial register of the local court ( Amtsgericht ) of Augsburg on July 11, 2013 under number HRB 27999.
6
Voxeljet Technology GmbH was subsequently merged by way of merger through assumption into VXLT 2013 AG on July 29, 2013 effective as of September 12, 2013 upon registration of the merger in the commercial register of the surviving entity, VXLT 2013 AG. The merger had retroactive effect as of January 1, 2013. As part of the merger, VXLT 2013 AG changed its name to voxeljet AG effective upon the registration of the merger in the commercial register. By way of merger through assumption, upon effectiveness, voxeljet AG, as the surviving entity, took over all assets and liabilities of Voxeljet Technology GmbH by universal assumption and accession under German mandatory law, and Voxeljet Technology GmbH ceased to exist.
Our website is www.voxeljet.de . This website address is included in this prospectus as an inactive textual reference only. The information and other content appearing on our website are not part of this prospectus. Our agent for service of process in the United States is Corporation Service Company, located at 1090 Vermont Avenue N.W., Washington, DC 20005, telephone number (800) 927-9800.
Office Location
Our principal executive offices are located at Paul-Lenz-Straße 1b, 86316 Friedberg, Germany, and our telephone number is +49 821 7483 100.
Our Risks and Challenges
Our ability to implement our business strategy is subject to numerous risks and uncertainties. You should carefully consider all of the information set forth in this prospectus, and, in particular, the information under the heading "Risk Factors," prior to making an investment in our ADSs. These risks include, among others, the following:
7
Implications of Being an Emerging Growth Company
As a company with less than $1.0 billion in revenues for our fiscal year ended December 31, 2012, we qualify as an "emerging growth company" as defined in Section 2(a) of the U.S. Securities Act of 1933, as amended, or the Securities Act, as modified by the Jumpstart Our Business Startups Act, or the JOBS Act, which was enacted in 2012. An emerging growth company may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including, but not limited to:
We may choose to take advantage of some or all of the available exemptions and have taken advantage of some of these exemptions in this prospectus. Accordingly, the information contained herein may be different from the information you receive from other public companies in which you hold shares. We do not know if some investors will find our ADSs less attractive as a result of our utilization of these or other exemptions. The result may be a less active trading market for our ADSs and increased volatility in the price of our ADSs.
In addition, Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We currently prepare our financial statements in accordance with International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board, or IASB, which do not have separate provisions for publicly traded and private companies. However, in the event we convert to generally accepted accounting principles in the United States, or U.S. GAAP, while we are still an emerging growth company, we may be able to take advantage of the benefits of this extended transition period.
We will remain an emerging growth company until the earliest of (a) the last day of our fiscal year during which we had total annual gross revenues of at least $1.0 billion; (b) the last day of our fiscal year following the fifth anniversary of the date of the first sale of ADSs in this offering; (c) the date on which we have, during the previous three-year period, issued more than $1.0 billion in non-convertible debt; or (d) the date on which we are deemed to be a "large accelerated filer" under the Securities Exchange Act of 1934, as amended, or the Exchange Act. Once we cease to be an emerging growth company, we will not be entitled to the exemptions provided to emerging growth companies in the JOBS Act.
8
The Offering
American Depositary Shares offered: | ||
By voxeljet AG |
5,600,000 ADSs |
|
By the selling shareholders |
900,000 ADSs |
|
ADSs to be outstanding immediately after this offering |
|
6,500,000 ADSs |
Ordinary shares to be outstanding immediately after this offering |
|
3,120,000 ordinary shares |
Offering price |
|
We currently estimate that the initial public offering price per ADS will be between $13.00 and $15.00. |
Over-allotment option |
|
975,000 ADSs offered by the selling shareholders |
The ADSs |
|
Each ADS represents one-fifth of an ordinary share. |
|
|
The depositary will hold the ordinary shares underlying your ADSs. You will have rights as provided in the deposit agreement. You may cancel your ADSs and withdraw the underlying ordinary shares. The depositary will charge you fees for, among other acts, any cancellation. In certain limited instances described in the deposit agreement, we may amend or terminate the deposit agreement without your consent. If you continue to hold your ADSs, you agree to be bound by the terms of the deposit agreement then in effect. |
|
|
To better understand the terms of the ADSs, you should carefully read "Description of American Depositary Shares" in this prospectus. You should also read the deposit agreement, which is an exhibit to the Registration Statement that includes this prospectus. |
Depositary |
|
Citibank, N.A. |
Custodian |
|
Citigroup Global Markets Deutschland AG |
Use of proceeds |
|
We expect to receive total estimated net proceeds from this offering of approximately $69.7 million, after deducting the estimated underwriting discounts and commissions and estimated offering expenses, assuming an initial public offering price of $14.00 per ADS, the midpoint of the price range set forth on the cover page of this prospectus. We intend to use the net proceeds of this offering for the following purposes: (i) expansion of our on-demand parts service center in Europe and establishment of new on-demand parts service centers in North America and Asia; (ii) research and development and sales and marketing initiatives; and (iii) general corporate purposes, including, without limitation, potential acquisitions. See "Use of Proceeds" in this prospectus. |
9
We will not receive any proceeds from the sale of ADSs offered by the selling shareholders. | ||
Dividend policy |
|
Neither we nor our predecessor entity, Voxeljet Technology GmbH, have ever declared any cash dividends on our ordinary shares, and we have no present intention of declaring or paying any dividends in the foreseeable future. |
Risk factors |
|
You should carefully read the information set forth under "Risk Factors" beginning on page 13 of this prospectus and the other information set forth in this prospectus before deciding to invest in the ADSs. |
Proposed New York Stock Exchange Symbol |
|
VJET |
Unless otherwise indicated, all information in this prospectus assumes that the underwriters do not exercise their over-allotment option.
10
Summary Financial and Operating Data
We present below the summary historical financial and operating data of Voxeljet Technology GmbH, our legal predecessor. The financial data as of December 31, 2012, 2011 and 2010 and for the years ended December 31, 2012, 2011 and 2010 have been derived from Voxeljet Technology GmbH's audited financial statements and the related notes, which are included elsewhere in this prospectus and which have been prepared in accordance with IFRS as issued by the IASB and audited in accordance with the standards of the Public Company Accounting Oversight Board (United States). Except for the As Adjusted Statement of Financial Position Data as of June 30, 2013, the financial data as of June 30, 2013 and 2012 and for the six months ended June 30, 2013 and 2012 have been derived from Voxeljet Technology GmbH's unaudited interim financial statements and the related notes, which are included elsewhere in this prospectus.
The historical results presented below are not necessarily indicative of the financial results to be expected for any future periods. You should read this information in conjunction with "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Selected Financial and Operating Data," and Voxeljet Technology GmbH's financial statements and related notes, each included elsewhere in this prospectus.
Statement of Comprehensive Income (Loss) Data:
|
Six Months Ended June 30, | Year Ended December 31, | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2013 | 2013 | 2012 | 2012 | 2012 | 2011 | 2010 | |||||||||||||||
|
($ in thousands,
except share and per share data) (1) |
(€ in thousands, except
share and per share data) |
($ in thousands,
except share and per share data) (1) |
(€ in thousands, except
share and per share data) |
||||||||||||||||||
Revenues |
$ | 5,826 | € | 4,478 | € | 4,644 | $ | 11,333 | € | 8,711 | € | 7,257 | € | 4,764 | ||||||||
Cost of sales |
3,857 | 2,965 | 2,479 | 6,449 | 4,957 | 4,337 | 2,660 | |||||||||||||||
Gross profit |
1,968 | 1,513 | 2,165 | 4,884 | 3,754 | 2,920 | 2,104 | |||||||||||||||
Selling expenses |
1,079 | 829 | 842 | 1,965 | 1,510 | 1,160 | 1,028 | |||||||||||||||
Administrative expenses |
619 | 476 | 355 | 986 | 758 | 670 | 606 | |||||||||||||||
Research and development expenses |
1,198 | 921 | 627 | 2,046 | 1,573 | 1,313 | 1,073 | |||||||||||||||
Other operating expenses |
221 | 170 | 46 | 81 | 62 | 140 | 81 | |||||||||||||||
Other operating (income) |
(690 | ) | (530 | ) | (372 | ) | (1,069 | ) | (822 | ) | (831 | ) | (762 | ) | ||||||||
Operating profit (loss) |
(459 | ) | (353 | ) | 667 | 876 | 673 | 468 | 78 | |||||||||||||
Finance expense |
248 | 191 | 181 | 472 | 363 | 389 | 359 | |||||||||||||||
Finance (income) |
(17 | ) | (13 | ) | (3 | ) | (23 | ) | (18 | ) | (5 | ) | (8 | ) | ||||||||
Financial result |
232 | 178 | 178 | 449 | 345 | 384 | 351 | |||||||||||||||
Profit (loss) before income taxes |
(691 | ) | (531 | ) | 489 | 427 | 328 | 84 | (273 | ) | ||||||||||||
Income tax expenses (benefit) |
(202 | ) | (155 | ) | 170 | 151 | 116 | 41 | (65 | ) | ||||||||||||
Profit (loss) |
$ | (489 | ) | € | (376 | ) | € | 319 | $ | 276 | € | 212 | € | 43 | € | (208 | ) | |||||
Other comprehensive (income) |
$ | | € | | € | (1 | ) | $ | (1 | ) | € | (1 | ) | € | (4 | ) | € | (7 | ) | |||
Total comprehensive income (loss) |
$ | (489 | ) | € | (376 | ) | € | 320 | $ | 277 | € | 213 | € | 47 | € | (201 | ) | |||||
Earnings (loss) per share (2) |
$ | (0.24 | ) | € | (0.19 | ) | € | 0.16 | $ | 0.14 | € | 0.11 | € | 0.02 | € | (0.10 | ) | |||||
Earnings (loss) per ADS (2) |
$ | (0.05 | ) | € | (0.04 | ) | € | 0.03 | $ | 0.03 | € | 0.02 | € | 0.00 | € | (0.02 | ) | |||||
Weighted average number of ordinary shares outstanding, adjusted to reflect changes in capital (2) |
2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 |
11
Statement of Financial Position Data:
|
As of June 30, | As of December 31, | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2013 (As Adjusted) (3) | 2013 (Actual) | 2013 | 2012 | 2012 | 2011 | 2010 | |||||||||||||||
|
($ in thousands)
|
($ in thousands)
(1)
|
(€ in thousands)
|
($ in thousands)
(1)
|
(€ in thousands)
|
|||||||||||||||||
Cash and cash equivalents |
$ | 70,153 | $ | 441 | € | 339 | $ | 392 | € | 301 | € | 498 | € | 654 | ||||||||
Inventories |
4,062 | 4,062 | 3,122 | 3,651 | 2,806 | 2,011 | 864 | |||||||||||||||
Total assets |
86,785 | 17,073 | 13,123 | 13,970 | 10,738 | 9,768 | 8,864 | |||||||||||||||
Total liabilities |
15,978 | 15,978 | 12,281 | 12,386 | 9,520 | 8,763 | 7,906 | |||||||||||||||
Shareholders' equity |
70,807 | 1,095 | 842 | 1,585 | 1,218 | 1,005 | 958 |
Other Data:
|
Six Months Ended June 30, | Year Ended December 31, | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2013 | 2013 | 2012 | 2012 | 2012 | 2011 | 2010 | |||||||||||||||
|
($ in thousands,
except 3D printers sold) (1) |
(€ in thousands, except 3D
printers sold) |
($ in thousands,
except 3D printers sold) (1) |
(€ in thousands, except
3D printers sold) |
||||||||||||||||||
EBITDA (4) |
$ | 515 | € | 396 | € | 1,306 | $ | 2,623 | € | 2,016 | € | 1,714 | € | 1,188 | ||||||||
3D printers sold (5) |
3 | 3 | 3 | 6 | 6 | 3 | 1 |
The following table reconciles profit (loss) to EBITDA for the periods presented:
12
Investing in our ADSs involves a high degree of risk. You should carefully consider the risks described below, which we believe are the material risks of our business, our industry, our intellectual property, the ADSs and this offering, before making an investment decision. If any of the following risks actually occurs, our business, financial condition and operating results could be harmed. In that case, the trading price of the ADSs could decline and you might lose all or part of your investment. In assessing these risks, you should also refer to the other information contained in this prospectus, including Voxeljet Technology GmbH's financial statements and the related notes thereto.
Risks Related to Our Business and Industry
We may not be able to introduce new 3D printers and related print materials acceptable to the market or to improve the technology and print materials used in our current 3D printers.
Our revenues are derived from the sale of 3D printers for, and products manufactured using, additive manufacturing. Our market is subject to innovation and technological change. A variety of technologies compete against one another in our market, which is, in part, driven by technological advances and end-user requirements and preferences, as well as the emergence of new standards and practices. Our ability to compete in the industrial additive manufacturing market depends, in large part, on our success in enhancing and developing new 3D printers, enhancing and adding to our technology and developing and qualifying new materials in which we can print. We believe that to remain competitive we must continuously enhance and expand the functionality and features of our products and technologies. However, we may not be able to:
Even if we successfully enhance our existing 3D printers or create new 3D printers, it is likely that new 3D printers and technologies that we develop will eventually supplant our existing 3D printers or that our competitors will create 3D printers that will replace our 3D printers. As a result, any of our products may be rendered obsolete or uneconomical by our or others' technological advances.
Our revenues and operating results may fluctuate.
Our revenues and operating results may fluctuate from quarter-to-quarter and year-to-year and are likely to continue to vary due to a number of factors, many of which are not within our control. A significant portion of our 3D printer orders are typically received during the second and fourth quarters of the fiscal year as a result of the timing of capital expenditures of our customers. Our 3D printers typically are shipped the next quarter after an order is received. Thus, revenues and operating results for any future period are not predictable with any significant degree of certainty. We also
13
typically experience weaker demand for our 3D printers in the first and third quarters. For these reasons, comparing our operating results on a period-to-period basis may not be meaningful. Until our business grows more significantly, the timing of individual printer sales, because of the cost of our largest printers, can have meaningful effects on and result in fluctuations in our quarterly results. You should not rely on our past results as an indication of our future performance.
Fluctuations in our operating results and financial condition may occur due to a number of factors, including, but not limited to, those listed below and those identified throughout this prospectus:
14
The long sales cycle for our products makes the timing of our revenues difficult to predict.
Generally, our 3D printers have a long sales cycle. Because our 3D printers are complex and typically involve significant capital investments by prospective purchasers, we and our sales agents generally need to invest a significant amount of time educating prospective purchasers about the benefits of our products. As a result, before purchasing our products, potential purchasers may spend a substantial amount of time performing internal assessments before making a purchase. This may cause us to devote significant effort in advance of a potential sale without any guarantee of receiving any related revenues. Delays in sales could cause significant variability in our revenues and operating results for any particular period.
Demand for our products may not increase adequately.
The marketplace for industrial manufacturing is dominated by conventional manufacturing methods that do not involve additive manufacturing technology. We may not be able to develop effective strategies to raise awareness among potential customers of the benefits of our additive manufacturing technology. If additive manufacturing technology does not gain market acceptance as an alternative for industrial manufacturing, or if the marketplace adopts additive manufacturing based on a technology other than our technology, we may not be able to increase or sustain the level of sales of our products and machines and our results of operations would be adversely affected as a result.
We may not be able to significantly increase the number of materials for use in our 3D printers fast enough to meet our business plan, and, if we are successful, we may attract more competitors into our markets, some of which may be much larger than we are.
Our business plan is dependent in part upon our ability to steadily increase the number of qualified materials in which our 3D printers can print, since this will increase our addressable market. However, qualifying new materials is a complicated engineering task, and there is no way to predict whether, or when, any given material will be qualified. If we cannot hire a sufficient number of skilled people to work on qualifying new materials for printing or if we lack the resources necessary to create a steady flow of new materials, we will not be able to meet our business goals and a competitor may emerge that is better at qualifying new materials, either of which would have an adverse effect on our business results.
If, however, we succeed in qualifying a growing number of materials for use in our 3D printers, that should increase our addressable market, both as to customers and products for customers. However, as we create a larger addressable market, our market may become more attractive to other 3D printing companies or large companies that are not 3D printing companies but which may see an economic opportunity in the markets we have created. Similarly, if our focus on selling large 3D printers and 3D printed products to industrial companies proves successful, an increase in the number of competitors in that particular market is likely to adversely affect our business and financial results.
We are highly dependent upon sales to certain industries.
Our revenues of machines and products are relatively concentrated in companies in the automotive, foundry, film and entertainment, aerospace and art and architecture industries and those industries' respective suppliers. To the extent any of these industries experiences a downturn and we are unable to penetrate and expand into other industries, our results of operations may be adversely affected. Additionally, if any of these industries or their respective suppliers or other providers of manufacturing services develop new technologies or alternatives to manufacture the products that are currently manufactured using our 3D printers, it may adversely affect our results of operations.
15
If our relationships with suppliers, especially with limited source suppliers of components of and consumables for our products, were to terminate or our manufacturing arrangements were to be disrupted, our business could be adversely affected.
We purchase components and certain sub-assemblies for our systems and consumables that are used in our print materials from third-party suppliers. While there are several potential suppliers of most of the components and sub-assemblies for our systems, and for most of the consumables for our print materials, we currently choose to use only a limited number of suppliers for several of these components and materials. Our reliance on a limited number of vendors involves a number of risks, including:
In addition, we require any new supplier to become "qualified" pursuant to our internal procedures. The qualification process involves evaluations of varying durations, which may cause production delays if we were required to qualify a new supplier unexpectedly. We generally assemble our systems based on our internal forecasts and the availability of consumables, assemblies, components and finished goods that are supplied to us by third parties, which are subject to various lead times. If certain suppliers were to decide to discontinue production of an assembly, component or consumable that we use, the unanticipated change in the availability of supplies, or unanticipated supply limitations, could cause delays in, or loss of, sales, increased production or related costs and, consequently, reduced margins, and damage to our reputation. If we are unable to find a suitable supplier for a particular component, consumable or compound, we could be required to modify our existing products to accommodate substitute components, consumables or compounds. In addition, because we use a limited number of suppliers, increases in the prices charged by our suppliers may have an adverse effect on our results of operations, as we may be unable to find a supplier who can supply us at a lower price. As a result, the loss of a limited source supplier could adversely affect our relationships with our customers and our results of operations and financial condition.
We may not be able to manage the expansion of our operations effectively in order to achieve our projected levels of growth.
We have expanded our operations significantly in recent periods, and our business plan calls for further expansion over the next several years, including expanding the capacity of our existing facilities. We anticipate that further development of our infrastructure and an increase in the number of our employees will be required to achieve our planned broadening of our product offerings and client base, improvements in our 3D printers and materials used in our 3D printers, and our planned international growth. In particular, we must increase our marketing and services staff to support new marketing and service activities and to meet the needs of both new and existing customers. Our ability to successfully increase our marketing efforts is not guaranteed, and if we are not able to successfully increase our marketing efforts, we may not be able to grow our business as intended. Our future success will depend in part upon the ability of our management to manage our growth effectively. If
16
our management is unsuccessful in meeting these challenges, we may not be able to achieve our anticipated level of growth, which would adversely affect our results of operations.
Our operations could suffer if we are unable to attract and retain key management or other key employees.
Our success depends upon the continued service and performance of our senior management and other key personnel. Our senior management team is critical to the management of our business and operations, as well as to the development of our strategy. The loss of the services of any members of our senior management team could delay or prevent the successful implementation of our growth strategy, or the commercialization of new applications for our 3D printers or other products, or could otherwise adversely affect our ability to manage our company effectively and carry out our business plan. Members of our senior management team may resign at any time. High demand exists for senior management and other key personnel in the additive manufacturing industry, and there can be no assurance that we will be able to retain such personnel. We do not carry key-man insurance on any member of our senior management team.
Our growth and success will also depend on our ability to attract and retain additional highly-qualified scientific, technical, sales, managerial and finance personnel. We have experienced and expect to continue to experience intense competition for qualified personnel. While we intend to continue to provide competitive compensation packages to attract and retain key personnel, some of our competitors for these employees have greater resources and more experience, making it difficult for us to compete successfully for key personnel. If we cannot attract and retain sufficiently qualified technical employees for our research and development and manufacturing operations, we may be unable to develop and commercialize new products or new applications for existing products. Furthermore, possible shortages of key personnel, including engineers, in the regions surrounding our European facilities could require us to pay more to hire and retain key personnel, thereby increasing our costs.
We may need to raise additional capital from time to time in order to meet our growth strategy and may be unable to do so on attractive terms, or at all.
We intend to continue to make investments to support the growth of our business and may require additional funds to respond to business challenges, including the need to implement our growth strategy, increase market share in our current markets or expand into other markets, or broaden our technology, intellectual property or service capabilities. Accordingly, we may require additional investments of capital from time to time, and our existing sources of cash and any funds generated from operations may not provide us with sufficient capital. For various reasons, including any noncompliance with existing or future lending arrangements, additional financing, including lease financing for sale and leaseback transactions, may not be available when needed, or may not be available on terms favorable to us. If we fail to obtain adequate capital on a timely basis or if capital cannot be obtained on terms satisfactory to us, we may not be able to achieve our planned rate of growth, which will adversely affect our results of operations.
We face significant competition in many aspects of our business, which could cause our revenues and gross profit margins to decline. Competition could also cause us to reduce sales prices or to incur additional marketing or production costs, which could result in decreased revenue, increased costs and reduced margins.
We compete for customers with a wide variety of producers of equipment for models, prototypes, other 3D objects and end-use parts as well as producers of print materials and services for this equipment. Some of our existing and potential competitors are researching, designing, developing and marketing other types of competitive equipment, print materials and services. Many of these
17
competitors have financial, marketing, manufacturing, distribution and other resources that are substantially greater than ours.
We also expect that future competition may arise from the development of allied or related techniques for equipment and print materials that are not encompassed by our patents, from the issuance of patents to other companies that may inhibit our ability to develop certain products, from our entry into new geographic markets and industries and from improvements to existing print materials and equipment technologies.
We intend to continue to follow a strategy of continuing product development to enhance our position to the extent practicable. We cannot assure you that we will be able to maintain our current position in the field or continue to compete successfully against current and future sources of competition. If we do not keep pace with technological change and introduce new products, our revenues and demand for our products may decrease.
There is no guarantee that purchase orders that relate to 3D printers in our backlog will be consummated.
Our backlog, which represents 3D printers for which a customer has signed a purchase order, but which we have not shipped yet, has grown steadily as we continue to experience growing demand for our 3D printers. Our backlog as of June 30, 2013 was €4.4 million and consisted of six 3D printers. The underlying purchase orders and, thus, total backlog are subject to adjustments inherent in our line of business. While we anticipate that the vast majority of 3D printers in our backlog will ship prior to December 31, 2013, with the remainder expected to ship prior to June 30, 2014, we have had a customer cancel a purchase order in the past without a penalty. In addition, the purchase orders related to our backlog are still subject to installation and a satisfactory dry run at the customer's site. As a result, there is no guarantee that these purchase orders will be consummated.
Our operations outside of Germany subject us to various risks, and our failure to manage these risks could adversely affect our results of operations.
Our business is subject to certain risks associated with doing business globally. Our sales outside of Germany represented 53% and 34% of our total sales in 2012 and 2011, respectively. One of our growth strategies is to pursue opportunities for our business in several areas of the world, both inside and outside of Germany and Europe, any or all of which could be adversely affected by the risks set forth below. Accordingly, we face significant operational risks as a result of doing business internationally, such as:
18
Our failure to manage the market and operational risks associated with our international operations effectively could limit the future growth of our business and adversely affect our results of operations.
Our international operations pose currency risks, which may adversely affect our operating results and net income.
Our operating results may be affected by volatility in currency exchange rates and our ability to effectively manage our currency transaction risks. In general, we conduct our business, earn revenues and incur costs in the local currency of the countries in which we operate. In 2012, 75% of our revenues were generated and 97% of our costs were incurred in euros. Although currency exchange rate fluctuations have not had an impact on our operations to date, as we realize upon our strategy to expand internationally, our exposure to currency risks will increase. We do not manage our foreign currency exposure in a manner that would eliminate the effects of changes in foreign exchange rates. Therefore, changes in exchange rates between these foreign currencies and the euro will affect our revenues, cost of goods sold, and operating margins, and could result in exchange losses in any given reporting period.
We incur currency transaction risks whenever we enter into either a purchase or a sale transaction using a different currency from the currency in which we report revenues. In such cases we may suffer an exchange loss because we do not currently engage in currency swaps or other currency hedging strategies to address this risk.
Given the volatility of exchange rates, we can give no assurance that we will be able to effectively manage our currency transaction risks or that any volatility in currency exchange rates will not have an adverse effect on our results of operations.
19
We may engage in future acquisitions that could disrupt our business, cause dilution to our shareholders and harm our financial condition and operating results.
While we currently have no specific plans to acquire any other businesses, we may, in the future, make acquisitions of, or investments in, companies that we believe have products or capabilities that are a strategic or commercial fit with our current business or otherwise offer opportunities for our company. In connection with these acquisitions or investments, we may:
We may not be able to complete acquisitions on favorable terms, if at all. If we do complete an acquisition, we cannot assure you that it will ultimately strengthen our competitive position or that it will be viewed positively by customers, financial markets or investors. Furthermore, future acquisitions could pose numerous additional risks to our operations, including:
Global economic, political and social conditions have adversely impacted our sales and may continue to do so.
The uncertain direction and relative strength of the global economy, difficulties in the financial services sector and credit markets, continuing geopolitical uncertainties and other macroeconomic factors all affect spending behavior of potential end-users of our products. The prospects for economic growth in Europe, the United States and other countries remain uncertain and may cause end-users to further
20
delay or reduce technology purchases. In particular, a substantial portion of our sales are made to customers in countries in Europe, which is experiencing a significant economic crisis. If global economic conditions remain volatile for a prolonged period or if European economies experience further disruptions, our results of operations could be adversely affected. The global financial crisis affecting the banking system and financial markets has resulted in a tightening of credit markets, lower levels of liquidity in many financial markets and extreme volatility in fixed income, credit, currency and equity markets. These conditions may make it more difficult for our end-users to obtain financing.
Failure to comply with the U.S. Foreign Corrupt Practices Act or other applicable anti-corruption legislation could result in fines, criminal penalties and an adverse effect on our business.
We operate in a number of countries throughout the world, including countries known to have a reputation for corruption. We are committed to doing business in accordance with applicable anti-corruption laws. We are subject, however, to the risk that our officers, directors, employees, agents and collaborators may take action determined to be in violation of such anti-corruption laws, including the U.S. Foreign Corrupt Practices Act of 1977, the U.K. Bribery Act 2010 and the European Union Anti-Corruption Act, as well as trade sanctions administered by the Office of Foreign Assets Control and the U.S. Department of Commerce. Any such violation could result in substantial fines, sanctions, civil and/or criminal penalties or curtailment of operations in certain jurisdictions, and might adversely affect our results of operations. In addition, actual or alleged violations could damage our reputation and ability to do business.
We rely on our information technology systems to manage numerous aspects of our business and customer and supplier relationships, and a disruption of these systems could adversely affect our results of operations.
We rely on our information technology, or IT, systems to manage numerous aspects of our business and provide analytical information to management. Our IT systems allow us to efficiently purchase products from our suppliers, provide procurement and logistic services, ship products to our customers on a timely basis, maintain cost-effective operations and provide service to our customers. Our IT systems are an essential component of our business and growth strategies, and a disruption to our IT systems could significantly limit our ability to manage and operate our business efficiently. Although we take steps to secure our IT systems, including our computer systems, intranet and internet sites, email and other telecommunications and data networks, the security measures we have implemented may not be effective and our systems may be vulnerable to, among other things, damage and interruption from power loss, including as a result of natural disasters, computer system and network failures, loss of telecommunication services, operator negligence, loss of data, security breaches, computer viruses and other disruptive events. Any such disruption could adversely affect our reputation, brand and financial condition.
Defects in new products or in enhancements to our existing products that give rise to product returns or warranty or other claims could result in material expenses, diversion of management time and attention, and damage to our reputation.
Our 3D printing systems may contain undetected defects or errors when first introduced or as enhancements are released that, despite testing, are not discovered until after a system has been used. This could result in delayed market acceptance of those systems or claims from sales agents, end-users or others, which may result in litigation, increased end-user service and support costs and warranty claims, damage to our reputation and business, or significant costs to correct the defect or error. We may from time to time become subject to warranty or product liability claims related to product quality issues that could lead us to incur significant expenses.
21
We could face liability if our 3D printers are used by our customers to print dangerous objects.
Customers may use our 3D printers to print parts that could be used in a harmful way or could otherwise be dangerous. For example, there have been recent news reports that 3D printers were used to print guns or other weapons. We have little, if any, control over what objects our customers print using our 3D printers, and it may be difficult, if not impossible, for us to monitor and prevent customers from printing weapons with our 3D printers. While we have never printed weapons in our service center, there can be no assurance that we will not be held liable if someone were injured or killed by a weapon printed by a customer using one of our 3D printers.
A loss of a significant number of our sales agents would impair our ability to sell our products and services and could reduce our revenues and adversely impact our operating results.
We expect most of our sales of our products to be made with the assistance of our network of sales agents. We rely heavily on these sales agents to facilitate sales of our products to end-users in their respective geographic regions. Furthermore, we rely on sales agents to service our products. These sales agents are generally not precluded from selling our competitors' products in addition to ours. In addition, they may not be effective in selling our products or servicing our end-users. Further, if a significant number of these sales agents were to terminate their relationships with us or otherwise fail or refuse to facilitate sales of our products, we may not be able to find replacements that are as qualified or as successful. If these sales agents do not perform as anticipated or if we are unable to find qualified and successful replacements, our sales will suffer, which would have a material adverse effect on our revenues and operating results.
Workplace accidents or environmental damage could result in substantial remedial obligations and damage to our reputation.
Accidents or other incidents that occur at our facilities or involve our personnel or operations could result in claims for damages against us. In addition, in the event we are found to be financially responsible, as a result of environmental or other laws or by court order, for environmental damages alleged to have been caused by us or occurring on our premises, we could be required to pay substantial monetary damages or undertake expensive remedial obligations. The amount of any costs, including fines or damages payments that we might incur under such circumstances could substantially exceed any insurance we have to cover such losses. Any of these events, alone or in combination, could have a material adverse effect on our business, financial condition and results of operations and could adversely affect our reputation.
Our operations are subject to environmental laws and other government regulations which could result in liabilities in the future.
We are subject to domestic and foreign environmental laws and regulations governing our operations, including, but not limited to, emissions into the air and water and the use, handling, disposal and remediation of hazardous substances. A certain risk of environmental liability is inherent in our production activities. Under certain environmental laws, we could be held solely or jointly and severally responsible, regardless of fault, for the remediation of any hazardous substance contamination at our facilities and at facilities where our products are used and the respective consequences arising out of human exposure to such substances or other environmental damage. We may not have been and may not be at all times in complete compliance with environmental laws, regulations and permits, and the nature of our operations exposes us to the risk of liabilities or claims with respect to environmental and worker health and safety matters. If we violate or fail to comply with environmental laws, regulations and permits, we could be subject to penalties, fines, restrictions on operations or other sanctions, and our operations could be interrupted.
22
The cost of complying with current and future environmental, health and safety laws applicable to our operations, or the liabilities arising from past releases of, or exposure to, hazardous substances, may result in future expenditures. Any of these developments, alone or in combination, could have a material adverse effect on our business, financial condition and results of operations.
We may not have adequate insurance for potential liabilities, including liabilities arising from litigation.
In the ordinary course of business, we have been, and in the future may be, subject to various product and non-product related claims, lawsuits and administrative proceedings seeking damages or other remedies arising out of our commercial operations, including litigation related to defects in our products. We maintain insurance to cover our potential exposure for most claims and losses. However, our insurance coverage is subject to various exclusions, self-retentions and deductibles, may be inadequate or unavailable to protect us fully, and may be cancelled or otherwise terminated by the insurer. Furthermore, we face the following additional risks related to our insurance coverage:
Even a partially uninsured claim of significant size, if successful, could have a material adverse affect on our business, financial condition, results of operations and liquidity. However, even if we successfully defend ourselves against any such claim, we could be forced to spend a substantial amount of money in litigation expenses, our management could be required to spend valuable time defending these claims and our reputation could suffer, any of which could adversely affect our results of operations.
If our manufacturing facility or on-demand parts service center is disrupted, sales of our products may be affected, which could result in loss of revenues and unforeseen costs.
We manufacture our machines at our facility in Europe. Our on-demand parts service center is also located in Europe. While we plan to add additional facilities in the future, all of our operations are currently performed at our facilities in Europe. If the operations of these facilities are materially disrupted, whether by natural disasters, demonstrations, acts of terror, or otherwise, we would be unable to fulfill customer orders for the period of the disruption, we would not be able to recognize revenues on orders, we could suffer damage to our reputation, and we might need to modify our standard sales terms to secure the commitment of new customers during the period of the disruption and perhaps longer. Depending on the cause of the disruption, we could incur significant costs to remedy the disruption and resume product shipments. Such a disruption could have an adverse effect on our results of operations.
23
New regulations related to conflict-free minerals may cause us to incur additional expenses and may create challenges with our customers.
The Dodd-Frank Wall Street Reform and Consumer Protection Act contains provisions to improve transparency and accountability regarding the use of "conflict" minerals mined from the Democratic Republic of Congo and adjoining countries, collectively, the DRC. The SEC has established new annual disclosure and reporting requirements for those companies who use "conflict" minerals sourced from the DRC in their products. As we use tungsten, a "conflict" mineral, in our research and development department, these new requirements could limit the pool of suppliers who can provide conflict-free minerals, and, as a result, we cannot ensure that we will be able to obtain these conflict-free minerals in sufficient quantities or at competitive prices. Compliance with these new requirements may also increase our costs. In addition, we may face challenges with our customers in the future if our customers require that all our products are certified as "conflict" mineral-free and we are unable to sufficiently verify the origins of the minerals used in our material sets.
Risks Related to Our Intellectual Property
If we are unable to obtain patent protection for our products or otherwise protect our intellectual property rights, our business could suffer.
We rely on a combination of patents, trademarks, trade secrets and confidentiality agreements and other contractual arrangements with our employees, end-users and others to maintain our competitive position. Our success depends, in part, on our ability to obtain patent protection for or maintain as trade secrets our proprietary products, technologies and inventions and to maintain the confidentiality of our trade secrets and know-how, operate without infringing upon the proprietary rights of others and prevent others from infringing upon our business proprietary rights.
Despite our efforts to protect our proprietary rights, it is possible that competitors or other unauthorized third parties may obtain, copy, use or disclose our technologies, inventions, processes or improvements. We cannot assure you that any of our existing or future patents or other intellectual property rights will be enforceable, will not be challenged, invalidated or circumvented, or will otherwise provide us with meaningful protection or any competitive advantage. In addition, our pending patent applications may not be granted, and we may not be able to obtain foreign patents or elect to file applications corresponding to our U.S. and E.U. patents. The laws of certain countries outside the United States and European Union may not provide the same level of patent protection as in the United States and the European Union, so even if we assert our patents or obtain additional patents in countries outside of the United States and the European Union, effective enforcement of such patents may not be available. If our patents do not adequately protect our technology, our competitors may be able to offer additive manufacturing systems or other products similar to ours. Our competitors may also be able to develop similar technology independently or design around our patents, and we may not be able to detect the unauthorized use of our proprietary technology or take appropriate steps to prevent such use. Any of the foregoing events would lead to increased competition and lower revenues or gross margins, which could adversely affect our operating results.
We may not be able to protect our trade secrets and intellectual property.
While some of our technology is licensed under patents belonging to others or is covered by process patents which are owned or applied for by us, much of our key technology is not protected by patents. Furthermore, patents are jurisdictional in nature and therefore only protect us in certain markets, rather than globally. In particular, in fast-growing markets such as China and India, our technology is not protected by patents. We have devoted substantial resources to the development of our technology, trade secrets, know-how and other unregistered proprietary rights. While we enter into confidentiality and invention assignment agreements intended to protect such rights, such agreements can be difficult
24
and costly to enforce or may not provide adequate remedies if violated. Such agreements may be breached and confidential information may be willfully or unintentionally disclosed, or our competitors or other parties may learn of the information in some other way. Since we cannot legally prevent one or more other companies from developing similar or identical technology to our unpatented technology, it is likely that, over time, one or more other companies may be able to replicate our technology, thereby reducing our technological advantages. If we do not protect our technology or are unable to develop new technology that can be protected by patents or as trade secrets, we may face increased competition from other companies, which may adversely affect our results of operations.
We enjoy license rights and exclusivity of certain patents and intellectual property and cannot adequately estimate the effects of their expiration upon the entrance or advancement of competitors into the additive manufacturing industrial market.
We have exclusive and non-exclusive license rights to certain patents that we utilize in the industrial market. Some of these patents have already expired, and others will expire within the next three-to-five years. We cannot adequately estimate the effect that the expiration of these patents will have upon the entrance or advancement of other additive manufacturing manufacturers into the industrial market. See "Business Intellectual Property."
We may be subject to claims alleging patent infringement.
Our products and technology, including the technology that we license from others, may infringe the intellectual property rights of third parties. Patent applications in the United States and most other countries are confidential for a period of time until they are published, and the publication of discoveries in scientific or patent literature typically lags actual discoveries by several months or more. As a result, the nature of claims contained in unpublished patent filings around the world is unknown to us, and we cannot be certain that we were the first to conceive inventions covered by our patents or patent applications or that we were the first to file patent applications covering such inventions. Furthermore, it is not possible to know in which countries patent holders may choose to extend their filings under the Patent Cooperation Treaty or other mechanisms. In addition, we may be subject to intellectual property infringement claims from individuals, vendors and other companies, including those that are in the business of asserting patents, but are not commercializing products in the field of 3D printing. Any claims that our products or processes infringe the intellectual property rights of others, regardless of the merit or resolution of such claims, could cause us to incur significant costs in responding to, defending and resolving such claims, and may prohibit or otherwise impair our ability to commercialize new or existing products. Any infringement by us or our licensors of the intellectual property rights of third parties may have a material adverse effect on our business, financial condition and results of operations.
Third-party claims of intellectual property infringement successfully asserted against us may require us to redesign infringing technology or enter into costly settlement or license agreements on terms that are unfavorable to us, prevent us from manufacturing or licensing certain of our products, subject us to injunctions restricting our sale of products and use of infringing technology, cause severe disruptions to our operations or the markets in which we compete, impose costly damage awards or require indemnification of our sales agents and end-users. In addition, as a consequence of such claims, we may incur significant costs in acquiring the necessary third-party intellectual property rights for use in our products or developing non-infringing substitute technology. Any of the foregoing developments could seriously harm our business.
25
We may incur substantial costs enforcing or acquiring intellectual property rights and defending against third-party claims as a result of litigation or other proceedings.
In connection with the enforcement of our intellectual property rights, opposing third parties from obtaining patent rights or disputes related to the validity or alleged infringement of our or third-party intellectual property rights, including patent rights, we have been and may in the future be subject or party to claims, negotiations or complex, protracted litigation. Intellectual property disputes and litigation, regardless of merit, can be costly and disruptive to our business operations by diverting attention and energies of management and key technical personnel, and by increasing our costs of doing business. We may not prevail in any such dispute or litigation, and an adverse decision in any legal action involving intellectual property rights, including any such action commenced by us, could limit the scope of our intellectual property rights and the value of the related technology. We have previously been involved in patent litigation with the Massachusetts Institute of Technology, or MIT, and Z Corporation, or Z Corp, which we resolved through a settlement agreement with MIT and Z Corp and by entering into a subsequent license agreement with Z Corp. While we strive to avoid infringing the intellectual property rights of third parties, we cannot provide any assurances that we will be able to avoid any infringement claims.
Obtaining and maintaining our patent protection depends on compliance with various procedural, documentary, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.
Periodic maintenance fees on any issued patent are due to be paid to the U.S. Patent and Trademark Office, or USPTO, and foreign patent agencies in several stages over the lifetime of the patent. The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents. If we or our exclusive licensors fail to maintain the patents and patent applications covering our products and processes, our competitive position would be adversely affected.
We may be subject to claims that our employees have wrongfully used or disclosed alleged trade secrets of their former employers.
Certain of our past and present employees were previously employed at other additive manufacturing companies, including our competitors or potential competitors. Some of these employees executed proprietary rights, non-disclosure and non-competition agreements in connection with such previous employment. Although we try to ensure that our employees do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or these employees have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such employee's former employer. We are not aware of any threatened or pending claims related to these matters, but in the future litigation may be necessary to defend against such claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable personnel or intellectual property rights. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management. As we expand our operations into the United States and elsewhere, we may face similar claims with regard to our future employees in these countries.
26
Certain of our employees and patents are subject to German law.
Almost all of our employees work in Germany and are subject to German employment law. Ideas, developments, discoveries and inventions made by such employees and consultants are subject to the provisions of the German Act on Employees' Inventions ( Gesetz über Arbeitnehmererfindungen ), which regulates the ownership of, and compensation for, inventions made by employees. We face the risk that disputes can occur between us and our employees or ex-employees pertaining to alleged non-adherence to the provisions of this act that may be costly to defend and take up our management's time and efforts whether we prevail or fail in such dispute. In addition, under the German Act on Employees' Inventions, certain employees retained rights to patents they invented or co-invented prior to 2009. Although most of these employees have subsequently assigned their interest in these patents to us, there is a risk that the compensation we provided to them may be deemed to be insufficient and we may be required under German law to increase the compensation due to such employees for the use of the patents. In those cases where employees have not assigned their interests to us, we may need to pay compensation for the use of those patents. If we are required to pay additional compensation or face other disputes under the German Act on Employees' Inventions, our results of operations could be adversely affected.
If we fail to comply with our obligations under our intellectual property-related agreements, we could lose rights that are important to our business or be subject to restrictions on the conduct of our business.
We have license agreements with respect to certain intellectual property that is important to our business with both Z Corp and The ExOne Company, or ExOne, that impose restrictions on our use of certain intellectual property. We are party to other intellectual property-related agreements that also are important to our business. Disputes may arise between the counterparties to these agreements and us that could result in termination of these agreements or in costly litigation or arbitration that diverts management attention and resources. If we fail to comply with our obligations under our intellectual property-related agreements, or misconstrue the scope of the rights granted to us or restrictions imposed on us under these agreements, the counterparties may have the right to terminate these agreements or sue us for damages or equitable remedies, including injunctive relief. Termination of these agreements, the reduction or elimination of our rights under these agreements, or the imposition of restrictions under these agreements that we have not anticipated may result in our having to negotiate new or reinstated licenses with less favorable terms, or to cease commercialization of licensed technology and products. This could materially adversely affect our business.
Certain technologies and patents have been developed with partners and we may face restrictions on this jointly-developed intellectual property.
We have entered into cooperation agreements with a number of industrial and commercial partners, as well as university partners. We have, in some cases individually and in other cases along with our partners, filed for patent protection for a number of technologies developed under these agreements and may in the future file for further intellectual property protection and/or seek to commercialize such technologies. Under some of these agreements, certain intellectual property developed by us and the relevant partner may be subject to joint ownership by us and the partner and our commercial use of such intellectual property may be restricted, or may require written consent from, or a separate agreement with, the partner. In other cases, we may not have any rights to use intellectual property solely developed and owned by the partner. If we cannot obtain commercial use rights for such jointly-owned intellectual property or partner-owned intellectual property, our future product development and commercialization plans may be adversely affected.
27
Risks related to the ADSs and this offering
As a new investor, you will experience substantial dilution as a result of this offering.
The public offering price per ADS will be substantially higher than the net tangible book value per ADS prior to this offering. Consequently, if you purchase ADSs in this offering at an assumed initial public offering price of $14.00, the midpoint of the price range set forth on the cover page of this prospectus, you will incur immediate dilution of $9.47 per ADS. For further information regarding the dilution resulting from this offering, please see the section entitled "Dilution" in this prospectus. This dilution is due in large part to the fact that our earlier investors paid substantially less than the assumed initial public offering price when they purchased their ordinary shares. In addition, if the underwriters exercise the overallotment option, you will experience additional dilution.
There is no established trading market for the ADSs or our ordinary shares.
This offering constitutes our initial public offering of ADSs, and no public market for the ADSs or our ordinary shares currently exists. We have been authorized to list the ADSs on the New York Stock Exchange subject to completion of customary procedures in the United States. Any delay in the commencement of trading of the ADSs on the New York Stock Exchange would impair the liquidity of the market for the ADSs and make it more difficult for holders to sell the ADSs. We do not intend to list our ordinary shares on a trading market and therefore do not expect that a trading market will develop for our ordinary shares not represented by the ADSs.
Even if the ADSs are listed on the New York Stock Exchange, there can be no assurance that an active trading market for the ADSs will develop or be sustained after this offering is completed. The initial offering price has been determined by negotiations among the lead underwriters and us. Among the factors considered in determining the initial offering price were our future prospects and the prospects of our industry in general, our revenue, net income and certain other financial and operating information in recent periods, and the financial ratios, market prices of securities and certain financial and operating information of companies engaged in activities similar to ours. However, there can be no assurance that following this offering the ADSs will trade at a price equal to or greater than the offering price.
In addition, the stock market generally has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of listed companies. Broad market and industry factors may negatively affect the market price of our ADSs, regardless of our actual operating performance. The market price and liquidity of the market for our ADSs that will prevail in the market after this offering may be higher or lower than the price you pay and may be significantly affected by numerous factors, some of which are beyond our control. These factors include:
28
Our principal shareholders and management own a significant percentage of our ordinary shares and will be able to exert significant influence over matters subject to shareholder approval.
Prior to this offering, members of our supervisory and management boards and holders of 5% or more of our ordinary shares beneficially owned 100% of our ordinary shares and, upon consummation of this offering, that same group will hold approximately 58.3% of our outstanding ordinary shares (including ordinary shares represented by ADSs), assuming no exercise of the underwriters' over-allotment option. These shareholders will have significant influence over the outcome of all matters requiring shareholder approval. For example, these shareholders may be able to influence the outcome of elections of members of our supervisory board, amendments of our organizational documents, or approval of any merger, sale of assets, or other major corporate transactions. This may prevent or discourage unsolicited acquisition proposals or offers for our ordinary shares or ADSs that you may feel are in your best interest as one of our shareholders. The interests of this group of shareholders may not always coincide with your interests or the interests of other shareholders, and they may act in a manner that advances their best interests and not necessarily those of other shareholders, including seeking a premium value for their ordinary shares, which might affect the prevailing market price for our ADSs.
Substantial future sales of our ordinary shares or ADSs in the public market, or the perception that these sales could occur, could cause the price of the ADSs to decline.
Additional sales of our ordinary shares or ADSs in the public market after this offering, or the perception that these sales could occur, could cause the market price of the ADSs to decline. Upon completion of this offering, we will have 6.5 million ADSs outstanding representing 1.3 million ordinary shares. All ADSs sold in this offering will be freely transferable without restriction or additional registration under the Securities Act. The ordinary shares and ADSs held by the members of our management board and supervisory board and the selling shareholders will be available for sale upon the expiration of a lock-up period, which will expire 180 days after the date of this prospectus. Any or all of these ordinary shares or ADSs may be released prior to expiration of the lock-up period with the prior written consent of Piper Jaffray & Co. and Citigroup Global Markets Inc. To the extent
29
ordinary shares or ADSs are released before the expiration of the lock-up period and these ordinary shares or ADSs are sold into the market, the market price of the ADSs could decline.
You may not have the same voting rights as the holders of our ordinary shares and may not receive voting materials in time to be able to exercise your right to vote.
Except as described in this prospectus and the deposit agreement, holders of the ADSs will not be able to exercise voting rights attaching to the ordinary shares evidenced by the ADSs on an individual basis. Under the terms of the deposit agreement, holders of the ADSs will appoint the depositary or its nominee as their representative to exercise the voting rights attaching to the ordinary shares represented by the ADSs. You may not receive voting materials in time to instruct the depositary to vote, and it is possible that you, or persons who hold their ADSs through brokers, dealers or other third parties, will not have the opportunity to exercise a right to vote.
You may not receive distributions on our ordinary shares represented by the ADSs or any value for them if it is illegal or impractical to make them available to holders of ADSs.
Under the terms of the deposit agreement, the depositary for the ADSs has agreed to pay to you the cash dividends or other distributions it or the custodian receives on our ordinary shares or other deposited securities after deducting its fees and expenses. You will receive these distributions in proportion to the number of our ordinary shares your ADSs represent. However, in accordance with the limitations set forth in the deposit agreement, it may be unlawful or impractical to make a distribution available to holders of ADSs. We have no obligation to take any other action to permit the distribution of the ADSs, ordinary shares, rights or anything else to holders of the ADSs. This means that you may not receive the distributions we make on our ordinary shares or any value from them if it is unlawful or impractical to make them available to you. These restrictions may have a material adverse effect on the value of your ADSs.
We have no present intention to pay dividends on our ordinary shares in the foreseeable future and, consequently, your only opportunity to achieve a return on your investment during that time is if the price of our ADSs appreciates.
We have no present intention to pay dividends on our ordinary shares in the foreseeable future. Any recommendation by our management and supervisory boards to pay dividends will depend on many factors, including our financial condition, results of operations, legal requirements and other factors. Accordingly, if the price of our ADSs declines in the foreseeable future, you will incur a loss on your investment, without the likelihood that this loss will be offset in part or at all by potential future cash dividends.
As a foreign private issuer, we are exempt from a number of rules under the U.S. securities laws and are permitted to file less information with the SEC than U.S. companies. This may limit the information available to holders of ADSs.
We are a "foreign private issuer," as defined in the SEC rules and regulations, and, consequently, we are not subject to all of the disclosure requirements applicable to companies organized within the United States. For example, we are exempt from certain rules under the Exchange Act that regulate disclosure obligations and procedural requirements related to the solicitation of proxies, consents or authorizations applicable to a security registered under the Exchange Act. In addition, members of our management board and supervisory board and our principal shareholders are exempt from the reporting and "short-swing" profit recovery provisions of Section 16 of the Exchange Act and related rules with respect to their purchases and sales of our securities. Moreover, we are not required to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. public
30
companies. Accordingly, there may be less publicly available information concerning our company than there is for U.S. public companies.
As a foreign private issuer, we will file an annual report on Form 20-F within four months of the close of each year ended December 31 and furnish reports on Form 6-K relating to certain material events promptly after we publicly announce these events. However, although we intend to issue quarterly financial information, because of the above exemptions for foreign private issuers, we are not required to do so, and, therefore, our shareholders will not be afforded the same protections or information generally available to investors holding shares in public companies organized in the United States.
As a foreign private issuer, we are not subject to certain New York Stock Exchange corporate governance rules applicable to U.S. listed companies.
In connection with this offering, we will be relying on provisions in the New York Stock Exchange Listed Company Manual that permit us to follow our home country corporate governance practices with regard to certain aspects of corporate governance. This allows us to follow German corporate law and the German Corporate Governance Code, which differ in significant respects from the corporate governance requirements applicable to U.S. companies listed on the New York Stock Exchange.
In accordance with our New York Stock Exchange listing, our Audit Committee is required to comply with or satisfy an exemption from the provisions of Section 301 of the Sarbanes-Oxley Act and Rule 10A-3 of the Exchange Act, both of which are also applicable to listed U.S. companies. Because we are a foreign private issuer, however, we generally are permitted to follow home country practice in lieu of the corporate governance standards provided in the New York Stock Exchange Listed Company Manual. In particular, we are not required to comply with the requirements that the members of our Audit Committee satisfy financial literacy standards, that a majority of the members of our supervisory board must be independent, that our Audit Committee and Compensation and Nominating Committee adopt written charters and that we adopt and disclose corporate governance guidelines. If some investors find the ADSs less attractive as a result of these differences, there may be a less active trading market for the ADSs and the price of the ADSs may be more volatile. See "Management Differences between Our Corporate Governance Practices and Those Set Forth in the New York Stock Exchange Listed Company Manual."
We may lose our foreign private issuer status in the future, which could result in significant additional costs and expenses.
As a foreign private issuer, we are not required to comply with all the periodic disclosure and current reporting requirements of the Exchange Act and related rules and regulations. The determination of foreign private issuer status is made annually on the last business day of an issuer's most recently completed second fiscal quarter. Accordingly, we will next make a determination with respect to our foreign private issuer status on June 30, 2014. There is a risk that we will lose our foreign private issuer status in the future.
We would lose our foreign private issuer status if, for example, more than 50% of our assets are located in the United States and we continue to fail to meet additional requirements necessary to maintain our foreign private issuer status. As of June 30, 2013, an immaterial amount of our assets were located in the United States. The regulatory and compliance costs to us under U.S. securities laws as a U.S. domestic issuer may be significantly greater than the costs we incur as a foreign private issuer. If we are not a foreign private issuer, we will be required to file periodic reports and registration statements on U.S. domestic issuer forms with the SEC, which are more detailed and extensive in certain respects than the forms available to a foreign private issuer. We would be required under current SEC rules to prepare our financial statements in accordance with U.S. GAAP and modify
31
certain of our policies to comply with corporate governance practices associated with U.S. domestic issuers. Such conversion and modifications would involve additional costs. In addition, we may lose our ability to rely upon exemptions from certain corporate governance requirements on U.S. stock exchanges that are available to foreign private issuers such as the ones described above and exemptions from procedural requirements related to the solicitation of proxies.
We are an "emerging growth company" and we intend to take advantage of reduced disclosure and governance requirements applicable to emerging growth companies, which could result in our ADSs being less attractive to investors.
We are an "emerging growth company," as defined in the JOBS Act, and we intend to take advantage of certain exemptions from various reporting and governance requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act and reduced disclosure obligations regarding executive compensation in our periodic reports and other public filings. We cannot predict if investors will find the ADSs less attractive because we will rely on such exemptions. If some investors find the ADSs less attractive as a result, there may be a less active trading market for the ADSs and the price of the ADSs may be more volatile. We may take advantage of these reporting and governance exemptions until we are no longer an emerging growth company, which in certain circumstances could be as late as the last day of our fiscal year following the fifth anniversary of the date of the first sale of ADSs in this offering. See "Prospectus Summary Implications of Being an Emerging Growth Company."
In addition, Section 107 of the JOBS Act also provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We currently prepare our financial statements in accordance with IFRS as issued by the IASB, which do not have separate provisions for publicly traded and private companies. However, in the event we convert to U.S. GAAP while we are still an emerging growth company, we may be able to take advantage of the benefits of this extended transition period and, as a result, during such time that we delay the adoption of any new or revised accounting standards, our financial statements may not be comparable to other companies that comply with all public company accounting standards.
If we fail to maintain an effective system of internal control over financial reporting in the future, we may not be able to accurately report our financial condition, results of operations or cash flows, which may adversely affect investor confidence in us .
The Sarbanes-Oxley Act requires, among other things, that we maintain effective internal control over financial reporting and disclosure controls and procedures. In particular, in the future, we will be required, under Section 404 of the Sarbanes-Oxley Act, to perform system and process evaluations and testing of our internal controls over financial reporting to allow management and our independent registered public accounting firm to report on the effectiveness of our internal control over financial reporting. This assessment will need to include disclosure of any material weaknesses in our internal control over financial reporting identified by our management or our independent registered public accounting firm. A material weakness is a control deficiency, or combination of control deficiencies, in internal control over financial reporting that results in more than a reasonable possibility that a material misstatement of annual or interim financial statements will not be prevented or detected on a timely basis. Section 404 of the Sarbanes-Oxley Act also generally requires an attestation from our independent registered public accounting firm on the effectiveness of our internal control over financial reporting. However, for as long as we remain an emerging growth company as defined in the JOBS Act, we intend to take advantage of the exemption permitting us not to comply with the independent
32
registered public accounting firm attestation requirement. At the time when we are no longer an emerging growth company, our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level at which our controls are documented, designed or operating. Our remediation efforts may not enable us to avoid a material weakness in the future.
Our compliance with Section 404 will require that we incur substantial accounting expense and expend significant management efforts. We currently do not have an internal audit group, and we will need to hire additional accounting and financial staff with appropriate public company experience and technical accounting knowledge, and compile the system and process documentation necessary to perform the evaluation needed to comply with Section 404. We may not be able to complete our evaluation, testing and any required remediation in a timely fashion. During the evaluation and testing process, if we identify one or more material weaknesses in our internal control over financial reporting, we will be unable to assert that our internal control over financial reporting is effective. We cannot assure you that there will not be material weaknesses or significant deficiencies in our internal control over financial reporting in the future. Any failure to maintain internal control over financial reporting could severely inhibit our ability to accurately report our financial condition, results of operations or cash flows. If we are unable to conclude that our internal control over financial reporting is effective, or if our independent registered public accounting firm determines we have a material weakness or significant deficiency in our internal control over financial reporting, we could lose investor confidence in the accuracy and completeness of our financial reports, the market price of the ADSs could decline, and we could be subject to sanctions or investigations by the New York Stock Exchange, the SEC or other regulatory authorities. Failure to remedy any material weakness in our internal control over financial reporting, or to implement or maintain other effective control systems required of public companies, could also restrict our future access to the capital markets.
We will incur significant increased costs as a result of operating as a company whose ADSs are publicly traded in the United States, and our management will be required to devote substantial time to new compliance initiatives.
As a company whose ADSs will be publicly traded in the United States, we will incur significant legal, accounting, insurance and other expenses that we did not previously incur. In addition, the Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act and related rules implemented by the SEC and the New York Stock Exchange have imposed various requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial controls. These costs will increase at the time when we are no longer an emerging growth company eligible to rely on exemptions under the JOBS Act from certain disclosure and governance requirements. Our management and other personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations will increase our legal and financial compliance costs and will make some activities more time-consuming and costly. We estimate that our annual compliance expenses following the completion of this offering will be approximately €1 million in each of the next two fiscal years. For example, we expect these rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required to incur substantial costs to maintain the same or similar coverage. These laws and regulations could also make it more difficult and expensive for us to attract and retain qualified persons to serve on our supervisory board or its committees or on our management board. Furthermore, if we are unable to satisfy our obligations as a public company, we could be subject to delisting of the ADSs, fines, sanctions and other regulatory action and potentially civil litigation.
33
U.S. investors may have difficulty enforcing civil liabilities against our Company or members of our management and supervisory boards and the experts named in this prospectus.
The members of our management and supervisory boards and certain of the experts named in this prospectus are non-residents of the United States, and all or a substantial portion of the assets of such persons are located outside the United States. As a result, it may not be possible, or may be very difficult, to serve process on such persons or us in the United States or to enforce judgments obtained in U.S. courts against them or us based on civil liability provisions of the securities laws of the United States. In addition, awards of punitive damages in actions brought in the United States or elsewhere may be unenforceable in Germany. An award for monetary damages under the U.S. securities laws would be considered punitive if it does not seek to compensate the claimant for loss or damage suffered and is intended to punish the defendant. The enforceability of any judgment in Germany will depend on the particular facts of the case as well as the laws and treaties in effect at the time. Litigation in Germany is also subject to rules of procedure that differ from the U.S. rules, including with respect to the taking and admissibility of evidence, the conduct of the proceedings and the allocation of costs. Proceedings in Germany would have to be conducted in the German language, and all documents submitted to the court would, in principle, have to be translated into German. For these reasons, it may be difficult for a U.S. investor to bring an original action in a German court predicated upon the civil liability provisions of the U.S. federal securities laws against us, the members of our management and supervisory boards and certain of the experts named in this prospectus. The United States and Germany do not currently have a treaty providing for recognition and enforcement of judgments (other than arbitration awards) in civil and commercial matters, though recognition and enforcement of foreign judgments in Germany is possible in accordance with applicable German laws.
You may be subject to limitations on the transfer of your ADSs.
Your ADSs are transferable on the books of the depositary. However, the depositary may close its books at any time or from time to time when it deems doing so expedient in connection with the performance of its duties. The depositary may close its books from time to time for a number of reasons, including in connection with corporate events such as a rights offering, during which time the depositary needs to maintain an exact number of ADS holders on its books for a specified period. The depositary may also close its books in emergencies, and on weekends and public holidays. The depositary may refuse to deliver, transfer or register transfers of our ADSs generally when our share register or the books of the depositary are closed, or at any time if we or the depositary thinks that it is advisable to do so because of any requirement of law or of any government or governmental body, or under any provision of the deposit agreement, or for any other reason in accordance with the terms of the deposit agreement. As a result, you may be unable to transfer your ADSs when you wish to.
If securities or industry analysts do not publish research or reports about our business, or if they adversely change their recommendations regarding our ADSs, the market price for our ADSs and trading volume could decline.
The trading market for our ADSs will be influenced by research or reports that industry or securities analysts publish about our business. If one or more analysts who cover us downgrade our ADSs, the market price for our ADSs would likely decline. If one or more of these analysts cease to cover us or fail to regularly publish reports on us, we could lose visibility in the financial markets, which, in turn, could cause the market price or trading volume for our ADSs to decline.
Your rights as a shareholder in a German corporation may differ from your rights as a shareholder in a U.S. corporation.
We are organized as a stock corporation ( Aktiengesellschaft ) under the laws of Germany, and by participating in this offering you will become a holder of ADSs with underlying shares in a German
34
stock corporation. You should be aware that the rights of shareholders under German law differ in important respects from those of shareholders in a U.S. corporation. These differences include, in particular:
For more information, we have provided summaries of relevant German corporation law and of our articles of association under "Management" and "Description of Share Capital."
Exchange rate fluctuations may reduce the amount of U.S. dollars you receive in respect of any dividends or other distributions we may pay in the future in connection with your ADSs.
Under German law, the determination of whether we have been sufficiently profitable to pay dividends is made on the basis of our unconsolidated annual financial statements prepared under the German Commercial Code ( Handelsgesetzbuch ) in accordance with accounting principles generally accepted in Germany. Exchange rate fluctuations may affect the amount in U.S. dollars that our shareholders receive upon the payment of cash dividends or other distributions we declare and pay in euro, if any. Such fluctuations could adversely affect the value of our ADSs and, in turn, the U.S. dollar proceeds that holders receive from the sale of our ADSs.
We have broad discretion to determine how to use the funds raised in this offering and may use them in ways that may not enhance our operating results or the price of the ADSs.
Our management will have broad discretion over the use of proceeds from this offering, and we could spend the proceeds from this offering in ways the holders of our ADSs may not agree with or that do not yield a favorable return, if any. We intend to use the net proceeds of this offering for the following purposes: (i) expansion of our on-demand parts service center in Europe and establishment of new on-demand parts service centers in North America and Asia; (ii) research and development and sales and marketing initiatives; and (iii) general corporate purposes, including, without limitation, potential acquisitions. However, our use of these proceeds may differ substantially from our current plans. You will not have the opportunity, as part of your investment decision, to assess whether proceeds are
35
being used appropriately. You must rely on the judgment of our management regarding the application of the net proceeds of this offering. If we do not invest or apply the proceeds of this offering in ways that improve our operating results, we may fail to achieve expected financial results, which could cause the price of our ADSs to decline.
In order to satisfy our obligations as a public company, we may need to hire qualified accounting and financial personnel with appropriate public company experience.
As a newly public company, we will need to establish and maintain effective disclosure and financial controls and make changes in our corporate governance practices. We may need to hire additional accounting and financial personnel with appropriate public company experience and technical accounting knowledge, and it may be difficult to recruit and retain such personnel. Even if we are able to hire appropriate personnel, our existing operating expenses and operations will be impacted by the direct costs of their employment and the indirect consequences related to the diversion of management resources from research and development efforts.
In the event we are or become treated as a passive foreign investment company, or PFIC, for U.S. federal income tax purposes, U.S. holders of our ADSs could be subject to adverse U.S. federal income tax consequences.
In the event we were treated as a PFIC, U.S. holders (as defined in "Taxation U.S. Taxation of ADSs") of our ADSs could be subject to adverse U.S. federal income tax consequences. These consequences include the following: (i) if our ADSs are "marketable stock" for purposes of the PFIC rules and a U.S. holder makes a mark-to-market election with respect to its ADSs, the U.S. holder will be required to include annually in its U.S. federal taxable income an amount reflecting any year-end increase in the value of its ADSs, (ii) if a U.S. holder does not make a mark-to-market election, it may incur significant additional U.S. federal income taxes on income resulting from distributions on, or any gain from the disposition of, our ADSs, as such income generally would be allocated over the U.S. holder's holding period for its ADSs and subject to tax at the highest rates of U.S. federal income taxation in effect for such years, with an interest charge then imposed on the resulting taxes in respect of such income, and (iii) dividends paid by us would not be eligible for reduced individual rates of U.S. federal income tax. In addition, U.S. holders that own an interest in a PFIC are required to file additional U.S. federal tax information returns.
A U.S. holder may in certain circumstances mitigate adverse tax consequences of the PFIC rules by filing an election to treat the PFIC as a qualified electing fund, or a QEF. However, in the event that we are or become a PFIC, we do not intend to comply with the reporting requirements necessary to permit U.S. holders to elect to treat us as a QEF. See "Taxation U.S. Taxation of ADSs Additional United States Federal Income Tax Consequences PFIC Rules."
36
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus contains forward-looking statements concerning our business, operations and financial performance and condition as well as our plans, objectives and expectations for our business operations and financial performance and condition. Any statements that are not of historical facts may be deemed to be forward-looking statements. You can identify these forward-looking statements by words such as "believes," "estimates," "anticipates," "expects," "plans," "intends," "may," "could," "might," "will," "should," "aims," or other similar expressions that convey uncertainty of future events or outcomes. Forward-looking statements appear in a number of places throughout this prospectus and include statements regarding our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations concerning, among other things, our intellectual property position, results of operations, cash needs, spending of the proceeds from this offering, financial condition, liquidity, prospects, growth and strategies, the industry in which we operate and the trends that may affect the industry or us.
By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics and industry change, and depend on economic circumstances that may or may not occur in the future or may occur on longer or shorter timelines than anticipated. Although we believe that we have a reasonable basis for each forward-looking statement contained in this prospectus, we caution you that forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. All of our forward-looking statements are subject to risks and uncertainties that may cause our actual results to differ materially from our expectations.
Actual results could differ materially from our forward-looking statements due to a number of factors, including, without limitation, risks related to:
37
Any forward-looking statements that we make in this prospectus speak only as of the date of such statement, and we undertake no obligation to update such statements to reflect events or circumstances after the date of this prospectus or to reflect the occurrence of unanticipated events. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless expressed as such, and should only be viewed as historical data. You should, however, review the factors and risks we describe in the reports we will file from time to time with the SEC after the date of this prospectus. See "Where You Can Find More Information."
You should also read carefully the factors described in the "Risk Factors" section of this prospectus and elsewhere to better understand the risks and uncertainties inherent in our business and underlying any forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this prospectus will prove to be accurate. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified timeframe, or at all.
This prospectus also contains estimates and other statistical data made by independent parties and by us relating to market size and growth and other data about our industry. We obtained the industry and market data in this prospectus from our own research as well as from industry and general publications, surveys and studies conducted by third parties, some of which may not be publicly available. This data involves a number of assumptions and limitations and contains projections and estimates of the future performance of the industries in which we operate that are subject to a high degree of uncertainty. We caution you not to give undue weight to such projections, assumptions and estimates. While we believe that these publications, studies and surveys are reliable, we have not independently verified the data contained in them.
38
Fluctuations in the exchange rate between the euro and the U.S. dollar will affect the U.S. dollar amounts received by owners of our ADSs on conversion of dividends, if any, paid in euro on the ordinary shares and will affect the U.S. dollar price of our ADSs on the New York Stock Exchange. The table below shows the period end, average, high and low exchange rates of U.S. dollars per euro for the periods shown. Average rates are computed by using the noon buying rate of the Federal Reserve Bank of New York for the euro on the last business day of each month during the relevant year indicated or each business day during the relevant month indicated. The rates set forth below are provided solely for your convenience and may differ from the actual rates used in the preparation of the financial statements of Voxeljet Technology GmbH, our legal predecessor, included in this prospectus and other financial data appearing in this prospectus.
Year Ended December 31,
|
High | Low | Average | Year end | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2010 |
1.4536 | 1.1959 | 1.3261 | 1.3269 | |||||||||
2011 |
1.4875 | 1.2926 | 1.3931 | 1.2973 | |||||||||
2012 |
1.3463 | 1.2062 | 1.2859 | 1.3186 |
Month Ended
|
High | Low | Average | Month end | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
January 2013 |
1.3584 | 1.3047 | 1.3304 | 1.3584 | |||||||||
February 2013 |
1.3692 | 1.3054 | 1.3347 | 1.3079 | |||||||||
March 2013 |
1.3098 | 1.2782 | 1.2953 | 1.2816 | |||||||||
April 2013 |
1.3168 | 1.2836 | 1.3025 | 1.3168 | |||||||||
May 2013 |
1.3192 | 1.2818 | 1.2983 | 1.2988 | |||||||||
June 2013 |
1.3407 | 1.3006 | 1.3197 | 1.3010 | |||||||||
July 2013 |
1.3282 | 1.2774 | 1.3088 | 1.3282 | |||||||||
August 2013 |
1.3426 | 1.3196 | 1.3314 | 1.3196 | |||||||||
September 2013 (through September 27, 2013) |
1.3537 | 1.3120 | 1.3355 | 1.3537 |
The noon buying rate of the Federal Reserve Bank of New York for the euro on September 27, 2013 was €1.00 = $1.3537.
39
We estimate that the net proceeds to us from this offering, after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us, will be approximately $69.7 million, assuming an initial public offering price of $14.00 per ADS, the midpoint of the price range set forth on the cover page of this prospectus.
A $1.00 increase (decrease) in the assumed initial public offering price of $14.00 per ADS would increase (decrease) the net proceeds from this offering to us by approximately $5.2 million, assuming no change to the number of ADSs offered as set forth on the cover page of this prospectus. An increase (decrease) of 1.0 million in the number of ADSs offered by us would increase (decrease) the net proceeds to us by approximately $13.0 million.
The selling shareholders will receive approximately $11.6 million in net proceeds from their sale of 900,000 ADSs in this offering, after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by the selling shareholders, which will be approximately $140,000, assuming an initial public offering price of $14.00 per share, the midpoint of the price range set forth on the cover page of this prospectus. If the underwriters' over-allotment option is exercised in full, we estimate the selling shareholders will receive net proceeds of approximately $24.3 million. We will not receive any proceeds from the sale of ADSs by the selling shareholders. See "Principal and Selling Shareholders" and "Underwriting."
We intend to use the net proceeds of this offering for the following purposes:
The foregoing represents our current intentions with respect to the use and allocation of the net proceeds of this offering based upon our present plans and business conditions, but our management will have significant flexibility and discretion in applying the net proceeds. The occurrence of unforeseen events or changed market and business conditions could result in the application of the net proceeds of this offering in a manner other than as described above. Pending our use of the net proceeds as described above, we may invest the net proceeds in short-term bank deposits or invest them in interest-bearing, investment-grade securities.
40
Neither we nor our legal predecessor, Voxeljet Technology GmbH, have ever declared or paid any cash dividends on our ordinary shares, and we have no present intention of declaring or paying any dividends in the foreseeable future. Any recommendation by our management and supervisory boards to pay dividends, subject to compliance with applicable law and any contractual provisions that restrict or limit our ability to pay dividends, including under agreements for indebtedness that we may incur, will depend on many factors, including our financial condition, results of operations, legal requirements, capital requirements, business prospects and other factors that our management and supervisory boards deem relevant.
All of the shares represented by the ADSs offered by this prospectus will have the same dividend rights as all of our other outstanding shares. Any distribution of dividends proposed by our management and supervisory boards requires the approval of our shareholders at a shareholders' meeting. See "Description of Share Capital," which explains in more detail the procedures we must follow and the German law provisions that determine whether we are entitled to declare a dividend.
For information regarding the German withholding tax applicable to dividends and related United States refund procedures, see "Taxation German Taxation of ADSs."
41
The following table sets forth our capitalization as of June 30, 2013:
|
As of June 30, 2013 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Actual | Pro Forma | |||||||||||
|
$
(1)
|
€
|
$
(1)
|
€
|
|||||||||
|
(in thousands)
|
||||||||||||
Bank overdrafts and lines of credit |
$ | 1,219 | € | 937 | $ | 1,219 | € | 937 | |||||
Long-term debt |
2,196 | 1,688 | 2,196 | 1,688 | |||||||||
Finance lease obligations |
5,654 | 4,346 | 5,654 | 4,346 | |||||||||
Shareholders' equity: |
|||||||||||||
Subscribed capital |
1,301 | 1,000 | 4,059 | 3,120 | |||||||||
Capital reserves |
1,642 | 1,262 | 68,595 | 52,725 | |||||||||
Accumulated deficit |
(1,847 | ) | (1,420 | ) | (1,847 | ) | (1,420 | ) | |||||
Total shareholders' equity |
1,095 | 842 | 70,807 | 54,425 | |||||||||
Total capitalization |
$ | 10,165 | € | 7,813 | $ | 79,877 | € | 61,396 | |||||
42
If you invest in our ADSs in this offering, your interest will be diluted immediately to the extent of the difference between the initial public offering price per ADS and the pro forma net tangible book value per ADS after this offering. Dilution results from the fact that the initial public offering price per ADS is substantially in excess of the net tangible book value per ADS attributable to our existing shareholders for our ordinary shares that will be outstanding immediately prior to the closing of this offering. We calculate net tangible book value per ordinary share by dividing the net tangible book value (total assets less intangible assets and total liabilities) by the number of outstanding ordinary shares. For purposes of illustration, the following discussion assumes that all of our outstanding shares both before and after this offering are in the form of ADSs, each representing one-fifth of an ordinary share. Dilution is determined by subtracting net tangible book value per ADS from the assumed initial public offering price per ADS.
The net tangible book value of Voxeljet Technology GmbH, our legal predecessor, as of June 30, 2013 was approximately $1.0 million, or $0.10 per ADS. After giving effect to the sale by us of our ADSs in this offering at an assumed initial public offering price of $14.00 per ADS, the midpoint of the price range set forth on the cover page of this prospectus, and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us, our pro forma net tangible book value as of June 30, 2013 would have been approximately $70.7 million, or $4.53 per ADS. This amount represents an immediate increase in our pro forma net tangible book value of $4.43 per ADS to our existing shareholders and an immediate dilution of $9.47 per ADS to new investors purchasing our ADSs in this offering at the initial public offering price.
The following table illustrates this dilution per ADS:
|
|
Per ADS
(in $) |
|||||
---|---|---|---|---|---|---|---|
Assumed initial public offering price |
$ | 14.00 | |||||
Net tangible book value before the change attributable to investors purchasing ADSs in this offering |
$ | 0.10 | |||||
Increase in net tangible book value attributable to investors purchasing ADSs in this offering |
4.43 | ||||||
Pro forma net tangible book value after giving effect to this offering |
4.53 | ||||||
Dilution to new investors |
$ | 9.47 | |||||
A $1.00 increase (decrease) in the assumed initial public offering price of $14.00 per ADS, the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) our pro forma net tangible book value after this offering by $0.34 per ADS, and the dilution in pro forma net tangible book value to new investors by $0.66 per ADS, assuming that the number of ADSs offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. Each increase (decrease) of 1.0 million ADSs in the number of ADSs offered by us would increase (decrease) our pro forma net tangible book value after this offering by $0.52 per ADS and decrease (increase) the dilution to investors participating in this offering by approximately $0.52 per ADS, assuming that the assumed initial public offering price remains the same and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.
The following table summarizes on a pro forma basis, as of June 30, 2013, the differences between the shareholders as of June 30, 2013 and the new investors with respect to the number of ordinary shares
43
purchased from us and the selling shareholders, the total consideration paid and the average price per ordinary share paid by existing shareholders and by investors participating in this offering at an assumed initial public offering price of $14.00 per ADS, the midpoint of the price range set forth on the cover page of the prospectus, before deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us:
|
Ordinary Shares
Purchased |
Total
Consideration |
|
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Average Price per
Ordinary Share |
Average
Price per ADS |
|||||||||||||||||
|
Number | Percent | Amount | Percent | |||||||||||||||
|
|
|
(in $)
|
|
(in $)
|
(in $)
|
|||||||||||||
Existing shareholders |
1,820,000 | 58.3 | % | 2,421,294 | 2.6 | % | $ | 1.33 | $ | 0.27 | |||||||||
New investors |
1,300,000 | 41.7 | 91,000,000 | 97.4 | % | $ | 70.00 | $ | 14.00 | ||||||||||
Total |
3,120,000 | 100.0 | % | 93,421,294 | 100.0 | % | $ | 29.94 | $ | 5.99 | |||||||||
A $1.00 increase (decrease) in the assumed initial public offering price of $14.00 per ADS, the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) total consideration paid by new investors by $6.5 million, assuming that the number of shares offered, as set forth on the cover page of this prospectus, remains the same, and before deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.
If the underwriters exercise their option to purchase additional ADSs in full, our existing shareholders would own 8,125,000 ADSs or, 52.1%, in the aggregate, and our new investors would own 7,475,000 ADSs or, 47.9%, in the aggregate, of the total number of ADSs outstanding after this offering.
To the extent that we grant options or other equity awards to our employees or members of our management or supervisory boards in the future, and those options or other equity awards are exercised or become vested or other issuances of our ordinary shares are made, there will be further dilution to new investors.
44
SELECTED FINANCIAL AND OPERATING DATA
We present below the summary historical financial and operating data of Voxeljet Technology GmbH, our legal predecessor. The financial data as of December 31, 2012, 2011 and 2010 and for the years ended December 31, 2012, 2011 and 2010 have been derived from Voxeljet Technology GmbH's audited financial statements and the related notes, which are included elsewhere in this prospectus and which have been prepared in accordance with IFRS as issued by the IASB and audited in accordance with the standards of the Public Company Accounting Oversight Board (United States). The financial data as of June 30, 2013 and 2012 and for the six months ended June 30, 2013 and 2012 have been derived from Voxeljet Technology GmbH's unaudited interim financial statements and the related notes, which are included elsewhere in this prospectus.
Our historical results are not necessarily indicative of the financial results to be expected in any future periods. You should read this information in conjunction with "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Capitalization," and Voxeljet Technology GmbH's financial statements and related notes, each included elsewhere in this prospectus.
Statement of Comprehensive
Income (Loss) Data: |
Six Months Ended June 30, | Year Ended December 31, | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2013 | 2013 | 2012 | 2012 | 2012 | 2011 | 2010 | |||||||||||||||
|
($ in thousands,
except share and per share data) (1) |
(€ in thousands,
except share and per share data) |
($ in thousands,
except share and per share data) (1) |
(€ in thousands, except share
and per share data) |
||||||||||||||||||
Revenues |
$ | 5,826 | € | 4,478 | € | 4,644 | $ | 11,333 | € | 8,711 | € | 7,257 | € | 4,764 | ||||||||
Cost of sales |
3,857 | 2,965 | 2,479 | 6,449 | 4,957 | 4,337 | 2,660 | |||||||||||||||
Gross profit |
1,968 | 1,513 | 2,165 | 4,884 | 3,754 | 2,920 | 2,104 | |||||||||||||||
Selling expenses |
1,079 | 829 | 842 | 1,965 | 1,510 | 1,160 | 1,028 | |||||||||||||||
Administrative expenses |
619 | 476 | 355 | 986 | 758 | 670 | 606 | |||||||||||||||
Research and development expenses |
1,198 | 921 | 627 | 2,046 | 1,573 | 1,313 | 1,073 | |||||||||||||||
Other operating expenses |
221 | 170 | 46 | 81 | 62 | 140 | 81 | |||||||||||||||
Other operating (income) |
(690 | ) | (530 | ) | (372 | ) | (1,069 | ) | (822 | ) | (831 | ) | (762 | ) | ||||||||
Operating profit (loss) |
(459 | ) | (353 | ) | 667 | 876 | 673 | 468 | 78 | |||||||||||||
Finance expense |
248 | 191 | 181 | 472 | 363 | 389 | 359 | |||||||||||||||
Finance (income) |
(17 | ) | (13 | ) | (3 | ) | (23 | ) | (18 | ) | (5 | ) | (8 | ) | ||||||||
Financial result |
232 | 178 | 178 | 449 | 345 | 384 | 351 | |||||||||||||||
Profit (loss) before income taxes |
(691 | ) | (531 | ) | 489 | 427 | 328 | 84 | (273 | ) | ||||||||||||
Income tax expenses (benefit) |
(202 | ) | (155 | ) | 170 | 151 | 116 | 41 | (65 | ) | ||||||||||||
Profit (loss) |
$ | (489 | ) | € | (376 | ) | € | 319 | $ | 276 | € | 212 | € | 43 | € | (208 | ) | |||||
Other comprehensive (income) |
$ | | € | | € | (1 | ) | $ | (1 | ) | € | (1 | ) | € | (4 | ) | € | (7 | ) | |||
Total comprehensive income (loss) |
$ | (489 | ) | € | (376 | ) | € | 320 | $ | 277 | € | 213 | € | 47 | € | (201 | ) | |||||
Earnings (loss) per share (2) |
$ | (0.24 | ) | € | (0.19 | ) | € | 0.16 | $ | 0.14 | € | 0.11 | € | 0.02 | € | (0.10 | ) | |||||
Earnings (loss) per ADS (2) |
$ | (0.05 | ) | € | (0.04 | ) | € | 0.03 | $ | 0.03 | € | 0.02 | € | 0.00 | € | (0.02 | ) | |||||
Weighted average number of ordinary shares outstanding, adjusted to reflect changes in capital (2) |
2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 |
45
Statement of Financial
Position Data: |
As of June 30, | As of December 31, | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2013 | 2013 | 2012 | 2012 | 2011 | 2010 | |||||||||||||
|
($ in thousands)
(1)
|
(€ in thousands)
|
($ in thousands)
(1)
|
(€ in thousands)
|
|||||||||||||||
Cash and cash equivalents |
$ | 441 | € | 339 | $ | 392 | € | 301 | € | 498 | € | 654 | |||||||
Inventories |
4,062 | 3,122 | 3,651 | 2,806 | 2,011 | 864 | |||||||||||||
Total assets |
17,073 | 13,123 | 13,970 | 10,738 | 9,768 | 8,864 | |||||||||||||
Total liabilities |
15,978 | 12,281 | 12,386 | 9,520 | 8,763 | 7,906 | |||||||||||||
Shareholders' equity |
1,095 | 842 | 1,585 | 1,218 | 1,005 | 958 |
Other Data:
|
Six Months Ended June 30, | Year Ended December 31, | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2013 | 2013 | 2012 | 2012 | 2012 | 2011 | 2010 | |||||||||||||||
|
($ in thousands,
except 3D printers sold) (1) |
(€ in thousands,
except 3D printers sold) |
($ in thousands,
except 3D printers sold) (1) |
(€ in thousands, except
3D printers sold) |
||||||||||||||||||
EBITDA (3) |
$ | 515 | € | 396 | € | 1,306 | $ | 2,623 | € | 2,016 | € | 1,714 | € | 1,188 | ||||||||
3D printers sold (4) |
3 | 3 | 3 | 6 | 6 | 3 | 1 |
The following table reconciles profit (loss) to EBITDA for the periods presented:
46
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
You should read the following discussion and analysis of our financial condition and results of operations in conjunction with the section entitled "Selected Financial and Operating Data" and Voxeljet Technology GmbH's financial statements and the related notes thereto included elsewhere in this prospectus. In addition to historical financial information, the following discussion contains forward-looking statements that reflect our plans, estimates and opinions. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to these differences or cause our actual results or the timing of selected events to differ materially from those anticipated in these forward-looking statements include those set forth under "Risk Factors," "Special Note Regarding Forward-Looking Statements" and elsewhere in this prospectus.
Overview
We are a leading provider of high-speed, large-format 3D printers and on-demand parts services to industrial and commercial customers. Our 3D printers employ a powder binding, additive manufacturing technology to produce parts using various material sets, which consist of particulate materials and proprietary chemical binding agents. We offer our customers the highest volumetric output rate in the industry due to the combination of our large build boxes and print speeds. We provide our 3D printers and on-demand parts services to industrial and commercial customers serving the automotive, aerospace, film and entertainment, art and architecture, engineering and consumer product end markets.
We currently offer five different 3D printer platforms, and plan to offer a sixth prior to the end of 2013, with build boxes that range from 300 × 200 × 150 millimeters to 4,000 × 2,000 × 1,000 millimeters, with various print speeds, which produce volumetric output rates ranging from 0.7 liters per hour to 123.0 liters per hour. All of our platforms support our commercialized material sets, sand and plastics, along with their respective proprietary chemical binding agents. We develop our material sets according to the needs of our industrial and commercial customers, and we are currently in varying stages of developing new material sets, including shell molding and chromite sands, PMMA-based plastics, ceramics, silicon carbide, tungsten carbide, wood powder and cement.
We believe that our innovations in 3D printers will continue to increase customer adoption of our additive manufacturing technology in industrial and commercial applications.
Our business is divided into two segments: Systems and Services.
In our Systems segment, we focus on the development, production and sale of 3D printers. In addition, we sell refurbished 3D printers which were produced for and used in our Services segment. We also provide consumables, including particulate materials and proprietary chemical binding agents, maintenance contracts and spare parts to our customers.
Historically, to our project and development partners, we have sold and leased test machines, which are smaller printers with limited functionality designed to provide full flexibility to change parameters for the purpose of testing materials and processes. In 2012, we introduced the VX200, a fully functional 3D printer with similar flexibility for process optimization and materials development. As a result, we do not plan on selling test machines in the future.
In our Services segment, we print on-demand custom parts for our customers. At our service center, which we believe is one of the largest additive manufacturing service centers in Europe, we create
47
parts, molds, cores and models based on designs produced using 3D computer-aided design, or CAD, software.
Our legal predecessor was founded in 1999 as Generis GmbH in Augsburg, Germany. We sold our first 3D printer in 2002 and commenced our on-demand parts services business in 2003. As of June 30, 2013, we had an installed base of 52 printers worldwide, which includes test machines and 3D printers installed at our customers' premises and in our service center in Europe. We currently operate one service center with approximately 16,000 square feet of production space.
Our revenues have grown to €8.7 million in 2012 from €4.8 million in 2010, representing a 35% compound annual growth rate.
Our total backlog of 3D printer orders at June 30, 2013 was €4.4 million. Our backlog has grown steadily as we continue to experience growing demand for our 3D printers. For the years ended December 31, 2012, 2011 and 2010, our backlog was €3.7 million, €1.7 million and €0.1 million, respectively. Our backlog, which consisted of six 3D printers as of June 30, 2013, represents 3D printers for which a customer has signed a purchase order, but which we have not shipped yet. We estimate that the vast majority of systems in our backlog will ship prior to December 31, 2013, with the remainder expected to ship prior to June 30, 2014.
Seasonality
Historically, our results of operations have been subject to seasonal factors. Purchases of our 3D printers often follow a seasonal pattern owing to the capital budgeting cycles of our customers. Generally, 3D printer sales are higher in our second and fourth fiscal quarters than in our first and third fiscal quarters. Sales in our Services segment generally are not affected by seasonality. See "Risk Factors Risks Related to Our Business and Industry Our revenues and operating results may fluctuate."
Growth Strategy
Our business strategy focuses on (i) growing our Services segment in order to print more parts for our existing customers and gain new customers, and (ii) using our knowledge and market position to increase sales of our 3D printers. Our growth strategy is also dependent in part on continuing our investment in research and development activities, which should enable us to meet the needs of our target customers through the development of new material sets and 3D printers with bigger build boxes and faster print speeds.
We intend to develop our customer base internationally, so that our revenues are not dependent on sales to any one region. We also seek to grow both our Systems and Services segments so that we are not overly reliant on either segment. We believe that this strategy will help to offset some of the variability in the Systems segment, which can be more susceptible to macroeconomic trends.
Outlook
We believe that interest in additive manufacturing is increasing as a result of increased commercialization of 3D printers and recent media attention worldwide. We occupy a defined space in the additive manufacturing market because of the size of our machines and their ability to print industrial products from qualified industrial materials. While our 3D printers may differ from those of many other additive manufacturing companies, we expect an increase in additive manufacturing to generally have a positive effect on the public's awareness of our industry.
48
Furthermore, we believe that additive manufacturing provides several advantages over traditional design and manufacturing processes, including:
There are a number of available additive manufacturing technologies, including powder binding, inkjet, fused deposition modeling, stereolithography and selective laser sintering. These technologies differ on the basis of accuracy, surface quality, variety and properties of consumables, capacity, speed, color variety, transparency and the ability to print multiple materials, among other factors. Our 3D printers employ a powder binding technology to produce parts using various material sets. Powder binding is a process in which layers of powder are bonded by a liquid agent that is deposited through a printhead. We believe this process has the fastest build speeds and the lowest materials cost relative to other additive manufacturing technologies.
We believe that our planned investments in additional capacity in Europe and new service centers in North America and Asia should position us to generate higher growth in our Services segment in the future.
The worldwide market for additive manufacturing products and services has grown from $1.3 billion in 2010 to $2.2 billion in 2012, representing a 29% compound annual growth rate, according to the Wohlers Report 2013. The Wohlers Report 2013 projects the worldwide additive manufacturing products and services market to reach approximately $6.0 billion by 2017 and $10.8 billion by 2021, representing 2012-2017 and 2012-2021 compound annual growth rates of 22% and 19%, respectively. Much of the recent growth has been driven by the demand for production parts.
We believe that our addressable market is larger than the worldwide market for additive manufacturing products detailed in the Wohlers Report 2013. For example, the global market for machine tools totaled $93.2 billion in 2012, according to the 2013 World Machine Tool Output & Consumption Survey. In addition, according to the American Foundry Society, 90% of all manufactured goods contain some metal castings, with the global metal casting industry producing 98.6 million metric tons of metal castings in 2011 and the United States shipping $32.4 billion in metal castings in 2012. We believe these markets represent significant short and long-term revenue opportunities due to the advantages offered by our technology and the early adoption of additive manufacturing technologies in these markets.
Key Measures of Our Business
We use several financial and operating metrics to measure our business. We use these metrics to assess the progress of our business, make decisions on where to allocate capital, time and technology
49
investments, and assess the longer-term performance of our marketplace. The key metrics are as follows:
Revenues
Our revenues are generated primarily by sales of our 3D printers, consumables and custom 3D printed parts produced at our service center. We operate in two segments: Systems and Services. The Systems segment derives its revenues from the sale of 3D printers and products and services related to our 3D printers, including consumables, which include particulate materials and proprietary chemical binding agents, maintenance contracts and spare parts. Systems revenue also includes revenue associated with the leasing of 3D printers to customers; however, revenue related to the leasing of 3D printers is not material. The Services segment derives its revenues from the on-demand printing of parts at our service center.
Our revenues are influenced by:
Sales of our 3D printers, particularly our higher-priced systems, typically involve long sales cycles, are subject to seasonality and can be difficult to forecast. Because each of our printers can represent a significant amount of revenue, a delay in a purchasing decision, our production schedule or the shipment of a printer can have a material impact on our periodic reporting of revenues.
In addition, the lack of available production capacity at our service center can influence the revenue we generate in our Services segment in a given period.
In the course of our routine activities, we sell to customers 3D printers that we have operated in our service center. Before these 3D printers are sold, they are generally fully refurbished, a process which includes the installation of a new printhead. On average, these refurbished printers have been operating within the service center for 1.5 to 2.5 years prior to their sale. The proceeds from the sale of such refurbished 3D printers are recognized as Systems revenue.
Gross Profit
Our gross profit (measured as the difference between our revenues and our costs of sales) and gross profit margin for our Systems and Services segments are mainly influenced by materials, labor and energy costs. In particular, the gross profit margins in our Systems segment on sales of our 3D printers also depend on the type and status of the sold products. Our Systems segment sometimes sells refurbished printers manufactured by us and previously set up in our service center. The gross profit is
50
lower on refurbished printers, and the number of refurbished printers sold in a period affects the gross profit margin of our Systems segment.
Critical Accounting Policies and Significant Estimates
The following paragraphs discuss the items that we believe are the critical accounting policies most affected by significant management estimates and judgments. Management has discussed and periodically reviews these critical accounting policies, the basis for their underlying assumptions and estimates and the nature of our related disclosures herein.
Revenue Recognition
We sell 3D printers that we make, either in new condition or after using them in our service center. We recognize revenue from these sales upon the transfer of risks and rewards of ownership to the buyer, which is upon completion of the installation of the 3D printer at the customer site, as evidenced by the customer's final acceptance. Revenue from the sale of custom-ordered printed products, consumables, spare parts and other machine parts is recognized upon transfer of title, generally upon shipment. Revenue for all deliverables in sales arrangements is recognized to the extent that it is probable that the economic benefit arising from the ordinary activities of the business will flow to us, provided that the amount of revenue and the costs incurred or to be incurred in respect of the sale can be measured reliably. We measure revenue at the fair value of the consideration received or receivable, which is fixed at the time of recognition of revenue. In instances where we receive revenues but the revenue recognition criteria are not met yet, amounts are recorded as deferred revenue and included in other liabilities and provisions in the accompanying statement of financial position.
We provide our customers with a standard one-year warranty agreement on all 3D printers we sell. The warranty is not treated as a separate service because the warranty is an integral part of the sale of the 3D printer.
After the initial one-year warranty period, we offer customers optional maintenance contracts. Maintenance contracts have a term of 12 months and automatically renew for another 12 months, if not previously cancelled. Deferred maintenance service revenue is recognized on a straight-line basis as the costs of providing services incurred under the contracts generally do not vary significantly throughout the year.
Shipping and handling costs billed to customers for 3D printer sales and sales of printed products and consumables are included in revenues in the statement of comprehensive income (loss). Costs incurred by us associated with shipping and handling are included in cost of sales in the statement of comprehensive income (loss).
Our terms of sale generally require payment within 30 to 60 days after shipment of a product, although we recognize that longer payment periods are customary in some countries in which we do business. To reduce credit risk in connection with 3D printer sales, we may, depending on the individual circumstances, require significant deposits prior to shipment. In some circumstances, we may require payment in full for our products prior to shipment and we may also require international customers to furnish letters of credit. These deposits are reported as customer deposits included in other liabilities and provisions in the accompanying statement of financial position. Services under maintenance contracts are billed to customers in advance on a monthly, quarterly, or annual basis, depending on the contract.
On two occasions, we have provided loans to customers to cover the purchase price of a 3D printer. These loans have a grace period of six to nine months after which they are to be repaid on a monthly
51
basis. The criteria to recognize revenue from the sale of these 3D printers as stated in IAS 18 are fulfilled, so we can recognize all revenue from the sale of these printers upon delivery. Generally, revenue from the sale of a 3D printer is recognized when all the following conditions have been satisfied:
As it relates to situations where we have provided loans to purchasers of our 3D printers, all of these conditions are fulfilled, as the risks and rewards were transferred with the legal title and the passing of possession for revenue recognition to our customers and we have established a process to assess the credit of each customer and confirm the customer's creditworthiness beforehand. We do not ordinarily offer loans to current or prospective customers to cover the purchase of 3D printers.
Sale and Leaseback Transactions
Finance leases consist primarily of borrowings associated with sale and leaseback transactions involving 3D printers that we manufactured and use in our Services segment. Additionally, we are a party to finance lease agreements for 3D printers manufactured by others and used in our service center. Our leased assets are recognized at the lower of fair value or the present value of minimum lease payments and depreciated over the asset's estimated useful life. We include assets under finance leases in "Property, plant and equipment" in the statement of financial position. Gain on sale and leaseback transactions is recorded as deferred income in the statement of comprehensive income (loss) and recognized as "Other operating income" over the term of the lease contract.
Allowance for Doubtful Accounts
In evaluating the collectability of our accounts receivable, we assess a number of factors, including a specific client's ability to meet its financial obligations to us, such as whether a customer has declared bankruptcy or not. Other factors assessed include the length of time the receivables are past due and historical collection experience. Based on these assessments, we record a reserve for specific customers based on their current economic situation. If circumstances related to specific customers change, or economic conditions deteriorate such that our past collection experience is no longer relevant, our estimate of the recoverability of our accounts receivable could be further reduced from the levels provided for in the financial statements.
We believe that our allowance for doubtful accounts is a critical accounting estimate because it is susceptible to change and dependent upon events that may or may not occur and because the impact of recognizing additional allowances for doubtful accounts may be material to the assets reported on our statement of financial position and in our statement of comprehensive income (loss).
52
Inventories
Our inventories are measured at the lower of acquisition cost, manufacturing cost or net realizable value, each as determined by the first-in, first-out (FIFO) method. Manufacturing costs are comprised of all costs that are directly attributable to the manufacturing process, such as direct materials and labor costs, and production-related overhead (based on normal operating capacity and normal consumption of materials, labor and other production costs), including depreciation charges. Net realizable value is the estimated selling price in the ordinary course of business less applicable variable selling expenses.
We evaluate the adequacy of our allowance for inventory on a yearly basis. Our determination of our inventory allowance is subject to change because it is based on management's current estimates of the allowance required and potential adjustments.
We believe that our allowance for inventory is a critical accounting estimate because it is susceptible to change and dependent upon events that may or may not occur and because the impact of recognizing an additional allowance may be material to the assets reported on our statement of financial position and in our statement of comprehensive income (loss).
Other Financial Information
We believe EBITDA (earnings before interest, taxes, depreciation and amortization) is meaningful to our investors to enhance their understanding of our financial performance. Although EBITDA is not necessarily a measure of our ability to fund our cash needs, we understand that it is frequently used by securities analysts, investors and other interested parties as a measure of financial performance and to compare our performance with the performance of other companies that report EBITDA. Our calculation of EBITDA may not be comparable to similarly titled measures reported by other companies.
We define EBITDA as profit (loss) plus income tax expenses (benefit), financial result, depreciation and amortization. Disclosure in this prospectus of EBITDA, which is a non-IFRS financial measure, is intended as a supplemental measure of our performance that is not required by, or presented in accordance with, IFRS. EBITDA should not be considered as an alternative to profit (loss) or any other performance measure derived in accordance with IFRS. Our presentation of EBITDA should not be construed to imply that our future results will be unaffected by unusual or non-recurring items.
Reconciliation of EBITDA to Profit (Loss)
|
Six Months
Ended June 30, |
Year Ended December 31, | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2013 | 2012 | 2012 | 2011 | 2010 | |||||||||||
|
(€ in thousands)
|
|||||||||||||||
Profit (loss) |
€ | (376 | ) | € | 319 | € | 212 | € | 43 | € | (208 | ) | ||||
Income tax expenses (benefit) |
(155 | ) | 170 | 116 | 41 | (65 | ) | |||||||||
Financial result |
178 | 178 | 345 | 384 | 351 | |||||||||||
Depreciation and Amortization |
749 | 639 | 1,343 | 1,246 | 1,110 | |||||||||||
EBITDA |
€ | 396 | € | 1,306 | € | 2,016 | € | 1,714 | € | 1,188 | ||||||
53
Statement of Comprehensive Income (Loss)
Six Months Ended June 30, 2013 compared to Six Months Ended June 30, 2012
The following table sets forth certain statements of comprehensive income (loss) data both on an actual basis and as a percentage of revenues for the periods indicated:
|
Six Months Ended June 30, |
|
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2013 | 2012 |
|
|||||||||||||
|
Amount |
Percentage
of Revenues |
Amount |
Percentage
of Revenues |
Period-over-
period change |
|||||||||||
|
(€ in thousands)
|
|
(€ in thousands)
|
|
(€ in thousands)
|
|||||||||||
Revenues |
€ | 4,478 | 100 | % | € | 4,644 | 100 | % | € | (166 | ) | |||||
Cost of sales |
2,965 | 66.2 | 2,479 | 53.4 | 486 | |||||||||||
Gross profit |
1,513 | 33.8 | 2,165 | 46.6 | (652 | ) | ||||||||||
Selling expenses |
829 | 18.5 | 842 | 18.1 | (13 | ) | ||||||||||
Administrative expenses |
476 | 10.6 | 355 | 7.6 | 121 | |||||||||||
Research and development expenses |
921 | 20.6 | 627 | 13.5 | 294 | |||||||||||
Other operating expenses |
170 | 3.8 | 46 | 1.0 | 124 | |||||||||||
Other operating (income) |
(530 | ) | 11.8 | (372 | ) | 8.0 | 158 | |||||||||
Operating profit (loss) |
(353 | ) | 7.9 | 667 | 14.4 | (1,020 | ) | |||||||||
Finance expense |
191 | 4.3 | 181 | 3.9 | 10 | |||||||||||
Finance (income) |
(13 | ) | 0.3 | (3 | ) | 0.1 | 10 | |||||||||
Financial result |
178 | 4.0 | 178 | 3.8 | 0 | |||||||||||
Profit (loss) before income taxes |
(531 | ) | 11.9 | 489 | 10.5 | (1,020 | ) | |||||||||
Income taxes expenses (benefit) |
(155 | ) | 3.5 | 170 | 3.7 | (325 | ) | |||||||||
Profit (loss) |
€ | (376 | ) | 8.4 | % | € | 319 | 6.9 | % | € | (695 | ) | ||||
Summary
We experienced a loss for the six months ended June 30, 2013 of €0.4 million compared to profit of €0.3 million for the six months ended June 30, 2012, which represents a decrease of €0.7 million.
Revenues for our Systems segment increased slightly. Revenues from the printing of on-demand parts for our customers in our Services segment decreased slightly.
As of June 30, 2013, our backlog, which consists of 3D printers for which a customer has signed a purchase order, but which we have not shipped yet, was approximately €4.4 million, compared to €3.7 million at December 31, 2012. Our backlog as of June 30, 2013 includes €2.2 million of 3D printers that were included in backlog as of December 31, 2012 and €2.2 million of 3D printers from purchase orders signed in the first six months of 2013. As production and delivery of our printers is
54
generally not characterized by long lead times, backlog is more dependent on the timing of customers' requested deliveries.
Our gross profit in the first six months of 2013 decreased by €0.7 million to €1.5 million. The decrease in gross profit was mainly due to higher cost of sales in the first six months of 2013, which resulted primarily from the sale of one 3D printer at a higher than normal cost of sales and lower gross margin than we would achieve for a typical 3D printer sale. This 3D printer was one of the first produced of its type, requiring a longer production time and higher material usage than a 3D printer in regular production. Additionally, we delivered this 3D printer to our customer on very short notice, thereby incurring additional material and overtime costs, further depressing our margin. We intend to sell additional units of this 3D printer in the future and expect to achieve gross margins on these sales that are more in line with our prior results.
We had an operating loss of €0.4 million in the first six months of 2013 compared to an operating profit of €0.7 million in the first six months of 2012 mainly due to a decrease in gross profit and increased expenses.
Revenues by Segment
The table below sets forth our revenues by segment for the six months ended June 30, 2013 and the six months ended June 30, 2012:
|
Six Months
Ended June 30, |
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
Period-over-
period change |
|||||||||
|
2013 | 2012 | ||||||||
|
(€ in thousands)
|
|||||||||
Systems |
€ | 2,049 | € | 2,041 | € | 8 | ||||
Services |
2,429 | 2,603 | (174 | ) | ||||||
Total Revenues |
€ | 4,478 | € | 4,644 | € | (166 | ) | |||
Systems segment
In our Systems segment, we focus on the development, production and sale of 3D printers. In addition, we sell refurbished 3D printers which were produced for and used in our Services segment. Before these 3D printers are sold, they are fully refurbished and a new printhead is installed. We also provide consumables, including particulate materials and proprietary chemical binding agents, maintenance contracts and spare parts to our customers.
|
Six Months
Ended June 30, |
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
Period-over-
period change |
|||||||||
|
2013 | 2012 | ||||||||
|
(€ in thousands)
|
|||||||||
Revenues |
€ | 2,049 | € | 2,041 | € | 8 | ||||
Cost of sales |
1,440 | 1,041 | 399 | |||||||
Gross profit |
€ | 609 | € | 1,000 | € | (391 | ) | |||
Gross margin percentage |
29.7 | % | 49.0 | % |
Revenues from the Systems segment for the six months ended June 30, 2013 were €2.0 million, representing a slight increase compared to the respective period in 2012. We sold three units in the first six months of 2013 in comparison to four units (including one test machine) in the first six
55
months of 2012. Test machines are smaller printers with limited functionality that are used to test materials. We did not sell any test machines in the first six months of 2013 and do not intend to sell test machines in future periods.
The 3D printers sold in the first six months of 2013 were larger systems ( e.g. , VX1000) than the 3D printers sold in the prior period and were sold for higher prices. Although we sold fewer units in the first six months of 2013 than in the prior period, our Systems segment revenues increased slightly due to higher system prices.
Gross profit for our Systems segment amounted to €0.6 million for the first six months of 2013 in comparison to €1.0 million in the respective period in 2012. This decrease in gross profit and gross margin resulted primarily from higher cost of sales. The decline in gross margin is mainly attributable to allocation of manufacturing costs associated with the sale in 2013 of one particular 3D printer, which was one of the first machines of its type we sold, as described above.
Services Segment
In our Services segment, we print on-demand custom parts for our customers. At our service center, which we believe is one of the largest additive manufacturing service centers in Europe, we create parts, molds, cores and models based on designs produced using 3D computer-aided design, or CAD, software.
|
Six Months
Ended June 30, |
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
Period-over-
period change |
|||||||||
|
2013 | 2012 | ||||||||
|
(€ in thousands)
|
|||||||||
Revenues |
€ | 2,429 | € | 2,603 | € | (174 | ) | |||
Cost of sales |
1,525 | 1,438 | 87 | |||||||
Gross profit |
€ | 904 | € | 1,165 | € | (261 | ) | |||
Gross margin percentage |
37.2 | % | 44.8 | % |
Revenues from the Services segment in the six months ended June 30, 2013 were €2.4 million, which represents a decrease of €0.2 million from €2.6 million for the respective period in 2012. Our ability to grow Services segment revenues was constrained by continued capacity limitations in our service center. Although the volume of printed parts increased, our revenues decreased, due to the sale of lower-priced parts. To remain flexible and grow revenues in the future, we are in the process of increasing production capacity both by expanding our current facility and planning the opening of new facilities. Currently, our new fabrication building is being built at our premises in Germany.
Our cost of sales increased slightly by €0.1 million, primarily driven by the hiring of new employees in anticipation of our expanded service center capacity.
Gross margin for our Services segment decreased by 7.6 percentage points from 44.8% for the first six months of 2012 to 37.2% for the first six months of 2013. Our gross margin decreased primarily due to the changed product mix in the six months ended June 30, 2013 compared to the respective period in 2012.
56
Operating Expenses
As shown in the table below, total operating expenses increased by €0.4 million to €1.9 million for the six months ended June 30, 2013 from €1.5 million for the six months ended June 30, 2012.
|
Six Months Ended June 30, |
|
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2013 | 2012 |
|
|||||||||||||
|
Amount |
Percentage
of revenues |
Amount |
Percentage
of revenues |
Period-over-
period change |
|||||||||||
|
(€ in thousands)
|
|
(€ in thousands)
|
|
(€ in thousands)
|
|||||||||||
Selling expenses |
€ | 829 | 18.5 | % | € | 842 | 18.1 | % | € | (13 | ) | |||||
Administrative expenses |
476 | 10.6 | 355 | 7.6 | 121 | |||||||||||
Research and development expenses |
921 | 20.6 | 627 | 13.5 | 294 | |||||||||||
Other operating expenses |
170 | 3.8 | 46 | 1.0 | 124 | |||||||||||
Other operating (income) |
(530 | ) | 11.8 | (372 | ) | 8.0 | 158 | |||||||||
Total |
€ | 1,866 | 41.7 | % | € | 1,498 | 32.3 | % | € | 368 | ||||||
The increase in operating expenses was primarily due to a €0.3 million increase in research and development expenses. Research and development, which includes the development of new material sets and enhancements to our 3D printers, is a key element of our growth strategy.
The increase in administrative expenses was mainly driven by an increase in costs for accounting services.
The increase in other operating income was mainly due to the recognition of deferred income from sale and leaseback transactions.
Other operating expenses increased as a result of costs incurred in relation to our anticipated initial public offering and consist of costs for consultants, lawyers and auditors.
Operating Profit (Loss)
Operating profit (loss) for the first six months of 2013 and 2012 was as follows:
|
Six Months Ended June 30, |
|
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2013 | 2012 |
|
|||||||||||||
|
Amount |
Percentage
of revenues |
Amount |
Percentage
of revenues |
Period-over-
period change |
|||||||||||
|
(€ in thousands)
|
|
(€ in thousands)
|
|
(€ in thousands)
|
|||||||||||
Operating profit (loss) |
€ | (353 | ) | 7.9 | % | € | 667 | 14.4 | % | € | (1,020 | ) |
Operating profit decreased by €1.0 million to an operating loss of €0.4 million for the six months ended June 30, 2013 due to lower gross profit and higher operating expenses.
Profit (Loss)
For the first six months of 2013, we had a loss of €0.4 million compared to a profit of €0.3 million for the first six months of 2012. The decrease in profit in the first six months of 2013 was driven by a €1.0 million decrease in operating profit, partially offset by an increase in tax benefit of €0.3 million.
57
Year Ended December 31, 2012 compared to Year Ended December 31, 2011
The following table sets forth certain statements of comprehensive income (loss) data both on an actual basis and as a percentage of revenues for the periods indicated:
|
Year Ended |
|
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
December 31, 2012 | December 31, 2011 |
|
|||||||||||||
|
Amount |
Percentage
of revenues |
Amount |
Percentage
of revenues |
Period-over-
period change 2012 vs. 2011 |
|||||||||||
|
(€ in thousands)
|
|
(€ in thousands)
|
|
(€ in thousands)
|
|||||||||||
Revenues |
€ | 8,711 | 100.0 | % | € | 7,257 | 100.0 | % | € | 1,454 | ||||||
Cost of sales |
4,957 | 56.9 | 4,337 | 59.8 | 620 | |||||||||||
Gross profit |
3,754 | 43.1 | 2,920 | 40.2 | 834 | |||||||||||
Selling expenses |
1,510 | 17.3 | 1,160 | 16.0 | 350 | |||||||||||
Administrative expenses |
758 | 8.7 | 670 | 9.2 | 88 | |||||||||||
Research and development expenses |
1,573 | 18.1 | 1,313 | 18.1 | 260 | |||||||||||
Other operating expenses |
62 | 0.7 | 140 | 1.9 | (78 | ) | ||||||||||
Other operating (income) |
(822 | ) | 9.4 | (831 | ) | 11.5 | (9 | ) | ||||||||
Operating profit |
673 | 7.7 | 468 | 6.4 | 205 | |||||||||||
Finance expense |
363 | 4.2 | 389 | 5.4 | (26 | ) | ||||||||||
Finance (income) |
(18 | ) | 0.2 | (5 | ) | 0.1 | 13 | |||||||||
Financial result |
345 | 4.0 | 384 | 5.3 | (39 | ) | ||||||||||
Profit before income taxes |
328 | 3.8 | 84 | 1.2 | 244 | |||||||||||
Income tax expenses |
116 | 1.3 | 41 | 0.6 | 75 | |||||||||||
Profit |
€ | 212 | 2.4 | % | € | 43 | 0.6 | % | € | 169 | ||||||
Summary
Our revenues increased by €1.5 million or 20% to €8.7 million in 2012 from €7.3 million in 2011. Revenues for 2012 increased primarily due to an increase in the number of 3D printers sold. Revenues from the printing of on-demand parts for our customers increased slightly, limited by capacity constraints in our service center.
At December 31, 2012, our backlog, which consists of 3D printers for which a customer has signed a purchase contract, but which we have not shipped yet, was €3.7 million, compared to €1.7 million at December 31, 2011. As production and delivery of our printers is generally not characterized by long lead times, backlog is more dependent on the timing of customers' requested deliveries.
Our gross profit for 2012 increased by €0.8 million or 28.6% to €3.8 million from €2.9 million in 2011. Our higher gross profit for 2012 arose primarily from increased sales of our 3D printers in 2012 and the product mix in the Systems segment. Our gross profit margin increased from 40.2% in 2011 to 43.1% in 2012.
Our operating profit grew to €0.7 million in 2012 from €0.5 million in 2011.
58
Revenues by Segment
The table below sets forth the change in revenues by segment from 2011 to 2012:
|
Year Ended
December 31, |
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
Period-over-
period change 2012 vs. 2011 |
|||||||||
|
2012 | 2011 | ||||||||
|
(€ in thousands)
|
|||||||||
Systems |
€ | 3,464 | € | 2,206 | € | 1,258 | ||||
Services |
5,247 | 5,051 | 196 | |||||||
Total Revenues |
€ | 8,711 | € | 7,257 | € | 1,454 | ||||
Revenues from the Systems segment for 2012 were €3.5 million, up 57% from 2011. We sold 10 units in 2012 compared to five units in 2011.
Overall, we sold more new 3D printers in 2012 than in 2011. The 3D printers sold in 2012 were on average larger systems ( i.e. , VX500 and VX800) with improved performance and higher prices per unit than in the prior year, which contributed to higher revenue. However, in 2012 we also sold four test machines, which are smaller printers with limited functionality that are used to test materials, compared to two test machines in 2011. Test machines tend to be sold at lower prices compared to our full function 3D printers.
Revenue depends not only on the number of units sold, but also on the composition of the units sold, with new, larger, higher-performance printers generating higher revenues per unit. We do not intend to sell test machines in future periods.
Revenues from the Services segment for 2012 were €5.2 million, which represents an increase of €0.2 million from €5.0 million in 2011. Our ability to grow Services revenue in 2012 was constrained by continued capacity limitations in our service center. To remain flexible and grow revenues in the future, we are in the process of increasing production capacity both by expanding our current facility and planning the opening of new facilities. Currently, our new fabrication building is being built at our premises in Germany.
Revenues by Geographic Region
The table below sets forth the change in revenues by geographic region from 2011 to 2012:
|
Year Ended
December 31, 2012 |
Year Ended
December 31, 2011 |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenues | Percentage | Revenues | Percentage | |||||||||
|
(€ in thousands)
|
|
(€ in thousands)
|
|
|||||||||
EMEA |
€ | 7,404 | 85.0 | % | € | 7,112 | 98.0 | % | |||||
Asia Pacific |
958 | 11.0 | 73 | 1.1 | |||||||||
Americas |
349 | 4.0 | 72 | 0.9 | |||||||||
Total |
€ | 8,711 | 100.0 | % | € | 7,257 | 100.0 | % | |||||
We generated most of our revenues in our Europe, Middle East and Africa, or EMEA, region in both 2012 and 2011. Overall, EMEA region revenues were stable, due in part to capacity limitations in our European service center. Our strategy to expand our presence in North America and Asia resulted in increased revenues outside of the EMEA region in 2012. Specifically, revenues in the Asia Pacific region increased due to new Systems customers in South Korea, and revenues in the Americas region increased as a result of the sale of a system to a new customer.
59
Gross Profit and Gross Profit Margin
Total gross profit for 2012 increased by €0.8 million or 28.6% reflecting higher sales in our Systems segment in 2012 compared to 2011. Our gross profit margin increased by 2.9 percentage points from 2011 to 2012 as a result of increased revenues in our Systems segment providing additional scale over our fixed cost base. The gross profit in the Systems segment increased mainly due to the above-mentioned sales of larger printers, which typically generate a higher contribution to gross profit.
The table below sets forth gross profit and gross profit margin for our Systems and Services segments:
|
Year Ended December 31, |
|
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2012 | 2011 |
|
|||||||||||||
|
Amount |
Gross margin
as percentage of relevant segment revenue |
Amount |
Gross margin
as percentage of relevant segment revenue |
Period-over-
period change |
|||||||||||
|
(€ in
thousands) |
|
(€ in
thousands) |
|
(€ in
thousands) |
|||||||||||
Systems |
€ | 1,399 | 40.4 | % | € | 569 | 25.8 | % | € | 830 | ||||||
Services |
2,355 | 44.9 | 2,351 | 46.5 | 4 | |||||||||||
Total |
€ | 3,754 | 43.1 | % | € | 2,920 | 40.2 | % | € | 834 | ||||||
Gross profit for our Systems segment increased to €1.4 million in 2012 from €0.6 million in 2011, while the gross profit margin of our Systems segment increased 14.6 percentage points to 40.4% in 2012 from 25.8% in 2011. This increase in gross profit margin resulted primarily from the higher number of higher-priced, higher-margin 3D printers sold in 2012.
Gross profit for our Services segment was essentially flat from 2011 to 2012, with the gross profit margin decreasing 1.6 percentage points from 46.5% in 2011 to 44.9% in 2012. As our total revenue increased, the margin contribution by the Services segment decreased due to the fact that more machines and more personnel were included in the Services segment to satisfy the increasing customer demand. As these increased costs could not be absorbed by the revenue increase, gross margin declined slightly.
Operating Expenses
As shown in the table below, total operating expenses increased by €0.6 million to €3.1 million in 2012 from €2.5 million in 2011, and increased to 35.4% of revenues compared to 33.6% in 2011. This increase was due primarily to a €0.3 million increase in research and development expenses and a €0.3 million increase in selling expenses.
|
Year Ended December 31, |
|
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2012 | 2011 |
|
|||||||||||||
|
Amount |
Percentage
of revenues |
Amount |
Percentage
of revenues |
Period-over-
period change |
|||||||||||
|
(€ in
thousands) |
|
(€ in
thousands) |
|
(€ in
thousands) |
|||||||||||
Operating expenses |
||||||||||||||||
Selling expenses |
€ | 1,510 | 17.3 | % | € | 1,160 | 16.0 | % | € | 350 | ||||||
Administrative expenses |
758 | 8.7 | 670 | 9.2 | 88 | |||||||||||
Research and development expenses |
1,573 | 18.1 | 1,313 | 18.1 | 260 | |||||||||||
Other operating expenses |
62 | 0.7 | 140 | 1.9 | (78 | ) | ||||||||||
Other operating (income) |
(822 | ) | 9.4 | (831 | ) | 11.5 | (9 | ) | ||||||||
Total |
€ | 3,081 | 35.4 | % | € | 2,452 | 33.6 | % | € | 629 | ||||||
60
Selling expenses increased by €0.3 million to €1.5 million in 2012 from €1.2 million in 2011, while administrative expenses increased by €0.1 million to €0.8 million in 2012 from €0.7 million in 2011. As a percentage of revenues, selling expenses were 17.3% and 16.0% in 2012 and 2011, respectively, while administrative expenses were 8.7% and 9.2% in 2012 and 2011, respectively.
The increase in selling expenses in 2012 was primarily related to increased headcount needed to support the growth of our business. Furthermore, we experienced higher costs related to our sales agents and attended more global exhibitions, which increased travel expenses significantly. As a result, our selling expenses increased at a faster rate than our revenues.
As our business grew in 2012, we continued to invest in research and development. Our research and development expenses amounted to 18.1% of our revenues in 2012, reflecting a 20.0% increase in our research and development expenses compared to 2011. Research and development, which includes the development of new material sets and enhancements to our 3D printers, is a key element of our growth strategy.
Operating Profit
Operating profit and operating profit as a percentage of total revenues in 2012 and 2011 were as follows:
|
Year Ended December 31, |
|
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2012 | 2011 |
|
|||||||||||||
|
(€ in
thousands) |
Percentage
of revenues |
(€ in
thousands) |
Percentage
of revenues |
Period-over-
period change |
|||||||||||
Operating profit |
€ | 673 | 7.7 | % | € | 468 | 6.4 | % | € | 205 |
Operating profit increased by €0.2 million to €0.7 million in 2012 from € 0.5 million in 2011. As a percentage of total revenues, operating profit increased by 1.3 percentage points. We expect our profitability to improve as we continue to achieve economies of scale and can further leverage our fixed expenses.
Financial Result
Financial result was a €0.3 million expense in 2012, a slight decrease from financial result of a €0.4 million expense in 2011. The decrease was caused primarily by lower interest expenses.
Provision for Income Taxes
Income tax expense for 2012 was €0.1 million compared to €0.04 million in 2011, with the increase due to an increase in profit before income taxes.
Taxation of the Company in Germany
German stock corporations are subject to a Corporation Tax of 15%. A 5.5% solidarity surcharge is imposed on the Corporation Tax, resulting in an overall tax rate of 15.825%. In addition, German stock corporations are by virtue of their legal form subject to a municipal profit-related German Trade Tax. The Trade Tax is calculated on the basis of the income taxable pursuant to the Corporation Tax as shown in the annual statutory profit and loss accounts of the stock corporation which, however, is subject to certain particular Trade Tax add-backs and deductions. The effective Trade Tax rate applicable depends on the municipality in which the stock corporation maintains a permanent establishment and ranges between approximately 7% and 17%. The Corporation Tax and Trade Tax combined will result in an overall tax burden for German stock corporations of approximately 28% on average. The deduction for a taxable loss carry-forward for the fiscal year has a limit of €1 million;
61
thereafter taxable income can only be offset by up to 60%. The loss carry-forward is reduced by the amount used and has an unlimited life. However, there are limitations on the use of loss carry-forwards upon a transfer of more than 25% of a stock corporation's shares or voting rights to a single purchaser, a related party or a group of purchasers within a specified time period.
Profit
In 2012 and 2011, we had a profit of €0.2 million and €0.04 million, respectively.
Year Ended December 31, 2011 Compared to Year Ended December 31, 2010
The following table sets forth certain statement of comprehensive income (loss) data both on an actual basis and as a percentage of revenues for the periods indicated:
|
Year Ended December 31, |
|
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2011 | 2010 |
|
|||||||||||||
|
Amount |
Percentage
of revenues |
Amount |
Percentage
of revenues |
Period-over-
period change 2011 vs. 2010 |
|||||||||||
|
(€ in
thousands) |
|
(€ in
thousands) |
|
(€ in
thousands) |
|||||||||||
Revenues |
€ | 7,257 | 100.0 | % | € | 4,764 | 100.0 | % | € | 2,493 | ||||||
Cost of sales |
4,337 | 59.8 | 2,660 | 55.8 | 1,677 | |||||||||||
Gross profit |
2,920 | 40.2 | 2,104 | 44.2 | 816 | |||||||||||
Selling expenses |
1,160 | 16.0 | 1,028 | 21.5 | 132 | |||||||||||
Administrative expenses |
670 | 9.2 | 606 | 12.7 | 64 | |||||||||||
Research and development expenses |
1,313 | 18.1 | 1,073 | 22.5 | 240 | |||||||||||
Other operating expenses |
140 | 1.9 | 81 | 1.7 | 59 | |||||||||||
Other operating (income) |
(831 | ) | 11.5 | (762 | ) | 15.9 | 69 | |||||||||
Operating profit (loss) |
468 | 6.4 | 78 | 1.6 | 390 | |||||||||||
Finance expense |
389 | 5.4 | 359 | 7.5 | 30 | |||||||||||
Finance (income) |
(5 | ) | 0.1 | (8 | ) | 0.2 | (3 | ) | ||||||||
Financial result |
384 | 5.3 | 351 | 7.4 | 33 | |||||||||||
Profit (loss) before income taxes |
84 | 1.2 | (273 | ) | 5.7 | 357 | ||||||||||
Income tax expenses (benefit) |
41 | 0.6 | (65 | ) | 1.3 | 106 | ||||||||||
Profit (loss) |
€ | 43 | 0.6 | % | € | (208 | ) | 4.4 | % | € | 251 | |||||
Summary
Our revenues increased by €2.5 million or 52.3% to €7.3 million in 2011 from €4.8 million in 2010. Revenues for 2011 increased primarily as a result of continued growth in our global sales agent network and sales resulting from increasing market demand.
Our gross profit for 2011 increased by €0.8 million or 38.7% to €2.9 million from €2.1 million in 2010. Our higher gross profit for 2011 arose primarily from the sale of additional 3D printers. Our gross profit margin decreased 4.0 percentage points from 44.2% in 2010 to 40.2% in 2011, as we sold two test machines in 2011, which generally generate lower profit margins than our 3D printers.
62
For 2011, our operating profit was €0.5 million, compared to an operating profit of €0.1 million in 2010, an improvement of €0.4 million.
At December 31, 2011, our backlog was €1.7 million, compared to €0.1 million at December 31, 2010.
Revenues by Segment
The table below sets forth the change in revenue by segment from 2010 to 2011:
|
Year Ended
December 31, 2011 |
Year Ended
December 31, 2010 |
Period-over-
period change 2011 vs. 2010 |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
|
|
(€ in thousands)
|
|
|||||||
Systems |
€ | 2,206 | € | 1,036 | € | 1,170 | ||||
Services |
5,051 | 3,728 | 1,323 | |||||||
Total Revenues |
€ | 7,257 | € | 4,764 | € | 2,493 | ||||
Revenues from the Systems segment increased 113.0% in 2011. We sold five units in 2011, consisting of three 3D printers and two test machines, compared to one 3D printer sold in 2010.
Revenues from the Services segment increased by 35.0% in 2011 primarily as a result of the increased production capacity provided by the additional 3D printers we installed in our service center in that year. We believe that the increase in our Services segment revenues resulted from the strengthening of the European economy.
Revenues by Geographic Region
The table below sets forth revenues by geographic region for 2011 compared to 2010:
|
Year Ended
December 31, 2011 |
Year Ended
December 31, 2010 |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenues | Percentage | Revenues | Percentage | |||||||||
|
(€ in thousands)
|
|
(€ in thousands)
|
|
|||||||||
EMEA |
€ | 7,112 | 98.0 | % | € | 4,621 | 96.9 | % | |||||
Asia Pacific |
73 | 1.1 | 48 | 1.1 | |||||||||
Americas |
72 | 0.9 | 95 | 2.0 | |||||||||
Total |
€ | 7,257 | 100.0 | % | € | 4,764 | 100.0 | % | |||||
We generated the vast majority of our revenues in the EMEA region in 2011 and 2010. Revenues in the EMEA region were 98.0% and 96.9% of our revenues in 2011 and 2010, respectively.
Gross Profit and Gross Profit Margin
Total gross profit for 2011 increased by €0.8 million, reflecting higher sales in both our Systems and Services segments in 2011 compared to 2010. Our gross profit margin decreased 4.0 percentage points from 2010 and 2011, as a result of higher payroll costs and costs of sales.
63
The table below sets forth gross profit and gross profit margin for our Systems and Services segments.
|
Year Ended December 31, |
|
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2011 | 2010 |
|
|||||||||||||
|
Amount |
Gross margin
as percentage of relevant segment revenue |
Amount |
Gross margin
as percentage of relevant segment revenue |
Period-over-
period change |
|||||||||||
|
(€ in
thousands) |
|
(€ in
thousands) |
|
(€ in
thousands) |
|||||||||||
Systems |
€ | 569 | 25.8 | % | € | 539 | 52.0 | % | € | 30 | ||||||
Services |
2,351 | 46.5 | 1,565 | 42.0 | 786 | |||||||||||
Total |
€ | 2,920 | 40.2 | % | € | 2,104 | 44.2 | % | € | 816 | ||||||
Gross profit for our Systems segment was €0.5 million in 2010 and remained nearly unchanged at €0.6 million in 2011, while gross profit margin decreased to 25.8% in 2011 from 52.0% in 2010. This decrease in gross profit margin resulted primarily from increased expenses for parts and external services. In addition, two refurbished 3D printers were sold in 2011. The margin on refurbished 3D printers is generally much lower than on new printers.
Gross profit for our Services segment increased by €0.8 million, with an increase in gross profit margin from 42.0% in 2010 to 46.5% in 2011. These increases were primarily due to higher volume in our service center.
Operating Expenses
As shown in the table below, total operating expenses increased by €0.4 million to €2.5 million for 2011 from €2.0 million for 2010, and decreased to 33.6% of revenues in 2011 compared to 42.5% in 2010. This increase in expenses was due primarily to a €0.2 million increase in research and development expenses and a €0.1 million increase in selling expenses, which are discussed below.
|
Year Ended December 31, |
|
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2011 | 2010 |
|
|||||||||||||
|
Amount |
Percentage
of Revenues |
Amount |
Percentage
of Revenues |
Period-over-
period change |
|||||||||||
|
(€ in
thousands) |
|
(€ in
thousands) |
|
(€ in
thousands) |
|||||||||||
Operating expenses |
||||||||||||||||
Selling expenses |
€ | 1,160 | 16.0 | % | € | 1,028 | 21.5 | % | € | 132 | ||||||
Administrative expenses |
670 | 9.2 | 606 | 12.7 | 64 | |||||||||||
Research and development expenses |
1,313 | 18.1 | 1,073 | 22.5 | 240 | |||||||||||
Other operating expenses |
140 | 1.9 | 81 | 1.7 | 59 | |||||||||||
Other operating (income) |
(831 | ) | 11.5 | (762 | ) | 15.9 | 69 | |||||||||
Total |
€ | 2,452 | 33.6 | % | € | 2,026 | 42.5 | % | € | 426 | ||||||
Selling expenses increased by €0.1 million to €1.2 million in 2011 from €1.0 million in 2010, while administrative expenses increased by €0.1 million to €0.7 million in 2011 from €0.6 million in 2010. As a percentage of revenues, selling expenses were 16.0% and 21.5% in 2011 and 2010, respectively, while administrative expenses were 9.2% and 12.7% in 2011 and 2010, respectively.
64
The increase in selling expenses in 2011 was primarily due to higher sales and commission costs. The increase in administrative expenses in 2011 resulted primarily from measures taken to support the growth of our business.
As our business grew in 2011, we continued to invest in research and development. Our research and development expenses amounted to 18.1% of our revenues in 2011 compared to 22.5% of our revenues in 2010. In 2010, research and development expenses as a percentage of revenues was higher due to our lower revenues in that year.
Other operating income includes government grants and amortization of gains relating to sale and leaseback transactions.
Operating Profit
Operating profit and operating profit as a percentage of total revenues in 2011 and 2010, as well as the change in operating profit from year to year, were as follows:
|
Year Ended
December 31, 2011 |
Year Ended
December 31, 2010 |
|
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
(€ in
thousands) |
Percentage
of revenues |
(€ in
thousands) |
Percentage
of revenues |
Period-over-
period change |
|||||||||||
Operating profit |
€ | 468 | 6.4 | % | € | 78 | 1.6 | % | € | 390 |
In 2011, we had operating profit of €0.5 million, compared to an operating profit of €0.1 million in 2010, an improvement of €0.4 million. As a percentage of total revenues, operating profit amounted to 6.4% in 2011 and 1.6% in 2010. The improvement in operating profit is mainly due to higher revenues as we leveraged our fixed expenses as we grew.
Financial Result
Financial result was €0.4 million in both 2011 and 2010. Finance expense includes leasing costs and interest expense for lines of credit.
Provision for Income Taxes
We recorded income tax expense of €0.04 million in 2011, compared to an income tax benefit of €0.1 million in 2010. The change from an income tax benefit in 2010 to income tax expense in 2011 was the result of having a profit in 2011, versus a loss in 2010. We also had an accumulated deferred tax asset of €0.3 million as of December 31, 2010.
Profit (Loss)
In 2011, we had a profit of €0.04 million, compared to a loss of €0.2 million in 2010.
Liquidity and Capital Resources
To date, we have operated our business with limited cash resources. To finance our growth strategy, we have used cash flow from operations, credit lines, research and development grants and sale and leaseback transactions.
In September 2009, we entered into a fixed rate loan agreement with LfA Foerderbank Bayern, which allowed us to invest up to €1.45 million in the development of a new printing technique and the creation of the VX1000 prototype machine. At June 30, 2013, this loan had a balance of €1.0 million.
65
To meet the demand for our Services business and to increase capacity, we installed in our service center a VX500 and a VX800 in 2010, as well as two additional VX800s in 2011 and 2012, all of which were financed by sale and leaseback transactions. Three 3D printers were installed in our service center in the first six months of 2013; one VX1000 and two VXC800s, all of which were financed by sale and leaseback transactions.
To finance the manufacturing of 3D printers, we have used credit lines, which are paid down when the 3D printers are sold to customers. To meet our working capital requirements as of June 30, 2013, we had cash and cash equivalents of €0.3 million and had €1.2 million of availability under several bank lines of credit.
We cannot provide certainty that our cash position and net cash provided by operating activities will be adequate to support the further growth of our business. We plan to utilize the proceeds of this offering to meet our capital needs, including the expansion of our service center capacity, the establishment of new service centers, research and development expenses, and sales and marketing expenses. We anticipate that we will have increased access to external funding sources as a public company, through equity financing or the incurrence of indebtedness; therefore, we believe that we will be able to raise additional capital or debt sufficient to support our operations. If we raise additional funds by issuing equity or convertible debt securities, the ownership percentages of existing shareholders would be reduced. In addition, the equity or debt securities that we may issue may have rights, preferences or privileges senior to those of our common stock.
Cash Flow
Our primary sources of cash were revenues and financings by (i) working capital lines and (ii) finance leases. Our primary uses of cash have traditionally been to finance our assets and our working capital.
The table below sets forth cash flows from operating, investing and financing activities for 2010, 2011 and 2012 and the six months ended June 30, 2012 and 2013:
|
Six Months
Ended June 30, 2013 |
Six Months
Ended June 30, 2012 |
Year Ended
December 31, 2012 |
Year Ended
December 31, 2011 |
Year Ended
December 31, 2010 |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
(€ in thousands)
|
|||||||||||||||
Cash provided by (used in) operating activities |
€ | (116 | ) | € | 299 | € | 436 | € | 102 | € | 325 | |||||
Cash (used in) investing activities |
(322 | ) | (346 | ) | (978 | ) | (310 | ) | (1,930 | ) | ||||||
Cash provided by (used in) financing activities |
476 | (186 | ) | 345 | 52 | 2,127 | ||||||||||
Increase (decrease) in cash and cash equivalents |
€ | 38 | € | (233 | ) | € | (197 | ) | € | (156 | ) | € | 522 | |||
At June 30, 2013, cash and cash equivalents remained largely unchanged at €0.3 million compared to December 31, 2012.
The decrease in cash and cash equivalents of €0.2 million, from €0.5 million at December 31, 2011 to €0.3 million at December 31, 2012, reflects investments in property, plant and equipment, partially offset by cash provided by operating and financing activities. These investments related to the relocation of our production site to the new premises in Friedberg, Germany and costs relating to the VX4000 we installed in our service center.
The period-over-period decrease in cash and cash equivalents of €0.2 million, from €0.7 million at December 31, 2010 to €0.5 million at December 31, 2011, was primarily driven by a €0.2 million investment in property, plant and equipment in 2011.
66
Operating Activities
Below is a reconciliation of profit (loss) adjusted for non-cash items (including depreciation) and the effect of changes in assets and liabilities to determine net cash used for operating activities for the six months ended June 30, 2012 and 2013.
|
Six Months Ended
June 30, |
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
Period-over-
period change |
|||||||||
|
2013 | 2012 | ||||||||
|
(€ in thousands)
|
|||||||||
Profit (loss) for the period |
€ | (376 | ) | € | 319 | € | (695 | ) | ||
Depreciation |
749 | 639 | 110 | |||||||
Proceeds from customer loans |
14 | 16 | (2 | ) | ||||||
Changes in deferred income taxes |
(198 | ) | 37 | (235 | ) | |||||
Deferred income |
(228 | ) | (169 | ) | (59 | ) | ||||
Change in working capital |
||||||||||
Trade and other receivables and current assets |
(1,198 | ) | (225 | ) | (973 | ) | ||||
Inventories |
(343 | ) | (170 | ) | (173 | ) | ||||
Trade payables |
196 | 37 | 159 | |||||||
Other liabilities and provisions |
1,271 | (285 | ) | 1,556 | ||||||
Income tax payable |
(3 | ) | 100 | (103 | ) | |||||
Net cash (used in) provided by operating activities |
€ | (116 | ) | € | 299 | € | (415 | ) |
Below is a reconciliation of profit (loss) adjusted for non-cash items (including depreciation) and the effect of changes in assets and liabilities to determine net cash used for operating activities for 2010, 2011 and 2012.
|
Year Ended
December 31, |
|
Year Ended
December 31, |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Period-over-
period change |
Period-over-
period change |
|||||||||||||||||
|
2012 | 2011 | 2011 | 2010 | |||||||||||||||
|
(€ in thousands)
|
||||||||||||||||||
Profit (loss) for the period |
€ | 212 | € | 43 | € | 169 | € | 43 | € | (208 | ) | € | 251 | ||||||
Depreciation |
1,343 | 1,246 | 97 | 1,246 | 1,110 | 136 | |||||||||||||
Non cash sale to customer in exchange for customer loans |
(250 | ) | 0 | (250 | ) | 0 | (340 | ) | 340 | ||||||||||
Proceeds from customer loans |
39 | 7 | 32 | 7 | 0 | 7 | |||||||||||||
Changes in deferred income taxes |
(45 | ) | (33 | ) | (12 | ) | (33 | ) | (97 | ) | 64 | ||||||||
Loss on disposal of assets |
0 | 0 | 0 | 0 | 10 | (10 | ) | ||||||||||||
Deferred income |
(274 | ) | (539 | ) | 265 | (539 | ) | (339 | ) | (200 | ) | ||||||||
Change in working capital |
|||||||||||||||||||
Trade and other receivables and current assets |
131 | (349 | ) | 480 | (349 | ) | 181 | (530 | ) | ||||||||||
Inventories |
(851 | ) | (864 | ) | 13 | (864 | ) | (177 | ) | (687 | ) | ||||||||
Trade payables |
42 | 230 | (188 | ) | 230 | 44 | 186 | ||||||||||||
Other liabilities and provisions |
128 | 365 | (237 | ) | 365 | 106 | 259 | ||||||||||||
Income tax payable |
(39 | ) | (4 | ) | (35 | ) | (4 | ) | 35 | (39 | ) | ||||||||
Net cash provided by operating activities |
€ | 436 | € | 102 | € | 334 | € | 102 | € | 325 | € | (223 | ) |
67
During the six months ended June 30, 2013, net cash used by operating activities was €0.1 million compared to cash generated of €0.3 million in the comparative interim period. The decrease was due to lower profit for the period partially offset by a smaller increase in working capital in the period.
Net cash provided by operating activities increased by €0.3 million to €0.4 million for the year ended December 31, 2012, compared to €0.1 million for the year ended December 31, 2011. This improvement was primarily due to the smaller increase in working capital in 2012.
Net cash provided by operating activities decreased by €0.2 million to €0.1 million for the year ended December 31, 2011, compared to €0.3 million for the year ended December 31, 2010. This was primarily due to an increase in inventory, as production occurred in 2011 for machines ordered by customers for delivery in 2012.
Investing Activities
Net cash of €0.5 million was provided by financing activities during the six months ended June 30, 2013, which consists of proceeds from sale and leaseback transactions that were used in part to repay other debt.
Investing activities consist primarily of setting up infrastructure, including equipment we install and use in our service center. In addition, we make cash deposits reported as financial assets. In 2010, we spent over €1.9 million on the move to our new production site in Friedberg, Germany, 3D printing equipment and leasehold improvements.
In 2011, a minimal investment was made in property, plant and equipment during the normal course of business, as most needed investments were made in 2010. In 2012, we invested primarily in the VX1000 prototype.
Financing Activities
Financing activities consist principally of borrowings and payments on our outstanding debt and proceeds from sale and leaseback transactions.
Net cash of €0.3 million was provided by financing activities in 2012 compared to €0.1 million in 2011. The increase reflects funds received from sale and leaseback transactions.
Net cash of €0.1 million was provided by financing activities in 2011 compared to €2.1 million in 2010. The majority of the cash received in 2010 came from a governmental loan agreement covering costs for a research and development project resulting in the VX1000 prototype.
Financing Agreements
As of June 30, 2013, we had several lines of credit with four German banks in a total amount of up to €2.1 million. Of this amount, €1.0 million is available for use in connection with the setup of 3D printers. Interest rates across our credit lines varied from 3.61% to 7.0% as of June 30, 2013. Additional cash borrowings in excess of the €1.0 million can be used for additional bank transactions ( e.g., bank guarantees, leasing and letters of credit). The interest rates for the additional cash borrowings varied from 4.75% to 11.00% as of June 30, 2013 across the four banks. There are commitment fees of 0.25% and 0.30% associated with the unused portion of two of our lines of credit.
As of June 30, 2013, we had long-term debt in the amount of €1.7 million compared to €1.85 million as of December 31, 2012.
68
Contractual Commitments
Future contractual payments as of June 30, 2013 consist of bank overdrafts, lines of credit and long-term debt, operating leases and finance leases.
Future contractual payments as of December 31, 2012 are discussed in greater detail below.
|
December 31, 2012 | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
(€ in thousands) | |||||||||||||||
|
Total |
Less than
a year |
1-3
years |
3-5
years |
More than
5 years |
|||||||||||
Bank overdrafts, lines of credit and long-term debt |
€ | 3,311 | € | 1,129 | € | 1,398 | € | 625 | € | 159 | ||||||
Leases: |
||||||||||||||||
Operating |
1,590 | 356 | 760 | 474 | 0 | |||||||||||
Finance |
3,183 | 1,237 | 1,385 | 561 | 0 | |||||||||||
|
€ | 8,084 | € | 2,722 | € | 3,543 | € | 1,660 | € | 159 | ||||||
After December 31, 2012, we repaid long-term debt of €0.2 million and entered into additional sale and leaseback transactions to finance four 3D printers. We installed three of these 3D printers in our service center and subleased one 3D printer to a customer.
Leases
Operating
We lease various manufacturing facilities, office and warehouse spaces, equipment and vehicles under operating leases. We expect leases that expire to be renewed or replaced by leases on other properties. Rental expense amounted to €0.4 million, €0.4 million and €0.3 million in 2012, 2011 and 2010, respectively.
Finance
Our finance leases relate primarily to production machinery. We entered into sale and leaseback transactions to finance 13 3D printers that we manufactured and installed in our service center.
Off-Balance Sheet Arrangements
We are not a party to any off-balance sheet arrangements other than an interest rate swap agreement. See Note 10 to the financial statements of Voxeljet Technology GmbH included elsewhere in this prospectus.
Impact of Inflation
Our statement of comprehensive income (loss) and statement of financial position are presented based on historical cost. While it is difficult to accurately measure the impact of inflation due to the imprecise nature of the estimates required, we believe the effects of inflation, if any, on our statement of comprehensive income (loss) and statement of financial position have been immaterial.
Quantitative and Qualitative Disclosures about Market Risk
We are exposed to market risk from fluctuations in interest rates and foreign currency exchange rates which may adversely affect our results of operations and financial condition. We seek to minimize these risks through regular operating and financing activities and, when we consider it to be
69
appropriate, through the use of derivative financial instruments. We do not purchase, hold or sell derivative financial instruments for trading or speculative purposes.
Interest rates
Our exposure to market risk for changes in interest rates relates primarily to loans that have variable interest rates. A hypothetical interest rate change of 1.0%, or 100 basis points, on these loans would result in an increase in our annual finance expense of less than €1,000. We entered into an interest rate swap agreement to hedge the interest rate risk associated with variable rate debt. The interest rate swap is recognized at fair value in "Financial liabilities" in the statement of financial position.
Foreign exchange rates
We transact business globally and are subject to risks associated with fluctuating foreign exchange rates. The geographic areas outside of the eurozone to which we sell are generally not considered to be highly inflationary. In 2012, 2011 and 2010, 25%, 23% and 16% of our revenues, respectively, were derived from sales outside of the eurozone. Receivables denominated in a foreign currency are initially recorded at the exchange rate at the transaction date and subsequently remeasured in euro based on period-end exchange rates. Transaction gains and losses that arise from exchange rate fluctuations are charged to income.
70
Our Company
We are a leading provider of high-speed, large-format 3D printers and on-demand parts services to industrial and commercial customers. Our 3D printers employ a powder binding, additive manufacturing technology to produce parts using various material sets, which consist of particulate materials and proprietary chemical binding agents. We offer our customers the highest volumetric output rate in the industry due to the combination of our large build boxes and print speeds. We provide our 3D printers and on-demand parts services to industrial and commercial customers serving the automotive, aerospace, film and entertainment, art and architecture, engineering and consumer product end markets.
We currently offer five different 3D printer platforms, and plan to offer a sixth prior to the end of 2013, with build boxes that range from 300 × 200 × 150 millimeters to 4,000 × 2,000 × 1,000 millimeters, with various print speeds, which produce volumetric output rates ranging from 0.7 liters per hour to 123.0 liters per hour. All of our platforms support our commercialized material sets, sand and plastics, along with their respective proprietary chemical binding agents. We develop our material sets according to the needs of our industrial and commercial customers, and we are currently in varying stages of developing new material sets, including shell molding and chromite sands, PMMA-based plastics, ceramics, silicon carbide, tungsten carbide, wood powder and cement.
We believe that our recent innovations in 3D printers will continue to increase customer adoption of our additive manufacturing technology in industrial and commercial applications. Recent key innovations include:
Our business is divided into two principal segments: Systems and Services.
In our Systems segment, we focus on the sale, production and development of 3D printers. In addition, we sell refurbished 3D printers which were produced for and used in our Services segment. We also provide consumables, including particulate materials and proprietary chemical binding agents, maintenance contracts and spare parts to our customers.
In our Services segment, we print on-demand parts for our customers. At our service center, which we believe is one of the largest additive manufacturing service centers in Europe, we create parts, molds, cores and models based on designs produced using 3D computer-aided design, or CAD, software.
71
Our legal predecessor was founded in 1999 as Generis GmbH. We sold our first 3D printer in 2002 and commenced our on-demand parts services business in 2003. As of June 30, 2013, we had an installed base of 52 printers worldwide, and we operated one service center with approximately 16,000 square feet of production space.
Our revenues have grown to €8.7 million in 2012 from €4.8 million in 2010, representing a 35% compound annual growth rate.
Our total backlog of 3D printer orders at June 30, 2013 was €4.4 million. Our backlog has grown steadily as we continue to experience growing demand for our 3D printers. For the years ended December 31, 2012, 2011 and 2010, our backlog was €3.7 million, €1.7 million and €0.1 million, respectively. Our backlog, which consisted of six 3D printers as of June 30, 2013, represents 3D printers for which a customer has signed a purchase order, but which we have not shipped yet. We estimate that the vast majority of systems in our backlog will ship prior to December 31, 2013, with the remainder expected to ship prior to June 30, 2014.
Our Industry
Additive manufacturing, which is often referred to as 3D printing, is a process in which 3D printers produce parts designed with CAD software through the successive addition of thin layers of material until a three-dimensional shape is created. Additive manufacturing has traditionally been used for prototyping and concept modeling, but is now also increasingly being used in tooling, casting and direct part production. Many industrial and commercial customers have realized cost and time savings through the incorporation of additive manufacturing into their existing workflows, either complementing or replacing traditional manufacturing methods. Additive manufacturing processes do not require tooling, an integral part of traditional manufacturing, which allows for quicker turnaround times and minimal setup costs relative to traditional manufacturing. As additive manufacturing technologies continue to improve, particularly with respect to print speed and materials, we believe the addressable market for 3D printing solutions will continue to expand.
We believe that additive manufacturing provides several advantages over traditional design and manufacturing processes, including:
72
There are a number of available additive manufacturing technologies, including powder binding, inkjet, fused deposition modeling, stereolithography and selective laser sintering. The technologies differ on the basis of accuracy, surface quality, variety and properties of consumables, capacity, speed, color variety, transparency and the ability to print multiple materials, among other factors. Our 3D printers employ a powder binding technology to produce parts using various material sets. Powder binding is a process in which layers of powder are bonded by a liquid agent that is deposited through a printhead. We believe this process has the fastest build speeds and the lowest materials cost relative to other additive manufacturing technologies.
The worldwide market for additive manufacturing products and services has grown from $1.3 billion in 2010 to $2.2 billion in 2012, representing a 29% compound annual growth rate, according to the Wohlers Report 2013. The Wohlers Report 2013 projects the worldwide additive manufacturing products and services market to reach approximately $6.0 billion by 2017 and $10.8 billion by 2021, representing 2012-2017 and 2012-2021 compound annual growth rates of 22% and 19%, respectively. Much of the recent growth has been driven by the demand for production parts.
We believe that our addressable market is larger than the worldwide market for additive manufacturing products detailed in the Wohlers Report 2013. For example, the global market for machine tools totaled $93.2 billion in 2012, according to the 2013 World Machine Tool Output & Consumption Survey. In addition, according to the American Foundry Society, 90% of all manufactured goods contain some metal castings, with the global metal casting industry producing 98.6 million metric tons of metal castings in 2011 and the United States shipping $32.4 billion in metal castings in 2012. We believe these markets represent significant short and long-term revenue opportunities due to the advantages offered by our technology and the early adoption of additive manufacturing technologies in these markets.
Our Competitive Strengths
We believe that our competitive strengths include:
Build box size. The size of the build box is important to many industrial and commercial customers, who may want to produce either large-scale industrial parts or large quantities of discrete parts in one batch. We currently offer five 3D printer platforms with varying build box sizes, ranging from 300 × 200 × 150 millimeters to 4,000 × 2,000 × 1,000 millimeters. Among our systems, the VX4000 system offers a build box of 4,000 × 2,000 × 1,000 millimeters, representing a volume that is more than six times the volume of the next largest commercially available 3D printer.
Volumetric output rate. Due to our build box sizes and print speeds, we believe that our 3D printers provide among the highest output efficiency, as measured by the rate of volume output per hour, relative to competing additive manufacturing technologies. For example, our VX4000 machine features a volumetric output rate of 123.0 liters per hour, which we believe is the highest in the industry. Our
73
industry leading volumetric output rates enable us to produce parts meeting the specifications of our customers at a cost and speed that is attractive relative to traditional manufacturing alternatives, which effectively expands our addressable market.
Material sets. Our 3D printers can utilize various material sets, which include the combination of a particulate material, including sand or plastic, and our proprietary chemical binding agents. We believe that our currently commercialized material sets and technology can more readily address industrial and commercial applications than other additive manufacturing technologies because our materials meet or exceed the desired performance characteristics for a wide range of industrial and commercial applications or are already commonly used in traditional manufacturing processes. To meet our customer requirements, we are in varying stages of development of new material sets which include:
Track record of innovation. Our technology portfolio reflects our continued investments in a range of disciplines, including physics, chemistry, mechanical and electrical engineering and software development. We believe that we have a strong base of technology know-how, backed by our portfolio of intellectual property featuring patents and trade secrets covering processes, materials and equipment. As of June 30, 2013, we owned or co-owned 20 issued U.S. patents and 13 pending U.S. patent applications. In addition, we own or co-own patent rights in Europe, Asia and Canada. In total, as of June 30, 2013 our patent portfolio consisted of over 170 U.S. and international patents and patent applications. We also exchange information between our Services and our Systems segments to ensure that our development efforts are aligned with our customers' needs. We believe that we have a culture of innovation, and we expect to continue to enhance our solutions both to drive further market adoption of 3D printing and to broaden our market reach.
Strong customer relationships. We are an early entrant in the market for additive manufacturing industrial part production, and we are one of the few providers of additive manufacturing solutions to commercial and industrial customers within the foundry, automotive, heavy equipment, power fluid handling and aerospace industries. We believe we have a reputation for providing high-quality systems and services in the marketplace and have relationships with a number of leading multinational customers, including Daimler AG, BMW AG, Ford Motor Company, Hyundai Motor Company, Liebherr Group, Alphaform AG, 3D Systems Corporation, 3M Company, Volkswagen AG and Porsche SE, as well as with other key users of additive manufacturing in the film and entertainment industry, such as Propshop, and technical universities, such as the University of Rostock, the Technical University of Munich and the Vaal University of Technology. Many of our customers, including Daimler AG, BMW AG, Ford Motor Company, Propshop and the Technical University of Munich, are customers of both our Systems and Services segments. We pride ourselves on our ability to retain customers over time, as Daimler AG, BMW AG, Ford Motor Company, Volkswagen, Porsche SE and
74
the Technical University of Munich have all been customers for over a decade. We also collaborate on research and development projects with a number of our automotive and technical university customers, including Daimler AG, BMW AG, Ford Motor Company, Volkswagen AG and the Technical University of Munich. Together, these relationships provide us with significant insights into our customers' needs and help us to direct our research and development efforts.
Extensive global sales agent network. In addition to our direct sales force, we have built an extensive global network of over 25 sales agents in Europe, the Americas, the Middle East, Africa, Asia and Australia. We will continue to invest in expanding our distribution footprint to further penetrate our existing markets and to reach attractive new geographies. We currently print parts on demand for our customers from our service center in Europe, and we plan to expand our services footprint to include service centers in North America and Asia that are in closer proximity to our sales agents and end customers.
Our Business Strategies
The principal elements of our growth strategy include:
Enable adoption of our additive manufacturing technology. Our business model facilitates the adoption of our additive manufacturing technology by providing customers the ability to utilize our technology, either through our on-demand parts services or through the purchase of our 3D printers. Our customer relationships typically begin with the customer's purchase of parts, which we print in our on-demand parts service center. As our parts customers embrace additive manufacturing and our technology, they typically either increase the volume of their on-demand parts orders or purchase one of our 3D printers, or both depending on their needs.
Expand capacity via the development of high-volume service centers in key geographic locations. Our on-demand parts business plays an integral role in the sale of our 3D printers, as a majority of our 3D printer sales have been generated from customers of our on-demand parts business. We believe that the establishment of large-scale service centers will allow us to take advantage of significant economies of scale and will maximize our return on investment in our on-demand parts business. We are in the process of expanding our existing European service center from approximately 16,000 square feet to over 40,000 square feet of production space and, with a portion of the proceeds from this offering, we plan to establish new service centers in North America and Asia.
Invest in research and development. We seek to identify ways we can apply our technology and expertise to meet a wider range of customer needs for both 3D printers and services. We have successfully introduced five printer platforms since 2007, including the VXC800 in 2012, which we believe is the only continuous build 3D printer currently on the market, and the VX4000 in 2011, which offers the largest commercially available 3D printer build box, and we anticipate introducing a sixth printer platform in the fourth quarter of 2013. We continuously work with our customers to develop new material sets that will facilitate the adoption of our technology. In 2012, 2011 and 2010, we spent 18%, 18% and 23% of our revenues, respectively, on research and development investment.
Expand our sales and marketing presence. We plan to increase our market awareness by adding sales agents and increasing marketing efforts in order to increase sales of 3D printers and on-demand parts. We plan to expand our direct sales force and our network of over 25 sales agents throughout Europe, the Americas, the Middle East, Africa, Asia and Australia. We currently market our brand and our services at industry conferences, trade shows, and across various forms of digital and traditional media, and we will increasingly expand our marketing efforts in North America and Asia in conjunction with our geographic expansion to those regions.
75
Further penetrate our targeted industry verticals. We continue to actively pursue opportunities in our targeted verticals, which utilize larger scale parts that require customization, complexity and short lead times. We believe our planned service center expansions, our continued investment in research and development and expanded sales and marketing capabilities will help us further penetrate these verticals. We serve our targeted industry verticals both directly and indirectly through foundries and service bureaus. Our targeted industry verticals include:
Our Additive Manufacturing Technology
Our printers build or print parts from digital designs produced using 3D CAD software by successively depositing thin layers of particulate materials. A printhead passes over each layer and deposits our proprietary chemical binding agent in the selected areas where the finished product will be created.
The following is a graphical depiction illustrating our manufacturing process:
Our 3D Printers
We currently produce five 3D printer platforms and we anticipate introducing a sixth printer platform in the fourth quarter of 2013. Our 3D printers consist of a build box that includes a machine platform and a controller. Our 3D printers differ based on build box size and print speeds, but all utilize our technology and can support each of our existing material sets and each of our material sets that are currently in development. As of June 30, 2013, we had an installed base of 52 printers worldwide, which includes (i) printers in our service center in Europe and (ii) printers which are no longer commercially available, but which we believe our customers continue to use.
76
The following table is a comparison of our 3D printer platforms:
Platform
|
VX4000 | VX2000 | VX1000 | |||
---|---|---|---|---|---|---|
Build Box (millimeters) |
4,000 × 2,000 × 1,000 | 2,000 × 1,000 × 1,000 | 1,060 × 600 × 500 | |||
External Dimensions (millimeters) |
19,500 × 3,800 × 7,000 | 4,900 × 2,600 × 2,300 | 2,400 × 2,800 × 2,000 | |||
Print Resolution (dots per inch) |
600 | 600 | 600 | |||
Layer Thickness (micrometers) |
120 300 | 100 400 | 100 300 | |||
Volumetric Output Rate (liters per hour) |
123 | 45 | 23 | |||
List Price* |
€1,600,000 | €995,000 €1,100,000 | €740,000 €785,000 | |||
Date of Introduction |
2011 | Q4 2013 est. | 2011 |
Platform
|
VXC800 | VX500 | VX200 | |||
---|---|---|---|---|---|---|
Build Box/Envelope ** (millimeters) |
850 × 500 × | 500 × 400 × 300 | 300 × 200 × 150 | |||
External Dimensions (millimeters) |
4,000 × 2,800 × 2,200 | 1,800 × 1,800 × 1,700 | 1,700 × 900 × 1,500 | |||
Print Resolution (dots per inch) |
600 | 600 | 300 | |||
Layer Thickness (micrometers) |
300 | 80 150 | 150 | |||
Volumetric Output Rate (liters per hour) |
18 | 3 | 0.7 | |||
List Price* |
€600,000 | €350,000 €370,000 | €125,000 | |||
Date of Introduction |
2012 | 2007 | 2012 |
Materials
Our commercialized material sets are comprised of sand and plastic particulate materials and their respective proprietary chemical binding agents. We believe these material sets are well suited for our commercial and industrial customers because these materials either (i) are commonly used in their existing manufacturing processes or (ii) match or exceed desired performance characteristics of existing materials being utilized in their manufacturing processes. Our sand material set offerings include four types of sands: (i) silica, (ii) kerphalite, (iii) zirconium oxide and (iv) chromite, with furane (used in our Services segment only), inorganic, shell molding and phenol resins as proprietary chemical binding agents. Our plastics material set offering is based on Poly(methyl methacrylate), or PMMA, and Polypor B and C as the proprietary chemical binding agents.
We are currently in varying stages of development of new material sets which include the following particulate materials:
77
On-demand Parts Services
At our service center, which, with approximately 16,000 square feet of production space, we believe is one of the largest additive manufacturing service centers in Europe, we create parts, molds, cores and models for a variety of industrial and commercial customers based on designs produced using 3D CAD software. We receive orders directly from customers and indirectly through our sales agents.
We help our customers move from the design stage to the production stage by assisting them in evaluating the optimal design and material sets for their production needs. After printing parts, we employ a thorough cleaning, finishing, quality control review and packaging and shipping process to ensure the customer receives high-quality and immediately-usable parts. Based on our capacity utilization, the lead time required for us to print a part for a customer ranges from three to 21 days and is typically five business days. Due to the size of the printers' build boxes utilized in our service center, specifically the VX4000 printer, we are able to print more parts simultaneously on one printer than anyone else in the industry, resulting in cost-effective and quick turnaround times for our customers' print jobs and increased revenue and profitability for us.
Our technicians also train customers on operating, maintaining and troubleshooting our 3D printers through hands-on experience at our service center. Additionally, our technicians provide field support to our customers as needed.
We are in the process of expanding our existing service center to approximately 40,000 square feet of production space, which we anticipate will be completed in the fourth quarter of 2013. With a portion of the proceeds from this offering, we plan to establish new on-demand parts service centers in North America and Asia.
Our Customers
We are an early entrant in the market for industrial part production utilizing additive manufacturing and are one of the few providers of additive manufacturing solutions to industrial customers, including the foundry, automotive, heavy equipment, power fluid handling and aerospace industries. We believe we have a reputation for providing high-quality systems and services in the marketplace with strong relationships with a number of leading multinational customers, including Daimler AG, BMW AG, Ford Motor Company, Hyundai Motor Company, Liebherr Group, Alphaform AG, 3D Systems Corporation, 3M Company, Volkswagen AG and Porsche SE, as well as with other key users of additive manufacturing in the film and entertainment industry, such as Propshop, and technical universities such as the University of Rostock, the Technical University of Munich and the Vaal University of Technology. Purchasers of our printers also include original equipment manufacturers, government agencies and independent service bureaus that provide rapid prototyping and manufacturing services to their customers. Many of our customers, including Daimler AG, BMW AG, Ford Motor Company, Propshop and the Technical University of Munich, are customers of both our Systems and Services segments. We pride ourselves on our ability to retain customers over time, as Daimler AG, BMW AG, Ford Motor Company, Volkswagen AG, Porsche SE and the Technical University of Munich have all been customers for over a decade. We also collaborate on research and development projects with a number of our automotive and technical university customers, including Daimler AG, BMW AG, Ford Motor Company, Volkswagen AG and the Technical University of Munich. As our customers integrate additive manufacturing into their production processes, they
78
typically continue to utilize our on-demand parts service center for a variety of reasons, including for incremental capacity and for parts printed from different material sets.
We conduct a significant portion of our business with a limited number of customers. Our top five customers represented 29%, 35% and 45% of total revenues for the years ended December 31, 2012, 2011 and 2010, respectively, though no single customer accounted for more than 10% of our revenues in the year ended December 31, 2012. These customers primarily purchased 3D printers. Sales of on-demand parts and consumables tend to be from repeat customers that may utilize the capability of our on-demand parts service center for one month or longer. Sales of 3D printers are low volume and generate significant revenues, but the same customers do not necessarily buy printers in each period. Timing of customer purchases is dependent on the customer's capital budgeting cycle, which may vary from period to period. The nature of the revenues from 3D printers does not leave us dependent upon a single or a limited number of customers. Rather, the timing of the sales can have a material effect on our period to period financial results.
Selected Applications of Our Technology
The following examples depict objects that have been created using our 3D printers:
Sand Parts: | ||||
|
|
|
|
|
Designer chair |
|
Art |
|
Sand mold for production of gear unit in Imperia GP Roadster car |
|
|
|
||
Racing intake manifold |
|
Pump housing |
|
Francis impeller |
79
Plastic Parts: | ||||
|
|
|
|
|
Aston Martin DB5 car model for the James Bond film "Skyfall" |
|
Designer lamp |
|
Architectural model |
|
|
|
|
|
Automotive 2-stroke-engine |
|
Art with complex geometry |
|
Formula 1 racing gearbox |
Sales and Marketing
We sell our 3D printers and related consumables both our direct sales force and with the assistance of our network of more than 25 sales agents globally. Our sales organization, including our dedicated sales, service and application engineers, is responsible for worldwide sales of our 3D printers and on-demand parts services, as well as for the management and coordination of our growing sales agent network. Our direct sales force focuses primarily on customers in Europe, while our sales agents are responsible for facilitating sales in other areas of the world where we do not operate directly. We have entered into partnership agreements with each of our sales agents, which grant the sales agent the right to market our products in a specified territory on either an exclusive or non-exclusive basis, depending on the sales agent; however, all sales contracts for our products are entered into between us and our customers. Certain of these sales agents also provide maintenance services to customers in their specified territories. Our application engineers provide professional services through pre-sales support and assist existing customers so that they can take advantage of our latest consumables and techniques to improve part quality and machine productivity. This group also leverages our customer contacts to help identify new application opportunities that utilize our proprietary processes. As of June 30, 2013, our worldwide sales staff for systems and parts consisted of 18 employees.
Educating our customers and raising awareness in our target markets about the many uses and benefits of our 3D printing technology is an important part of our sales process. We believe that customers who experience the efficiency gains, decreased lead times, increased design flexibility and reduced costs of 3D printing as compared to subtractive manufacturing are more likely to purchase our 3D printers and utilize our on-demand parts services. We encourage potential purchasers of our 3D printers to first utilize our on-demand parts services so that they can experience firsthand the benefits of our 3D printing technology. We currently market our brand and our services at industry conferences, trade shows, and across various forms of digital and traditional media and plan to increasingly expand our
80
marketing efforts in North America and Asia in conjunction with our geographic expansion to those regions.
Services and Warranty
Our fully-trained service technicians perform installations of our 3D printers. For the first year following the purchase of one of our 3D printers, we provide complimentary service and support under a warranty. We also offer service contracts under which our customers can purchase maintenance and services beyond the one-year term of the warranty. These service contracts contain varying degrees of support services and are priced accordingly. Finally, we sell spare parts which we maintain in stock to assist in providing service expeditiously to our customers. Historically, we have not experienced a high level of warranty claims.
Manufacturing and Suppliers
Manufacturing
We assemble our 3D printers at our facility in Friedberg, Germany using components sourced from distributors of standard electrical or mechanical parts, as well as from manufacturers which design custom parts tailored to the proprietary designs of our machines. We periodically review the quality and performance of our distributors and manufacturers. Upon completion of the assembly of our 3D printers, we perform tests to ensure that the printer is functioning properly before the system is shipped and again after the system is installed at the customer's site.
To provide customers with assurance regarding the quality and consistency of our systems, we obtained ISO 9001: 2008 certification for our facilities in 2010. ISO 9001: 2008 provides a structure for a quality management system that strives for customer satisfaction, consistent quality and efficiency. In addition, there are internal benefits such as improved customer satisfaction, interdepartmental communications, work processes and customer-and-supplier partnerships. The ISO 9000 family of standards relates to quality management systems and is designed to help organizations ensure that they meet the needs of customers and other stakeholders.
Inventory and Suppliers
We maintain an inventory of certain parts to facilitate the timely assembly of products required by our production plan. While most components used in our 3D printers are available from multiple suppliers, certain of these components are only available from limited sources. We consider our limited-source suppliers, including the suppliers of our printheads, to be reliable; however, the loss of one of these suppliers could result in a delay in our operations. This type of delay could require us to find and re-qualify components supplied by one or more new vendors. Although we consider our relationships with our suppliers to be good, we continue to develop risk management plans for these critical suppliers.
Research and Development
We have an ongoing research and development program to develop new 3D printers and material sets and to improve and expand the capabilities of our existing 3D printers and related material sets. As of June 30, 2013, we had approximately 50 active research and development projects in various stages of completion. Our development efforts are augmented by development arrangements with research institutions, customers and suppliers of material and hardware, among others. In certain instances, such development arrangements involve commitments from us for prospective research and development expenditures. As of June 30, 2013, we had 24 employees working in our research and development department.
81
In addition to our internally-developed technology platforms, we have licensed the rights to intellectual property developed by third parties through licensing agreements that may obligate us to pay a license fee or royalty, typically based upon a dollar amount per unit or a percentage of the revenues generated by such products. The amount of such royalties was not material to our results of operations or financial position for the year ended December 31, 2012.
Our research and development expenses were €1.6 million, €1.3 million and €1.1 million for the years ended December 31, 2012, 2011 and 2010, respectively.
A significant portion of our research and development expenditures have been focused upon developing proprietary systems, processes and materials, including:
We also regularly apply for research and development grants and subsidies under European and German grant rules for small and medium enterprises. The majority of these grants and subsidies are non-refundable. We have received grants and subsidies from different authorities, including the German Federal Ministry of Economics and Technology ( Bundesministerium für Wirtschaft und Technologie ), the Bavarian Research Foundation ( Bayerische Forschungsstiftung ) and the German Federal Foundation Environment ( Deutsche Bundesstiftung Umwelt ).
We expect to continue to invest significantly in research and development in the future.
Intellectual Property
We consider our proprietary technology to be important to the development, manufacture, and sale of our products and seek to protect such technology through a combination of patents, trademarks, and trade secrets. We also have in place confidentiality agreements and other contractual arrangements with our employees, consultants, customers and others.
Patents. As of June 30, 2013, we owned or co-owned 20 issued U.S. patents and 13 pending U.S. patent applications. In addition, we own or co-own patent rights in Europe, Asia and Canada. In total, as of June 30, 2013 our patent portfolio consisted of over 170 U.S. and international patents and patent applications. Our currently issued patents will expire at different times in the future, with the earliest expiring in 2017 and the latest expiring in 2029. Our currently pending applications will generally remain in effect for 20 years from the date of the initial applications.
These patent assets are complemented by our marketing, business development and applications know-how and our ongoing research and development efforts. Nevertheless, there can be no assurance
82
that our patents, licenses or other intellectual property rights will afford us a meaningful competitive advantage in the fast-paced and innovative field in which we operate.
Trade Secrets. As is true in our industry generally, the development of our products, processes and materials has involved a considerable amount of experience, manufacturing and processing know-how and research and development techniques. We protect our proprietary processes and technologies with a blend of patent protection and trade secret protection. As part of our overall intellectual property strategy, we protect our non-patented proprietary knowledge as trade secrets through confidentiality controls and through the use of nondisclosure and confidentiality agreements.
Licenses. We are a party to various licenses and other arrangements that allow us to practice and improve our technology under a range of patents, patent applications and other intellectual property, including license agreements with ExOne, Z Corp, and Bego Medical GmbH, or Bego, each described in more detail below.
In 2003, we entered into an agreement with Extrude Hone GmbH (now doing business as ExOne and parent company to Prometal RCT GmbH, the entity currently holding the transferred rights) related to patents and technologies using certain binders and sand-based casting methods. Under the terms of this agreement, we granted to ExOne exclusive rights to make and sell machines exploiting these technologies in return for a purchase by ExOne of a 40% ownership share in the relevant patents and related technologies and an ongoing obligation to pay royalties to us. We also agreed to a corresponding 60%/40% split in revenues generated from any licenses granted by ExOne. Under this agreement, we are permitted to use machines and provide services relating to these technologies, but not to make or sell machines utilizing these technologies without ExOne's consent, although ExOne has an obligation to consent if the machines do not compete with products engineered, manufactured or sold by ExOne or its affiliates. If we intend to sell any of the intellectual property that is the subject of this agreement, we are required to notify ExOne thereof and ExOne would then have the option to acquire our ownership share of such intellectual property at fair market value within one month of such notice. Similarly, ExOne has a right of first refusal regarding the purchase of any developments and improvements we make to such intellectual property and a set of six patents (including one U.S. patent) related to wax technologies, as well as the right to negotiate to receive a license to such developments and improvements. We later signed an amendment with ExOne specifically allowing us to use the subject patents for our own 3D printers working with plastics. As a part of this agreement, we also agreed to pay a license fee in the low single digits that is based on the net sales price of covered plastic printing machines. The obligation of both parties to pay royalties under this agreement extends until the expiration of the last issued patent included in the list of transferred patent assets.
While our rights are restricted regarding use of certain binders and sand-based casting methods in 3D printers under our agreements with ExOne, we believe these restrictions will not materially impact the growth of our business, as we have developed processes which do not rely upon the subject patent portfolio, associated agreements and related technologies.
In 2004, we entered into a non-exclusive license and sublicense agreement with Z Corp, which allows us to make, use and sell 3D printing equipment for the fabrication of plastic parts utilizing organic powder binders under certain Z Corp and MIT patents. In return for these rights, we agreed to pay an initial license fee and ongoing tiered royalties at a royalty rate in the mid-single digits. We later amended this agreement, expanding our permitted use of the licensed powder-binder technology to include inorganic powder, ceramics, and concrete printing in a process that does not require post-processing other than oven baking parts or liquid infiltration, but restricting us to monochromatic color configurations. The agreement extends until the expiration of the licensed patents; we can terminate the agreement with six months prior written notice, and Z Corp can terminate the
83
agreement if we fail to make payments or otherwise commit a material breach that we fail to cure. In the event of a change in our control, which includes any transaction that involves the transfer of more than 50% of the voting power of our securities to a person or persons different from the persons who held those securities immediately prior to such transaction, Z Corp has the right to terminate the agreement by written notice to us, but has agreed to consider our interests as well as its own before terminating the agreement.
In 2012, we entered into a cross-licensing agreement with Bego pursuant to which each party granted to the other certain exclusive rights regarding each parties' patents and applications directed to continuous additive manufacturing. We granted to Bego an exclusive license to market patent-covered products in the field of laser-sintering and other related technologies, while Bego granted to us an exclusive license to market patent-covered products in the field of powder-binder technology (other than for dental applications). We also agreed to pay to Bego a royalty in the low single digits and to pay a participation fee to Bego in the event that we grant any sublicenses to the technology (which, to date, we have not done). This agreement automatically terminates upon the expiration of the last patent subject to the agreement.
Trademarks. We have secured the Voxeljet trademark in Europe.
Competition
Our principal competitors consist of other developers of 3D printing systems and providers of 3D printing services. These companies use a variety of additive manufacturing technologies, including:
Some of the companies that have developed and use one or more additive manufacturing technologies to compete with us include: ExOne, 3D Systems Corporation, Stratasys Ltd. and EOS GmbH.
These technologies, which compete for market share in the additive manufacturing industry, possess various competitive advantages and disadvantages relative to one another within key categories, including resolution, accuracy, surface quality, variety and properties of the materials they use and produce, capacity, speed, color, transparency and the ability to print multiple materials. Due to these multiple categories, we believe end-users usually make technology purchasing decisions based on the characteristics that they value most for a particular application. The competitive environment that has developed is therefore intense and dynamic, as market players often position their technologies to capture multiple vertical markets.
Despite the challenging competitive landscape, we believe that we have several competitive advantages, including the size of our build platforms, our printing speeds, the volumetric output rate of our 3D printers and the variety of qualified material sets that we offer to commercial and industrial customers.
84
We also compete with established subtractive manufacturers in the industrial products market. However, we believe that we are well positioned to expand our share of the industrial products market as additive manufacturing gains recognition and increases its cost-effectiveness. As our technologies improve and our unit cost of production decreases, we expect to be able to better compete with subtractive manufacturing on a wide range of products, thereby expanding our addressable market.
Seasonality
Historically, our results of operations have been subject to seasonal factors. Purchases of our 3D printers often follow a seasonal pattern owing to the capital budgeting cycles of our customers. Generally, 3D printer sales are higher in our second and fourth fiscal quarters than in our first and third fiscal quarters. Sales in our Services segment generally are not affected by seasonality. See "Risk Factors Risks Related to Our Business and Industry Our revenues and operating results may fluctuate."
Backlog
Our total backlog of 3D printer orders at June 30, 2013 was €4.4 million. Our backlog has grown steadily as we continue to experience growing demand for our 3D printers. For the years ended December 31, 2012, 2011 and 2010, our backlog was €3.7 million, €1.7 million and €0.1 million, respectively. Our backlog, which consisted of six 3D printers as of June 30, 2013, represents 3D printers for which a customer has signed a purchase order, but which we have not shipped yet. We estimate that the vast majority of systems in our backlog will ship prior to December 31, 2013, with the remainder expected to ship prior to June 30, 2014.
Employees
As of June 30, 2013, we had a total of 87 employees, including trainees and temporary staff. Almost all of our current employees are located in Germany, paid in euros and subject to German labor law.
None of our employees is a member of a labor union or is a party to a collective bargaining agreement. We consider our employee relations to be good and have never experienced a work stoppage.
Properties
Our corporate headquarters and on-demand parts service center are located in Friedberg, Germany, where we currently lease or sublease production hall spaces of approximately 33,150 square feet, office spaces of approximately 10,950 square feet and storage spaces of approximately 3,800 square feet. In October 2012, we renewed and extended our lease agreement regarding these premises. The renewed lease agreement covers additional spaces consisting of a new production hall and a new office building, both of which are currently being constructed by the landlord. After we move into these additional spaces, our lease will cover production hall spaces of approximately 60,050 square feet, office spaces of approximately 21,635 square feet and storage spaces of approximately 6,380 square feet. Our modified lease agreement expires on September 30, 2028, subject to an option to extend. The aggregate annual lease and sublease payments for our facilities in 2012 were €0.3 million. In addition, we plan to use a portion of the proceeds from this offering to establish new on-demand parts service centers in North America and Asia. We believe that our existing facilities, together with our new facilities under construction, are adequate for our current and foreseeable requirements.
We do not currently own any real property.
85
Regulatory/Environmental Matters
We are subject to environmental, health and safety regulations in Germany, as well as in the countries where our products and materials are used or sold.
Germany
Legal Requirements for Manufacturing Sites
Emissions Control Law. We currently do not require any permits granted under the Federal Emissions Control Act ( Bundes-Immissionsschutzgesetz , or BImSchG). However, we currently use resins ( Harze ) to create models for customers. A building permit that was granted to us in June 2010 by the city of Friedberg permitted us to use the building in a different manner and reconstruct one of our production sites for the usage of several resins. The building permit was granted under the condition ( Auflage ) that the amount of resins processed by us does not exceed 10 kilograms per hour. If we process more resin in the future, we will need to obtain a permit under BImSchG. Facilities that are subject to BImSchG are required to comply with the current state of the art ( Stand der Technik ) in emissions reduction and safety technology. It is therefore possible that we will need to periodically upgrade our facilities that are subject to BImSchG requirements in the future in order to comply with evolving technical standards.
Production, Possession and Handling of Waste and Dangerous Goods. Our business activities result in the generation, possession and handling of waste, including hazardous waste. Under the German Act on Recycling ( Kreislaufwirtschaftsgesetz , or KrWG), the generation, possession and handling of waste is subject to several obligations, depending, among other things, on the waste concerned. As the producer ( Erzeuger ) and possessor ( Besitzer ) of waste, we are generally responsible for the proper handling of this waste.
Section 50 of the KrWG requires producers, possessor, collectors and transporters of waste and disposal firms to verify to the competent authority proper disposal of hazardous waste ( gefährliche Abfälle ). Whether a certain substance qualifies as hazardous waste is determined according to the German Ordinance on the European Waste List (Verordnung über das Europäische Abfallverzeichnis ).
We further comply with the International Maritime Dangerous Goods Code, which is accepted as an international guideline for the safe transportation or shipment of dangerous goods or hazardous materials by water.
We also comply with the Regulation (EC) No. 1907/2006 of the European Parliament and of the Council of December 18, 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH).
We have entered into an agreement with a third party in Germany to serve as our external risk prevention officer ( Gefahrgutbeauftragter ). The risk prevention officer ensures that we comply with specific regulations and provisions when dangerous goods are shipped.
Legal Requirements Related to Products
Product Safety. Our products are used in a wide range of industries. As some of our products may be used directly by customers, we are subject to the Product Safety Act ( Produktsicherheitsgesetz , or ProdSG), which relates to general product safety. With the ProdSG of November 8, 2011 and the ninth regulation to the ProdSG as amended ( Neunte Verordnung zum Produktsicherheitsgesetz ( Maschinenverordnung )), the German legislature transformed, among other European Directives, the Directive 2006/42/EC of the European Parliament and of the Council of May 17, 2006 on machinery
86
into German law. The ProdSG applies whenever products are made available on the market, exhibited or used for the first time in the context of a commercial activity, but only in the absence of other legal provisions that provide for corresponding or more far-reaching provisions.
Under the ProdSG, a product may be made available on the market only if it complies with specific regulations for such product, or, in the absence of such specific regulations, if its intended or foreseeable use does not put the health and safety of persons at risk.
In addition to compliance with this safety requirement, if products are made available to consumers, manufacturers must provide consumers with the necessary information to enable them to assess the risks inherent in such product where such risks are not immediately obvious without adequate warnings and to take precautions against those risks. If manufacturers or distributors of consumer products discover that a product is dangerous, they must notify the competent authorities and, if necessary, cooperate with them. Under certain circumstances, a product may have to be recalled.
Occupational Health and Safety Requirements. Where the working environment may pose threats to employees, occupational health and safety laws are applicable. German law on occupational safety is heavily influenced by the requirements of EU law. The central rules on occupational safety in Germany are contained in the Act on Occupational Safety ( Arbeitsschutzgesetz , or ArbSchG), which requires employers to provide for their employees' safety. This general obligation is put into effect through several ordinances ( Rechtsverordnungen ) under the ArbSchG, which are defined in technical guidelines. One central element is the Workplaces Ordinance ( Arbeitsstättenverordnung ), which contains various regulations on workplace conditions relating to, for example, ventilation, temperature and illumination.
Potential Liability for Products and Environmental Losses
Our business activities are such that product liability and liability for environmental damage are possible. Under general rules of the German Civil Code ( Bürgerliches Gesetzbuch , or BGB), fault-based compensation ( Schadensersatz ) is to be paid for breach of contract or unlawful infringements of legally protected rights. This obligation does not only apply to our own acts but may extend to behavior of individuals that work or undertake tasks for us under Sections 278, 831 BGB.
In addition, we may be strictly liable ( i.e. , liable regardless of our fault), as a Producer under the Product Liability Act ( Produkthaftungsgesetz , or ProdHaftG), for damages caused by a defective product. "Producer" means any participant in the production process, the importer of the defective product, any person putting a name, trademark or other distinguishing feature on the product, and any person supplying a product whose actual producer cannot be identified. "Defectiveness" means the lack of the safety which the general public is entitled to expect when taking into account, among other things, the presentation of the product and the uses to which it can reasonably be put.
Additionally, in case of damage to persons or property caused by our facility, we may additionally be strictly liable under the Act on Liability for Environmental Damage ( Umwelthaftungsgesetz ) and under the Environmental Damage Act ( Umweltschadensgesetz ).
Worldwide
Our operations and the activities of our employees, contractors and agents around the world are subject to the laws and regulations of numerous countries, including the United States. These laws and regulations include data privacy requirements, labor relations laws, tax laws, anti-competition regulations, prohibitions on payments to governmental officials, import and trade restrictions and export requirements. Violations of these laws and regulations could result in fines, criminal sanctions
87
against our officers, our employees, or us and may result in prohibitions on the conduct of our business. Any such violations could also result in prohibitions on our ability to offer our products and services in one or more countries and could materially damage our reputation, our ability to attract and retain employees, our business and our operating results.
Our operations (particularly in those countries with developing economies) are also subject to risks of violations of laws prohibiting improper payments and bribery, including the European Union Anti-Corruption Act, U.K. Bribery Act, U.S. Foreign Corrupt Practices Act and similar regulations in other jurisdictions. Although we intend to implement policies and procedures designed to ensure compliance with these laws, our employees, contractors, and agents may take actions in violation of such policies. Any such violations, even if prohibited by our policies, could subject us to civil or criminal penalties or otherwise have an adverse effect on our business and reputation.
Legal Proceedings
From time to time, we may be subject to various claims or legal, arbitral or administrative proceedings that arise in the ordinary course of our business. We are currently not a party to, and we are not aware of any threat of, any legal, arbitral or administrative proceedings which, in the opinion of our management, is likely to have a material adverse effect on our business, financial condition or results of operations.
Insurance
We maintain comprehensive business liability insurance coverage ( Betriebshaftpflichtversicherung "Compact-Firmenversicherung" ) for our business operations. In addition, we have obtained directors and officers liability insurance, which covers expenses, capped at a certain amount, that our management and supervisory board members and our executive managers may incur in connection with their conduct as members of our management and supervisory boards or executive managers. We also maintain insurance policies on our 3D printers, a group insurance policy for our employees covering occupational accidents, car insurance policies and a legal expenses insurance policy. We consider the insurance coverage we have to be adequate in light of the risks we face.
Geographic Information
Our revenues by geographic region for the year ended December 31, 2012 were EMEA 85%, Asia Pacific 11% and Americas 4%, as compared to EMEA 98%, Asia Pacific 1% and Americas 1% for the same period in 2011.
88
Overview
We are a German stock corporation ( Aktiengesellschaft , or AG ) with our registered seat in Germany. We are subject to German legislation on stock corporations, most importantly the German Stock Corporation Act ( Aktiengesetz, or AktG ). In accordance with the German Stock Corporation Act ( Aktiengesetz ), our corporate bodies are the management board ( Vorstand ), the supervisory board ( Aufsichtsrat ) and the shareholders' meeting ( Hauptversammlung ). Our management board and our supervisory board are entirely separate and, as a rule, no individual may simultaneously be a member of both boards.
Our management board is responsible for the day-to-day management of our business in accordance with applicable laws, our articles of association ( Satzung ) and the management board's internal rules of procedure ( Geschäftsordnung ). Our management board represents us in our dealings with third parties.
The principal function of our supervisory board is to supervise our management board. The supervisory board is also responsible for appointing and removing the members of our management board and representing us in connection with transactions between a current or former member of the management board and us.
Under German law, members of both boards owe a duty of loyalty and care to us. In carrying out their duties, they are required to exercise the standard of care of a prudent and diligent businessperson. If they fail to observe the appropriate standard of care, they may become liable to us.
In carrying out their duties, the members of both boards may take into account a broad range of considerations when making decisions, including our interests and the interests of our shareholders, employees, creditors and, to a limited extent, the general public, while respecting the rights of our shareholders to be treated on equal terms. Additionally, the management board is responsible for implementing an internal monitoring system for risk management purposes.
Our supervisory board has comprehensive monitoring responsibilities. To ensure that our supervisory board can carry out these functions properly, our management board must, among other things, regularly report to our supervisory board regarding our current business operations and future business planning (including financial, investment and personnel planning). In addition, our supervisory board is entitled to request special reports from the management board at any time.
Under German law, our shareholders have no direct recourse against the members of our management board or our supervisory board if they have breached their duty of loyalty and care to us. Apart from insolvency or other special circumstances, only the company has the ability to claim damages against the members of our two boards. We may waive these claims to damages or settle these claims only if at least three years have passed since any violation of a duty occurred and only if our shareholders approve the waiver or settlement at a shareholders' meeting with a simple majority of the votes cast; provided that shareholders who in the aggregate hold one-tenth or more of our share capital do not oppose the waiver or settlement and have their opposition formally recorded in the meeting's minutes by a German civil law notary.
The following description, as far as it relates to our articles of association, is based on the articles of association, which are expected to be adopted by our general shareholders' meeting on October 11, 2013.
89
Supervisory Board
Our supervisory board currently consists of three members, which is the minimum number of members allowed under German law. As we grow, our supervisory board may be required to include employee representatives subject to the provisions of the German One-Third Employee Representation Act ( Drittelbeteiligungsgesetz ) and the German Codetermination Act ( Mitbestimmungsgesetz ).
Currently, all of the members of our supervisory board are elected by the shareholders' meeting in accordance with the provisions of the German Stock Corporation Act ( Aktiengesetz ). German law does not require the majority of our supervisory board members to be independent. The rules of procedure for our supervisory board provide that the supervisory board should be composed of a majority of independent members, as determined by the supervisory board. Under the supervisory board's rules of procedure, a board member is deemed to be independent if such member has no business or personal relationships with us or the management board that could constitute a conflict of interest.
Under German law, the members of a supervisory board may be elected for a term of up to approximately five years, depending on the dates of the annual general meeting at which the members of the supervisory board are elected, which is the standard term of office. Reelection, including repeated reelection, is permissible. The shareholders' meeting may specify a term of office for individual members or all of the members of our supervisory board which is shorter than the standard term of office and, subject to statutory limits, may set different start and end dates for the terms of members of our supervisory board. Since voxeljet AG was incorporated (as VXLT 2013 AG) on July 2, 2013, the original members of the supervisory board were elected to serve only until the end of the shareholders' meeting which resolves the discharge of the first business year. In other words, an election of members to our supervisory board will occur at the shareholders' meeting that takes place in 2014.
The shareholders' meeting may, at the same time as it elects the members of the supervisory board, elect one or more substitute members. The substitute members replace members who cease to be members of our supervisory board and take their place for the remainder of their respective terms of office. We have not elected any substitute members.
Members of our supervisory board may be dismissed at any time during their term of office by a resolution of the shareholders' meeting adopted by a simple majority of the votes cast. In addition, any member of our supervisory board may resign at any time by giving one month written notice of his or her resignation to the chairperson of our supervisory board (in case the chairperson resigns, such notice is to be given to the vice chairperson). Our supervisory board may agree upon a shorter notice period.
Our supervisory board elects a chairperson and a vice chairperson from its members. The vice chairperson exercises the chairperson's rights and obligations whenever the chairperson is unable to do so. On July 2, 2013, Peter Nietzer, Dr. Stefan Söhn and Prof. Dr. Joachim Heinzl were appointed as members of our supervisory board. The members of our supervisory board have elected Peter Nietzer as chairperson and Dr. Stefan Söhn as vice chairperson, each for the term of their respective membership on our supervisory board.
The supervisory board meets at least twice during the first half and twice during the second half of each fiscal year. Our articles of association and the supervisory board's rules of procedure provide that a quorum of the supervisory board members is present if at least half of its members, but in any case no less than three members, participate in the vote. Members of our supervisory board are deemed present if they participate via telephone or video conference, subject to no other member of the
90
supervisory board raising any objection to this type of participation. Any absent member may also participate in the voting by submitting his or her written vote through another member.
Resolutions of our supervisory board are passed by the vote of a simple majority unless otherwise required by law, our articles of association or the rules of procedure of our supervisory board. In the event of a tie, the chairperson casts the tie-breaking vote.
Our supervisory board is not permitted to make management decisions, but, in accordance with German law and in addition to its statutory responsibilities, it has determined that the following matters, among others, require its prior consent:
Our supervisory board may designate further types of actions requiring its approval.
Section 2(2) of the rules of procedure of our supervisory board provides that a supervisory board member may not continue to serve on our supervisory board past their 75th birthday.
91
The following table sets forth the names and functions of the current members of our supervisory board, their ages, their terms (which expire on the date of the relevant year's general shareholders' meeting) and their principal occupations outside of our company as of September 1, 2013:
Name
|
Age | Term Expires | Principal occupation | ||||
---|---|---|---|---|---|---|---|
Peter Nietzer (Chairman) |
52 | 2014 * | Managing director of asset management firm | ||||
Dr. Stefan Söhn (Vice Chairman) |
59 | 2014 * | Consultant and lawyer | ||||
Prof. Dr. Joachim Heinzl |
73 | 2014 * | University professor (retired) |
The business address of the members of our supervisory board is the same as our business address: voxeljet AG, Paul-Lenz-Straße 1b, 86316 Friedberg, Germany. Our supervisory board has determined that all members of our supervisory board are independent under German law and the New York Stock Exchange Listed Company Manual.
The following is a brief summary of the business experience of the members of our supervisory board:
Peter Nietzer , born in 1960 in Heilbronn, Germany, has been the chairman of our supervisory board since July 2, 2013. Mr. Nietzer has served as owner and managing director of KITES Industriebeteiligungen GmbH, a private investment holding company, and of M59 Advisory Services, since January 2013 and as Partner and Chief Financial Officer of GermanCapital GmbH, a private equity company he co-founded and that specializes in mid-market buy-outs, since July 2005. Mr. Nietzer has served as a Non-Executive Director of Cognis Credit Opportunities Fund Ltd., Cognis Credit Opportunities Master Fund Ltd. and Cognis Credit Opportunities Manager (Cayman) Ltd. since September 2013. Since April 2000, Mr. Nietzer has been an executive board member and Managing Partner of Felicitas GmbH (which was previously known as GI Ventures AG), a fund management company he helped found. Mr. Nietzer served as a Managing Director in the private equity unit of PartnersGroup AG from January to October 2011. Mr. Nietzer holds a M.B.A. from Friedrich-Alexander University Erlangen-Nürnberg, Germany. We believe that Mr. Nietzer's over 12 years of experience in private equity and his previous roles as a supervisory board member provide him with valuable insight into our business, particularly in the areas of financing and acquisition opportunities, while his focus on technology companies gives him insight into our operations and industry. In addition, Mr. Nietzer's work as a chief financial officer provides the supervisory board with expertise in financial matters.
Dr. Stefan Söhn , born in 1954 in Düsseldorf, Germany, has been the vice chairman of our supervisory board since July 2, 2013. Since January 2010, Dr. Söhn has served as a Partner and Managing Director of MBL China Consulting GmbH, as owner and manager of Söhn Industrial Consulting and as Of Counsel Lawyer and Head of China Desk of Sonntag & Partner Wirtschaftsprüfer, Steuerberater, Rechtsanwälte in Augsburg and Munich, Germany. Dr. Söhn held executive positions at KUKA Systems GmbH, an equipment supplier to the automotive industry, from July 2000 to December 2009, serving as its Chief Financial Officer from July 2000 to December 2006 and as its Chief Executive Officer from January 2007 to December 2009. Dr. Söhn also served on KUKA Systems GmbH's management board from January 2009 to December 2009. During his time at KUKA Systems GmbH, Dr. Söhn led the successful expansion of its business in Asia. Dr. Söhn also serves as the chairman of the supervisory board of PW Automation AG, as the deputy chairman of the supervisory board of Scheuffele Holding and as a member of the supervisory board of Stadtsparkasse Augsburg. Dr. Söhn holds a law degree from the University of Augsburg, Germany and a Master of Science in Management for the London Business School. We believe that Dr. Söhn's business experience in the automotive
92
industry and in expanding corporate operations into Asia will assist us as we seek to grow our business. In addition, we believe that Dr. Söhn's various experiences throughout his career, including his work as an attorney, chief financial officer and member of the supervisory boards of several companies, including public companies, provides our supervisory board with a broad range of knowledge and insight.
Prof. Dr. Joachim Heinzl , born in 1940 in Aussig, Czech Republic, has been a member of our supervisory board since July 2, 2013. Prof. Dr. Heinzl has served as Professor Emeritus at the Technical University of Munich, Germany since 2005. Prior to becoming Professor Emeritus, Prof. Dr. Heinzl had been the Chair for Precision Engineering and Micro Technology at the Technical University of Munich since 1978 and served the Technical University of Munich as Vice-Dean and Dean of the Faculty of Mechanical Engineering from 1988 to 1992 and as First Vice President from 1995 to 2002. Prof. Dr. Heinzl focused a large portion of his research on technology relating to 3D printing while on the faculty of the Technical University of Munich. From 2006 to 2012, Prof. Dr. Heinzl was the President of the Bavarian Research Foundation. Prof. Dr. Heinzl also co-founded our company as Generis GmbH in 1999. Prof. Dr. Heinzl holds a diploma in mechanical engineering and a doctorate in electroacoustics from the Technical University of Munich. We believe that Prof. Dr. Heinzl's vast knowledge of technical and engineering matters, including 3D printing technology, provides our supervisory board with additional insight into the technical details of our operations and industry.
Supervisory Board Practices
Decisions are generally made by our supervisory board as a whole; however, decisions on certain matters may be delegated to committees of our supervisory board to the extent permitted by law. The chairperson, or if he or she is prevented from doing so, the vice chairperson, chairs the meetings of the supervisory board and determines the order in which the agenda items are discussed, the method and order of the voting, any adjournment of the discussion and passing of resolutions on individual agenda items after a due assessment of the circumstances.
Pursuant to Section 107(3) AktG, the supervisory board may form committees from among its members and charge them with the performance of specific tasks. The committees' tasks, authorizations and processes are determined by the supervisory board. Where permissible by law, important powers of the supervisory board may also be transferred to committees.
Under Article 7 of its internal rules of procedure, the supervisory board has set up and appointed a Compensation and Nomination Committee and an Audit Committee.
Compensation and Nomination Committee
Pursuant to our articles of association and the rules of procedure of our supervisory board, the Compensation and Nomination Committee prepares hiring and personnel decisions for approval by the supervisory board and performs the following functions:
93
The Compensation and Nomination Committee monitors the management board's adherence to the rules of procedure of the management board. The rules of procedure of the management board contain, among other things, obligations for the management board to provide certain information to the Compensation and Nomination Committee.
All current members of the supervisory board are members of the Compensation and Nomination Committee. Our supervisory board will make a determination as to whether each member of the Compensation and Nomination Committee satisfies the independence requirements of the New York Stock Exchange.
Audit Committee
Our Audit Committee assists the supervisory board in overseeing the accuracy and integrity of our accounting and financial reporting processes and audits of our financial statements, the effectiveness of the internal control system and our compliance with legal and regulatory requirements, the independent auditors' qualifications and independence and the performance of the independent auditors.
The Audit Committee's duties and responsibilities to carry out its purposes include, among others:
94
In addition, under German law, each member of the supervisory board is obliged to carry out his or her duties and responsibilities personally, and such duties and responsibilities cannot be generally and permanently delegated to third parties. However, the supervisory board and its committees, including the Audit Committee, have the right to appoint third party experts for the review and analysis of specific circumstances in accordance with its control and supervision duties under German law. For example, the supervisory board could retain an audit firm and/or legal counsel if it wants to investigate potentially illegal activities occurring in a foreign subsidiary. We will bear the costs for any such independent experts that are retained by the supervisory board or any of its committees, including the Audit Committee.
The Audit Committee consists of three members. The chairman of the Audit Committee shall be independent and shall, in particular, not be a former member of our management board whose appointment ended less than two years prior to his or her appointment as chairman of the Audit Committee.
Furthermore, the chairman of the Audit Committee shall have special knowledge and experience in the application of accounting principles and internal control procedures and shall therefore qualify as an "audit committee financial expert" as defined under the Exchange Act.
Management Board
Overview
Under German law and the company's articles of association, the management board must consist of one or more persons and the supervisory board determines the exact number of members of the management board. The supervisory board also appoints the chairman and the deputy chairman of the management board, if any. Currently, the management board consists of two members, with Dr. Ingo Ederer appointed as Chief Executive Officer and Rudolf Franz appointed as Chief Financial Officer.
Members of our management board conduct the daily business of our company in accordance with applicable laws, our articles of association and the rules of procedure for the management board. The management board is in general responsible for the management of our company and for handling our daily business relations with third parties, the internal organization of our business and communications with our shareholders. In addition, the management board has the responsibility for:
95
The supervisory board appoints the members of the management board for a maximum term of five years. Reappointment or extension of the term for up to five years is permissible. The supervisory board may revoke the appointment of a management board member prior to the expiration of his or her term for good cause only, such as for gross breach of fiduciary duties or if the shareholders' meeting passes a vote of no-confidence with respect to such member, unless the supervisory board deems the no-confidence vote to be clearly unreasonable. The supervisory board is also responsible for entering into, amending and terminating service agreements with the management board members and, in general, for representing us in disputes with the management board, both in and out of court. The supervisory board may assign these duties to a committee of the supervisory board, except in certain cases where the approval of the entire supervisory board is required, such as the approval of the compensation of members of our management board and the reduction of the compensation of members of our management board upon a deterioration of our situation, which includes, among other things, a bankruptcy or the layoff of a significant number of employees.
According to our articles of association, as long as there are two or more management board members, either (i) two management board members or (ii) one management board member acting jointly with an authorized representative ( Prokurist ) have the authority to act on our behalf. The supervisory board may grant any management board member the right to represent us alone and may release any member of the management board from the restrictions on multiple representations under Section 181, 2nd Case of the German Civil Code ( Bürgerliches Gesetzbuch ).
Under the board member service agreements and by a special resolution of the supervisory board, all members of the management board have been granted authority to represent us alone and were released from the restrictions imposed by Section 181, 2nd Case of the German Civil Code.
The management board has the authority to determine our business areas and operating segments and resolve upon the internal allocation of responsibility for certain business areas and operating segments among the various members of the management board by setting up a business responsibility plan ( Geschäftsverteilungsplan ). Since we currently have only two members of the management board, we do not have a business responsibility plan in place at this time.
Section 3(7) of the rules of procedure of our supervisory board provides that a management board member may not continue to serve on our management board past their 65th birthday.
Members of the Management Board
The following table sets forth the names and functions of the current members of our management board, their ages and their terms as of September 1, 2013:
Name
|
Age | Term ends | Position | ||||
---|---|---|---|---|---|---|---|
Dr. Ingo Ederer |
46 | June 30, 2017 | Chief Executive Officer | ||||
Rudolf Franz |
46 | June 30, 2017 | Chief Financial Officer |
The business address of the members of our management board is the same as our business address: voxeljet AG, Paul-Lenz-Straße 1b, 86316 Friedberg, Germany.
96
The following is a brief summary of the business experience of the members of our management board:
Dr. Ingo Ederer , born in 1967 in Weilheim, Germany, is one of our founders and is the key inventor of our technology. He has served as our Chief Executive Officer since 2013. Dr. Ederer co-founded our company as Generis GmbH in 1999 and served as our Managing Director from our incorporation in 1999 to 2013, building up the company from the start-up phase to become a leading provider of 3D printers for industrial and commercial customers. After graduating with a degree in mechanical engineering from the Technical University of Munich in 1993, Dr. Ederer started his career as researcher at the department of precision engineering at the Technical University of Munich where he received his Ph.D. in 2000 with a thesis on piezo-based micro-jetting devices. He contributes more than 20 years of experience in the 3D printing equipment market and is a holder of more than 50 patents in the field of 3D printing.
Rudolf Franz , born in 1967 in Friedberg, Germany, has served as our Chief Financial Officer since 2013. Mr. Franz, through his venture fund, Franz Industriebeteiligungen AG, has been one of our shareholders since 2003 and served as our Chief Operating Officer from 2003 to 2013, focusing on building our global sales and finance, accounting and administration structures. Mr. Franz has been the chairman of the supervisory board of Rettenmeier Holding AG since 2011. From 2007 to 2009, Mr. Franz served as the Managing Director of Hama Holding GmbH and was the chairman of the supervisory board of Wavelight AG from 2005 to 2009. In 1995, Mr. Franz was appointed as investment manager of Technologieholding VC GmbH, an international venture capital fund that invested in European technologies, and became partner in 1997, where he was responsible for managing the Munich investment team. After he sold his shares in Technologieholding VC GmbH to 3i Group plc in 2000, Mr. Franz served as Managing Director of 3i Group plc and was responsible for technology investments in the German-speaking market from 2000 to 2002. Mr. Franz studied political economics and industrial engineering at the University of Augsburg and the University of Munich and earned a master's degree from the University of Applied Science Munich in 1991.
Service Agreements
Dr. Ingo Ederer
On September 13, 2013, we entered into a service agreement with Dr. Ingo Ederer to serve as our Chief Executive Officer and a member of our management board. The service agreement has an effective date of September 1, 2013. This service agreement has a fixed term that expires on June 30, 2017. Dr. Ederer's service agreement can be terminated prior to June 30, 2017 only if he is terminated for cause by us or if he terminates the agreement for cause. Under German law, a contract can be terminated for cause only in exceptional circumstances ( i.e. , if the continuation of the contractual relationship is unacceptable for the terminating party). Termination for cause generally requires that a party repeatedly and severely breaches its contractual duties. To the extent Dr. Ederer's employment with us terminates during a business year, he is entitled to a pro rata portion of his bonus that reflects the percentage of the year that he worked for us.
Dr. Ederer's service agreement contains a covenant pursuant to which Dr. Ederer has agreed not to compete with us for a period of two years following the termination of his service agreement. Under German law, a non-compete covenant is only valid if the employee is compensated during the term of the non-compete obligation. As compensation for his non-compete covenant, Dr. Ederer will receive 100% of his fixed salary (but in no event less than 50% of the total compensation received in the preceding year) under his service agreement for the entire two-year term of the non-compete covenant. If Dr. Ederer is terminated for cause, we are not obligated to pay the compensation for the non-compete covenant, so long as we provide Dr. Ederer with a written statement disclaiming our obligation to pay this compensation. Furthermore, if Dr. Ederer's service agreement is terminated other
97
than for cause, we can waive Dr. Ederer's obligation to not compete, in which case we would not be required to pay the non-compete compensation to Dr. Ederer.
Rudolf Franz
On September 13, 2013, we entered into a service agreement with Rudolf Franz to serve as our Chief Financial Officer and a member of our management board. The service agreement has an effective date of September 1, 2013. This service agreement has a fixed term that expires on June 30, 2017. Mr. Franz's service agreement can be terminated prior to June 30, 2017 only if he is terminated for cause by us or if he terminates the agreement for cause. To the extent Mr. Franz's employment with us terminates during a business year, he is entitled to a pro rata portion of his bonus that reflects the percentage of the year that he worked for us.
Mr. Franz's service agreement contains a covenant pursuant to which Mr. Franz has agreed not to compete with us for a period of 18 months following the termination of his service agreement. As compensation for his non-compete covenant, Mr. Franz will receive 100% of his fixed salary (but in no event less than 50% of the total compensation received in the preceding year) under his service agreement for the entire 18-month term of the non-compete covenant. If Mr. Franz is terminated for cause, we are not obligated to pay the compensation for the non-compete covenant, so long as we provide Mr. Franz with a written statement disclaiming our obligation to pay this compensation. Furthermore, if Mr. Franz's service agreement is terminated other than for cause, we can waive Mr. Franz's obligation to not compete, in which case we would not be required to pay the non-compete compensation to Mr. Franz.
German Corporate Governance Code
The German Corporate Governance Code, or Corporate Governance Code, was originally published by the German Ministry of Justice ( Bundesministerium der Justiz ) in 2002 and was most recently amended on May 13, 2013 and published in the German Federal Gazette ( Bundesanzeiger ) on June 10, 2013. The Corporate Governance Code contains recommendations ( Empfehlungen) and suggestions ( Anregungen) relating to the management and supervision of German companies that are listed on a stock exchange. It follows internationally and nationally recognized standards for good and responsible corporate governance. The purpose of the Corporate Governance Code is to make the German system of corporate governance transparent for investors. The Corporate Governance Code includes corporate governance recommendations and suggestions with respect to shareholders and shareholders' meetings, the management and supervisory boards, transparency, accounting policies, and auditing.
There is no obligation to comply with the recommendations or suggestions of the Corporate Governance Code. The German Stock Corporation Act ( Aktiengesetz ) requires only that the management board and supervisory board of a German listed company issue an annual declaration that either (i) states that the company has complied with the recommendations of the Corporate Governance Code or (ii) lists the recommendations that the company has not complied with and explains its reasons for deviating from the recommendations of the Corporate Governance Code (so called Entsprechenserklärung) . In addition, a listed company is also required to state in this annual declaration whether it intends to comply with the recommendations or list the recommendations it does not plan to comply with in the future. These declarations have to be published permanently on the company's website. If the company changes its policy on certain recommendations between such annual declarations, it must disclose this fact and explain its reasons for deviating from the recommendations. Non-compliance with suggestions contained in the Corporate Governance Code need not be disclosed.
Following our listing on the New York Stock Exchange, the Corporate Governance Code will apply to us and we will be required to issue the annual declarations described above.
98
According to their respective rules of procedure, our management board and the supervisory board are obliged to comply with the Corporate Governance Code except for such provisions which they have explicitly listed in their annual declaration and for which they have stated that they do not comply with.
In particular, we adhere to the following significant recommendations of the Corporate Governance Code: (i) the supervisory board will establish a compensation and nomination committee ( Vergütungs-und Nominierungsausschuss ) as well as an audit committee ( Prüfungsausschuss ); (ii) the management board must keep the supervisory board closely informed, in particular with respect to measures which can fundamentally affect our financial situation; and (iii) significant management measures are subject to supervisory board approval.
However, particularly in the initial phase after our listing on the New York Stock Exchange, we expect to deviate from the recommendations and suggestions of the Corporate Governance Code in various respects. All deviations from the Corporate Governance Code recommendations will be published in the official annual declarations.
Code of Business Conduct and Ethics
In connection with the consummation of this offering, we intend to adopt a written code of business conduct and ethics, or code of conduct, which will outline the principles of legal and ethical business conduct under which we do business. The code of conduct will apply to all of our supervisory board members, management board members and employees. Upon the effectiveness of the registration statement of which this prospectus forms a part, the full text of the code of conduct will be available on our website at www.voxeljet.de . This website address is included in this prospectus as an inactive textual reference only. The information and other content appearing on our website are not part of this prospectus. Any amendments or waivers from the provisions of the code of conduct for members of our supervisory or management boards will be made only after approval by the appropriate body and will be disclosed on our website promptly following the date of such amendment or waiver.
Differences between Our Corporate Governance Practices and Those Set Forth in the New York Stock Exchange Listed Company Manual
In general, under Section 303A.11 of the New York Stock Exchange Listed Company Manual, foreign private issuers such as us are permitted to follow home country corporate governance practices instead of certain provisions of the New York Stock Exchange Listed Company Manual without having to seek individual exemptions from the New York Stock Exchange. A foreign private issuer making its initial U.S. listing on the New York Stock Exchange and following home country corporate governance practices in lieu of the corresponding corporate governance provisions of the New York Stock Exchange Listed Company Manual must disclose in its registration statement or on its website any significant ways in which its corporate governance practices differ from those followed by U.S. companies under the New York Stock Exchange Listed Company Manual. In addition, we also may qualify for certain exemptions under the New York Stock Exchange Listed Company Manual as a foreign private issuer that may affect our corporate governance practices.
The significant differences between the corporate governance practices that we follow and those set forth in the New York Stock Exchange Listed Company Manual are described below:
99
composed of a majority of independent members, though this is not a mandatory requirement. All current members of our supervisory board are independent.
Compensation of Management Board and Supervisory Board Members
Compensation of Management Board Members
We have entered into service agreements with the current members of our management board. These agreements generally provide for an annual fixed compensation (base salary), an annual performance award (annual bonus) with a target of up to 40% of the yearly base salary, as well as a long-term performance award for a three-business-year period (long-term bonus) with a target of up to 60% of the yearly base salary. The performance targets of the annual and long-term bonuses are a mixture of certain financial and non-financial targets, such as revenue and profitability goals, as well as a certain increase of the price of the ADSs being offered hereby. In addition to the fixed and variable
100
remuneration components, under the terms of their service agreements, the members of our management board are entitled to additional benefits (including company car arrangements, mobile phone, accident and director and officer liability insurance) and reimbursement of necessary and reasonable expenses.
We believe that the service agreements between us and the members of our management board provide for payments and benefits (including upon termination of employment) that are in line with customary market practice for similar companies who are operating in our industry.
In 2013, the two members of our management board are entitled to receive total compensation of up to €700,000, which includes base salary, bonus payments and other compensation as a result of other benefits as described above. In 2012, Dr. Ederer received total compensation of €250,996, which included base salary, bonus payments, company car allowance and other benefits including our contribution to a direct insurance plan for Dr. Ederer. In 2012, Mr. Franz was not one of our employees, but received €150,574 from us pursuant to an advisory agreement between us and Franz Industriebeteiligungen AG, a company owned by Mr. Franz and members of his family.
Compensation of Supervisory Board Members
Under mandatory German law, the compensation of the first supervisory board of a German stock corporation can only be determined by the shareholders' meeting that resolves on the discharge of the first members of the supervisory board. Because the supervisory board appointed at the time of our incorporation on July 2, 2013 is our first supervisory board, the final consideration payable to supervisory board members will be decided at our annual general shareholders' meeting that will take place in 2014.
However, we believe that the following remuneration system will be proposed to our shareholders at our 2014 annual general shareholders' meeting:
After its approval by our general shareholders' meeting in 2014, this proposed remuneration system will remain in force until it has been amended or terminated by our general shareholders' meeting.
Remuneration and Benefits in the Business Year 2012
Our supervisory board was established for the first time upon the incorporation of voxeljet AG (as VXLT 2013 AG), which was resolved upon on July 2, 2013 and became effective by registration with the commercial register on July 11, 2013. Our legal predecessor, Voxeljet Technology GmbH, did not have a supervisory board. Therefore, for the business years 2012 and earlier, no remuneration or benefits in kind were granted to supervisory board members, and no amounts were set aside or accrued by us for these purposes.
101
Share Ownership by Members of Supervisory Board and Management Board
Supervisory Board
Supervisory board member Prof. Dr. Joachim Heinzl holds 94,000 of our ordinary shares, which represented 4.7% of our ordinary shares as of September 12, 2013 (the date of the effectiveness of the merger between voxeljet AG and Voxeljet Technology GmbH) (or 2.7% after giving effect to this offering). None of the other members of the supervisory board held any of our ordinary shares as of September 1, 2013.
Management Board
Our CEO and founder, Dr. Ingo Ederer, holds 754,000 of our ordinary shares, which represented 37.7% of our ordinary shares as of September 12, 2013 (the date of the effectiveness of the merger between voxeljet AG and Voxeljet Technology GmbH) (or 22.0% after giving effect to this offering).
Our CFO, Rudolf Franz, holds 338,000 of our ordinary shares through Franz Industriebeteiligungen AG, which is wholly owned by Mr. Franz and members of his family, which represented 16.9% of our ordinary shares as of September 12, 2013 (the date of the effectiveness of the merger between voxeljet AG and Voxeljet Technology GmbH) (or 9.9% after giving effect to this offering).
102
Since January 1, 2010, there has not been, nor is there currently proposed, any material transaction or series of similar material transactions to which we were or are a party in which any of the members of our supervisory board and management board, executive officers, holders of more than 10% of any class of our voting securities, or any member of the immediate family of any of the foregoing persons, had or will have a direct or indirect material interest, other than the compensation and shareholding arrangements we describe where required in "Management" and "Principal and Selling Shareholders," and the transactions we describe below.
Shareholders' Agreement
On July 2, 2013, we entered into a shareholders' agreement with all of our shareholders prior to this offering. The shareholders' agreement defines the rights and obligations of the parties thereto as our shareholders and includes, inter alia , voting and approval requirements, rights of first refusal, tag-along and drag-along rights and potential redemption procedures. The shareholders' agreement automatically terminates upon closing and settlement of an initial public offering of our company.
Advisory Agreement with Franz Industriebeteiligungen AG
We entered into an advisory agreement with our shareholder Franz Industriebeteiligungen AG, or Franz AG, on November 18, 2003, as amended on June 30, 2009. Franz AG is wholly owned by Rudolf Franz, a member of our management board, and members of his family. The agreement provides for Franz AG to provide advisory services to us regarding business strategy, marketing, finance and international business development. Payments made to Franz AG under the advisory agreement were €150,574, €101,000 and €72,000 for the years ended December 31, 2012, 2011 and 2010, respectively.
The advisory agreement was mutually terminated by the parties on August 31, 2013.
Dr. Ederer's Personal Guarantee of a Loan from Bayerische Hypo-und Vereinsbank AG to the Company
The documents relating to a loan from Bayerische Hypo-und Vereinsbank AG to us provide for a separate personal guarantee of €75,000 of the loan by Dr. Ederer; however, Dr. Ederer has not entered into a separate document with Bayerische Hypo-und Vereinsbank AG guaranteeing the loan. We pay interest at a rate of 6.00% per annum on the amount that Dr. Ederer guarantees that is not otherwise reimbursed by one of our other shareholders (see immediately below). We paid interest to Dr. Ederer in connection with his guarantee in the amount of €1,125 in each of the years ended December 31, 2012, 2011 and 2010.
Shareholders' Undertaking Regarding Personal Guarantee of Dr. Ederer vis-à-vis Bayerische Hypo-und Vereinsbank AG
In connection with Dr. Ederer's personal guarantee of the loan from Bayerische Hypo-und Vereinsbank AG, pursuant to an agreement dated September 1, 2010, three of our shareholders have each agreed to reimburse Dr. Ederer €18,750 in case we default on the loan and Dr. Ederer is required to pay any sums under his personal guarantee. We pay an interest rate of 6.00% per annum on the amount that each of the three shareholders guarantees. We have paid interest to the three shareholders in the aggregate amount of €3,375 in each of the years ended December 31, 2012, 2011 and 2010.
103
Service Agreements
We have entered into service agreements with the members of our management board. See "Management Management Board Service Agreements."
Long Term Cash Incentive Plan
Effective January 1, 2013, we implemented a long-term cash incentive plan, or the Cash Incentive Plan, which we fund and which has a term of five years. The purpose of the Cash Incentive Plan is to motivate, attract and retain highly-qualified and valued senior management and other key personnel who are not members of our management board by linking their personal interests with the success of our business and the interests of our shareholders. Our supervisory board, which has adopted the Cash Incentive Plan, will oversee its operation. Our management board will implement and administer the plan. Participants in the Cash Incentive Plan are carefully selected by our management board in consultation with our supervisory board. The Cash Incentive Plan is an additional component of compensation to the respective employee beneficiary's salary and other employee benefits.
Under the Cash Incentive Plan, we issue Award Units to the selected employee beneficiaries. Each Award Unit entitles the beneficiary to participate in a fixed amount of any cash award that is declared by our management board. Each cash payment is subject to our achievement of certain long-term goals over assessment periods that are at least one year in length. The first cash payment, if any, is based on two performance targets: (1) top-line revenue growth for the annual business year and (2) the successful completion of our initial public offering of ADSs on the New York Stock Exchange on or before March 31, 2014. The ensuing assessment periods are each two years in duration and payments are based on two performance targets: (1) top-line revenue growth and (2) an increase in the average closing price of our listed ADSs over the initial public offering price during any 120-day period. Award Units bear certain forfeiture risks for the beneficiary, and payments under each Award Unit are due only if we continue to employ the beneficiary at the time of the close of the relevant assessment period.
The Cash Incentive Plan has a maximum distributable amount over the five-year period of up to 10% of the net proceeds that we receive from the closing of our initial public offering of ADSs on the New York Stock Exchange ( i.e. , gross proceeds less underwriting discounts and commissions and offering expenses). After the first assessment, up to 20% of the total distributable amount may be distributed based on actual performance in relation to the relevant performance targets. After the second assessment, 40% of the total distributable amount may be awarded, and after the third and final assessment, an additional 40% of the total distributable amount may be awarded. The relevant weighting of the performance targets after each assessment period to arrive at the cash award, if any, will be made in our management board's sole discretion based on our actual performance with respect to each target. Our management board, in consultation with our supervisory board, may change the performance targets applicable to any assessment period to reflect actual performance based on other acceptable performance metrics that are set forth in the Cash Incentive Plan and/or may extend the timeline for the accomplishment of the performance targets into the next assessment period in light of the circumstances arising at such time. The performance targets are not designed to be minimum thresholds that must be met before an award may be declared for the assessment period. Our management board may declare a cash award under the Cash Incentive Plan for such period if the management board, in consultation with our supervisory board, believes that our actual performance, while not attaining one or more of the specified targets, is nevertheless material and merits an award. Additionally, our supervisory board may amend or terminate the Cash Incentive Plan in its sole discretion at any time in its exercise of good faith judgment.
104
PRINCIPAL AND SELLING SHAREHOLDERS
The following table sets forth information, as of September 12, 2013 (the date of the effectiveness of the merger between voxeljet AG and Voxeljet Technology GmbH), regarding the beneficial ownership of our ordinary shares: (i) immediately prior to the consummation of this offering and (ii) as adjusted to reflect the sale of our ADSs in this offering, for:
The column entitled "Ordinary Shares Beneficially Owned Prior to the Offering Percent" is based on 2,000,000 ordinary shares outstanding as of September 12, 2013 (the date of the effectiveness of the merger between voxeljet AG and Voxeljet Technology GmbH). The columns entitled "Ordinary Shares Beneficially Owned After the Offering Excluding Exercise of Over-Allotment Percent" and "Ordinary Shares Beneficially Owned After the Offering Including Exercise of Over-Allotment Percent" are both based on 3,120,000 ordinary shares to be issued and outstanding immediately after the closing of this offering.
Beneficial ownership is determined in accordance with the rules and regulations of the SEC. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, we have included shares that the person has the right to acquire within 60 days of September 12, 2013 (the date of the effectiveness of the merger between voxeljet AG and Voxeljet Technology GmbH), including through the vesting of deferred share awards, exercise of any option, warrant or other right or the conversion of any other security. These shares, however, are not included in the computation of the percentage ownership of any other person. Unless otherwise indicated, the
105
business address of each such person is c/o voxeljet AG, Paul-Lenz Straße 1, 86316 Friedberg, Germany.
|
|
|
|
Ordinary Shares Beneficially
Owned After this Offering |
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ordinary Shares
Beneficially Owned Prior to this Offering |
Ordinary
Shares Sold in this Offering |
||||||||||||||||||||
|
Excluding
Exercise of Over-Allotment |
Including
Exercise of Over-Allotment |
||||||||||||||||||||
5% Shareholders and Members of our Supervisory and Management Boards
|
||||||||||||||||||||||
Number (1) | Percent (1) | Number | Number | Percent | Number | Percent | ||||||||||||||||
Franz Industriebeteiligungen AG (2) |
338,000 | 16.9 | % | 30,420 | 307,580 | 9.9 | % | 274,625 | 8.8 | % | ||||||||||||
Startkapital-Fonds Augsburg GmbH (3) |
338,000 | 16.9 | % | 30,420 | 307,580 | 9.9 | % | 274,625 | 8.8 | % | ||||||||||||
AleSta Beteiligungs GmbH (4) |
250,000 | 12.5 | % | 22,500 | 227,500 | 7.3 | % | 203,125 | 6.5 | % | ||||||||||||
Technologie Beteiligungsfonds Bayern GmbH & Co. KG (5) |
226,000 | 11.3 | % | 20,340 | 205,660 | 6.6 | % | 183,625 | 5.9 | % | ||||||||||||
Dr. Ingo Ederer |
754,000 | 37.7 | % | 67,860 | 686,140 | 22.0 | % | 612,625 | 19.6 | % | ||||||||||||
Rudolf Franz (6) |
338,000 | 16.9 | % | 30,420 | 307,580 | 9.9 | % | 274,625 | 8.8 | % | ||||||||||||
Prof. Dr. Joachim Heinzl |
94,000 | 4.7 | % | 8,460 | 85,540 | 2.7 | % | 76,375 | 2.4 | % | ||||||||||||
Peter Nietzer |
0 | | 0 | 0 | | 0 | | |||||||||||||||
Dr. Stefan Söhn |
0 | | 0 | 0 | | 0 | | |||||||||||||||
All Members of our Supervisory and Management Boards as a Group (5 persons): |
1,186,000 | 59.3 | % | 106,740 | 1,079,260 | 34.6 | % | 963,625 | 30.9 | % |
As of September 12, 2013, there were six individual holders of record entered in our share register, none of which we believe were U.S. residents. The number of individual holders of record is based exclusively upon our share register and does not address whether a share or shares may be held by the holder of record on behalf of more than one person or institution who may be deemed to be the beneficial owner of a share or shares in our company.
None of our shareholders will have different voting rights from other shareholders after the closing of this offering. We are not aware of any arrangement that may, at a subsequent date, result in a change of control of our company.
106
The following description is a summary of certain information relating to our share capital as well as certain provisions of our articles of association and the German Stock Corporation Act ( Aktiengesetz ). Unless stated otherwise, the description insofar as it relates to our articles of association is based on the amended version of our articles of association as adopted by our shareholders' meeting on , 2013, which is expected to be registered in the commercial register in due course prior to the completion of this offering. This summary does not purport to be complete and speaks as of the date of this prospectus. Copies of the articles of association will be publicly available from the commercial register ( Handelsregister ) of the local court in Augsburg, Germany, electronically at www.unternehmensregister.de and as an exhibit to the Registration Statement of which this prospectus forms a part.
Share Capital
As of the date of this prospectus, we have share capital registered in the commercial register in the amount of € , which is divided into ordinary registered shares ( Namensaktien ). All shares are no par-value shares ( Stückaktien ohne Nennbetrag ).
Incorporation of the Company
The legal predecessor of our company was founded as Generis GmbH on May 5, 1999 by our founders, Dr. Ingo Ederer, Prof. Dr. Joachim Heinzl and Rainer Höchsmann. The incorporation was registered with the commercial register of the local court ( Amtsgericht ) of Augsburg under the number HRB 17081 on May 25, 1999.
By a shareholders' resolution as of November 18, 2003, the name of our company was changed from Generis GmbH to Voxeljet Technology GmbH. The name change was registered with the commercial register of the local court of Augsburg on January 7, 2004.
On July 2, 2013, the former shareholders of Voxeljet Technology GmbH, Startkapital-Fonds Augsburg GmbH, Technologie Beteiligungsfonds Bayern GmbH & Co. KG, Franz Industriebeteiligungen AG, Dr. Ingo Ederer, Prof. Dr. Joachim Heinzl and AleSta Beteiligungs GmbH incorporated VXLT 2013 AG, which was registered in the commercial register of the local court of Augsburg on July 11, 2013 under number HRB 27999. Upon its incorporation, VXLT 2013 AG had a nominal share capital amounting to €50,000.
Voxeljet Technology GmbH was subsequently merged by way of merger through assumption into VXLT 2013 AG on July 29, 2013 effective as of September 12, 2013 upon registration of the merger in the commercial register of the surviving entity, VXLT 2013 AG. The merger had retroactive effect as of January 1, 2013. As part of the merger, VXLT 2013 AG changed its name to voxeljet AG effective upon the registration of the merger in the commercial register. By way of merger through assumption, voxeljet AG, as the surviving entity, has taken over all assets and liabilities of Voxeljet Technology GmbH by universal assumption and accession under German mandatory law, and Voxeljet Technology GmbH ceased to exist. As a result of the merger, voxeljet AG increased its share capital by €1,950,000, from €50,000 to €2,000,000 by issuing ordinary shares to the shareholders of the contributing entity, Voxeljet Technology GmbH, as compensation for the transfer and merger of Voxeljet Technology GmbH into voxeljet AG.
Since the merger was concluded within two years after the incorporation of voxeljet AG, the merger is considered to be a post-incorporation acquisition contract ( Nachgründungsvertrag ), which must be registered in the local commercial register with the local court of Augsburg in order to be valid pursuant to Section 67 of the German Transformation Act ( Umwandlungsgesetz ) in connection with
107
Section 52 AktG. We have complied with the respective requirements under German law, and the merger agreement was duly registered as a post-incorporation acquisition contract on September 12, 2013.
Two of our current shareholders, Startkapital-Fonds Augsburg GmbH and Technologie Beteiligungsfonds Bayern GmbH & Co. KG, used to be silent partners ( stille Gesellschafter ) in our legal predecessor, Voxeljet Technology GmbH. The silent partnership with Startkapital-Fonds Augsburg GmbH was terminated on November 18, 2003, on which date Startkapital-Fonds Augsburg GmbH and Technologie Beteiligungsfonds Bayern GmbH & Co. KG became direct shareholders in Voxeljet Technology GmbH. The silent partnership with Technologie Beteiligungsfonds Bayern GmbH & Co. KG was terminated on April 30, 2007.
Form, Certification and Transferability of the Shares
Our shares are in registered form. The form and contents of our share certificates, any dividend certificates, renewal certificates and interest coupons are determined by our management board with the approval of our supervisory board. A shareholder's right to certificated shares is excluded, to the extent permitted by law and to the extent certification is not required by the stock exchange on which the shares are admitted to trading. We are permitted to issue share certificates that represent one or more shares.
All of our outstanding shares are no par-value ordinary registered shares. Under German law, if a resolution regarding a capital increase does not specify whether such increase will be in bearer or registered form, the new shares resulting from such capital increase will be no par-value ordinary registered shares by default. Any resolution regarding a capital increase may determine the profit participation of the new shares resulting from such capital increase.
Our shares are freely transferable under German law, with the transfer of ownership governed by the rules of the relevant clearing system.
General Information on Capital Measures
Pursuant to our articles of association, an increase of our share capital generally requires a resolution passed at our shareholders' meeting with both a simple majority of the share capital represented at the relevant shareholders' meeting and a simple majority of the votes cast. The shareholders at such meeting may authorize our management board to increase our share capital with the consent of our supervisory board within a period of five years by issuing shares for a certain total amount ( genehmigtes Kapital or authorized capital), which is a concept under German law that enables us to issue shares without going through the process of obtaining a shareholders' resolution.
Furthermore, our shareholders may resolve to amend or create conditional capital ( bedingtes Kapital ); however, they may do so only to issue conversion or subscription rights to holders of convertible bonds, in preparation for a merger with another company or to issue subscription rights to employees and members of the management of our company or of an affiliated company by way of a consent or authorization resolution.
According to German law, any resolution pertaining to the creation of authorized or conditional capital requires the vote of at least three-quarters of the share capital represented at the relevant shareholders' meeting and a simple majority of the votes cast. The shareholders may also resolve to increase the share capital from company resources by converting capital reserve and profit reserves into share capital. Pursuant to our articles of association, any resolution pertaining to an increase in share capital from company resources requires the vote of a simple majority of the share capital represented at the relevant shareholders' meeting and a simple majority of the votes cast.
108
The aggregate nominal amount of the authorized capital created by the shareholders may not exceed one-half of the share capital existing at the time of registration of the authorized capital with the commercial register.
According to German law, the aggregate nominal amount of the conditional capital created at the shareholders' meeting may not exceed one-half of the share capital existing at the time of the shareholders' meeting adopting such resolution. The aggregate nominal amount of the conditional capital created for the purpose of granting subscription rights to employees and members of the management of our company or of an affiliated company may not exceed 10% of the share capital existing at the time of the shareholders' meeting adopting such resolution.
Any resolution relating to a reduction of our share capital requires the vote of at least three-quarters of the share capital represented at the relevant shareholders' meeting as well as a simple majority of the votes cast according to mandatory German law.
Changes in Our Share Capital during the Last Three Fiscal Years
As of July 2, 2013, the date of the incorporation of voxeljet AG, our share capital as registered with the commercial register amounted to €50,000. Since then, our share capital has changed as follows:
Authorized Capital
Our authorized capital as of the date of this prospectus amounted to € and was created by the resolution of our shareholders' meeting on October , 2013. Under this authorized capital, the management board is authorized, subject to the consent of the supervisory board, to increase the company's share capital by up to € through one or more issuances on or before by issuance of new no par-value shares against cash contributions and/or contributions in kind ( Genehmigtes Kapital ). With the consent of the supervisory board, the management board is authorized to exclude the shareholders' subscription rights in the following circumstances:
109
German Stock Corporation Act) than the stock exchange price for our shares of the same class and having the same conditions already listed at the time of the final determination of the issue price, and further provided that the amount of the share capital represented by the shares issued under the exclusion of the statutory subscription right granted pursuant to German law does not exceed 10% of the share capital at the time of this authorization coming into effect or being exercised. The 10% threshold shall include new or treasury shares of our company which are issued or transferred during the term of this authorized capital on another legal basis under the exclusion of the statutory subscription rights granted pursuant to German law.
Subscription Rights
According to the German Stock Corporation Act, every shareholder is generally entitled to subscription rights (commonly known as preemptive rights) to any new shares issued within the framework of a capital increase, including convertible bonds, bonds with warrants, profit-sharing rights or income bonds in proportion to the number of shares he or she holds in the corporation's existing share capital. Under German law, these rights do not apply to shares issued out of conditional capital. A minimum subscription period of two weeks must be provided for the exercise of such subscription rights.
Under German law, the shareholders' meeting may pass a resolution excluding subscription rights if at least three-quarters of the share capital represented adopts the resolution. To exclude subscription rights, the management board must also make a report available to the shareholders justifying the exclusion and demonstrating that the company's interest in excluding the subscription rights outweighs the shareholders' interest in having them. In addition to approval by the general shareholders' meeting, the exclusion of subscription rights requires a justification. The justification must be based on the principle that our interest in excluding subscription rights outweighs the shareholders' interest in their subscription rights and may be subject to judicial review. Accordingly, under German law, the exclusion of subscription rights upon the issuance of new shares is permitted, in particular, if we increase the share capital against cash contributions, if the amount of the capital increase does not exceed 10% of the existing share capital and the issue price of the new shares is not significantly lower than the market price of our shares.
The authorization of the management board to issue convertible bonds or other securities convertible into shares must be limited to a period not exceeding five years as of the respective shareholder resolution.
Shareholders' Meetings, Resolutions and Voting Rights
Pursuant to our articles of association, shareholders' meetings may be held at our registered offices, at the registered seat of a German stock exchange or in a German city with more than 100,000 inhabitants. In general, shareholders' meetings are convened by our management board. The supervisory board is additionally required to convene a shareholders' meeting in cases where this is required under binding statutory law ( i.e. , if this is in the best interest of our company). In addition, shareholders who, individually or as a group, own at least 5% of our share capital may request that our management board convene a shareholders' meeting. If our management board does not convene a shareholders' meeting upon such a request, the shareholders may petition the competent German court for authorization to convene a shareholders' meeting.
Pursuant to our articles of association, the notice of the convening of a shareholders' meeting must be made public at least 36 days prior to the meeting. Shareholders who, individually or as a group, own at least 5% or €500,000 of our share capital may require that modified or additional items be added to the agenda of the shareholders' meeting and that these items be published before the shareholders' meeting takes place.
110
Under German law, our annual general shareholders' meeting must take place within the first eight months of each fiscal year. Among other things, the general shareholders' meeting is required to decide on the following issues:
Each share carries one vote at a shareholders' meeting.
Our articles of association provide in Article 19 that the resolutions of the shareholders' meeting are adopted by a simple majority of the votes cast. To the extent required by law, certain resolutions may have to be approved by a simple majority of share capital represented at the meeting, in addition to the majority of votes cast.
Neither the German laws nor our articles of association provide for a minimum participation for a quorum for our shareholders' meetings.
Under German law, certain resolutions of fundamental importance require the vote of at least three-quarters of the share capital present or represented in the voting at the time of adoption of the resolution. Resolutions of fundamental importance include, in particular, capital increases with exclusion of subscription rights, capital decreases, the creation of authorized or conditional share capital, the dissolution of a company, a merger into or with another company, split-offs and split-ups, the conclusion of inter-company agreements ( Unternehmensverträge ), in particular control agreements ( Beherrschungsverträge ) and profit and loss transfer agreements ( Ergebnisabführungsverträge ), and a change of the legal form of a company.
Dividend Rights
Under German law, distributions of dividends on shares for a given fiscal year are generally determined by a process in which the management board and supervisory board submit a proposal to our annual general shareholders' meeting held in the subsequent fiscal year and such annual general shareholders' meeting adopts a resolution. German law provides that a resolution concerning dividends and distribution thereof may be adopted only if the company's unconsolidated financial statements under the applicable law show net retained profits. In determining the profit available for distribution, the result for the relevant year must be adjusted for profits and losses brought forward from the previous year and for withdrawals from or transfers to reserves. Certain reserves are required by law and must be deducted when calculating the profit available for distribution.
Shareholders participate in profit distributions in proportion to the number of shares they hold. Dividends on shares resolved by the general shareholders' meeting are paid annually, shortly after the general shareholders' meeting, in compliance with the rules of the respective clearing system. Dividend payment claims are subject to a three-year statute of limitation in the company's favor.
111
Liquidation Rights
Apart from liquidation as a result of insolvency proceedings, we may be liquidated only with a vote of the holders of at least three-quarters of the share capital represented at the shareholders' meeting at which such a vote is taken. If we are liquidated, any assets remaining after all of our liabilities have been paid off would be distributed among our shareholders in proportion to their holdings in accordance with German statutory law. The German Stock Corporation Act provides certain protections for creditors which must be observed in the event of liquidation.
Authorization to Acquire Our Own Shares
The shareholders' meeting adopted a resolution on October , 2013 authorizing the management board, for a period until October 10, 2018, subject to the consent of the supervisory board and provided it complies with the legal requirement of equal treatment, to purchase our shares in an amount up to 10% of our total share capital. The shares may be purchased by means of a sale on a stock exchange or an offer to all shareholders in one or more tranches and may be used for any purpose permitted by law. The management board is authorized to redeem the purchased shares without further resolution by the shareholders' meeting. The management board is also authorized to sell the purchased shares in other ways than a sale on a stock exchange or an offer to all shareholders under full or partial exclusion of the statutory subscription rights of the shareholders with the supervisory board's consent as follows: (i) to exclude shareholders' subscription rights for fractional amounts, (ii) by selling the purchased shares against consideration, (iii) by selling the purchased shares against cash consideration, if the consideration is not significantly lower than the market price at the time of the sale and (iv) to satisfy our obligations from option or conversion rights or conversion obligations (or combinations of these instruments) which grant a conversion or option right or an obligation to convert.
Squeeze-Out of Minority Shareholders
Under German law, the shareholders' meeting of a stock corporation may resolve upon request of a shareholder that holds at least 95% of the share capital that the shares held by any remaining minority shareholders be transferred to this shareholder against payment of "adequate cash compensation" ( Ausschluss von Minderheitsaktionären) . This amount must take into account the full value of the company at the time of the resolution, which is generally determined using the future earnings value method ( Ertragswertmethode ).
Objects and Purposes of Our Company
Our business purpose, as described in section 2 of our articles of association, is the development, production and distribution of 3D printers, 3D printing systems, three dimensional moulds, models and other 3D printing solutions and 3D products of materials of all kinds as well as supply of related services in that field including web-based sales.
We may engage in all business activities which serve, directly or indirectly, our business purpose. In particular, we are allowed to invest in, acquire interests in and dispose of other companies, and to establish domestic and foreign branch offices and subsidiaries. Furthermore, we may enter into agreements with our affiliates and third parties against consideration in the context of acting as a management holding company or operational holding company by way of direct or indirect corporate governance, management and administration of our affiliates.
Registration of the Company with Commercial Register
We are a German stock corporation ( Aktiengesellschaft , or AG ) that is organized under the laws of Germany. On July 11, 2013, our company was registered in the commercial register of Augsburg, Germany under the number HRB 27999.
112
DESCRIPTION OF AMERICAN DEPOSITARY SHARES
Citibank, N.A. has agreed to act as the depositary for the American Depositary Shares. Citibank's depositary offices are located at 388 Greenwich Street, New York, New York 10013. American Depositary Shares are frequently referred to as "ADSs" and represent ownership interests in securities that are on deposit with the depositary. ADSs may be represented by certificates that are commonly known as "American Depositary Receipts" or "ADRs." The depositary typically appoints a custodian to safekeep the securities on deposit. In this case, the custodian is Citigroup Global Markets Deutschland AG, located at Reuterweg 16, 60323 Frankfurt, Germany.
We have appointed Citibank as depositary pursuant to a deposit agreement. A copy of the deposit agreement will be filed with the SEC prior to effectiveness of the registration statement of which this prospectus forms a part under cover of a Registration Statement on Form F-6. You may obtain a copy of the deposit agreement from the SEC's Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549 and from the SEC's website at www.sec.gov . Please refer to Registration Number 333-191526 when retrieving such copy.
We are providing you with a summary description of the material terms of the ADSs and of your material rights as an owner of ADSs. Please remember that summaries by their nature lack the precision of the information summarized and that the rights and obligations of an owner of ADSs will be determined by reference to the terms of the deposit agreement and not by this summary. We urge you to review the deposit agreement in its entirety.
Each ADS represents the right to receive, and to exercise the beneficial ownership interest in, one-fifth of an ordinary share on deposit with the custodian. An ADS also represents the right to receive any other property received by the depositary or the custodian on behalf of the owner of the ADS but that has not been distributed to the owners of ADSs because of legal restrictions or practical considerations. The custodian, the depositary and their respective nominees will hold all deposited property for the benefit of the holders and beneficial owners of ADSs. The deposited property does not constitute the proprietary assets of the depositary, the custodian or their nominees. Beneficial ownership in the deposited property will under the terms of the deposit agreement be vested in the beneficial owners of the ADSs. The depositary, the custodian and their respective nominees will be the record holders of the deposited property represented by the ADSs for the benefit of the holders and beneficial owners of the corresponding ADSs. A beneficial owner of ADSs may or may not be the holder of ADSs. Beneficial owners of ADSs will be able to exercise beneficial ownership interests in the deposited property only through the registered holders of the ADSs, by the registered holders of the ADSs (on behalf of the applicable ADS owners) only through the depositary, and by the depositary (on behalf of the owners of the corresponding ADSs) directly, or indirectly through the custodian or their respective nominees, in each case upon the terms of the deposit agreement.
If you become an owner of ADSs, you will become a party to the deposit agreement and therefore will be bound to its terms and to the terms of any ADR that represents your ADSs. The deposit agreement and the ADR specify our rights and obligations as well as your rights and obligations as owner of ADSs and those of the depositary. As an ADS holder you appoint the depositary to act on your behalf in certain circumstances. The deposit agreement and the ADRs are governed by New York law. However, our obligations to the holders of ordinary shares will continue to be governed by the laws of Germany, which may be different from the laws in the United States.
In addition, applicable laws and regulations may require you to satisfy reporting requirements and obtain regulatory approvals in certain circumstances. You are solely responsible for complying with such reporting requirements and obtaining such approvals. Neither the depositary, the custodian, us or
113
any of their or our respective agents or affiliates shall be required to take any actions whatsoever on your behalf to satisfy such reporting requirements or obtain such regulatory approvals under applicable laws and regulations.
As an owner of ADSs, we will not treat you as one of our shareholders and you will not have direct shareholder rights. The depositary will hold on your behalf the shareholder rights attached to the ordinary shares underlying your ADSs. As an owner of ADSs you will be able to exercise the shareholders rights for the ordinary shares represented by your ADSs through the depositary only to the extent contemplated in the deposit agreement. To exercise any shareholder rights not contemplated in the deposit agreement you will, as an ADS owner, need to arrange for the cancellation of your ADSs and become a direct shareholder.
As an owner of ADSs, you may hold your ADSs either by means of an ADR registered in your name, through a brokerage or safekeeping account, or through an account established by the depositary in your name reflecting the registration of uncertificated ADSs directly on the books of the depositary (commonly referred to as the "direct registration system," or DRS). The direct registration system reflects the uncertificated (book-entry) registration of ownership of ADSs by the depositary. Under the DRS, ownership of ADSs is evidenced by periodic statements issued by the depositary to the holders of the ADSs. The DRS includes automated transfers between the depositary and The Depository Trust Company, or DTC, the central book-entry clearing and settlement system for equity securities in the United States. If you decide to hold your ADSs through your brokerage or safekeeping account, you must rely on the procedures of your broker or bank to assert your rights as ADS owner. Banks and brokers typically hold securities such as the ADSs through clearing and settlement systems such as DTC. The procedures of such clearing and settlement systems may limit your ability to exercise your rights as an owner of ADSs. Please consult with your broker or bank if you have any questions concerning these limitations and procedures. All ADSs held through DTC will be registered in the name of a nominee of DTC. This summary description assumes you have opted to own the ADSs directly by means of an ADS registered in your name and, as such, we will refer to you as the "holder." When we refer to "you," we assume the reader owns ADSs and will own ADSs at the relevant time.
The registration of the ordinary shares in the name of the depositary or the custodian shall, to the maximum extent permitted by applicable law, vest in the depositary or the custodian the record ownership in the applicable ordinary shares with the beneficial ownership rights and interests in such ordinary shares being at all times vested with the beneficial owners of the ADSs representing the ordinary shares. The depositary or the custodian shall at all times be entitled to exercise the beneficial ownership rights in all deposited property, in each case only on behalf of the holders and beneficial owners of the ADSs representing the deposited property.
Dividends and Distributions
As a holder of ADSs, you generally have the right to receive the distributions we make on the securities deposited with the custodian. Your receipt of these distributions may be limited, however, by practical considerations and legal limitations. Holders of ADSs will receive such distributions under the terms of the deposit agreement in proportion to the number of ADSs held as of a specified record date, after deduction of the applicable fees, taxes and expenses.
Distributions of Cash
Whenever we make a cash distribution for the securities on deposit with the custodian, we will deposit the funds with the custodian. Upon receipt of confirmation of the deposit of the requisite funds, the
114
depositary will arrange for the funds to be converted into U.S. dollars and for the distribution of the U.S. dollars to the holders, subject to the laws and regulations of Germany.
The conversion into U.S. dollars will take place only if practicable and if the U.S. dollars are transferable to the United States. The depositary will apply the same method for distributing the proceeds of the sale of any property (such as undistributed rights) held by the custodian in respect of securities on deposit.
The distribution of cash will be made net of the fees, expenses, taxes and governmental charges payable by holders under the terms of the deposit agreement. The depositary will hold any cash amounts it is unable to distribute in a non-interest bearing account for the benefit of the applicable holders and beneficial owners of ADSs until the distribution can be effected or the funds that the depositary holds must be escheated as unclaimed property in accordance with the laws of the relevant states of the United States.
Distributions of Ordinary Shares
Whenever we make a free distribution of ordinary shares for the securities on deposit with the custodian, we will deposit the applicable number of ordinary shares with the custodian. Upon receipt of confirmation of such deposit, the depositary will either distribute to holders new ADSs representing the ordinary shares deposited or modify the ADS-to-ordinary shares ratio, in which case each ADS you hold will represent rights and interests in the additional ordinary shares so deposited. Only whole new ADSs will be distributed. Fractional entitlements will be sold and the proceeds of such sale will be distributed as in the case of a cash distribution.
The distribution of new ADSs or the modification of the ADS-to-ordinary shares ratio upon a distribution of ordinary shares will be made net of the fees, expenses, taxes and governmental charges payable by holders under the terms of the deposit agreement. In order to pay such taxes or governmental charges, the depositary may sell all or a portion of the new ordinary shares so distributed.
No such distribution of new ADSs will be made if it would violate a law ( i.e. , the U.S. securities laws) or if it is not operationally practicable. If the depositary does not distribute new ADSs as described above, it may sell the ordinary shares received upon the terms described in the deposit agreement and will distribute the proceeds of the sale as in the case of a distribution of cash.
Distributions of Rights
Whenever we intend to distribute rights to purchase additional ordinary shares, we will give prior notice to the depositary and we will assist the depositary in determining whether it is lawful and reasonably practicable to distribute rights to purchase additional ADSs to holders.
The depositary will establish procedures to distribute rights to purchase additional ADSs to holders and to enable such holders to exercise such rights if it is lawful and reasonably practicable to make the rights available to holders of ADSs, and if we provide all of the documentation contemplated in the deposit agreement (such as opinions to address the lawfulness of the transaction). You may have to pay fees, expenses, taxes and other governmental charges to subscribe for the new ADSs upon the exercise of your rights. The depositary is not obligated to establish procedures to facilitate the distribution and exercise by holders of rights to purchase new ordinary shares other than in the form of ADSs.
115
The depositary will not distribute the rights to you if:
The depositary will sell the rights that are not exercised or not distributed if such sale is lawful and reasonably practicable. The proceeds of such sale will be distributed to holders as in the case of a cash distribution. If the depositary is unable to sell the rights, it will allow the rights to lapse.
Elective Distributions
Whenever we intend to distribute a dividend payable at the election of shareholders either in cash or in additional ADSs, we will give prior notice thereof to the depositary and will indicate whether we wish the elective distribution to be made available to you. In such case, we will assist the depositary in determining whether such distribution is lawful and reasonably practicable.
The depositary will make the election available to you only if it is reasonably practicable and if we have provided all of the documentation contemplated in the deposit agreement. In such case, the depositary will establish procedures to enable you to elect to receive either cash or additional ADSs, in each case as described in the deposit agreement.
If the election is not made available to you, you will receive either cash or additional ADSs, depending on what a shareholder in Germany would receive upon failing to make an election, as more fully described in the deposit agreement.
Other Distributions
Whenever we intend to distribute property other than cash, ordinary shares or rights to purchase ordinary shares, we will notify the depositary in advance and will indicate whether we wish such distribution to be made to you. If so, we will assist the depositary in determining whether such distribution to holders is lawful and reasonably practicable.
If it is reasonably practicable to distribute such property to you and if we provide all of the documentation contemplated in the deposit agreement, the depositary will distribute the property to the holders in a manner it deems practicable.
The distribution will be made net of fees, expenses, taxes and governmental charges payable by holders under the terms of the deposit agreement. In order to pay such taxes and governmental charges, the depositary may sell all or a portion of the property received.
The depositary will not distribute the property to you and will sell the property if:
116
The proceeds of such a sale will be distributed to holders as in the case of a cash distribution.
Redemption
Whenever we decide to redeem any of the securities on deposit with the custodian, we will notify the depositary in advance. If it is practicable and if we provide all of the documentation contemplated in the deposit agreement, the depositary will provide notice of the redemption to the holders.
The custodian will be instructed to surrender the shares being redeemed against payment of the applicable redemption price. The depositary will convert the redemption funds received into U.S. dollars upon the terms of the deposit agreement and will establish procedures to enable holders to receive the net proceeds from the redemption upon surrender of their ADSs to the depositary. You may have to pay fees, expenses, taxes and other governmental charges upon the redemption of your ADSs. If less than all ADSs are being redeemed, the ADSs to be retired will be selected by lot or on a pro rata basis, as the depositary may determine.
Changes Affecting Ordinary Shares
The ordinary shares held on deposit for your ADSs may change from time to time. For example, there may be a change in nominal or par value, a split-up, cancellation, consolidation or any other reclassification of such ordinary shares or a recapitalization, reorganization, merger, consolidation or sale of assets of us.
If any such change were to occur, your ADSs would, to the extent permitted by law, represent the right to receive the property received or exchanged in respect of the ordinary shares held on deposit. The depositary may in such circumstances deliver new ADSs to you, amend the deposit agreement, the ADRs and the applicable Registration Statement(s) on Form F-6, call for the exchange of your existing ADSs for new ADSs and take any other actions that are appropriate to reflect as to the ADSs the change affecting the ordinary shares. If the depositary may not lawfully distribute such property to you, the depositary may sell such property and distribute the net proceeds to you as in the case of a cash distribution.
Issuance of ADSs upon Deposit of Ordinary Shares
Upon the completion of this offering, the share certificates representing the ordinary shares that are being offered for sale by us and the selling shareholders pursuant to this prospectus will be deposited with the custodian. Upon receipt of confirmation of such deposit, the depositary will issue the ADSs to the underwriters named in this prospectus.
After the closing of this offering, the depositary may create ADSs on your behalf if you or your broker deposit ordinary shares with the custodian. The depositary will deliver these ADSs to the person you indicate only after you pay any applicable issuance fees and any charges and taxes payable for the transfer of the ordinary shares to the custodian. Your ability to deposit ordinary shares and receive ADSs may be limited by U.S. and German legal considerations applicable at the time of deposit.
The issuance of ADSs may be delayed until the depositary or the custodian receives confirmation that all required approvals have been given and that the ordinary shares have been duly transferred to the custodian. The depositary will only issue ADSs in whole numbers.
117
When you make a deposit of ordinary shares, you will be responsible for transferring good and valid title to the depositary. As such, you will be deemed to represent and warrant that:
If any of the representations or warranties are incorrect in any way, we and the depositary may, at your cost and expense, take any and all actions necessary to correct the consequences of the misrepresentations.
Transfer, Combination and Split Up of ADRs
As an ADR holder, you will be entitled to transfer, combine or split up your ADRs and the ADSs evidenced thereby. For transfers of ADRs, you will have to surrender the ADRs to be transferred to the depositary and also must:
To have your ADRs either combined or split up, you must surrender the ADRs in question to the depositary with your request to have them combined or split up, and you must pay all applicable fees, charges and expenses payable by ADR holders, pursuant to the terms of the deposit agreement, upon a combination or split up of ADRs.
Withdrawal of Ordinary Shares Upon Cancellation of ADSs
As a holder, you will be entitled to present your ADSs to the depositary for cancellation and then receive the corresponding number of underlying ordinary shares at the custodian's offices. Your ability to withdraw the ordinary shares may be limited by U.S. and German considerations applicable at the time of withdrawal. In order to withdraw the ordinary shares represented by your ADSs, you will be required to pay to the depositary the fees for cancellation of ADSs and any charges and taxes payable
118
upon the transfer of the ordinary shares being withdrawn. You assume the risk for delivery of all funds and securities upon withdrawal. Once canceled, the ADSs will not have any rights under the deposit agreement.
If you hold ADSs registered in your name, the depositary may ask you to provide proof of identity and genuineness of any signature and such other documents as the depositary may deem appropriate before it will cancel your ADSs. The withdrawal of the ordinary shares represented by your ADSs may be delayed until the depositary receives satisfactory evidence of compliance with all applicable laws and regulations. Please keep in mind that the depositary will only accept ADSs for cancellation that represent a whole number of securities on deposit.
You will have the right to withdraw the securities represented by your ADSs at any time except for:
The deposit agreement may not be modified to impair your right to withdraw the securities represented by your ADSs except to comply with mandatory provisions of law.
Voting Rights
As a holder, you generally have the right under the deposit agreement to instruct the depositary to exercise the voting rights for the ordinary shares represented by your ADSs. The voting rights of holders of ordinary shares are described in the section entitled "Description of Share Capital Shareholders' Meetings, Resolutions and Voting Rights" in this prospectus.
At our request, the depositary will distribute to you any notice of shareholders' meeting received from us together with information explaining how to instruct the depositary to exercise the voting rights of the securities represented by ADSs.
If the depositary timely receives voting instructions from a holder of ADSs, it will endeavor to vote the securities (in person or by proxy) represented by the holder's ADSs in accordance with such voting instructions.
Please note that the ability of the depositary to carry out voting instructions may be limited by practical and legal limitations and the terms of the securities on deposit. We cannot assure you that you will receive voting materials in time to enable you to return voting instructions to the depositary in a timely manner. Securities for which no voting instructions have been received will not be voted.
119
Fees and Charges
As an ADS holder, you will be required to pay the following fees under the terms of the deposit agreement:
Service
|
Fees
|
|
---|---|---|
(1) Issuance of ADSs upon deposit of shares (excluding issuances as a result of distributions of shares described in (4) below) | Up to U.S. 5¢ per ADS issued | |
(2) Cancellation of ADSs |
|
Up to U.S. 5¢ per ADS canceled |
(3) Distribution of cash dividends or other cash distributions ( i.e. , sale of rights or other entitlements) |
|
Up to U.S. 5¢ per ADS held |
(4) Distribution of ADSs pursuant to (i) stock dividends or other free stock distributions or (ii) exercise of rights to purchase additional ADSs. |
|
Up to U.S. 5¢ per ADS held |
(5) Distribution of securities other than ADSs or rights to purchase additional ADSs ( i.e. , spin-off shares) |
|
Up to U.S. 5¢ per ADS held |
(6) ADS Services |
|
Up to U.S. 5¢ per ADS held on the applicable record date(s) established by the depositary |
As an ADS holder you will also be responsible to pay certain charges such as:
ADS fees and charges payable upon (i) deposit of ordinary shares against issuance of ADSs and (ii) surrender of ADSs for cancellation and withdrawal of ordinary shares are charged to the person to whom the ADSs are delivered (in the case of ADS issuances) and to the person who delivers the ADSs for cancellation (in the case of ADS cancellations). In the case of ADSs issued by the depositary into
120
DTC or presented to the depositary via DTC, the ADS issuance and cancellation fees and charges are charged to the DTC participant(s) receiving the ADSs or the DTC participant(s) surrendering the ADSs for cancellation, as the case may be, on behalf of the beneficial owner(s) and will be charged by the DTC participant(s) to the account(s) of the applicable beneficial owner(s) in accordance with the procedures and practices of the DTC participant(s) as in effect at the time. ADS fees and charges in respect of distributions and the ADS service fee are charged to the holders as of the applicable ADS record date. In the case of distributions of cash, the amount of the applicable ADS fees and charges is deducted from the funds being distributed. In the case of (i) distributions other than cash and (ii) the ADS service fee, holders as of the ADS record date will be invoiced for the amount of the ADS fees and charges. For ADSs held through DTC, the ADS fees and charges for distributions other than cash and the ADS service fee are charged to the DTC participants in accordance with the procedures and practices prescribed by DTC and the DTC participants in turn charge the amount of such ADS fees and charges to the beneficial owners for whom they hold ADSs.
In the event of refusal to pay the depositary fees, the depositary may, under the terms of the deposit agreement, refuse the requested service until payment is received or may set off the amount of the depositary fees from any distribution to be made to the ADS holder.
Note that the fees and charges you may be required to pay may vary over time and may be changed by us and by the depositary. You will receive prior notice of such changes.
The depositary may reimburse us for certain expenses incurred by us in respect of the ADR program by making available a portion of the ADS fees charged in respect of the ADR program or otherwise, upon such terms and conditions as we and the depositary agree from time to time.
Amendments and Termination
We may agree with the depositary to modify the deposit agreement at any time without your consent. We undertake to give holders 30 days' prior notice of any modifications that would materially prejudice any of their substantial rights under the deposit agreement. We will not consider to be materially prejudicial to your substantial rights any modifications or supplements that are reasonably necessary for the ADSs to be registered under the Securities Act or to be eligible for book-entry settlement, in each case without imposing or increasing the fees and charges you are required to pay. In addition, we may not be able to provide you with prior notice of any modifications or supplements that are required to accommodate compliance with applicable provisions of law.
You will be bound by the modifications to the deposit agreement if you continue to hold your ADSs after the modifications to the deposit agreement become effective. The deposit agreement cannot be amended to prevent you from withdrawing the ordinary shares represented by your ADSs (except as permitted by law).
We have the right to direct the depositary to terminate the deposit agreement. Similarly, the depositary may in certain circumstances on its own initiative terminate the deposit agreement. In either case, the depositary must give notice to the holders at least 30 days before termination. Until termination, your rights under the deposit agreement will be unaffected.
After termination, the depositary will continue to collect distributions received (but will not distribute any such property until you request the cancellation of your ADSs) and may sell the securities held on deposit. After the sale, the depositary will hold the proceeds from such sale and any other funds then held for the holders of ADSs in a non-interest bearing account. At that point, the depositary will have no further obligations to holders other than to account for the funds then held for the holders of ADSs still outstanding (after deduction of applicable fees, taxes and expenses).
121
Books of Depositary
The depositary will maintain ADS holder records at its depositary office. You may inspect such records at such office during regular business hours, but solely for the purpose of communicating with other holders in the interest of business matters relating to the ADSs and the deposit agreement.
The depositary will maintain in New York facilities to record and process the issuance, cancellation, combination, split-up and transfer of ADSs. These facilities may be closed from time to time, to the extent not prohibited by law.
Limitations on Obligations and Liabilities
The deposit agreement limits our obligations and the depositary's obligations to you. Please note the following:
122
Pre-Release Transactions
Subject to the terms and conditions of the deposit agreement, the depositary may issue to broker/dealers ADSs before receiving a deposit of ordinary shares or release ordinary shares to broker/dealers before receiving ADSs for cancellation. These transactions are commonly referred to as "pre-release transactions" and are entered into between the depositary and the applicable broker/dealer. The deposit agreement limits the aggregate size of pre-release transactions (not to exceed 30% of the ordinary shares on deposit in the aggregate) and imposes a number of conditions on such transactions ( i.e. , the need to receive collateral, the type of collateral required, the representations required from brokers, etc.). The depositary may retain the compensation received from the pre-release transactions.
Taxes
You will be responsible for the taxes and other governmental charges payable on the ADSs and the securities represented by the ADSs. We, the depositary and the custodian may deduct from any distribution the taxes and governmental charges payable by holders and may sell any and all property on deposit to pay the taxes and governmental charges payable by holders. You will be liable for any deficiency if the sale proceeds do not cover the taxes that are due.
The depositary may refuse to issue ADSs, to deliver, transfer, split and combine ADRs or to release securities on deposit until all taxes and charges are paid by the applicable holder. The depositary and the custodian may take reasonable administrative actions to obtain tax refunds and reduced tax withholding for any distributions on your behalf. However, you may be required to provide to the depositary and to the custodian proof of taxpayer status and residence and such other information as the depositary and the custodian may require to fulfill legal obligations. You are required to indemnify us, the depositary and the custodian for any claims with respect to taxes based on any tax benefit obtained for you.
Foreign Currency Conversion
The depositary will arrange for the conversion of all foreign currency received into U.S. dollars if such conversion is practical, and it will distribute the U.S. dollars in accordance with the terms of the deposit agreement. You may have to pay fees and expenses incurred in converting foreign currency, such as fees and expenses incurred in complying with currency exchange controls and other governmental requirements.
123
If the conversion of foreign currency is not practical or lawful, or if any required approvals are denied or not obtainable at a reasonable cost or within a reasonable period, the depositary may take the following actions in its discretion:
124
SHARES ELIGIBLE FOR FUTURE SALES
Upon completion of this offering, we will have outstanding 6.5 million ADSs representing approximately 41.7% of our outstanding ordinary shares. All of the ADSs sold in this offering will be freely transferable by persons other than by our "affiliates" without restriction or further registration under the Securities Act. Sales of substantial amounts of our ADSs in the public market could adversely affect prevailing market prices of our ADSs. Prior to this offering, there has been no public market for our ordinary shares or the ADSs, and although we have been authorized to list the ADSs on the New York Stock Exchange, we cannot assure you that a regular trading market will develop in the ADSs. We do not intend to list our ordinary shares on a trading market and therefore do not expect that a trading market will develop for our ordinary shares not represented by the ADSs. Furthermore, since no ordinary shares or ADSs will be available for sale by our shareholders after the completion of this offering because of the contractual and legal restrictions on resale described below, sales of substantial numbers of ADSs in the public market after these restrictions lapse could adversely affect the prevailing market price and our ability to raise equity capital in the future.
Lock-Up Agreements
The members of our management board and supervisory board and the selling shareholders have agreed to certain restrictions on our and their ability to sell additional ADSs or ordinary shares for a period of 180 days after the date of this prospectus. We and they have agreed not to directly or indirectly offer for sale, sell, contract to sell, grant any option for the sale of, or otherwise issue or dispose of, any ADSs or ordinary shares, options or warrants to acquire ADSs or ordinary shares, or any related security or instrument, without the prior written consent of Piper Jaffray & Co. and Citigroup Global Markets Inc. The agreements provide exceptions for, among other things, sales to underwriters pursuant to the underwriting agreement. For more information, see "Underwriting."
Rule 144
In general, under Rule 144 under the Securities Act as in effect on the date of this prospectus, beginning 90 days after the effective date of the Registration Statement of which this prospectus forms a part, a person who is not an affiliate of ours at any time during the three months preceding a sale, and who has held their ordinary shares for at least six months, as measured by SEC rule, including the holding period of any prior owner other than one of our affiliates, may sell ordinary shares without restriction, provided current public information about us is available. In addition, under Rule 144, any person who is not an affiliate of ours at any time during the three months preceding a sale, and who has held their ordinary shares for at least one year, as measured by SEC rule, including the holding period of any prior owner other than one of our affiliates, would be entitled to sell an unlimited number of ordinary shares immediately upon consummation of this offering without regard to whether current public information about us is available.
Beginning 90 days after the effective date of the Registration Statement of which this prospectus forms a part, a person who is an affiliate of ours and who has beneficially owned "restricted" ordinary shares for at least six months, as measured by SEC rule, including the holding period of any prior owner other than one of our affiliates, is entitled to sell a number of restricted ordinary shares within any three-month period that does not exceed the greater of:
125
Sales of restricted ordinary shares under Rule 144 held by our affiliates are also subject to requirements regarding the manner of sale, notice and the availability of current public information about us. Rule 144 also requires that affiliates relying on Rule 144 to sell ordinary shares that are not restricted shares must nonetheless comply with the same restrictions applicable to restricted shares, other than the holding period requirement.
In addition, in each case, these ordinary shares would remain subject to lock-up arrangements and would only become eligible for sale when the lock-up period expires.
Regulation S
Regulation S under the Securities Act provides that shares owned by any person may be sold without registration in the United States, provided that the sale is effected in an offshore transaction and no directed selling efforts are made in the United States (as these terms are defined in Regulation S), subject to certain other conditions. In general, this means that our shares may be sold outside the United States without registration in the United States being required.
Rule 701
Under Rule 701 under the Securities Act, ordinary shares acquired upon the exercise of options or pursuant to other rights granted under a written compensatory stock or option plan or other written agreement in compliance with Rule 701 may be resold by:
As of September 12, 2013, no options to purchase ordinary shares were outstanding.
126
EXCHANGE CONTROLS AND LIMITATIONS AFFECTING SHAREHOLDERS
There are currently no legal restrictions in Germany on international capital movements and foreign-exchange transactions, except in limited embargo circumstances ( Teilembargo ) relating to certain areas, entities or persons as a result of applicable resolutions adopted by the United Nations and the European Union. Restrictions currently exist with respect to, among others, Belarus, Congo, Egypt, Eritrea, Guinea, Guinea-Bissau, Iran, Iraq, Ivory Coast, Lebanon, Liberia, Libya, North Korea, Somalia, South Sudan, Sudan, Syria, Tunisia, and Zimbabwe.
For statistical purposes, there are, however, limited notification requirements regarding transactions involving cross-border monetary transfers. With some exceptions, every corporation or individual residing in Germany must report to the German Central Bank ( Deutsche Bundesbank ) (i) any payment received from, or made to, a non-resident corporation or individual that exceeds €12,500 (or the equivalent in a foreign currency) and (ii) any claim against, or liability payable to, a non-resident or corporation in excess of €5 million (or the equivalent in a foreign currency) at the end of any calendar month. Payments include cash payments made by means of direct debit, checks and bills, remittances denominated in euros and other currencies made through financial institutions, as well as netting and clearing arrangements.
127
German Taxation
The following discussion describes the material German tax consequences for a holder that is a U.S. person of acquiring, owning, and disposing of the ADSs. A holder that is a U.S. person, which we refer to as a "U.S. treaty beneficiary", is a resident of the United States for purposes of the Agreement between the Federal Republic of Germany and United States of America for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with respect to Taxes on Income and on Capital as of June 4, 2008 ( Abkommen zwischen der Bundesrepublik Deutschland und den Vereinigten Staaten von Amerika zur Vermeidung der Doppelbesteuerung und zur Verhinderung der Steuerverkürzung auf dem Gebiet der Steuern vom Einkommen und vom Vermögen und einiger anderer Steuern in der Fassung vom 4. Juni 2008 ), which we refer to as the "Treaty," who is fully eligible for benefits under the Treaty.
A holder will be a U.S. treaty beneficiary entitled to full Treaty benefits in respect of the ADSs if it is, inter alia :
Special rules apply to pension funds and certain other tax-exempt investors.
This discussion does not address the treatment of ADSs that are (i) held in connection with a permanent establishment or fixed base through which a U.S. treaty beneficiary carries on business or performs personal services in Germany or (ii) part of business assets for which a permanent representative in Germany has been appointed.
With the exemption of the subsection " General Rules for the Taxation of Shareholders Tax Resident in Germany" below, which provides an overview of dividend taxation with regards to the general principles applicable on tax residents in Germany, this discussion applies only to U.S. treaty beneficiaries that acquire ADSs in the initial offering and hold ADSs as capital assets for U.S. federal income tax purposes. It does not purport to be a comprehensive description of all tax considerations that may be relevant to a decision to purchase ADSs by any particular investor, including tax considerations that arise from rules of general application to all taxpayers or to certain classes of taxpayers that are generally assumed to be known by investors. In particular, this discussion does not address tax considerations applicable to a U.S. treaty beneficiary that may be subject to special tax rules, including, without limitation, a dealer in securities or currencies, a trader in securities that elects to use a mark-to-market method of accounting for securities holdings, banks, thrifts, or other financial
128
institutions, U.S. expatriates, an insurance company, a tax-exempt organization, a person that holds ADSs as part of a hedge, straddle, conversion or other integrated transaction for tax purposes, a person that purchases or sells ordinary shares or ADSs as part of a wash sale for tax purposes, a person whose functional currency for tax purposes is not the U.S. dollar, a person subject to the U.S. alternative minimum tax, or a person that owns or is deemed to own 10% or more of the company's voting stock. In addition, the discussion does not address tax consequences to an entity treated as a partnership (or other pass-through entity) for U.S. federal income tax purposes that holds ADSs. The U.S. federal income tax treatment of each partner of the partnership generally will depend upon the status of the partner and the activities of the partnership. Prospective purchasers that are partners in a partnership holding ADSs should consult their own tax advisors.
This discussion is based on German tax laws, including, but not limited to interpretation circulars issued by German tax authorities, which are not binding on the courts, and the Treaty. It is based upon tax laws in effect at the time of preparation of this prospectus (July 2013). These laws are subject to change, possibly on a retroactive basis. There is no assurance that German tax authorities will not challenge one or more of the tax consequences described in this discussion.
In addition, this discussion is based upon the assumption that each obligation in the deposit agreement and any related agreement will be performed in accordance with its terms. It does not purport to be a comprehensive or exhaustive description of all German or U.S. tax considerations that may be of relevance in the context of acquiring, owning and disposing of ADSs.
Prospective holders of ADSs should consult their own tax advisors regarding the German tax consequences of the purchase, ownership and disposition of our ADSs in light of their particular circumstances, including the effect of any state, local, or other foreign or domestic laws or changes in tax law or interpretation.
German Taxation of ADSs
This subsection "German Taxation of ADSs" is the opinion of Dechert LLP.
General
As of the date hereof, no published German tax court cases exist as to the German tax treatment of ADRs or ADSs, but based on the interpretation circular issued by the German Federal Ministry of Finance (BMF-Schreiben) (dated May 24, 2013, reference number IV C 1-S2204/12/10003) (the "ADR Tax Circular"), for German tax purposes, although it is not free from doubt, the ADSs should represent a beneficial ownership interest in the underlying shares and qualify as ADRs for the purpose of the ADR Tax Circular. If the ADSs qualify as ADRs under the ADR Tax Circular, dividends would accordingly be attributable to U.S. treaty beneficiaries of the ADSs for tax purposes, and not to the legal owner of the ordinary shares ( i.e. , the financial institution on behalf of whom the ordinary shares are stored at a domestic depository for the ADS holders), and U.S. treaty beneficiaries are treated as holding an interest in the company's ordinary shares for German tax purposes. However, investors should note that interpretation circulars published by the German tax administration (including the ADR Tax Circular) are not binding on German courts, including German tax courts, and it is unclear whether a German tax court would follow the ADR Tax Circular in determining the German tax treatment of ADRs or ADSs. For the purpose of this German tax section it is assumed that the ADSs qualify as ADRs within the meaning of the ADR Tax Circular.
129
German Taxation of Dividends and Capital Gains
General Rules for the Taxation of Shareholders Tax Resident in Germany
This subsection provides an overview of dividend taxation with regards to the general principles applicable on tax residents in Germany.
The German dividend and capital gains taxation rules applicable to German tax residents require a distinction between shares held as private assets ( Kapitalvermögen ) and shares held as business assets ( Gewerbebetrieb ).
In case the shares are held as private assets, dividends and capital gains are taxed as investment income and are principally subject to 25% German flat income tax on capital income ( Abgeltungsteuer ) (plus a 5.5% solidarity surcharge ( Solidaritätszuschlag ) thereon, resulting in an aggregate rate of 26.375%), which is levied in the form of withholding tax ( Kapitalertragsteuer ). The shareholder is taxed on its gross personal investment income, less the saver's tax-free allowance of €801 for an individual or €1,602 for a married couple filing taxes jointly. The deduction of income related expenses actually incurred is generally not possible. Private investors can apply to have their investment income assessed in accordance with the general rules on determining an individual's tax bracket if this would result in a lower tax burden. In this case, the shareholder will be taxed on gross personal investment income, less the saver's tax-free allowance of €801 (€1,602 for married couples filing jointly), without deduction of income-related expenses actually incurred. If tax is initially withheld, it will be credited against the amount of personal income tax assessed against the shareholder.
Losses resulting from the disposal of shares can only be offset by capital gains from the sale of shares. If, however, a shareholder directly or indirectly held at least 1% of the share capital of the company at any time during the five years preceding the sale, 60% of any capital gains resulting from the sale are taxable at the shareholder's personal income tax rate (plus 5.5% solidarity surcharge thereon). Conversely, 60% of any capital losses are recognized for tax purposes.
In case the shares are held as business assets, the taxation depends on the legal form of the shareholder ( i.e. , whether the shareholder is a corporation, an individual or a partnership). Irrespective of the legal form of the shareholder, dividends are subject to the aggregate withholding tax rate of 26.375%. The withholding tax ( Kapitalertragsteuer ) is credited against the respective shareholder's final (corporate) income tax liability. To the extent the amount withheld exceeds the (corporate) income tax liability, the withholding tax will be refunded, provided that certain requirements are met.
Special rules apply to financial institutions ( Kreditinstitute ), financial services providers ( Finanzdienstleistungsinstitute ), financial enterprises ( Finanzunternehmen ), life insurance and health insurance companies, and pension funds.
With regard to shareholders in the legal form of a corporation , dividends and capital gains are effectively 95% tax exempt from corporate income tax (including solidarity surcharge). However, with regards to dividends (not to capital gains) realized after February 28, 2013, the 95% corporate income tax exemption only applies if the corporation holds at least 10% of the shares in the company at the beginning of the calendar year. Business expenses actually incurred in connection with the dividends and capital gains might not be tax deductible for corporate income and trade tax purposes except if certain requirements are met.
Dividends are fully subject to trade tax ( Gewerbesteuer ), unless the shareholder holds at least 15% of the shares in the company at the beginning of the tax assessment period. In the latter case, effectively
130
95% of the dividends are also exempt from trade tax. Capital gains, however, are, irrespective of the size of the shareholding, 95% exempt from trade tax. Losses from the sale of shares are not tax deductible for corporate income tax and trade tax purposes.
With regards to individuals holding shares as business assets, 60% of dividends and capital gains are taxed at the individual's personal income tax rate (plus 5.5% solidarity surcharge thereon). Correspondingly, only 60% of business expenses related to the dividends and capital gains are principally deductible for income tax purposes.
If shares are held as business assets of a commercial permanent establishment located in Germany, dividends are fully subject to trade tax, unless the sole proprietor holds at least 15% of the company's shares at the beginning of the tax assessment period. In this case dividends are fully tax exempt from trade tax. With regards to capital gains, only 60% of the gains are subject to trade tax. 60% of any losses from the sale of shares are tax deductible for income tax and trade tax purposes. All or part of the trade tax is generally credited as a lump sum against the income taxes of the individual.
General rules for the Taxation of Shareholders Not Tax Resident in Germany
Non German resident holders of ADSs are subject to German taxation with respect to German source income ( beschränkte Steuerpflicht ). According to the ADR Tax Circular dated May 24, 2013, income from the shares should be attributed to the holder of the ADSs for German tax purposes. As a consequence, income from the ADSs should be treated as German source income ( beschränkte Steuerpflicht ).
The full amount of a dividend distributed by the company to a non German resident shareholder which does not maintain a permanent establishment or other taxable presence in Germany is subject to (final) German withholding tax ( Kapitalertragsteuer ) at an aggregate rate of 26.375%. The basis for the withholding tax is the approval of the dividend for distribution by the company's general shareholder meeting. The amount of the relevant taxable income is based on the gross amount in euro; any currency differences shall be irrelevant.
German withholding tax is withheld and remitted to the German tax authorities by the disbursing agent ( i.e. , the German bank, financial services institution, securities trading enterprise or securities trading bank (each as defined in the German Banking Act ( Kreditwesengesetz ) and in each case including a German branch of a foreign enterprise, but excluding a foreign branch of a German enterprise) that holds or administers the underlying shares in custody and disburses or credits the dividend income from the underlying shares or disburses or credits the dividend income from the underlying shares on delivery of the dividend coupons or disburses such dividend income to a foreign agent or the central securities depository ( Wertpapiersammelbank) in terms of the German Depositary Act ( Depotgesetz )) holding the underlying shares in a collective deposit, if such central securities depository disburses the dividend income from the underlying shares to a foreign agent, regardless of whether or not a holder must report the dividend for tax purposes and regardless of whether or not a holder is a resident of Germany.
Pursuant to the Treaty, the German withholding tax may not exceed 15% of the dividends received by U.S. treaty beneficiaries. The excess of the total withholding tax, including the solidarity surcharge, over the maximum rate of withholding tax permitted by the Treaty is refunded to U.S. treaty beneficiaries upon application. For example, for a declared dividend of 100, a U.S. treaty beneficiary initially receives 73.625 (100 minus the 26.375% withholding tax). The U.S. treaty beneficiary is entitled to a partial refund from the German tax authorities in the amount of 11.375% of the gross dividend (of 100). As a result, the U.S. treaty beneficiary ultimately receives a total of 85 (85% of the
131
declared dividend) following the refund of the excess withholding. However, investors should note that it is unclear how the German tax administration will apply the refund process to dividends on the ADSs and ADRs. Further, such refund is subject to the German anti-avoidance treaty shopping rule (as described below in section " Withholding Tax Refund for U.S. Treaty Beneficiaries").
German Taxation of Capital Gains of the U.S. Treaty Beneficiaries of the ADSs
The capital gains from the disposition of ADSs realized by a non German resident shareholder which does not maintain a permanent establishment or other taxable presence in Germany would be treated as German source income and subject to German tax ( beschränkte Steuerpflicht ) if such holder at any time during the five years preceding the disposition, directly or indirectly, held ADSs that represent 1% or more of the company's shares. If such holder had acquired the ADSs without consideration, the previous owner's holding period and size of the holding would also be taken into account.
However, U.S. treaty beneficiaries are eligible for treaty benefits under the Treaty (as discussed above in the section " German Taxation"). Pursuant to the Treaty, U.S. treaty beneficiaries are not subject to German tax even under the circumstances described in the preceding paragraph.
German statutory law requires the disbursing agent to levy withholding tax on capital gains from the sale of shares or other securities held in a custodial account in Germany. With regards to the German taxation of capital gains, disbursing agent means a German bank, a financial services institution, a securities trading enterprise or a securities trading bank (each as defined in the German Banking Act ( Kreditwesengesetz ) and, in each case including a German branch of a foreign enterprise, but excluding a foreign branch of a German enterprise) that holds the ADSs in custody or administers the ADSs for the investor or conducts sales or other dispositions and disburses or credits the income from the ADSs to the holder of the ADSs. The German statutory law does not explicitly condition the obligation to withhold taxes on capital gains being subject to taxation in Germany under German statutory law or on an applicable income tax treaty permitting Germany to tax such capital gains.
However, an interpretation circular issued by the German Federal Ministry of Finance (BMF-Schreiben) (dated October 9, 2012, reference number IV C 1-S2252/10/10013) provides that taxes need not be withheld when the holder of the custody account is not a resident of Germany for tax purposes and the income is not subject to German taxation. The interpretation circular further states that there is no obligation to withhold such tax even if the non-resident holder owns 1% or more of the shares of a German company. While interpretation circulars issued by the German Federal Ministry of Finance are only binding on the tax authorities but not on the tax courts, in practice, the disbursing agents nevertheless typically rely on guidance contained in such interpretation circulars. Therefore, a disbursing agent would only withhold tax at 26.375% on capital gains derived by a U.S. treaty beneficiary from the sale of ADSs held in a custodial account in Germany in the unlikely event that the disbursing agent did not follow this guidance. In this case, the U.S. treaty beneficiary should be entitled to claim a refund of the withholding tax from the German tax authorities under the Treaty (as described in the section " Withholding Tax Refund for U.S. Treaty Beneficiaries").
Withholding Tax Refund for U.S. Treaty Beneficiaries
U.S. treaty beneficiaries are generally eligible for treaty benefits under the Treaty (as discussed above in Section " German Taxation"). Accordingly, U.S. treaty beneficiaries are entitled to claim a refund of the portion of the otherwise applicable 26.375% German withholding tax on dividends that exceeds the applicable Treaty rate. However, as previously discussed, investors should note that it is unclear how the German tax administration will apply the refund process to dividends on the ADSs and ADRs. Further, such refund is subject to the German anti-avoidance treaty shopping rule according to section 50d para. 3 of the German Income Tax Act ( Einkommensteuergesetz ). Generally, this rule
132
requires that the U.S. treaty beneficiary (in case it is a non German resident company) maintains its own administrative substance and conducts its own business activities. In particular, a foreign company has no right to a full or partial refund to the extent persons holding ownership interests in the company would not be entitled to the refund if they derived the income directly and the gross income realized by the foreign company is not caused by the business activities of the foreign company, and there are either no economic or other valid reasons for the interposition of the foreign company, or the foreign company does not participate in general commerce by means of a business organization with resources appropriate to its business purpose. However, this shall not apply if the foreign company's principal class of stock is regularly traded in substantial volume on a recognized stock exchange, or if the foreign company is subject to the provisions of the German Investment Tax Act ( Investmentsteuergesetz ).
Individual claims for refunds may be made on a separate form, which must be filed with the German Federal Central Tax Office ( Bundeszentralamt für Steuern ), An der Küppe 1, 53225 Bonn, Germany. The form is available at the same address, on the German Federal Tax Office's website ( www.bzst.de ) or from the Embassy of the Federal Republic of Germany, 2300 M Street, NW, Washington DC 20037. Generally, the refund claim becomes time-barred after four years following the calendar year in which the dividend is received. As part of the individual refund claim, a U.S. treaty beneficiary must submit to the German tax authorities the original withholding certificate (or a certified copy thereof) issued by the disbursing agent and documenting the tax withheld, and an official certification of United States tax residency on IRS Form 6166. IRS Form 6166 may be obtained by filing a properly completed IRS Form 8802 with the Internal Revenue Service, P.O. Box 71052, Philadelphia, PA 19176-6052. Requests for certification must include the U.S. treaty beneficiary's name, social security number or employer identification number, the type of U.S. tax return filed, the tax period for which the certification is requested and a user fee of $85. An online payment option is also available at www.irs.gov . If the online payment option is used, then the completed IRS Form 8802 and all required attachments should be mailed to Department of the Treasury, Internal Revenue Service, Philadelphia, PA 19255-0625. The Internal Revenue Service will send the certification on IRS Form 6166 to the U.S. treaty beneficiary, who must then submit the certification with the claim for refund of withholding tax.
Under a simplified refund procedure based on electronic data exchange ( Datenträgerverfahren ) a disbursing agent that is registered as a participant in the electronic data exchange procedure with the German Federal Central Tax Office ( Bundeszentralamt für Steuern ) may file an electronic collective refund claim on behalf of all of the U.S. treaty beneficiaries for whom it holds the company's ADSs in custody. However the simplified refund procedure only allows for a refund up to the regular tax rate provided in the Treaty. It is not possible to use the simplified refund procedure to claim a further refund, for example based on special privileges under the Treaty.
Due to the legal structure of the ADSs, only limited guidance of the German tax authorities exists on the practical application of this procedure with respect to the ADSs.
German Inheritance and Gift Tax ( Erbschaft-und Schenkungsteuer )
It is unclear whether the German inheritance or gift tax applies to the transfer of the ADSs as the ADR Tax Circular does not refer explicitly to the German Inheritance and Gift Tax Act. However, if German inheritance or gift tax is applicable to ADSs, then under German domestic law, the transfer of the ordinary shares in the company and, as a consequence, the transfer of the ADSs would be subject to German gift or inheritance tax if:
133
in Germany at the time of the transfer, or (ii) is a German citizen who has spent no more than five consecutive years outside Germany without maintaining a residence in Germany or (iii) is a German citizen who serves for a German entity established under public law and is remunerated for his or her service from German public funds (including family members who form part of such person's household, if they are German citizens) and is only subject to estate or inheritance tax in his or her country of residence or habitual abode with respect to assets located in such country (special rules apply to certain former German citizens who neither maintain a residence nor have their habitual abode in Germany), or
Under the Agreement between the Federal Republic of Germany and the United States of America for the avoidance of double taxation with respect to taxes on inheritances and gifts ( Abkommen zwischen der Bundesrepublik Deutschland und den Vereinigten Staaten von Amerika zur Vermeidung der Doppelbesteuerung auf dem Gebiet der Nachlass-, Erbschaft- und Schenkungsteuern in der Fassung vom 21. Dezember 2000 ), hereinafter referred to as the "United States-Germany Inheritance and Gifts Tax Treaty", a transfer of ADSs by gift or upon death is not subject to German inheritance or gift tax if the donor or the transferor is domiciled in the United States, within the meaning of the United States-Germany Inheritance and Gift Tax Treaty, and is neither a citizen of Germany nor a former citizen of Germany and, at the time of the transfer, the ADSs are not held by the decedent or donor as business assets forming part of a permanent establishment in Germany or for which a permanent representative in Germany has been appointed.
Notwithstanding the foregoing, in case the heir, transferee or other beneficiary (i) has, at the time of the transfer, his or her residence or habitual abode in Germany, or (ii) is a German citizen who has spent no more than five (or, in certain circumstances, ten) consecutive years outside Germany without maintaining a residence in Germany or (iii) is a German citizen who serves for a German entity established under public law and is remunerated for his or her service from German public funds (including family members who form part of such person's household, if they are German citizens) and is only subject to estate or inheritance tax in his or her country of residence or habitual abode with respect to assets located in such country (or special rules apply to certain former German citizens who neither maintain a residence nor have their habitual abode in Germany), the transferred ADSs are subject to German inheritance or gift tax.
If, in this case, Germany levies inheritance or gift tax on the ADSs with reference to the heir's, transferee's or other beneficiary's residence in Germany or his or her German citizenship, and the United States also levies federal estate tax or federal gift tax with reference to the decedent's or donor's residence (but not with reference to the decedent's or donor's citizenship), the amount of the U.S. federal estate tax or the U.S. federal gift tax, respectively, paid in the United States with respect to the transferred ADSs is credited against the German inheritance or gift tax liability, provided the U.S. federal estate tax or the U.S. federal gift tax, as the case may be, does not exceed the part of the German inheritance or gift tax, as computed before the credit is given, which is attributable to the transferred ADSs. A claim for credit of the U.S. federal estate tax or the U.S. federal gift tax, as the case may be, may be made within one year of the final determination (administrative or judicial) and payment of the U.S. federal estate tax or the U.S. federal gift tax, as the case may be, provided that
134
the determination and payment are made within ten years of the date of death of the decedent or of the date of the making of the gift by the donor. Similarly, U.S. state-level estate or gift taxes are also creditable against the German inheritance or gift tax liability to the extent that U.S. federal estate or gift tax is creditable.
United States Taxation of ADSs and Ordinary Shares
The following discussion describes the material U.S. federal income tax consequences that are relevant with respect to the acquisition, ownership and disposition of the ADSs and ordinary shares by a U.S. holder (as defined below) and is the opinion of Dechert LLP insofar as it relates to legal conclusions with respect to matters of U.S. federal income tax law. The information provided below is based on the Internal Revenue Code of 1986, as amended, or the Code, Internal Revenue Service, or IRS, rulings and pronouncements, and judicial decisions all as now in effect and all of which are subject to change or differing interpretations, possibly with retroactive effect. This summary addresses only U.S. federal income tax considerations of U.S. holders that will hold ADSs or ordinary shares as capital assets. It does not provide a complete analysis of all potential tax considerations. In particular, this summary does not address all of the tax considerations applicable to a particular holder of the ADSs or ordinary shares in light of the holder's circumstances (for example, financial institutions; insurance companies; dealers or traders in securities; currencies or notional principal contracts; persons that will hold ADSs or ordinary shares as part of a hedging or conversion transaction or as a position in a straddle or other integrated transactions for U.S. federal income tax purposes; persons that have a functional currency other than the U.S. dollar; persons that own (or are deemed to own) 10% or more (by voting power) of our share capital who would, if we were considered to be a controlled foreign corporation for U.S. federal income tax purposes, be subject to special rules; regulated investment companies, real estate investment trusts; tax-exempt entities; persons who hold ADSs or ordinary shares through partnerships or other pass-through entities; tax-deferred or other retirement accounts; certain former citizens or residents of the United States; or persons deemed to sell ADSs or ordinary shares under the constructive sale provisions of the Code). Finally, the summary does not describe the effect of the U.S. federal estate and gift tax laws on U.S. holders or the effects of any applicable foreign, state or local laws.
For purposes of this summary, a "U.S. holder" is a beneficial owner of ADSs or ordinary shares that for U.S. federal income tax purposes, is (1) an individual who is a citizen or resident of the United States, (2) a corporation, or an entity treated as a corporation for U.S. federal income tax purposes, created or organized in or under the laws of the United States or any state of the United States, including the District of Columbia, (3) an estate, the income of which is subject to U.S. federal income taxation regardless of its source, or (4) a trust, if it (i) is subject to the primary supervision of a U.S. court and the control of one or more U.S. persons or (ii) has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a U.S. person. A "non-U.S. holder" is a beneficial owner of the ADSs or ordinary shares, other than a partnership or entity treaty as a partnership, that is not a U.S. holder.
If a partnership (including an entity or arrangement, domestic or foreign, treated as a partnership for U.S. federal income tax purposes) holds ADSs or ordinary shares, the tax treatment of a partner in the partnership will depend upon the status of the partner and the activities of the partnership. A holder of ADSs or ordinary shares that is a partnership, and partners in such partnership, should consult their own tax advisors about the U.S federal income and estate tax consequences of purchasing, owning and disposing of the ADSs or ordinary shares.
Each prospective holder of ADSs should consult its own tax advisors regarding the U.S. federal, state and local or other tax consequences of acquiring, owning and disposing of the company's ADSs in
135
light of their particular circumstances. U.S. holders should also review the discussion under "German Taxation of ADSs" for the German tax consequences to a U.S holder of the ownership of the ADSs.
General
In general, and taking into account the earlier assumptions, a U.S. holder of ADSs is treated as the owner of the ordinary shares represented by such ADSs. Exchanges of ordinary shares for ADSs, and ADSs for ordinary shares, respectively, generally will not be subject to U.S. federal income tax.
Distributions
Under the United States federal income tax laws, and subject to the passive foreign investment company, or PFIC, rules discussed below, the gross amount of any distribution that is actually or constructively received by a U.S. holder with respect to its ordinary shares (including shares deposited in respect of ADSs) will be a dividend includible in gross income of a U.S. holder as ordinary income to the extent the amount of such distribution is paid out of our current and accumulated earnings and profits, as determined for U.S. federal income tax purposes. To the extent the amount of such distribution exceeds our current and accumulated earnings and profits as so computed, it will be treated first as a non-taxable return of capital to the extent of such U.S. holder's adjusted tax basis in its ADSs or ordinary shares, and to the extent the amount of such distribution exceeds such adjusted tax basis, will be treated as gain from the sale of the ADSs or ordinary shares. If you are a non-corporate U.S. holder, dividends paid to you that constitute qualified dividend income will be taxable to you at a preferential rate (rather than the higher rates of tax generally applicable to items of ordinary income) provided that you hold our ADSs or ordinary shares for more than 60 days during the 121-day period beginning 60 days before the ex-dividend date and meet other holding period requirements. If we are a passive foreign investment company (as discussed below under "Additional United States Federal Income Tax Consequences PFIC Rules"), distributions paid by us with respect ADSs or ordinary shares will not be eligible for the preferential income tax rate. Prospective investors should consult their own tax advisors regarding the taxation of distributions under these rules.
You must include any German tax withheld from the dividend payment in this gross amount even though you do not in fact receive it. The gross amount of the dividend is taxable to you when you receive the dividend, actually or constructively. Dividends paid on ADSs or ordinary shares generally will constitute income from sources outside the United States and will not be eligible for the dividends-received deduction generally available to corporate U.S. holders. The gross amount of any dividend paid in foreign currency will be included in the gross income of a U.S. holder in an amount equal to the U.S. dollar value of the foreign currency calculated by reference to the exchange rate in effect on the date the dividend distribution is includable in the U.S. holder's income, regardless of whether the payment is in fact converted into U.S. dollars. If the foreign currency is converted into U.S. dollars on the date of receipt by the depositary, in the case of ADSs, or the U.S. holder, in the case of ordinary shares, a U.S. holder generally should not be required to recognize foreign currency gain or loss in respect of the dividend. If the foreign currency received is not converted into U.S. dollars on the date of receipt, a U.S. holder will have a basis in the foreign currency equal to its U.S. dollar value on the date of receipt. Any gain or loss on a subsequent conversion or other disposition of the foreign currency will be treated as ordinary income or loss, and will generally be income or loss from sources within the United States for foreign tax credit limitation purposes. The amount of any distribution of property other than cash will be the fair market value of the property on the date of the distribution, less the sum of any encumbrance assumed by the U.S. holder.
For foreign tax credit purposes, our dividend distributions will, depending on the U.S. holder's circumstances, be either "passive" or "general" income for purposes of computing the foreign tax credit allowable to the U.S. holder. The amount of the qualified dividend income, if any, paid to a U.S.
136
holder that is subject to the reduced dividend income tax rate and that is taken into account for purposes of calculating the U.S. holder's U.S. foreign tax credit limitation must be reduced by the rate differential portion of the dividend. Prospective investors should consult their own tax advisors regarding the implications of the foreign tax credit provisions for them, in light of their particular situation.
U.S. Taxation of Sale or Other Disposition
Subject to the discussion below under "Additional United States Federal Income Tax Consequences PFIC Rules," a U.S. holder will generally recognize a gain or loss for U.S. federal income tax purposes upon the sale or other disposition of ADSs or ordinary shares in an amount equal to the difference between the U.S. dollar value of the amount realized from such sale or other disposition and the U.S. holder's tax basis in such ADSs or ordinary shares. Such gain or loss generally will be capital gain or loss. Capital gain of a non-corporate U.S. holder recognized on the sale or other disposition of ADSs or ordinary shares held for more than one year is generally eligible for a reduced rate of taxation. The gain or loss will generally be income or loss from sources within the United States for foreign tax credit limitation purposes. The deductibility of capital losses is subject to limitations.
A U.S. holder that receives foreign currency on the sale or other disposition of ADSs or ordinary shares will realize an amount equal to the U.S. dollar value of the foreign currency on the date of sale (or, in the case of cash basis and electing accrual basis taxpayers, the U.S. dollar value of the foreign currency on the settlement date) provided that the ADSs or ordinary shares, as the case may be, are treated as being "traded on an established securities market." If a U.S. holder receives foreign currency upon a sale or exchange of ADSs or ordinary shares, gain or loss, if any, recognized on the subsequent sale, conversion or disposition of such foreign currency will be ordinary income or loss, and will generally be income or loss from sources within the United States for foreign tax credit limitation purposes. However, if such foreign currency is converted into U.S. dollars on the date received by the U.S. holder, a cash basis or electing accrual U.S. holder should not recognize any gain or loss on such conversion.
Redemption
A redemption of ADSs or ordinary shares by us will be treated as a sale of the redeemed ADSs or ordinary shares by the U.S. holder or as a distribution to the U.S. holder (which is taxable as described above under " Distributions").
Additional United States Federal Income Tax Consequences
PFIC Rules. Special adverse U.S. federal income tax rules apply to U.S. holders owning shares of a passive foreign investment company, or PFIC. We believe that our ADSs and ordinary shares should not be treated as stock of a PFIC for United States federal income tax purposes, for our taxable year ending December 31, 2013 or the foreseeable future. In general, if you are a U.S. holder, we will be a PFIC with respect to you if for any taxable year in which you held our ADSs or ordinary shares: (i) at least 75% of our gross income for the taxable year is passive income or (ii) at least 50% of the value, determined on the basis of a quarterly average, of our assets is attributable to assets that produce or are held for the production of passive income. The determination of whether we are a PFIC will be made annually. Accordingly, it is possible that we may become a PFIC in the current or any future taxable year due to changes in our asset or income composition. Because we have valued our goodwill based on the market value of our equity, a decrease in the price of our ADSs or ordinary shares may also result in our becoming a PFIC. In addition, the composition of income and assets will be affected by how, and how quickly, we spend the cash we raise in this offering.
137
Passive income generally includes dividends, interest, royalties, rents (other than certain rents and royalties derived in the active conduct of a trade or business), annuities and gains from the disposition of assets that produce passive income. Any cash we hold, including the cash raised in this offering, generally will be treated as held for the production of passive income for the purpose of the PFIC test, and any income generated from cash or other liquid assets generally will be treated as passive income for such purpose. If a foreign corporation owns at least 25% by value of the stock of another corporation, the foreign corporation is treated for purposes of the PFIC tests as owning its proportionate share of the assets of the other corporation, and as receiving directly its proportionate share of the other corporation's income.
If we were to be treated as a PFIC, except as otherwise provided by election regimes described below, a U.S. Holder would be subject to special adverse tax rules with respect to (i) "excess distributions" received on our ADSs or ordinary shares and (ii) any gain recognized upon a sale or other disposition (including a pledge) of our ADSs or ordinary shares. A U.S. holder would be treated as if it had realized such gain and certain "excess distributions" ratably over its holding period for our ADSs or ordinary shares and would be taxed at the highest tax rate in effect for each such year to which the gain was allocated, together with an interest charge in respect of the tax attributable to each such year. Special rules apply for calculating the amount of the foreign tax credit with respect to "excess distributions" by a PFIC.
With certain exceptions, a U.S. holder's ADSs or ordinary shares will be treated as stock in a PFIC if we were a PFIC at any time during the U.S. holder's holding period in for its ordinary shares or ADSs, even if we are not currently a PFIC.
Dividends that a U.S. holder receives from us will not be eligible for the special tax rates applicable to qualified dividend income if we are treated as a PFIC either in the taxable year of the distribution or the preceding taxable year, but instead will be taxable at rates applicable to ordinary income.
If a U.S. holder owns ordinary shares in a PFIC that are treated as "marketable stock," the U.S. holder may make a mark-to-market election. If a U.S. holder makes this election, the U.S. holder will not be subject to all of the PFIC rules described above. Instead, in general, the U.S. holder will include as ordinary income the excess, if any, of the fair market value of its ADSs or ordinary shares at the end of the taxable year over the U.S. holder's adjusted basis in its ADSs or ordinary shares. Similarly, any gain realized on the sale, exchange or other disposition of the ADSs or ordinary shares will be treated as ordinary income, and will not be eligible for the favorable tax rates applicable to qualified dividend income or long-term capital gains. The U.S. holder will also be allowed to take an ordinary loss in respect of the excess, if any, of the adjusted basis of its ADSs or ordinary shares over the fair market value at the end of the taxable year (but only to the extent of the net amount of previously included income as a result of the mark-to-market election). A U.S. holder's basis in the ADSs or ordinary shares will be adjusted to reflect any such income or loss amounts.
A U.S. holder may in certain circumstances also mitigate adverse tax consequences of the PFIC rules by filing an election to treat the PFIC as a qualified electing fund, or a QEF, if the PFIC complies with certain reporting requirements. However, in the event that we are or become a PFIC, we do not intend to comply with such reporting requirements necessary to permit U.S. holders to elect to treat us as a QEF.
U.S. holders should consult their own tax advisors regarding the application of the PFIC rules to their investment in our ADSs or ordinary shares and the elections discussed above.
138
Medicare Tax. Certain U.S. holders who are individuals, estates and trusts will be required to pay an additional 3.8% tax on some or all of their "net investment income," which generally includes its dividend income and net gains from the disposition of our ADSs or ordinary shares. U.S. holders should consult their own tax advisors regarding the applicability of this additional tax on their particular situation.
Information with Respect to Foreign Financial Assets. Owners of "specified foreign financial assets" with an aggregate value in excess of $50,000 (and in some circumstances, a higher threshold) may be required to file an information report with respect to such assets on their tax returns. "Specified foreign financial assets" may include financial accounts maintained by foreign financial institutions, as well as the following, but only if they are not held in accounts maintained by financial institutions: (i) stocks and securities issued by non-U.S. persons, (ii) financial instruments and contracts held for investment that have non-U.S. issuers or counterparties, and (iii) interests in foreign entities. U.S. holders are urged to consult their tax advisors regarding the application of this legislation to their ownership of the ADSs and ordinary shares.
Backup Withholding and Information Reporting. Backup withholding and information reporting requirements will generally apply to certain payments to U.S. holders of dividends on ADSs or ordinary shares. We, our agent, a broker or any paying agent, may be required to withhold tax from any payment that is subject to backup withholding unless the U.S. holder (1) is an exempt payee, or (2) provides the U.S. holder's correct taxpayer identification number and complies with applicable certification requirements. Payments made to U.S. holders by a broker upon a sale of our ADSs or ordinary shares will generally be subject to backup withholding and information reporting. If the sale is made through a foreign office of a foreign broker, however, the sale will generally not be subject to either backup withholding or information reporting. This exception may not apply if the foreign broker is owned or controlled by U.S. persons, or is engaged in a U.S. trade or business.
Backup withholding is not an additional tax. Any amounts withheld from a payment to a U.S. holder of ADSs or ordinary shares under the backup withholding rules can be credited against any U.S. federal income tax liability of the U.S. holder, provided the required information is timely furnished to the IRS. A U.S. holder generally may obtain a refund of any amounts withheld under the backup withholding rules that exceeds the U.S. holder's income tax liability by filing a refund claim with the IRS. Prospective investors should consult their own tax advisors as to their qualification and procedure for exemption from backup withholding.
139
Subject to the terms and conditions described in the underwriting agreement dated the date of this prospectus, among us, the selling shareholders and the representatives of the underwriters, we and the selling shareholders have agreed to sell to the underwriters, and the underwriters severally have agreed to purchase from us, the number of ADSs listed opposite their respective names below. Piper Jaffray & Co. and Citigroup Global Markets Inc. are acting as the representatives of the underwriters named below.
Underwriters
|
Number of ADSs | |||
---|---|---|---|---|
Piper Jaffray & Co. |
||||
Citigroup Global Markets Inc. |
||||
Cowen and Company, LLC |
||||
Stephens Inc. |
||||
Total |
6,500,000 | |||
The underwriters have advised us and the selling shareholders that they propose to offer the ADSs to the public at $ per ADS. The underwriters propose to offer the ADSs to certain dealers at the same price less a concession of not more than $ per ADS. The underwriters may allow and the dealers may reallow a concession of not more than $ per ADS on sales to certain other brokers and dealers. After the offering, these figures may be changed by the underwriters.
The selling shareholders have granted to the underwriters an option to purchase up to an additional 975,000 ADSs, on a pro rata basis, at the same price to the public, and with the same underwriting discount, as set forth in the table above. The underwriters may exercise this option any time during the 30-day period after the date of this prospectus, but only to cover over-allotments, if any. To the extent the underwriters exercise the option, each underwriter will become obligated, subject to certain conditions, to purchase approximately the same percentage of the additional ADSs as it was obligated to purchase under the underwriting agreement.
The following table shows the underwriting fees to be paid to the underwriters in connection with this offering. These amounts are shown assuming both no exercise and full exercise of the over-allotment option.
|
No Exercise | Full Exercise | |||||
---|---|---|---|---|---|---|---|
Per Share |
$ | $ | |||||
Total |
$ | $ |
We have agreed to reimburse the underwriters for their expenses in an amount up to $25,000, which may be incurred in connection with the review by Financial Industry Regulatory Authority, Inc., or FINRA, of the terms of the ADSs offered hereby.
We and the selling shareholders have agreed to indemnify the underwriters against certain liabilities, including civil liabilities under the Securities Act, or to contribute to payments that the underwriters may be required to make in respect of those liabilities.
In compliance with the German stock corporation law applicable when issuing new shares for new investors, the representatives of the underwriters will initially subscribe, on behalf of the underwriters, for all of the shares underlying the ADSs to be sold by us at a subscription price per share equal to
140
their nominal value per share. This subscription price will be credited against the amount due from the underwriters at closing.
The members of our management board and supervisory board and the selling shareholders have agreed to certain restrictions on our and their ability to sell additional ADSs or ordinary shares for a period of 180 days after the date of this prospectus. We and they have agreed not to directly or indirectly offer for sale, sell, contract to sell, grant any option for the sale of, or otherwise issue or dispose of, any ADSs or ordinary shares, options or warrants to acquire ADSs or ordinary shares, or any related security or instrument, without the prior written consent of Piper Jaffray & Co. and Citigroup Global Markets Inc. The agreements provide exceptions for sales to underwriters pursuant to the underwriting agreement and certain other exceptions.
We have been authorized to list our ADSs on the New York Stock Exchange under the symbol "VJET."
Prior to this offering, there has been no established trading market for the ADSs. The initial public offering price for the ADSs offered by this prospectus was negotiated by us and the underwriters. The factors considered in determining the initial public offering price include the history of and the prospects for the industry in which we compete, our past and present operations, our historical results of operations, our prospects for future earnings, the recent market prices of securities of generally comparable companies and the general condition of the securities markets at the time of the offering and other relevant factors. There can be no assurance that the initial public offering price of the ADSs will correspond to the price at which the ADSs will trade in the public market subsequent to this offering or that an active public market for the ADSs will develop and continue after this offering.
To facilitate this offering, the underwriters may engage in transactions that stabilize, maintain or otherwise affect the price of the ADSs during and after this offering. Specifically, the underwriters may over-allot or otherwise create a short position in the ADSs for their own account by selling more ADSs than have been sold to them by us and the selling shareholders. The underwriters may elect to cover any such short position by purchasing ADSs in the open market or by exercising the over-allotment option granted to the underwriters. In addition, the underwriters may stabilize or maintain the price of the ADSs by bidding for or purchasing ADSs in the open market and may impose penalty bids. If penalty bids are imposed, selling concessions allowed to syndicate members or other broker-dealers participating in the offering are reclaimed if ADSs previously distributed in the offering are repurchased, whether in connection with stabilization transactions or otherwise. The effect of these transactions may be to stabilize or maintain the market price of the ADSs at a level above that which might otherwise prevail in the open market. The imposition of a penalty bid may also affect the price of the ADSs to the extent that it discourages resales of the ADSs. The magnitude or effect of any stabilization or other transactions is uncertain. These transactions may be effected on the New York Stock Exchange or otherwise and, if commenced, may be discontinued at any time.
These activities may have the effect of raising or maintaining the market price of the ADSs or preventing or retarding a decline in the market price of the ADSs, and, as a result, the price of the ADSs may be higher than the price that would otherwise prevail in the open market. If the underwriters commence these activities, they may discontinue them at any time. The underwriters may carry out these transactions on the New York Stock Exchange or otherwise.
Certain of the underwriters and their affiliates may provide from time to time certain commercial banking, financial advisory, investment banking and other services for us and such affiliates in the ordinary course of their business, for which they may receive customary fees and commissions. In addition, from time to time, certain of the underwriters and their affiliates may effect transactions for
141
their own account or the account of customers, and hold on behalf of themselves or their customers, long or short positions in our debt or equity securities or loans, and may do so in the future.
No action has been taken in any jurisdiction (except in the United States) that would permit a public offering of our ADSs, or the possession, circulation or distribution of this prospectus or any other material relating to us or our ADSs in any jurisdiction where action for that purpose is required. Accordingly, the shares of ADSs may not be offered or sold, directly or indirectly, and neither this prospectus nor any other offering material or advertisements in connection with our ADSs may be distributed or published, in or from any country or jurisdiction, except in compliance with any applicable rules and regulations of any such country or jurisdiction.
Each of the underwriters may arrange to sell the ADSs offered hereby in certain jurisdictions outside the United States, either directly or through affiliates, where they are permitted to do so.
European Economic Area. This document has been prepared on the basis that any offer of ADSs in any member state of the European Economic Area which has implemented the Prospectus Directive, each, a Relevant Member State, will be made pursuant to an exemption under Article 3 of the Prospectus Directive from the requirement to publish a prospectus for offers of ADSs. Accordingly any person making or intending to make an offer in that Relevant Member State of shares which are the subject of the offering contemplated in this document may only do so in circumstances in which no obligation arises for us or any of the underwriters to publish a prospectus pursuant to Article 3 of the Prospectus Directive in relation to such offer. Neither we nor the underwriters have authorized, nor do they authorize, the making of any offer of ADSs in circumstances in which an obligation arises for us or the underwriters to publish a prospectus for such offer.
In relation to each Relevant Member State, no offer of ADSs may be made to the public in that Relevant Member State other than:
provided that no such offer of ADSs shall require us or any underwriter to publish a prospectus pursuant to Article 3 of the Prospectus Directive.
For purposes of this provision, the expression an "offer of securities to the public" in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer and the ADSs to be offered, so as to enable an investor to decide to purchase or subscribe for the ADSs, as the expression may be varied in that Relevant Member State by any measure implementing the Prospectus Directive in that member state, the expression "Prospectus Directive" means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in the Relevant Member State) and includes any relevant implementing measure in the Relevant Member State, and the expression "2010 PD Amending Directive" means Directive 2010/73/EU.
142
United Kingdom. This document is only being distributed to, and is only directed at (i) persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 as amended, or the Order, (ii) persons falling within Article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the Order; or (iii) persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as "relevant persons"). Any investment or investment activity to which this document relates is available only to relevant persons and will be engaged in only with relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents.
France. Neither this prospectus nor any other offering material relating to the ADSs described in this prospectus has been submitted to the clearance procedures of the Autorité des Marchés Financiers or of the competent authority of another member state of the European Economic Area and notified to the Autorité des Marchés Financiers. The ADSs have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in France. Neither this prospectus nor any other offering material relating to the ADSs has been or will be:
Such offers, sales and distributions will be made in France only:
The ADSs may be resold directly or indirectly, only in compliance with articles L.411-1, L.411-2, L.412-1 and L.621-8 through L.621-8-3 of the French Code monétaire et financier .
Hong Kong. The ADSs may not be offered or sold in Hong Kong by means of any document other than (i) in circumstances which do not constitute an offer to the public within the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong), (ii) to "professional investors" within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder, or (iii) in other circumstances which do not result in the document being a "prospectus" within the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong) and no advertisement, invitation or document relating to the ADSs may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is
143
directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the laws of Hong Kong) other than with respect to ADSs which are or are intended to be disposed of only to persons outside Hong Kong or only to "professional investors" within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder.
India. This prospectus is for information purposes only and does not constitute an offer or invitation for any investment or subscription for ADSs in India. Any person who is in possession of this prospectus is hereby notified that no action has been or will be taken that would allow an offering of the ADSs in India and neither this prospectus nor any offering material relating to the ADSs has been submitted to the Registrar of Companies or the Securities and Exchange Board of India for prior review or approval. Further, no document filing has been made with the Registrar of Companies, India. Accordingly, the ADSs may not be offered, sold, transferred or delivered and neither this prospectus nor any offering material relating to the ADSs may be distributed or made available (in whole or in part) in India, directly or indirectly in connection with any offer or invitation for any investment or subscription for the ADSs in India. You are advised to read this disclaimer carefully and consult with your advisors before accessing, reading or making any other use of this prospectus.
Japan. The ADSs offered in this prospectus have not been registered under the Financial Instruments and Exchange Act of Japan. The ADSs have not been offered or sold and will not be offered or sold, directly or indirectly, in Japan or to or for the account of any resident of Japan, except (i) pursuant to an exemption from the registration requirements of the Financial Instruments and Exchange Act of Japan and (ii) in compliance with any other applicable requirements of Japanese law.
Singapore. This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the ADSs may not be circulated or distributed, nor may the ADSs be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i) to an institutional investor under Section 274 of the Securities and Futures Act, Chapter 289 of Singapore, or the SFA, (ii) to a relevant person pursuant to Section 275(1), or any person pursuant to Section 275(1A), and in accordance with the conditions specified in Section 275 of the SFA or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA, in each case subject to compliance with conditions set forth in the SFA.
Where the ADSs are subscribed or purchased under Section 275 of the SFA by a relevant person which is:
144
offer that is made on terms that such shares, debentures and units of shares and debentures of that corporation or such rights and interest in that trust are acquired at a consideration of not less than S$200,000 (or its equivalent in a foreign currency) for each transaction, whether such amount is to be paid for in cash or by exchange of securities or other assets, and further for corporations, in accordance with the conditions specified in Section 275 of the SFA;
In addition, investors in Singapore should note that the securities acquired by them are subject to resale and transfer restrictions specified under Section 276 of the SFA, and they, therefore, should seek their own legal advice before effecting any resale or transfer of their securities.
Switzerland. The ADSs may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange, or SIX, or on any other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing material relating to the ADSs or the offering may be publicly distributed or otherwise made publicly available in Switzerland.
Neither this document nor any other offering or marketing material relating to the offering, the company or the ADSs have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of ADSs will not be supervised by, the Swiss Financial Market Supervisory Authority, and the offer of ADSs has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes, or the CISA. The investor protection afforded to acquirers of interests in collective investment schemes under the CISA does not extend to acquirers of ADSs.
Dubai International Financial Centre. This prospectus relates to an Exempt Offer in accordance with the Offered Securities Rules of the Dubai Financial Services Authority, or the DFSA. This prospectus is intended for distribution only to persons of a type specified in the Offered Securities Rules of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA has no responsibility for reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this prospectus nor taken steps to verify the information set forth herein and has no responsibility for the prospectus. The ADSs to which this prospectus relates may be illiquid and/or subject to restrictions on their resale. Prospective purchasers of the ADSs offered should conduct their own due diligence on the ADSs. If you do not understand the contents of this prospectus you should consult an authorized financial advisor.
145
EXPENSES RELATED TO THIS OFFERING
The following table sets forth the main expenses we and the selling shareholders identified in this prospectus will be required to pay in connection with this offering, other than the underwriting discounts and commissions. All amounts are estimated, except the SEC registration fee, The New York Stock Exchange listing fee and the filing fee of FINRA:
Expenses
|
Amount | |||
---|---|---|---|---|
SEC registration fee |
$ | 15,202 | ||
FINRA filing fee |
17,319 | |||
New York Stock Exchange listing fee |
125,000 | |||
Legal fees and expenses |
2,000,000 | |||
Accounting fees and expenses |
550,000 | |||
Printing fees |
240,000 | |||
Depositary expenses |
0 | |||
Other fees and expenses |
252,479 | |||
Total |
$ | 3,200,000 | ||
The validity of the shares and the ADSs with respect to German and U.S. federal law and New York state law in connection with this offering will be passed upon for us by Dechert LLP, our German and U.S. counsel. Certain legal matters with respect to German and U.S. federal law and New York state law in connection with this offering will be passed upon for the underwriters by Paul Hastings LLP, German and U.S. counsel for the underwriters.
The financial statements of Voxeljet Technology GmbH, our legal predecessor, as of December 31, 2012, 2011 and 2010 and January 1, 2010, and for each of the years in the three-year period ended December 31, 2012, included in this prospectus have been so included in reliance on the report of KPMG AG Wirtschaftsprüfungsgesellschaft (Munich, Germany), an independent registered public accounting firm, appearing elsewhere herein, and upon the authority of said firm as experts in auditing and accounting.
SERVICE OF PROCESS AND ENFORCEMENT OF CIVIL LIABILITIES
voxeljet AG is a German stock corporation ( Aktiengesellschaft or AG ), and its registered offices and all of its assets are located outside of the United States. In addition, most of the members of our management board, our supervisory board, our senior management and the experts named herein are residents of Germany and jurisdictions other than the United States. As a result, it may not be possible for you to effect service of process within the United States upon these individuals or upon voxeljet AG or to enforce judgments obtained in U.S. courts based on the civil liability provisions of the U.S. securities laws against voxeljet AG in the United States. Awards of punitive damages in actions brought in the United States or elsewhere are generally not enforceable in Germany. In addition, actions brought in a German court against voxeljet AG or the members of its management board and supervisory board, its senior management and the experts named herein to enforce liabilities based on U.S. federal securities laws may be subject to certain restrictions; in particular, German courts generally do not award punitive damages. Litigation in Germany is also subject to rules of procedure that differ from the U.S. rules, including with respect to the taking and admissibility of evidence, the conduct of the proceedings and the allocation of costs. Proceedings in Germany would have to be conducted in the German language, and all documents submitted to the court would, in principle, have to be
146
translated into German. For these reasons, it may be difficult for a U.S. investor to bring an original action in a German court predicated upon the civil liability provisions of the U.S. federal securities laws against us, the members of our management board, supervisory board and senior management and the experts named in this prospectus. In addition, even if a judgment against our company, the non-U.S. members of our management board, supervisory board, senior management or the experts named in this prospectus based on the civil liability provisions of the U.S. federal securities laws is obtained, a U.S. investor may not be able to enforce it in U.S. or German courts.
147
WHERE YOU CAN FIND MORE INFORMATION
We have filed with the SEC a Registration Statement on Form F-1 under the Securities Act, including amendments and relevant exhibits and schedules, covering the underlying ordinary shares represented by the ADSs to be sold in this offering. We have also filed with the SEC a related Registration Statement on Form F-6 to register the ADSs. This prospectus, which constitutes a part of the Registration Statement, summarizes material provisions of contracts and other documents that we refer to in the prospectus. Since this prospectus does not contain all of the information contained in the Registration Statement, you should read the Registration Statement and its exhibits and schedules for further information with respect to us and our ADSs.
Immediately upon the effectiveness of the Registration Statement, we will become subject to periodic reporting and other informational requirements of the Exchange Act as applicable to foreign private issuers. Our annual reports on Form 20-F for the year ended December 31, 2013 and for all subsequent years will be due within four months after fiscal year end. We are not required to disclose certain other information that is required from U.S. domestic issuers. Also, as a foreign private issuer, we are exempt from the rules of the Exchange Act prescribing the furnishing of proxy statements to shareholders and members of our management and supervisory boards and our principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act.
You may review and copy the Registration Statement, reports and other information we file at the SEC's public reference room at 100 F Street, N.E., Washington, D.C. 20549. You may also request copies of these documents upon payment of a duplicating fee by writing to the SEC. For further information on the public reference facility, please call the SEC at 1-800-SEC-0330. Our SEC filings, including the Registration Statement, are also available to you on the SEC's website at http://www.sec.gov .
As a foreign private issuer, we are also exempt from the requirements of Regulation FD (Fair Disclosure) which, generally, are meant to ensure that select groups of investors are not privy to specific information about an issuer before other investors. We are, however, still subject to the anti-fraud and anti-manipulation rules of the SEC, such as Rule 10b-5. Since many of the disclosure obligations required of us as a foreign private issuer are different than those required by other U.S. domestic reporting companies, our shareholders, potential shareholders and the investing public in general should not expect to receive information about us in the same amount and at the same time as information is received from, or provided by, other U.S. domestic reporting companies. We are liable for violations of the rules and regulations of the SEC which do apply to us as a foreign private issuer.
148
F-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The
Board of Directors
voxeljet technology GmbH:
We have audited the accompanying statements of financial position of voxeljet technology GmbH (the "Company") as of December 31, 2012, 2011, 2010 and January 1, 2010, and the related statements of comprehensive income (loss), changes in equity, and cash flows for each of the years in the three-year period ended December 31, 2012. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of voxeljet technology GmbH as of December 31, 2012, 2011, 2010 and January 1, 2010, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2012 in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board.
[s]
KPMG AG Wirtschaftsprüfungsgesellschaft
Munich,
Germany
August 7, 2013
F-2
voxeljet technology GmbH
STATEMENT OF FINANCIAL POSITION
Thousands of Euros
|
Notes | 12/31/2012 | 12/31/2011 | 12/31/2010 | 01/01/2010 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current assets |
4,104 | 3,448 | 2,076 | 2,240 | ||||||||||||
Cash and cash equivalents |
301 | 498 | 654 | 132 | ||||||||||||
Financial assets |
6 | 108 | 39 | 7 | 0 | |||||||||||
Trade receivables |
7 | 625 | 850 | 424 | 525 | |||||||||||
Inventories |
8 | 2,806 | 2,011 | 864 | 1,376 | |||||||||||
Other assets |
264 | 50 | 127 | 207 | ||||||||||||
Non-current assets |
6,634 | 6,320 | 6,788 | 3,963 | ||||||||||||
Financial assets |
6 | 925 | 506 | 457 | 83 | |||||||||||
Intangible assets |
9 | 52 | 34 | 24 | 35 | |||||||||||
Property, plant and equipment |
9 | 5,299 | 5,347 | 5,908 | 3,543 | |||||||||||
Deferred tax assets |
17 | 358 | 313 | 279 | 182 | |||||||||||
Other assets |
| 120 | 120 | 120 | ||||||||||||
Total assets |
10,738 | 9,768 | 8,864 | 6,203 | ||||||||||||
Thousands of Euros
|
Notes | 12/31/2012 | 12/31/2011 | 12/31/2010 | 01/01/2010 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current liabilities |
4,322 | 3,139 | 2,603 | 1,723 | ||||||||||||
Deferred income |
9 | 533 | 348 | 342 | 201 | |||||||||||
Trade payables |
560 | 517 | 287 | 243 | ||||||||||||
Income tax payable |
17 | 17 | 56 | 60 | 25 | |||||||||||
Financial liabilities |
10 | 2,366 | 1,498 | 1,559 | 1,003 | |||||||||||
Other liabilities and provisions |
11 | 846 | 720 | 355 | 251 | |||||||||||
Non-current liabilities |
5,198 | 5,624 | 5,303 | 3,321 | ||||||||||||
Deferred income |
9 | 1,063 | 1,013 | 807 | 420 | |||||||||||
Financial liabilities |
10 | 4,128 | 4,606 | 4,491 | 2,898 | |||||||||||
Other liabilities and provisions |
11 | 7 | 5 | 5 | 3 | |||||||||||
Equity |
1,218 | 1,005 | 958 | 1,159 | ||||||||||||
Subscribed capital |
1,000 | 1,000 | 1,000 | 1,000 | ||||||||||||
Capital reserves |
1,262 | 1,262 | 1,262 | 1,262 | ||||||||||||
Accumulated deficit |
(1,044 | ) | (1,256 | ) | (1,299 | ) | (1,091 | ) | ||||||||
Accumulated other comprehensive loss |
10 | 0 | (1 | ) | (5 | ) | (12 | ) | ||||||||
Total equity and liabilities |
10,738 | 9,768 | 8,864 | 6,203 | ||||||||||||
F-3
voxeljet technology GmbH
STATEMENT OF COMPREHENSIVE INCOME (LOSS)
Thousands of Euros (except share and per share data)
|
Notes | 2012 | 2011 | 2010 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenues |
13 | 8,711 | 7,257 | 4,764 | |||||||||
Cost of sales |
14 | (4,957 | ) | (4,337 | ) | (2,660 | ) | ||||||
Gross profit |
3,754 | 2,920 | 2,104 | ||||||||||
Selling expenses |
(1,510 | ) | (1,160 | ) | (1,028 | ) | |||||||
Administrative expenses |
(758 | ) | (670 | ) | (606 | ) | |||||||
Research and development expenses |
(1,573 | ) | (1,313 | ) | (1,073 | ) | |||||||
Other operating expenses |
15 | (62 | ) | (140 | ) | (81 | ) | ||||||
Other operating income |
15 | 822 | 831 | 762 | |||||||||
Operating profit |
673 | 468 | 78 | ||||||||||
Finance expense |
16 | (363 | ) | (389 | ) | (359 | ) | ||||||
Finance income |
16 | 18 | 5 | 8 | |||||||||
Financial result |
16 | (345 | ) | (384 | ) | (351 | ) | ||||||
Profit (loss) before income taxes |
328 | 84 | (273 | ) | |||||||||
Income tax (expenses) benefit |
17 | (116 | ) | (41 | ) | 65 | |||||||
Profit (loss) |
212 | 43 | (208 | ) | |||||||||
Other comprehensive income |
10 | 1 | 4 | 7 | |||||||||
Total comprehensive income (loss) |
213 | 47 | (201 | ) | |||||||||
Weighted average number of ordinary shares outstanding |
20,000 | 20,000 | 20,000 | ||||||||||
Earnings per share basic and diluted (EUR) |
10.60 | 2.15 | (10.40 | ) |
F-4
voxeljet technology GmbH
STATEMENT OF CHANGES IN EQUITY
Thousands of Euros
|
Subscribed
capital |
Capital
reserves |
Accumulated
deficit |
Accumulated
other comprehensive loss |
Total equity | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance at January 1, 2010 |
1,000 | 1,262 | (1,091 | ) | (12 | ) | 1,159 | |||||||||
Loss for the year |
| | (208 | ) | | (208 | ) | |||||||||
Other comprehensive income |
| | | 7 | 7 | |||||||||||
Balance at December 31, 2010 |
1,000 | 1,262 | (1,299 | ) | (5 | ) | 958 | |||||||||
Balance at January 1, 2011 |
1,000 | 1,262 | (1,299 | ) | (5 | ) | 958 | |||||||||
Profit for the year |
| | 43 | | 43 | |||||||||||
Other comprehensive income |
| | | 4 | 4 | |||||||||||
Balance at December 31, 2011 |
1,000 | 1,262 | (1,256 | ) | (1 | ) | 1,005 | |||||||||
Balance at January 1, 2012 |
1,000 | 1,262 | (1,256 | ) | (1 | ) | 1,005 | |||||||||
Profit for the year |
| | 212 | | 212 | |||||||||||
Other comprehensive income |
| | | 1 | 1 | |||||||||||
Balance at December 31, 2012 |
1,000 | 1,262 | (1,044 | ) | | 1,218 | ||||||||||
F-5
voxeljet technology GmbH
STATEMENT OF CASH FLOWS
Thousands of Euros
|
Notes | 2012 | 2011 | 2010 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from operating activities |
|||||||||||||
Profit (loss) for the period |
212 | 43 | (208 | ) | |||||||||
Depreciation and amortization |
9 | 1,343 | 1,246 | 1,110 | |||||||||
Noncash sale to customer in exchange for customer loan |
6 |
(250 |
) |
|
(340 |
) |
|||||||
Proceeds from customer loans |
39 | 7 | | ||||||||||
Changes in deferred income taxes |
(45 | ) | (33 | ) | (97 | ) | |||||||
Loss on disposal of assets |
9 | | | 10 | |||||||||
Amortization of deferred income |
9, 15 | (274 | ) | (539 | ) | (339 | ) | ||||||
Change in working capital |
|||||||||||||
Trade receivables and other assets |
7 | 131 | (349 | ) | 181 | ||||||||
Inventories |
8 | (851 | ) | (864 | ) | (177 | ) | ||||||
Trade payables |
42 | 230 | 44 | ||||||||||
Other liabilities and provisions |
128 | 365 | 106 | ||||||||||
Income tax payable |
(39 | ) | (4 | ) | 35 | ||||||||
Total |
436 | 102 | 325 | ||||||||||
Cash Flow from investing activities |
|||||||||||||
Proceeds from disposal of property, plant and equipment and intangible assets |
9 | | | 15 | |||||||||
Payments to acquire property, plant and equipment and intangible assets |
9 | (702 | ) | (222 | ) | (1,904 | ) | ||||||
Payments to acquire financial assets |
6 | (276 | ) | (88 | ) | (41 | ) | ||||||
Total |
(978 | ) | (310 | ) | (1,930 | ) | |||||||
Cash Flow from financing activities |
|||||||||||||
Proceeds from financial liabilities |
10 | 1,250 | 859 | 2,012 | |||||||||
Repayment of financial liabilities |
10 | (1,681 | ) | (1,757 | ) | (1,441 | ) | ||||||
Proceeds from sale and leaseback |
776 | 950 | 1,556 | ||||||||||
Total |
345 | 52 | 2,127 | ||||||||||
Net increase (decrease) in cash and cash equivalents |
(197 | ) | (156 | ) | 522 | ||||||||
Cash and cash equivalents at beginning of period |
6 | 498 | 654 | 132 | |||||||||
Cash and cash equivalents at end of period |
6 | 301 | 498 | 654 | |||||||||
Supplemental Cash Flow Information |
|||||||||||||
Interest paid net |
16 | 320 | 359 | 343 | |||||||||
Income taxes paid net |
17 | 171 | 45 | 0 | |||||||||
Non-cash items: |
|||||||||||||
Additions to property, plant and equipment through lease |
9 | 822 | 956 | 1,586 |
F-6
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS
Basis of preparation
1. The reporting entity
voxeljet technology GmbH (' voxeljet' or the 'Company') is a privately owned high-tech Company headquartered in Friedberg, Germany. As a manufacturer of three-dimensional ("3D") printing systems, voxeljet has specialized in the development, production and distribution of industrial printing machines and the sale of customized printed products to industrial customers. The Company operates in two business divisions: Systems and Services. The voxeljet Systems business division creates innovative 3D printers. Today, voxeljet has a product range that reaches from smaller entry models to large-format machines, and therefore offers 3D printer systems for a wide range of application areas.
Through its Services business division, the Company also offers customized printed products such as sand molds and plastic models based on CAD data through its 'on-demand production' service centre. Small-batch and prototype manufacturers utilize the Company's machines for the automatic, patternless manufacture of their casting moulds and 3D models. The Company's customer base includes automotive manufacturers and suppliers as well as companies from the arts and design industries.
2. Preparation of financial statements
The financial statements of the Company were prepared in accordance with International Financial Reporting Standards (IFRS) as set forth by the International Accounting Standards Board (IASB) and interpretations of the IFRS Interpretations Committee (IFRIC). The designation IFRS also includes all valid IAS; the designation IFRIC also includes all valid interpretations of the Standing Interpretations Committee ("SIC").
The financial statements were authorized for issue by the Managing Director on August 7, 2013. The Company transitioned to IFRS as of January 1, 2010 and presents a statement of financial position as of the transition date.
These are the Company's first financial statements prepared in accordance with IFRS. Therefore IFRS 1 "First-time Adoption of International Financial Reporting Standards" has been applied. An explanation of the transition from German GAAP to IFRS and its impact on the financial position and financial performance of the Company reported under the German Commercial Code in prior years can be found in note 25 "Explanation of transition from German GAAP to IFRS" below.
These financial statements were prepared on the basis of historical cost with the exception of derivative financial instruments, which are measured at fair value.
The balance sheet was structured in accordance with IAS 1, separating current from non-current assets and liabilities. Assets and liabilities were classified as current if they are expected to be realized within twelve months of the balance sheet date.
The financial statements were prepared in Euros, the Company's functional currency. Unless indicated otherwise, all amounts are presented in thousands of Euros (kEUR). Due to rounding, numbers presented throughout these notes may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.
F-7
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
2. Preparation of financial statements (Continued)
The Company has no subsidiaries, and does not hold any investments or participation in other entities.
The financial statements were prepared on the assumption that the Company will continue as a going concern.
For clarity, various line items of the statement of financial position and statement of comprehensive income (loss) have been combined. These items are explained in the notes.
3. Summary of significant accounting policies
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all financial years presented, as well as in the preparation of the opening balance sheet as of January 1, 2010.
Recognition of income and expenses
Revenue
Revenue from the sale of new or refurbished 3D printers is recognized upon the transfer of risks and rewards of ownership to the buyer, which is upon completion of the installation of the 3D printers at the customer site and evidenced through final acceptance by the customer. Revenue from the sale of custom-ordered printed product, consumables, or spare parts and other machine parts is recognized upon transfer of title, generally upon shipment. Revenue for all deliverables in sales arrangement is recognized to the extent that it is probable that the economic benefit arising from the ordinary activities of the business will flow to the Company and, provided that the amount of revenue and the costs incurred or to be incurred in respect of the sale can be measured reliably. Revenue is measured at the fair value of the consideration received or receivable, which is fixed at the time of recognition of revenue. In instances where revenue recognition criteria are not met, amounts are recorded as deferred income in the accompanying statements of financial position.
The Company provides customers with a standard warranty agreement on all machines for up to one year. The warranty is not treated as a separate service because the warranty is an integral part of the sale of the machine. The provision associated with these warranty obligations was not significant in 2012, 2011 or 2010.
After the initial one year warranty period, the Company offers its customers optional maintenance contracts. Maintenance contracts are provided for a period of twelve months and automatically extended for another twelve months if not cancelled on time. Deferred maintenance service revenue is recognized on a straight-line basis as the costs of providing services incurred under the contracts generally do not vary significantly throughout the year.
Shipping and handling costs billed to customers for machine sales and sales of printed products and consumables are included in revenue in the statements of comprehensive income (loss). Costs incurred by the Company associated with shipping and handling is included in selling expenses in the statements of comprehensive income (loss).
F-8
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
3. Summary of significant accounting policies (Continued)
The Company's terms of sale generally require payment within 30 to 60 days after shipment of a product, although the Company also recognizes that longer payment periods are customary in some countries where it transacts business. To reduce credit risk in connection with machine sales, the Company may, depending upon the circumstances, require significant deposits prior to shipment. In some circumstances, the Company may require payment in full for its products prior to shipment and may require international customers to furnish letters of credit. These deposits are reported as customer deposits included in other liabilities and provisions in the accompanying statements of financial position. Services under maintenance contracts are billed to customers in advance on a monthly, quarterly, or annual basis, depending on the contract and are included in deferred income in the statement of financial position.
In the course of the Company's ordinary business activities refurbished 3D printers, which were operating in the Service segment on average for 1.5 to 2.5 years, are routinely sold to customers. These 3D printers were operated in the production for manufacturing products ordered by customers. Prior to their sale these 3D printers are generally fully refurbished, which includes setting up a new printhead. Proceeds from the sale of such refurbished 3D printers are recognized as revenue.
Research and development expenses
The Company is continuously involved in research and development of new methods and technologies relating to its products. All research and development costs are charged to expense as incurred.
Government grants
Government grants awarded for project funding are recorded in "Other operating income" if the research and development costs are incurred and provided that the conditions for the funding have been met. Until then, amounts received under government grants are recorded as deferred income in the statement of financial position.
The benefit of a government loan at a below-market rate of interest is treated as a government grant. The loan is recognized and measured in accordance with IAS 39. The benefit of the below-market rate of interest is measured as the difference between the initial carrying value of the loan determined in accordance with IAS 39 and the proceeds received (refer to Note 15). The value of the government grant is recorded as deferred income in the statement of financial position and recognized in the same period as the relevant research expenditures are incurred.
Leases
Finance leases consist primarily of borrowings associated with sale and leaseback transactions of 3D printers that were manufactured and used within the Services segment. Additionally, the Company has entered into finance lease agreements for 3D printers manufactured by others. Maturity of the financing leases extend to 2017. Leased assets are recognized at the lower of fair value or the present value of minimum lease payments and depreciated over the asset's estimated useful life. Assets under finance leases are included in "Property, plant and equipment" in the statement of financial position. Gains on sale and leaseback transactions are recorded as deferred income in the statement of financial position and recognized as "Other operating income" over the respective lease term.
F-9
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
3. Summary of significant accounting policies (Continued)
Operating leases consist of various lease agreements for the rental of manufacturing facilities, office and warehouse spaces, vehicles, and office and IT equipment, expiring in various years through 2013 to 2017. Rent expense under operating leases is charged to profit or loss on a straight-line basis over the term of the lease.
voxeljet leased in 2012 and 2011 two 3D printers to customers under operating leases. Rental income is recognized straight-line over the term of the lease as revenue.
Foreign currencies
The financial statements were prepared in Euros, the Company's functional currency. Within the respective periods no changes in the functional currency occurred.
Monetary transactions denominated in foreign currencies are translated to Euros at the exchange rates prevailing on the transaction date. Monetary assets and liabilities in foreign currency are translated at the closing rate at the date of the statement of financial position. All realized and unrealized exchange gains or losses are included in the statement of comprehensive income (loss).
Income Tax
Income tax expense (benefit) consists of current and deferred tax expense and benefit in accordance with IAS 12.
Current income tax expense (benefit) is based on taxable profit (loss) for the year. Taxable profit (loss) differs from profit (loss) as reported in the statement of comprehensive income (loss) because it excludes items of income or expense that are taxable or deductible in other years and further excludes items that are never taxable or deductible. Current income tax expense (benefit) is calculated using tax rates that have been enacted or substantively enacted by the end of the respective reporting period.
Deferred income tax expense (benefit) is recognized on temporary differences between the carrying amounts of assets and liabilities in the statement of financial position and the corresponding tax base used in the computation of taxable profit (loss).
Deferred tax liabilities are generally recognized for all taxable temporary differences and deferred tax assets, including for carry forward losses, are recognized to the extent that it is probable that taxable profits will be available against which deductible temporary differences can be utilized. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer more probable than not that sufficient taxable profits will be available to allow all or a part of the assets to be recovered.
Deferred tax expense (benefit) is calculated at the tax rates that are expected to apply in the periods when the liability is settled or the asset is realized, based on tax rates (and tax regulations) that have been enacted or substantively enacted by the end of the reporting period. The measurement of deferred tax liabilities and assets reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities. Deferred tax expense (benefit) is charged or credited to profit or loss, except
F-10
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
3. Summary of significant accounting policies (Continued)
when it relates to items charged or credited directly to equity, in which case the deferred taxation is also recorded to equity.
Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off tax assets against tax liabilities and when they relate to income taxes levied by the same taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis.
Intangible Assets
Intangible assets are entirely comprised of acquired intangible assets. These assets with finite useful lives mainly software and licenses are carried at cost less accumulated amortization. Amortization for intangible assets with finite useful lives is recognized on a straight-line basis over their useful lives.
The estimated useful economic lives of acquired intangible assets are presented in the following table:
USEFUL LIFE OF INTANGIBLE ASSETS
Software |
3 years | |
Licenses |
6 years |
An intangible asset is derecognized upon disposal or when no future economic benefits are expected to arise from the continued use of the asset. Any gain or loss arising on derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the item) is included in the profit or loss in the period in which the item is derecognized.
Property, Plant and Equipment
Property, plant and equipment are carried at acquisition or manufacturing (for internally manufactured equipment) cost and depreciated on a straight-line basis over the estimated useful lives of the related assets, taking into account estimated residual values. Realized gains and losses are recognized upon disposal or retirement of the related assets and are reflected in "Other operating income". Subsequent expenditures are capitalized only if it is probable that voxeljet will receive additional economic benefits from the particular asset associated with these expenditures, and the costs can be determined reliably. Repair and maintenance are expensed as incurred.
The estimated useful economic lives of items of property, plant and equipment are as follows:
USEFUL LIFE OF PROPERTY, PLANT AND EQUIPMENT
Leasehold improvements |
6-9 years | |
Plant and machinery |
7-8 years | |
Other facilities, machinery and factory equipment |
2-10 years | |
Office equipment |
3-12 years |
F-11
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
3. Summary of significant accounting policies (Continued)
Useful lives, depreciation methods and residual values are reviewed at least annually and in case they change significantly, depreciation charges for current and future periods are adjusted accordingly.
Inventories
Inventories are measured at the lower of acquisition cost, as determined on the first-in, first-out (FIFO) method, or manufacturing cost and net realizable value. Manufacturing costs comprise all costs that are directly attributable to the manufacturing process, such as direct material and labor, and production related overheads (based on normal operating capacity and normal consumption of material, labor and other production costs), including depreciation charges. Net realizable value is the estimated selling price in the ordinary course of business less applicable variable selling expenses.
Impairment of non-financial assets
The Company assesses at the end of each reporting period whether there is an indication that a non-financial asset may be impaired. The asset is tested for impairment if there are indicators that the carrying amounts may not be recoverable. An impairment loss is recognized in the amount by which the asset's carrying amount exceeds its recoverable amount. The recoverable amount is defined as the higher of an asset's fair value less cost to sell and its value in use.
If the fair value less cost to sell cannot be determined, or if it is lower than the carrying amount, the value in use is calculated. In calculating the value in use by discounting the future expected cash flows at a risk-adequate pre-tax interest rate, current and expected future cash flows are taken into account, together with technological, economic and general development trends, on the basis of approved and adjusted financial plans.
Financial instruments
Non-derivative financial assets
The Company initially recognizes financial assets on the trade date, which is the date that the Group becomes a party to the contractual provisions of the instrument. The Company classifies non-derivative financial assets into the 'loans and receivables' category.
Loans and receivables
Loans and receivables are financial assets with fixed or determinable payments that are not quoted in an active market. Such assets are recognized initially at fair value. Subsequent to initial recognition, loans and receivables are measured at amortized cost using the effective interest method, less any impairment losses.
Cash and Cash equivalents
Cash and cash equivalents include cash, deposits and other short-term, highly liquid financial assets that have an original maturity of not more than three months and are exposed only insignificantly to the risk of changes in their fair value. The Company maintains cash balances with financial institutions located in Germany and the United States. Restricted cash is restricted as to withdrawal or use and consists of cash deposits pledged as collateral for bank borrowings.
F-12
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
3. Summary of significant accounting policies (Continued)
Derivative financial instruments
The Company entered into an interest rate swap agreement to hedge the interest rate risk associated with variable rate debt. The Company does not purchase, hold or sell derivative financial instruments for trading or speculative purposes. The interest rate swap is recognized at fair value in "Financial liabilities" in the statement of financial position. The effective part of gains or losses from changes in the fair value of the interest rate swap is recognized in 'Other comprehensive income' in the statement of comprehensive income (loss).
Other assets
Other assets include mainly security deposits for leases, prepaid expenses and deferred charges as well as amounts relating to VAT.
Other liabilities and provisions
Other liabilities and provisions consist mainly of customer deposits in relation to machine sales and provisions for personnel such as bonuses, royalties and vacation pay.
Deferred income
Deferred income consists of deferred gain from 3D printers sold and leased back under finance leases, prepaid customer fees for maintenance contracts and deferred grant income related to the below-market loan.
Equity
The subscribed capital of the Company consists of 20,000 shares of voting common stock based on a per share price of EUR 50.
4. Changes in reporting standards
The IASB issued a number of new IFRS standards which become effective for the Company's financial year beginning on January 1, 2013.
The Company has not early adopted the following new and revised standards, amendments or interpretations that have been issued but are not yet effective for the relevant periods.
IAS 32 |
Offsetting Financial Assets and Financial Liabilities (1) | |
IAS 36 |
Recoverable Amount Disclosures for Non-Financial Assets (2) | |
IFRS 1 |
Government Loans (1) | |
IFRS 7 |
Disclosures Offsetting Financial Assets and Liabilities (1) | |
IFRS 9 |
Financial Instruments (2) | |
IFRS 7/IFRS 9 |
Mandatory Effective Date and Transition Disclosures | |
IFRS 13 |
Fair Value Measurement (1) |
F-13
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
4. Changes in reporting standards (Continued)
The Company has determined that the new standards, amendments or interpretations have no impact on the financial statements.
In May 2012, as part of its 'Annual Improvement Project 2009-2011', the IASB also published limited editorial changes to various standards: IAS 1 'Presentation of Financial Statements', IAS 16 'Property Plant and Equipment', IAS 32 'Financial Instruments: Presentation', IAS 34 'Interim Reporting', and including IFRS 1 'First-time adoption of IFRS'. These changes are to be applied for the first time for financial years beginning January 1, 2013.
5. Critical accounting judgment and key sources of estimation and uncertainty
In the process of applying the Company's accounting policies, management is required to make judgments, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. These estimates and associated assumptions are based on the knowledge available as of the preparation date of the financial statements and historical experiences as well as other factors that are considered to be relevant. The estimates and underlying assumptions are reviewed on an ongoing basis.
Unforeseeable developments outside management's control may cause actual amounts to differ from the original estimates. In that case, the underlying assumptions and if necessary, the carrying amounts of the pertinent assets and liabilities, are adjusted accordingly. Revisions to accounting estimates are recognized in the period in which the estimate is revised, if the revision affects only that period or in the period of the revision and future periods, if the revision affects both current and future periods.
The assumptions and estimates refer primarily to the determination of the useful lives of property, plant and equipment, the application of the criteria for recognizing finance leases, the realization of receivables and customer loans, measurement of inventory, the recognition and measurement of provisions and the possibility of using tax loss carry-forwards.
The key assumptions concerning the future and other key sources of estimation uncertainty at the end of the reporting period, that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year, are discussed below.
Sales agents are used in connection with the sale of 3D printers. These sales agents receive a sales commission based on a percentage of the sale price for each sale initiated by them. The commission is paid only after the customer has paid the final invoice.
Useful lives
The estimated useful lives and depreciation methods for and property, plant and equipment are based on experiential values. The estimation of the useful life of an asset is based on the experience of the Company with similar assets that are used in a similar way. Additional depreciation is recorded if the estimated useful lives and/or the residual values of property, plant and equipment are different from the previous estimation (see note 9 'Intangible assets and property, plant and equipment').
F-14
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
5. Critical accounting judgment and key sources of estimation and uncertainty (Continued)
Criteria for classifying leases as lessee
A finance lease is an arrangement that transfers substantially all the risks and rewards incident to ownership of an asset to the lessee. Whether a lease is a finance lease or an operating lease depends on the substance of the transaction rather than the form of the contract. The criteria to classify a lease as a finance lease are as follows (one criterion is sufficient to meet the classification as finance lease):
All of our leaseback arrangements for 3D printers transfer ownership of the asset to us at the end of the lease term, therefore, these leases are accounted for as finance leases.
Trade receivables and customer loans
The Company evaluates customer accounts with past-due outstanding balances or specific accounts for which it has information that the customer may be unable to meet its financial obligations. Based upon a review of these accounts and management's analysis and judgment, the Company estimates the future cash flows expected to be recovered from these receivables. The amount of the impairment on doubtful receivables is measured individually and recorded as a specific allowance against that customer's receivable balance to the amount expected to be recovered. The allowance is re-evaluated and adjusted periodically as additional information is received.
Inventories
Management reviews inventories on a product-by-product basis at the end of each reporting period to identify obsolete and slow-moving inventory items that are no longer suitable for use in production. Management estimates the net realizable value of finished goods, work-in progress and raw materials primarily based on current market conditions and based on its experience in manufacturing and selling products of similar nature; if net realizable value is lower than cost an allowance is recorded.
F-15
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
5. Critical accounting judgment and key sources of estimation and uncertainty (Continued)
Provisions
Provisions are recognized and measured on the basis of the estimate and probability of future outflows of resources embodying benefits, as well as on the basis of experiential values and the circumstances known at the end of the reporting period. Assumptions also are made as to the probabilities whether and within what ranges the provisions may be used. The assessment of whether a present obligation exists is generally based on assessments of internal experts. Estimates can change on the basis of new information and the actual charges may affect the performance and financial position of the Company.
Notes to the Statement of Financial Position
6. Financial assets
Financial assets consist of customer loans and restricted cash. Loans in the amount of kEUR 250 and kEUR 340 were granted to customers in 2012 and 2010, respectively, as a means of financing their acquisition of 3D printers. The loans carry interest at a fixed rate of 4.75% and 1.5% and are due October 2017 and September 2016, respectively. Redemption of the first loan started in November 2012. At December 31, 2012, these loans had a balance of kEUR 255 and kEUR 292, respectively. Sales of 3D printers in exchange for customer loans represent noncash transactions for purposes of the cash flow statement.
The following table details the composition of restricted cash at each reporting date:
RESTRICTED CASH
Thousands of Euros
|
12/31/2012 | 12/31/2011 | 12/31/2010 | 01/01/2010 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash deposit |
340 | 67 | 65 | 65 | |||||||||
Safeguard retention LfA |
145 | 145 | 59 | 18 | |||||||||
Total |
485 | 212 | 124 | 83 | |||||||||
The safeguard retention LfA amount relates to an amount withheld by LfA Foerderbank Bayern from proceeds provided under a subsidized loan. LfA Foerderbank Bayern is commissioned by the government to promote regional economic developments with instruments of a bank.
F-16
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
7. Trade receivables
Credit terms to customers are determined individually and are dependent on already existing customer relationships and the customer's payment history. The aging of trade receivables was as follows at each reporting date:
AGING STRUCTURE OF TRADE RECEIVABLES
Thousands of Euros
|
12/31/2012 | 12/31/2011 | 12/31/2010 | 01/01/2010 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Not due at the end of the reporting period |
295 | 639 | 333 | 240 | |||||||||
Amount past due for the following time ranges |
|||||||||||||
Less than 3 months |
321 | 204 | 85 | 234 | |||||||||
Between 3 and 6 months |
8 | 3 | 5 | 9 | |||||||||
Between 6 and 9 months |
1 | | | 40 | |||||||||
Between 9 and 12 months |
| 4 | 1 | | |||||||||
More than 12 months |
| | | 2 | |||||||||
Total |
625 | 850 | 424 | 525 | |||||||||
As of June 30, 2013 payments of kEUR 576 have been received in relation to trade receivables outstanding at December 31, 2012.
The change in allowances for doubtful accounts is:
Change in the allowance for doubtful accounts
Thousands of Euros
|
12/31/2012 | 12/31/2011 | 12/31/2010 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Balance at beginning of period |
| | 10 | |||||||
Charges |
17 | | 1 | |||||||
Release to income |
| | (10 | ) | ||||||
Write offs |
(1 | ) | | (1 | ) | |||||
Balance at end of period |
16 | | | |||||||
8. Inventories
Inventories consist of the following for the years reported:
INVENTORIES BY CATEGORY
Thousands of Euros
|
12/31/2012 | 12/31/2011 | 12/31/2010 | 01/01/2010 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Raw Materials |
170 | 143 | 100 | 189 | |||||||||
Work in progress |
2,252 | 1,583 | 563 | 1,121 | |||||||||
Finished goods |
384 | 285 | 201 | 66 | |||||||||
Total |
2,806 | 2,011 | 864 | 1,376 | |||||||||
F-17
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
8. Inventories (Continued)
Impairment of inventories was recorded in 2012 amounting to kEUR 11; no impairments were recorded in 2011 and 2010.
9. Intangible assets and property, plant and equipment
Thousands of Euros
|
12/31/2012 | 12/31/2011 | 12/31/2010 | 01/01/2010 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leasehold improvements |
17 | 20 | 24 | 22 | |||||||||
Plant and machinery (includes assets under finance lease) |
4,578 | 4,575 | 5,088 | 3,188 | |||||||||
Other facilities, factory and office equipment |
704 | 752 | 796 | 333 | |||||||||
Total |
5,299 | 5,347 | 5,908 | 3,543 | |||||||||
Thereof pledged assets of Property, Plant and Equipment: |
1,180 | 933 | 1,089 | 236 | |||||||||
Thereof leased assets included in Property, Plant and Equipment: |
3,244 | 3,336 | 3,584 | 2,644 | |||||||||
Printing machines |
3,166 | 3,293 | 3,536 | 2,619 | |||||||||
Other factory equipment |
78 | 43 | 48 | 25 |
The assets were pledged as a security for certain bank borrowings, credit lines and other transactions and facilities.
The following table presents the composition of, and annual movement in, intangible assets and property, plant and equipment for the financial years 2012, 2011 and 2010, respectively:
2012
F-18
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
9. Intangible assets and property, plant and equipment (Continued)
2011
2010
A kEUR 20 impairment of non-financial assets was recognized at December 31, 2010 for an intelligent crane system, which was no longer useable to the Company. No other impairments of non-financial assets were recorded within the respective years.
The Company has entered into sale and leaseback transactions for 13 self-produced 3D printers, which were sold to banks and leased back with the intention to be used in the Services segment for the purpose of producing custom-ordered printed products and to sell them to customers as used printers.
In connection with sale and leaseback transactions, the Company sold 3D printers with manufacturing costs of kEUR 266, kEUR 199, and kEUR 689 in 2012, 2011 and 2010, respectively and leased them back under the terms of finance leases. The gain from the sale of kEUR 510, kEUR 751, and kEUR 867 was deferred and is amortized over the respective lease term resulting in other operating income of kEUR 362, kEUR 523, and kEUR 304 in 2012, 2011 and 2010, respectively.
F-19
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
9. Intangible assets and property, plant and equipment (Continued)
In connection with the sale of refurbished 3D printers to customers, the Company early terminated one finance lease in each of 2012 and 2011 and purchased the 3D printers from the lessor. Two other refurbished 3D printers (one each in 2012 and 2011) that had been carried as property, plant and equipment were sold to customers.
Leases of 3D printers are noncash transactions for purposes of the cash flow statement.
In addition to the sale and leaseback transactions of self-produced equipment in 2012, 2011 and 2010, the Company entered into finance lease agreements for property, plant, and equipment with costs of kEUR 46, kEUR 6, and kEUR 29, respectively.
10. Financial liabilities
Financial liabilities consist of the following: bank overdraft and lines of credit, long-term debt, finance lease obligations and derivatives.
Bank overdraft and lines of credit
The Company has lines of credit with several banks to fund working capital requirements. The following table provides relevant details:
Bank overdrafts and lines of credit
The Company entered into the first line of credit per April 2009 with a nominal value of kEUR 500 to fund working capital requirements. It provides for borrowing, repayment and reborrowing from time to time. The fixed interest rate changed from 5.5% to 4.75% in April 2012. The line of credit is secured by two machines, VX1000 III and VX1000 IV.
The second line of credit was concluded in November 2011 with a nominal value of kEUR 500 to fund working capital requirements. The agreed interest rate is 3.61%, for the amount of kEUR 3 exceeding the line of credit the interest rate is 7.6%. The line of credit is secured by two machines, VX800 XV and VX800 XVI.
F-20
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
10. Financial liabilities (Continued)
Long-term debt
In 2007, the Company entered into a kEUR 700 variable-rate loan agreement with a five year term. Quarterly interest payments are based on the 3-month EURIBOR + 1.8%. Quarterly repayments amount to kEUR 35. The loan balanced to zero as of December 31, 2012.
In September 2009, voxeljet entered into a fixed rate loan agreement with LfA Foerderbank Bayern to receive funding for research into high-speed 3D printing technology. This loan was granted at favorable terms, including an interest-free period through June 2011 and a stated interest rate of 2.8% for the remaining term, which was deemed to be below market at the inception of the loan (based on the Company's credit spread of 3.05% and the 3-month EURIBOR rate). The loan has a term of nine years. Payments of kEUR 90 are due semi-annually on June 30 and December 30, starting on December 30, 2011. Proceeds from the loan were received as follows: kEUR 179 in 2009, kEUR 412 in 2010, kEUR 859 in 2011, and kEUR zero in 2012. Maximum proceeds from the loan are kEUR 1,450. As security, 10% of loan proceeds were withheld by the bank and deposited in a safeguard retention LfA deposit account, which is included in restricted cash.
The value of the favorable terms represents a government grant, which was recognized as 'Deferred income' and a grant asset of kEUR 179 at inception. As the loan compensates voxeljet for research expenditure during the period proceeds are received, the grant income is recognized as 'Other operating income' in the same period as the relevant expenses were incurred through December 2011. Grant income of kEUR 8, kEUR 101, and kEUR 70 in 2009, 2010 and 2011, respectively.
Upon receipt of the loan proceeds, the grant asset was offset against the related loan liability. The loan liability is accreted over the term of the loan using the effective interest method. At December 31, 2012, the LfA loan had a balance of kEUR 1,066.
In July 2010, the Company entered into a kEUR 650 loan agreement due June 30, 2016. Interest is payable at a fixed rate of 6.0%. Payments of kEUR 11 are due monthly. At December 31, 2012, the loan had a balance of kEUR 407.
In December 2010, the Company entered into a kEUR 550 loan agreement due September 30, 2017. Interest is payable at a fixed rate of 5.38%. Payments of kEUR 20 are due quarterly. At December 31, 2012, the loan had a balance of kEUR 373.
Finance lease obligations
voxeljet finances part of its production machinery and associated equipment by means of sale and leaseback transactions, expiring in various years through 2013 to 2017. Please refer to note 22 'Leases' below for detailed information.
Derivatives
In order to mitigate the Company's exposure arising from the above mentioned variable-rate loan agreement, an interest rate swap with the same nominal value, term structure and maturity was entered into. The Company fair value of the interest rate swap at December 31, 2012, 2011, and 2010
F-21
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
10. Financial liabilities (Continued)
was kEUR 0, kEUR 1 and kEUR 7, respectively. Gains of kEUR 1, kEUR 6 and kEUR 9 were recognized in 'Other comprehensive income' in 2012, 2011 and 2010.
The following table shows the maturity profile of voxeljet's financial liabilities based on contractual undiscounted payments:
MATURITIES OF FINANCIAL LIABILITIES
12/31/2012
|
|
|
|
|
Remaining term | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Carrying amount |
|
||||||||||||||||||||
|
Gross
cash outflow |
|
|
> 5 years | ||||||||||||||||||
Thousands of Euros
|
Current | Non-current | Total | < 1 year | 1-5 years | |||||||||||||||||
Bank overdrafts and lines of credit |
740 | 725 | 1,465 | 1,465 | 740 | 725 | | |||||||||||||||
Long-term debt |
389 | 1,457 | 1,846 | 2,168 | 439 | 1,638 | 91 | |||||||||||||||
Finance lease obligations |
1,237 | 1,946 | 3,183 | 3,926 | 1,464 | 2,462 | | |||||||||||||||
Interest rate swap |
| | | | | | | |||||||||||||||
Total financial liabilities |
2,366 | 4,128 | 6,494 | 7,559 | 2,643 | 4,825 | 91 | |||||||||||||||
12/31/2011
12/31/2010
F-22
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
10. Financial liabilities (Continued)
01/01/2010
11. Other liabilities and provisions
Other liabilities and provisions include accruals for tax, warranties and personnel expenses. Accruals for tax comprise VAT payables and other taxes. Accruals for personnel expense relate to social security, performance-related bonuses, outstanding vacation entitlements, and compensation to employees for inventions.
The included customer deposits amount to kEUR 482, kEUR 305, kEUR 4 in 2012, 2011 and 2010, respectively.
In 2012, 2011 and 2010 product warranty expense amounted to kEUR 17, kEUR 11 and kEUR 3, respectively, and was included in other operating expenses.
12. Financial instruments
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy defines the following levels:
F-23
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
12. Financial instruments (Continued)
FINANCIAL LIABILITIES
|
12/31/2012 | 12/31/2011 | 12/31/2010 | 01/01/2010 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thousands of Euros
|
carrying
amount |
fair value |
carrying
amount |
fair value |
carrying
amount |
fair value |
carrying
amount |
fair value | |||||||||||||||||
Bank overdrafts and lines of credit |
1,465 | 1,465 | | | 2 | 2 | 134 | 134 | |||||||||||||||||
Long-term debt |
1,846 | 1,988 | 2,725 | 2,858 | 2,420 | 2,501 | 1,041 | 1,036 | |||||||||||||||||
Finance lease obligations |
3,183 | 3,186 | 3,378 | 3,412 | 3,621 | 3,621 | 2,710 | 2,777 | |||||||||||||||||
Interest rate swap |
| | 1 | 1 | 7 | 7 | 16 | 16 | |||||||||||||||||
Total |
6,494 | 6,639 | 6,104 | 6,271 | 6,050 | 6,131 | 3,901 | 3,963 | |||||||||||||||||
The Company has one financial instrument measured at fair value on a recurring basis. This financial instrument, an interest rate swap, is categorized as Level 2 according to the fair value hierarchy. The fair value of the interest rate swap at December 31, 2012, 2011, 2010 and January 1, 2010 was kEUR 0, kEUR 1, kEUR 7 and kEUR 16, respectively.
The fair value of long-term debt was determined using discounted cash flow models based on the relevant forward interest rate yield curves. The fair value of finance lease obligations was determined using discounted cash flow models based on market interest rates available to the Company for similar transactions at the relevant date.
The tables on the following pages list the carrying values and fair values of all non-derivative financial instruments held by voxeljet. The carrying amounts of current assets and liabilities approximate fair value due to their short maturities.
Due to the short maturity and the current low level of interest rates, the carrying amount of credit lines and bank overdrafts approximate fair value.
The fair values and carrying amounts of financial assets categorized as loans and receivables are as follows:
FINANCIAL ASSETS
|
12/31/2012 | 12/31/2011 | 12/31/2010 | 01/01/2010 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thousands of Euros
|
carrying
amount |
fair value |
carrying
amount |
fair value |
carrying
amount |
fair value |
carrying
amount |
fair value | |||||||||||||||||
Cash and cash equivalents |
301 | 301 | 498 | 498 | 654 | 654 | 132 | 132 | |||||||||||||||||
Trade receivables |
625 | 625 | 850 | 850 | 424 | 424 | 525 | 525 | |||||||||||||||||
Financial assets |
1,033 | 1,049 | 545 | 578 | 464 | 505 | 83 | 83 | |||||||||||||||||
Total |
1,959 | 1,975 | 1,893 | 1,926 | 1,542 | 1,583 | 740 | 740 | |||||||||||||||||
The fair value of customer loans included in financial assets was determined using a discounted cash flow model based on observable inputs from the relevant forward interest rate yield curve plus an appropriate risk premium.
F-24
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
13. Revenues
In the respective years, voxeljet's revenues were generated in the following geographical regions:
REVENUES BY GEOGRAPHICAL REGION
Thousands of Euros
|
2012 | 2011 | 2010 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
EMEA |
7,404 | 7,112 | 4,621 | |||||||
Germany |
4,094 | 4,790 | 3,382 | |||||||
Other EMEA |
3,310 | 2,322 | 1,239 | |||||||
Asia Pacific |
958 | 73 | 48 | |||||||
Americas |
349 | 72 | 95 | |||||||
Total |
8,711 | 7,257 | 4,764 | |||||||
During 2011 and 2010, the Company conducted a significant portion of its business with a limited number of customers. The Company had one customer in 2011 and 2010 (Daimler AG, Stuttgart, Germany), which individually represented 11% and 22% of total revenues in those respective years. There were no customers that individually represented 10% or greater of total revenue in 2012.
14. Cost of sales
Costs of sales include cost of material, purchased services, cost for finished goods and allocated costs directly related to production.
COST OF SALES
Thousands of Euros
|
2012 | 2011 | 2010 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Personnel expenses |
(2,215 | ) | (1,676 | ) | (1,200 | ) | ||||
Material costs |
(1,299 | ) | (1,228 | ) | (168 | ) | ||||
Depreciation |
(956 | ) | (901 | ) | (783 | ) | ||||
Rental expense |
(487 | ) | (532 | ) | (509 | ) | ||||
Total |
(4,957 | ) | (4,337 | ) | (2,660 | ) | ||||
15. Other operating income and expense
Other operating income includes primarily government grants received for ongoing research and development projects and the recognition of the gain on the sale and leaseback transactions upon release from deferred income.
F-25
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
15. Other operating income and expense (Continued)
The details of other operation income are presented in the table below:
OTHER OPERATING INCOME
Thousands of Euros
|
2012 | 2011 | 2010 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Government grant income |
436 | 308 | 329 | |||||||
Amortization of gain on sale and leaseback transactions |
362 | 523 | 304 | |||||||
Other |
24 | | 129 | |||||||
Total |
822 | 831 | 762 | |||||||
For the respective periods other operating expenses relate mainly to additions to the allowances for receivables or write-off of receivables and to a negative effect on derecognition of financial liabilities.
16. Financial result
For the periods 2012, 2011 and 2010, the financial result is mainly driven by interest expense on finance leases, bank overdrafts and drawings under credit lines and long-term debt. Interest expense on finance lease obligations were kEUR 224, kEUR 237 and kEUR 212 in the financial years 2012, 2011 and 2010, respectively.
17. Income taxes
Income taxes consist of the following:
Income taxes
Thousands of Euros
|
2012 | 2011 | 2010 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Current tax expense |
(137 | ) | (91 | ) | (35 | ) | ||||
Deferred tax benefit |
21 | 50 | 100 | |||||||
Total income tax (expenses) benefit |
(116 | ) | (41 | ) | 65 | |||||
F-26
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
17. Income taxes (Continued)
Deferred tax assets and liabilities
The components of net deferred income taxes at the end of the respective reporting periods were as follows:
SOURCES OF DEFERRED TAX ASSETS AND LIABILITIES
|
12/31/2012 | 12/31/2011 | 12/31/2010 | 01/01/2010 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thousands of Euros
|
Deferred tax
assets |
Deferred tax
liabilities |
Deferred tax
assets |
Deferred tax
liabilities |
Deferred tax
assets |
Deferred tax
liabilities |
Deferred tax
assets |
Deferred tax
liabilities |
|||||||||||||||||
Trade receivables |
5 | (4 | ) | | (4 | ) | | (4 | ) | | (3 | ) | |||||||||||||
Other receivables and current assets |
| | | | | | | (5 | ) | ||||||||||||||||
Property, Plant & Equipment |
| (914 | ) | | (950 | ) | | (1,017 | ) | | (746 | ) | |||||||||||||
Current deferred income |
125 | | 96 | | 89 | | 40 | | |||||||||||||||||
Other current financial liabilities |
346 | | 242 | | 275 | | 168 | | |||||||||||||||||
Other current liabilities and provisions |
| (28 | ) | | (17 | ) | | (17 | ) | | | ||||||||||||||
Non-current deferred income |
293 | | 284 | | 226 | | 118 | | |||||||||||||||||
Other current financial liabilities |
569 | (34 | ) | 704 | (42 | ) | 742 | (47 | ) | 591 | (45 | ) | |||||||||||||
Accumulated other comprehensive loss |
| | | | 2 | | 5 | | |||||||||||||||||
Tax losses carried forward |
| | | | 30 | | 59 | | |||||||||||||||||
Tax assets (liabilities) |
1,338 | (980 | ) | 1,326 | (1,013 | ) | 1,364 | (1,085 | ) | 981 | (799 | ) | |||||||||||||
Set off of tax |
(980 | ) | 980 | (1,013 | ) | 1,013 | (1,085 | ) | 1,085 | (799 | ) | 799 | |||||||||||||
Net tax assets |
358 | 0 | 313 | 0 | 279 | 0 | 182 | 0 | |||||||||||||||||
Reconciliation of profit before income taxes to income tax
The reconciliation between profit before income taxes and income tax (expenses) benefit is as follows:
RECONCILIATION OF INCOME TAXES
Thousands of Euros
|
2012 | 2011 | 2010 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Profit (loss) before income taxes |
328 | 84 | (273 | ) | ||||||
Tax expense at prevailing statutory rate (28%) |
(92 | ) | (24 | ) | 76 | |||||
Non-deductible expenses |
(15 | ) | (14 | ) | (12 | ) | ||||
Other |
(9 | ) | (3 | ) | 1 | |||||
Income tax (expenses) benefit |
(116 | ) | (41 | ) | 65 | |||||
F-27
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
18. Personnel expenses
Personnel expenses included in cost of sales, research and development, selling and administrative expenses comprise:
PERSONNEL EXPENSES
Thousands of Euros
|
2012 | 2011 | 2010 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Wages and salaries |
2,797 | 2,439 | 1,965 | |||||||
Social security contributions |
591 | 512 | 437 | |||||||
Total |
3,388 | 2,951 | 2,402 | |||||||
19. Segment reporting
voxeljet operates in two reportable segments Systems and Services which reflect the internal organizational and management structure according to the distinct nature of the two businesses. The Systems business derives its revenues from the manufacture of 3D printers, and the Services business provides custom-ordered printed product to customers.
The measurement principles used by voxeljet in preparing this segment reporting are also the basis for segment performance assessment. The managing director of voxeljet acts as a chief operating decision maker. As a performance indicator, the chief operating decision maker controls the performance by the Company's revenues and gross profit.
The following table summarizes segment reporting for each of the reporting periods ended December 31. As management's controlling instrument is mainly revenue-based, the reporting information does not include a detailed breakdown of all assets and liabilities by category. The sum of the amounts for the two segments equals the total for the Company in each of the years.
SEGMENT REPORTING
|
12/31/2012 | 12/31/2011 | 12/31/2010 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thousands of Euros
|
SYSTEMS | SERVICES | SYSTEMS | SERVICES | SYSTEMS | SERVICES | |||||||||||||
Revenues |
3,464 | 5,247 | 2,206 | 5,051 | 1,036 | 3,728 | |||||||||||||
Gross profit |
1,399 | 2,355 | 569 | 2,351 | 539 | 1,565 | |||||||||||||
Gross profit in % |
40.4 | % | 44.9 | % | 25.8 | % | 46.5 | % | 52.0 | % | 42.0 | % | |||||||
Plant, machinery, other facilities and leased products |
854 | 4,445 | 592 | 4,755 | 656 | 5,252 | |||||||||||||
Trade receivables |
189 | 436 | 167 | 683 | 57 | 367 | |||||||||||||
Trade payables |
318 | 242 | 268 | 249 | 113 | 174 | |||||||||||||
Depreciation and amortisation (excl. Intangible assets) |
229 | 1,107 | 171 | 1,059 | 146 | 944 | |||||||||||||
F-28
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
19. Segment reporting (Continued)
Systems revenues include revenues from the sales of used 3D printers of kEUR 500, kEUR 519 and kEUR 0 for the years ended December 31, 2012, 2011 and 2010, respectively.
20. Financial risk management
The Company's Management director is responsible for implementing the finance policy and for ongoing risk management. Transactions related to activities in the area of financial instruments require the prior approval of the Management director. Derivative financial instruments have not been used for speculative purposes and have served solely to hedge risks connected with business operations.
Foreign exchange risk
For the year ended December 31, 2012, voxeljet generated 75% of its revenues in the eurozone. Additionally, the majority of the Company's sourcing transactions are also transacted in Euros in that zone. voxeljet's statement of financial position is not significantly exposed to foreign exchange risk.
Interest rate risk
voxeljet's principal interest-bearing positions are liabilities for bank borrowings and finance lease obligations. These liabilities are entirely at a fixed interest rate, with the exception of one variable loan which is converted to a fixed-rate position through the use of an interest rate swap. As such, changes in market interest rates have no effect on the accounts.
Credit risk
Credit risk is the risk of the Company suffering a financial loss as the result of its counterparties being unable to perform their obligations. The Company is exposed to credit risk from its operating activities (mainly trade receivables and customer loan) and from its financing activities including deposits with banks and financial institutions. voxeljet seeks to minimize such risk by entering into transactions with counterparties that are believed to be creditworthy business partners or with financial institutions which meet high credit rating requirements. In addition, the portfolio of receivables and customer advances is monitored on a continuous basis. Credit risk is limited to a specified amount with regard to individual receivables.
Financing risk
A lack of available funding or impeded access to sufficient funding could have a materially adverse financial impact on the Company. The availability of existing borrowing depends particularly on the Company's leverage ratio. The Company seeks to mitigate financing risk by actively managing its financial profile. See note 21 'Capital Management' for more detailed information.
Liquidity risk
Liquidity risk is the risk that voxeljet might not have sufficient cash to meet its payment obligations. This risk is countered by systematic, day-by-day liquidity management whose absolute fundamental requirement is that solvency must be guaranteed at all times. A major responsibility of key management is to monitor the cash balances and to set up and update cash planning on monthly basis
F-29
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
20. Financial risk management (Continued)
to ensure liquidity. At all times cash and cash equivalents are projected on the basis of a regular financial and liquidity planning.
21. Capital management
Equity is monitored by the Company's equity ratio. The equity used as a basis for determining the equity ratio corresponds to the equity disclosed in the Statement of Financial Position.
Key elements of the internal control system are the planning and ongoing monitoring of profitability, as measured by management. The relevant performance indicators are submitted to the Management Board for consideration as part of regular reporting.
As part of active management of borrowings, particular attention is given to managing leverage, measured as the ratio of net debt to turnover, assessing needs for capital and liquidity, and to matching the timing of refinancing measures.
Part of the capital management strategy is also to enter into sale and leaseback transactions to finance the 3D printing equipment used in the production of printed product for customers.
voxeljet's capital structure as of the end of the reporting periods 2012, 2011 and 2010 was as follows:
CAPITAL STRUCTURE
|
12/31/2012 | 12/31/2011 | 12/31/2010 | 01/01/2010 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity |
1,218 | 1,005 | 958 | 1,159 | |||||||||
Share of total equity and liabilities |
11.3 | % | 10.3 | % | 10.8 | % | 18.7 | % | |||||
Current financial liabilities |
2,366 | 1,498 | 1,559 | 1,003 | |||||||||
Non-current financial liabilities |
4,128 | 4,606 | 4,491 | 2,898 | |||||||||
Total financial liabilities |
6,494 | 6,104 | 6,050 | 3,901 | |||||||||
Share of total equity and liabilities |
60.5 | % | 62.5 | % | 68.3 | % | 62.9 | % | |||||
Total equity and liabilities |
10,738 | 9,768 | 8,864 | 6,203 | |||||||||
There were no changes to the capital management strategy during the considered years.
F-30
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
22. Leases
Finance leases
Future minimum lease payments under financing lease arrangements at the end of the considered reporting periods are approximately as follows:
PRESENT VALUE OF MINIMUM LEASE PAYMENTS
2012
Thousands of Euros
|
Minimum future
lease payments obligation |
Unamortized
interest expense |
Present value of
minimum future lease payments obligation |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
due within 1 year |
1,464 | (227 | ) | 1,237 | ||||||
due between 1 and 5 years |
2,462 | (516 | ) | 1,946 | ||||||
due in more than 5 years |
| | | |||||||
Total |
3,926 | (743 | ) | 3,183 | ||||||
2011
Thousands of Euros
|
Minimum future
lease payments obligation |
Unamortized
interest expense |
Present value of
minimum future lease payments obligation |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
due within 1 year |
1,229 | (365 | ) | 864 | ||||||
due between 1 and 5 years |
3,061 | (547 | ) | 2,514 | ||||||
due in more than 5 years |
| | | |||||||
Total |
4,290 | (912 | ) | 3,378 | ||||||
2010
Thousands of Euros
|
Minimum future
lease payments obligation |
Unamortized
interest expense |
Present value of
minimum future lease payments obligation |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
due within 1 year |
1,267 | (285 | ) | 982 | ||||||
due between 1 and 5 years |
3,157 | (518 | ) | 2,639 | ||||||
due in more than 5 years |
| | | |||||||
Total |
4,424 | (803 | ) | 3,621 | ||||||
F-31
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
22. Leases (Continued)
Operating Leases
Lessee
The estimated payment schedule regarding operating leases is as follows:
OPERATING LEASE OBLIGATIONS
Thousands of Euros
|
12/31/2012 | 12/31/2011 | 12/31/2010 | 01/01/2010 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Less than 1 year |
356 | 361 | 368 | 28 | |||||||||
1 to 5 years |
1,234 | 1,474 | 1,631 | 24 | |||||||||
Over five years |
| | 158 | | |||||||||
Total |
1,590 | 1,835 | 2,157 | 52 | |||||||||
Operating lease expenses were kEUR 371, kEUR 375 and kEUR 329 in the financial years 2012, 2011 and 2010, respectively.
Lessor
voxeljet leased two of its self-produced 3D printers to customers. Under the lease contracts, voxeljet bears all the substantial risks and rewards of the underlying assets.
Operating lease payments receivable for subleases
Thousands of Euros
|
12/31/2012 | 12/31/2011 | 12/31/2010 | 01/01/2010 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Less than 1 year |
96 | 0 | 26 | 105 | |||||||||
1 to 5 years |
96 | 0 | 0 | 27 | |||||||||
Over five years |
0 | 0 | 0 | 0 | |||||||||
Total |
192 | 0 | 26 | 132 | |||||||||
The operating lease income was kEUR 96, kEUR 96 and kEUR 130 in the financial years 2012, 2011 and 2010, respectively, and recorded as revenue.
23. Commitments, contingent assets and liabilities
In connection with the enforcement of voxeljet's intellectual property rights, the acquisition of third-party intellectual property rights, or disputes related to the validity or alleged infringement of the Company's or third-party intellectual property rights, including patent rights, voxeljet has been and may in the future be subject or party to claims, negotiations or complex, protracted litigation.
24. Related party transactions
Related party transactions at voxeljet mainly comprise transactions with key management and related individuals.
F-32
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
24. Related party transactions (Continued)
Transactions with key management
Key management is defined as those people having authority and responsibility for planning, directing and controlling the activities of the Company within their function and within the interest of the Company.
The following table presents the amount and components of key management compensation:
MANAGEMENT COMPENSATION
Thousands of Euros
|
12/31/2012 | 12/31/2011 | 12/31/2010 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Fixed compensation |
173 | 138 | 110 | |||||||
Variable compensation |
78 | 39 | 52 | |||||||
Total |
251 | 177 | 162 | |||||||
Managing director remuneration currently consists of a fixed monetary remuneration, other fixed benefits (including company car allowances and contributions to a direct contribution plan), and a variable bonus.
Voxeljet 's managing director has agreed to personally guarantee EUR 75,000 of a loan from Bayerische Hypo- und Vereinsbank AG, Munich to the Company. Three of the shareholders of voxeljet pursuant to an agreement, dated September 1, 2010, have each agreed to reimburse the managing director EUR 18,750 in case voxeljet default on the loan and he is required to pay any sums under his personal guarantee. The Company pays an interest rate of 6.00% per annum on the guaranteed amount to each guarantor.
Transactions with related parties
A related party relationship could have an effect on the profit and loss and financial position of the Company. Defined as related parties are individuals or other third parties with whom voxeljet has common control relationships.
OTHER RELATED PARTIES
Name
|
Nature of relationship | Duration of relationship | ||
---|---|---|---|---|
Franz Industriebeteiligungen AG, Augsburg |
Owner | 10/01/2003-12/12/2012 | ||
Prof. Dr. Joachim Heinzl, Munich |
Owner | 05/01/1999-Current | ||
AleSta Beteiligungs GmbH, Augsburg |
Owner | 06/01/2009-Current | ||
Schlosserei und Metallbau Ederer, Dießen |
Supplier | 05/01/1999-Current |
The main transactions with other related individuals were the following:
Franz Industriebeteiligungen AG, Augsburg is owned by Mr. Rudolf Franz and he works as an external consultant at voxeljet . Therefore Franz Industriebeteiligungen AG, Augsburg received a compensation on a regular basis which is split into a fixed and variable component, amounted to the following in the
F-33
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
24. Related party transactions (Continued)
years 2012, 2011 and 2010, respectively: kEUR 151 (kEUR 117 fixed; kEUR 34 variable), kEUR 101 (kEUR 101 fixed, kEUR 0 variable), and kEUR 72 (kEUR 72 fixed). Other transactions with Franz Industriebeteiligungen AG comprise the rental of office space in Augsburg, Germany. Rental expenses amounted to kEUR 2, kEUR 2, and kEUR 1 in 2012, 2011 and 2010, respectively. In addition, Franz Industriebeteiligungen AG received payments related to the use of certain paintings which are placed in the administrative building in Friedberg. Associated rental expenses amount to kEUR 2, kEUR 2, and kEUR 1 in 2012, 2011 and 2010, respectively.
AleSta Beteiligungs GmbH, Augsburg, which holds 12.5% of subscribed capital, provided consulting services in 2010. Associated expenses amounted to kEUR 2.2. Further, voxeljet acquired goods amounting to kEUR 14, kEUR 13, and kEUR 34 in 2012, 2011 and 2010 from 'Schlosserei und Metallbau Ederer', which is owned by the brother of Dr. Ingo Ederer (CEO).
25. Explanation of transition from German GAAP to IFRS
Bases for first-time adoption of IFRS
The Company presents a statement of financial position as of January 1, 2010, the date of transition to IFRS.
This is the first set of financial statements prepared under IFRS. All periods presented were prepared in accordance with the IFRS whose application was obligatory as of December 31, 2012.
The Company did not choose to apply any exemptions for the application of the IFRS applicable at December 31, 2012, to the opening balance sheet under IFRS as of January 1, 2010.
Reconciliation of equity and profit (loss) for the period from German GAAP to IFRS
The differences in recognition and measurement of assets and liabilities in the opening balance sheet under IFRS on January 1, 2010, resulting from the first-time adoption of IFRS, compared to the financial statements of voxeljet under the German Commercial Code, are recorded in retained earnings.
F-34
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
25. Explanation of transition from German GAAP to IFRS (Continued)
The first-time adoption of IFRS had the following effects on the equity of voxeljet at the respective reporting periods:
RECONCILIATION OF EQUITY
Thousands of Euros
|
12/31/2012 | 12/31/2011 | 12/31/2010 | 01/01/2010 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity according to German GAAP |
2,157 | 1,858 | 1,567 | 1,416 | |||||||||
Property, plant and equipment depreciation method |
23 | 56 | 37 | 18 | |||||||||
Recognition of lease assets and liabilities due to classification as finance lease |
60 | (42 | ) | (37 | ) | (65 | ) | ||||||
Gain deferral from sale-and-lease-back |
(1,490 | ) | (1,354 | ) | (1,056 | ) | (393 | ) | |||||
Adjustments due to other provisions and liabilities |
116 | 160 | 162 | 8 | |||||||||
Adjustments to receivables and other current assets |
(6 | ) | 15 | 13 | 9 | ||||||||
Recognition of financial instruments at fair value |
| (1 | ) | (7 | ) | (16 | ) | ||||||
Adjustments of deferred taxes (IAS 12) |
358 | 313 | 279 | 182 | |||||||||
Equity according to IFRS |
1,218 | 1,005 | 958 | 1,159 | |||||||||
Reconciliation of profit for the period between German GAAP and IFRS
The first-time adoption of IFRS had the following effects on profit:
RECONCILIATION OF PROFIT (LOSS)
Thousands of Euros
|
12/31/2012 | 12/31/2011 | 12/31/2010 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Profit or loss according to German GAAP |
299 | 291 | 151 | |||||||
Property, plant and equipment depreciation method |
16 | 17 | 18 | |||||||
Recognition of lease assets and liabilities due to classification as finance lease |
(81 | ) | (303 | ) | (635 | ) | ||||
Adjustments due to other provisions and liabilities |
(34 | ) | (1 | ) | 155 | |||||
Adjustments to receivables and other current assets |
(20 | ) | 2 | 4 | ||||||
Adjustments of deferred taxes (IAS 12) |
32 | 37 | 99 | |||||||
Profit (loss) |
212 | 43 | (208 | ) | ||||||
Reconciliation of other comprehensive income from German GAAP to IFRS
The information included in other comprehensive income under IFRS is not recognized under the German Commercial Code. Therefore all components of other comprehensive income represent a deviation from German GAAP.
F-35
voxeljet technology GmbH
NOTES TO THE FINANCIAL STATEMENTS (Continued)
25. Explanation of transition from German GAAP to IFRS (Continued)
Other information on the reconciliation from German GAAP to IFRS
The principal differences between the accounting policies under the German Commercial Code and IFRS pertain to the following matters:
Property, plant, and equipment
In accordance with IAS 16, property, plant and equipment are normally depreciated straight-line over their expected useful life in these financial statements under IFRS. Under the German GAAP accelerated depreciation is recorded in accordance with German tax rules.
Leases
The Company sells assets and leases them back. Under IFRS the leasebacks are classified as finance leases and the Company records the asset, and a corresponding liabilities. Any gain from the sale is deferred and amortized over the lease term; the leased assets are recorded as property, plant and equipment and depreciated over their useful lives. Under German GAAP, the lease is classified as operating lease resulting in the derecognition of the asset and immediate gain recognition.
Provisions and liabilities
Provisions are recorded under IFRS when an obligation is probable and the amount can be estimated reliably. Under German GAAP, provisions are recorded under prudent judgment, even when not probable.
Deferred tax
Under IAS 12, deferred taxes are generally to be recognized for all temporary differences between the values measured for assets and liabilities in the statement of financial position under IFRS and their tax base. Deferred taxes are calculated on the basis of the expected future tax rates. Recognition of other deferred tax assets was optional. Deferred taxes in the financial statements under the German Commercial Code were calculated using the current tax rate.
F-36
voxeljet technology GmbH
STATEMENT OF FINANCIAL POSITION
Thousands of Euros
|
Notes | 06/30/2013 | 12/31/2012 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
|
|
(unaudited)
|
|
|||||||
Current assets |
5,840 | 4,104 | ||||||||
Cash and cash equivalents |
7 | 339 | 301 | |||||||
Financial assets |
3,7 | 293 | 108 | |||||||
Trade receivables |
7,8 | 1,372 | 625 | |||||||
Inventories |
3,122 | 2,806 | ||||||||
Other assets |
714 | 264 | ||||||||
Non-current assets |
7,283 | 6,634 | ||||||||
Financial assets |
3,7 | 671 | 925 | |||||||
Intangible assets |
56 | 52 | ||||||||
Property, plant and equipment |
4 | 6,000 | 5,299 | |||||||
Deferred tax assets |
556 | 358 | ||||||||
Total assets |
13,123 | 10,738 | ||||||||
Thousands of Euros
|
Notes | 06/30/2013 | 12/31/2012 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Current liabilities |
5,564 | 4,322 | ||||||||
Deferred income |
773 | 533 | ||||||||
Trade payables |
756 | 560 | ||||||||
Income tax payable |
13 | 17 | ||||||||
Financial liabilities |
5,7 | 1,905 | 2,366 | |||||||
Other liabilities and provisions |
6 | 2,117 | 846 | |||||||
Non-current liabilities |
6,717 | 5,198 | ||||||||
Deferred income |
1,644 | 1,063 | ||||||||
Financial liabilites |
5,7 | 5,066 | 4,128 | |||||||
Other liabilities and provisions |
7 | 7 | ||||||||
Equity |
842 | 1,218 | ||||||||
Subscribed Capital |
1,000 | 1,000 | ||||||||
Capital reserves |
1,262 | 1,262 | ||||||||
Accumulated deficit |
(1,420 | ) | (1,044 | ) | ||||||
Total equity and liabilities |
13,123 | 10,738 | ||||||||
F-37
voxeljet technology GmbH
STATEMENT OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)
Thousands of Euros (except share and per share data)
|
Notes |
six months
ended 06/30/2013 |
six months
ended 06/30/2012 |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenues |
8,9 | 4,478 | 4,644 | |||||||
Cost of sales |
(2,965 | ) | (2,479 | ) | ||||||
Gross profit |
8 | 1,513 | 2,165 | |||||||
Selling expenses |
(829 | ) | (842 | ) | ||||||
Administrative expenses |
(476 | ) | (355 | ) | ||||||
Research and development expenses |
(921 | ) | (627 | ) | ||||||
Other operating expenses |
(170 | ) | (46 | ) | ||||||
Other operating income |
530 | 372 | ||||||||
Operating profit (loss) |
(353 | ) | 667 | |||||||
Finance expense |
(191 | ) | (181 | ) | ||||||
Finance income |
13 | 3 | ||||||||
Financial result |
(178 | ) | (178 | ) | ||||||
Profit (loss) before income taxes |
(531 | ) | 489 | |||||||
Income taxes |
155 | (170 | ) | |||||||
Profit (loss) |
(376 | ) | 319 | |||||||
Other comprehensive income |
| 1 | ||||||||
Total comprehensive income (loss) |
(376 | ) | 320 | |||||||
Weighted average number of ordinary shares outstanding |
2,000,000 | 2,000,000 | ||||||||
Earnings per share basic and diluted |
10 | (0.19 | ) | 0.16 |
F-38
voxeljet technology GmbH
STATEMENT OF CHANGES IN EQUITY (UNAUDITED)
Thousands of Euros
|
Subscribed
capital |
Capital
reserves |
Accumulated
deficit |
Accumulated
other comprehensive income (loss) |
Total equity | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance at January 1, 2012 |
1,000 | 1,262 | (1,256 | ) | (1 | ) | 1,005 | |||||||||
Profit for the period |
| | 319 | | 319 | |||||||||||
Other comprehensive income |
| | | 1 | 1 | |||||||||||
Balance at June 30, 2012 |
1,000 | 1,262 | (937 | ) | | 1,325 | ||||||||||
Thousands of Euros
|
|
|
|
|
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance at January 1, 2013 |
1,000 | 1,262 | (1,044 | ) | | 1,218 | ||||||||||
Loss for the period |
| | (376 | ) | | (376 | ) | |||||||||
Balance at June 30, 2013 |
1,000 | 1,262 | (1,420 | ) | | 842 | ||||||||||
F-39
voxeljet technology GmbH
STATEMENT OF CASH FLOWS (UNAUDITED)
Thousands of Euros
|
six months
ended 06/30/2013 |
six months
ended 06/30/2012 |
|||||
---|---|---|---|---|---|---|---|
Cash Flow from operating activities |
|||||||
Profit (loss) for the period |
(376 | ) | 319 | ||||
Depreciation and amortization |
749 | 639 | |||||
Proceeds from customer loans |
14 | 16 | |||||
Changes in deferred income taxes |
(198 | ) | 37 | ||||
Amortization of deferred income |
(228 | ) | (169 | ) | |||
Change in working capital |
|||||||
Trade receivables and other assets |
(1,198 | ) | (225 | ) | |||
Inventories |
(343 | ) | (170 | ) | |||
Trade payables |
196 | 37 | |||||
Other liabilities and provisions |
1,271 | (285 | ) | ||||
Income tax payable |
(3 | ) | 100 | ||||
Total |
(116 | ) | 299 | ||||
Cash Flow from investing activities |
|||||||
Payments to acquire property, plant and equipment and intangible assets |
(83 | ) | (225 | ) | |||
Payments to acquire financial assets |
(239 | ) | (121 | ) | |||
Total |
(322 | ) | (346 | ) | |||
Cash Flow from financing activities |
|||||||
Proceeds from financial liabilities |
| 815 | |||||
Repayment of financial liabilities |
(1,424 | ) | (1,001 | ) | |||
Proceeds from sale and leaseback |
1,900 | | |||||
Total |
476 | (186 | ) | ||||
Net increase (decrease) in cash and cash equivalents |
38 | (233 | ) | ||||
Cash and cash equivalents at beginning of period |
301 | 498 | |||||
Cash and cash equivalents at end of period |
339 | 265 | |||||
Supplemental Cash Flow Information |
|||||||
Interest paid net |
60 | 69 | |||||
Income taxes paid net |
60 | 31 | |||||
Non-cash items: |
|||||||
Additions to property, plant and equipment through lease |
1,900 | |
F-40
voxeljet technology GmbH
NOTES TO THE INTERIM FINANCIAL STATEMENTS
1. Preparation of financial statements
The interim financial statements of the voxeljet technology GmbH, ('the Company') were prepared in compliance with all of the measurement and presentation rules contained in International Financial Reporting Standards (IFRS) as set forth by the International Accounting Standards Board (IASB) and Interpretations of the IFRS Interpretations Committee (IFRIC). The designation IFRS also includes all valid IAS; the designation IFRIC also includes all valid interpretations of the Standing Interpretations Committee ('SIC'). Especially they were prepared in accordance with the disclosure requirements and the measurement principles for interim financial reporting purposes specified by IAS 34.
The IASB issued a number of new IFRS standards which became effective for the Company's financial year beginning on January 1, 2013.
IFRS 1 | Amendment Government Loans | |
IFRS 7 | Amendment Disclosures Offsetting Financial Assets and Financial Liabilities | |
IFRS 13 | Fair Value Measurement |
The Company applied the new standards and amendments and determined that they have no impact on the interim financial statements.
The interim financial statements as of and for the six months ended June 30, 2013 and 2012 were authorized for issue by the Chief Executive Officer on September 16, 2013.
2. Summary of significant accounting policies
The principal accounting policies applied in the preparation of these interim financial statements are set out in the financial statements as of December 31, 2012. These policies have been applied to all financial periods presented.
3. Financial assets
The financial assets as of June 30, 2013 consisted of a customer loan and restricted cash. A loan in the amount of kEUR 250 was granted to a customer in 2012 for the purpose of financing their acquisition of a 3D printer.
In February 2013, the Company repurchased a 3D printer that it had sold subject to a loan in 2010 and waived the unamortized balance on this loan, which was kEUR 294, in a non-cash transaction. This printer was then sold and leased back in a transaction with a bank and concurrently subleased to a different customer pursuant to an operating lease.
F-41
voxeljet technology GmbH
NOTES TO THE INTERIM FINANCIAL STATEMENTS (Continued)
4. Property, plant and equipment
PROPERTY, PLANT AND EQUIPMENT
Thousands of Euros
|
06/30/2013 | 12/31/2012 | |||||
---|---|---|---|---|---|---|---|
Leasehold improvements |
15 | 17 | |||||
Plant and machinery (includes assets under finance lease) |
5,319 | 4,578 | |||||
Other facilities, factory and office equipment |
666 | 704 | |||||
Total |
6,000 | 5,299 | |||||
Thereof leased assets included in Property, Plant and Equipment: |
4,475 | 3,244 | |||||
Printing machines |
4,397 | 3,166 | |||||
Other factory equipment |
78 | 78 |
No impairment of non-financial assets was recorded.
In the first six months of 2013 the Company entered into sale and leaseback transactions for four self-produced 3D printers with a total value of kEUR 1,900. In connection with these transactions the Company sold 3D printers with manufacturing costs of kEUR 851. The gain from the sale of kEUR 1,049 was deferred and is amortized over the respective lease term. Three of the 3D printers are used in the Services segment and one was leased to a customer under an operating lease.
In the comparative first six months of 2012 no sale and leaseback transactions occurred.
Leases of 3D printers are non-cash transactions for purposes of the cash flow statement.
5. Financial liabilities
Financial liabilities consist of the following: bank overdraft and lines of credit, long-term debt and finance lease obligations. The long-term debt had a carrying amount of kEUR 1,688 as of June 30, 2013 (kEUR 1,846 as of December 31, 2012). Future minimum lease payments under financing lease arrangements at the end of the considered reporting periods at present value amounted to kEUR 4,346 as of June 30, 2013 and kEUR 3,183 as of December 31, 2012.
The Company has lines of credit with several banks to fund working capital requirements.
The nominal value of one line of credit was extended by kEUR 250 amounting to kEUR 750 as of June 30, 2013, compared to year end 2012. Another credit line was extended by kEUR 100 to kEUR 250 in May 2013.
6. Other liabilities and provisions
The increase in other liabilities and provisions is primarily due to an increase in customer deposits received by kEUR 1,191 to kEUR 1,673 as of June 30, 2013.
F-42
voxeljet technology GmbH
NOTES TO THE INTERIM FINANCIAL STATEMENTS (Continued)
7. Financial instruments
The fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.
The Company has no financial instruments that are measured at fair value on a recurring basis.
The fair values and carrying amounts of financial liabilities for the considered reporting periods were as follows:
FINANCIAL LIABILITIES
|
06/30/2013 | 12/31/2012 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thousands of Euros
|
carrying
amount |
fair value |
carrying
amount |
fair value | |||||||||
Bank overdrafts and lines of credit |
937 | 937 | 1,465 | 1,465 | |||||||||
Long-term debt |
1,688 | 1,753 | 1,846 | 1,988 | |||||||||
Finance lease obligations |
4,346 | 4,385 | 3,183 | 3,186 | |||||||||
Total |
6,971 | 7,075 | 6,494 | 6,639 | |||||||||
The fair value of long-term debt was determined using discounted cash flow models based on the relevant forward interest rate yield curves. The fair value of finance lease obligations was determined using discounted cash flow models on market interest rates available to the Company for similar transactions at the relevant date.
The fair values and carrying amounts of financial assets categorized as loans and receivables for the considered reporting periods were as follows:
FINANCIAL ASSETS
|
06/30/2013 | 12/31/2012 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thousands of Euros
|
carrying
amount |
fair value |
carrying
amount |
fair value | |||||||||
Cash and cash equivalents |
339 | 339 | 301 | 301 | |||||||||
Trade receivables |
1,372 | 1,372 | 625 | 625 | |||||||||
Financial assets |
964 | 965 | 1,033 | 1,049 | |||||||||
Total |
2,675 | 2,676 | 1,959 | 1,975 | |||||||||
The fair value of customer loans included in financial assets was determined using a discounted cash flow model based on observable inputs from the relevant forward interest rate yield curve plus an appropriate risk premium.
F-43
voxeljet technology GmbH
NOTES TO THE INTERIM FINANCIAL STATEMENTS (Continued)
8. Segment reporting
The following table summarizes segment reporting for the two reporting periods. The sum of the amounts of the two segments equals the total for the Company in each of the periods.
SEGMENT REPORTING
|
six months ended
06/30/2013 |
six months ended
06/30/2012 |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thousands of Euros
|
SYSTEMS | SERVICES | SYSTEMS | SERVICES | |||||||||
Revenues |
2,049 | 2,429 | 2,041 | 2,603 | |||||||||
Gross profit |
609 | 904 | 1,000 | 1,165 | |||||||||
Gross profit in % |
29.7 | % | 37.2 | % | 49.0 | % | 44.8 | % | |||||
Trade receivables |
813 | 559 | 371 | 665 |
9. Revenues
The revenues by geographical region were as follows:
REVENUES BY GEOGRAPHICAL REGION
Thousands of Euros
|
six months
ended 06/30/2013 |
six months
ended 06/30/2012 |
|||||
---|---|---|---|---|---|---|---|
EMEA |
4,332 | 3,669 | |||||
Germany |
2,489 | 1,867 | |||||
Other EMEA |
1,843 | 1,802 | |||||
Asia Pacific |
75 | 895 | |||||
Americas |
71 | 80 | |||||
Total |
4,478 | 4,644 | |||||
10. Reorganization and earnings (loss) per share
On July 2, 2013, the shareholders of voxeljet technology GmbH formed a new entity named VXLT 2013 AG with a nominal share capital of kEUR 50. Upon formation, the new entity's equity consisted of 50,000 ordinary shares with no par value and a stated value of one Euro (EUR 1) and each shareholder owned the same proportionate interest as in voxeljet technology GmbH.
Effective September 12, 2013, the Company was merged into VXLT 2013 AG upon registration of the merger in the commercial register of the surviving entity, VXLT 2013 AG. Concurrent with the effectiveness of the merger, VXLT 2013 AG changed its name to voxeljet AG.
In connection with the merger, 1,950,000 ordinary shares of voxeljet AG were issued in exchange for the contribution of voxeljet technology GmbH. Combined with the previously issued 50,000 ordinary shares, the post-merger share capital of voxeljet AG consists of 2,000,000 ordinary shares.
F-44
voxeljet technology GmbH
NOTES TO THE INTERIM FINANCIAL STATEMENTS (Continued)
10. Reorganization and earnings (loss) per share (Continued)
The merger is considered a transaction under common control and will be reflected in the financial statements of voxeljet AG using the carrying amounts of the assets and liabilities of voxeljet technology GmbH, the predecessor to voxeljet AG. No adjustments have been made to the interim financial statements of the Company as of and for the six months ended June 30, 2013 and 2012, except that the calculation of earnings (loss) per share is adjusted retrospectively to reflect the number of voxeljet AG shares issued and outstanding after the merger.
Basic earnings per share amounts are calculated by dividing profit (loss) by the weighted average number of two million ordinary shares of voxeljet AG. There are no dilutive instruments issued and outstanding; both basic and diluted earnings (loss) per share are calculated based on the amount of ordinary shares of voxeljet AG.
EARNINGS PER SHARE
|
six months
ended 06/30/2013 |
six months
ended 06/30/2012 |
|||||
---|---|---|---|---|---|---|---|
Thousands of Euros (except share and per share data) |
|||||||
Profit (Loss) for the period |
(376 | ) | 319 | ||||
Weighted average number of ordinary shares |
2,000,000 | 2,000,000 | |||||
Basic / diluted earnings per share |
(0.19 | ) | 0.16 |
F-45
6,500,000 American Depositary Shares
Representing 1,300,000 Ordinary Shares
voxeljet AG
PROSPECTUS
Until , 2013, federal securities laws may require all dealers that effect transactions in these securities, whether or not participating in this offering, to deliver a prospectus. This requirement is in addition to the dealers' obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.
Piper Jaffray
Citigroup
Cowen and Company
Stephens Inc.
, 2013
Item 6.
Indemnification of Directors and Officers
Under German law, we may not, as a general matter, indemnify members of our management board and supervisory board. Certain limited exceptions may apply if the indemnification is in the legitimate interest of our company. We will indemnify our management board and supervisory board members, to the extent permissible under German law, from and against any liabilities arising out of or in connection with their services.
We have provided directors' and officers' liability insurance for the members of our management and supervisory boards against civil liabilities, which they may incur in connection with their activities on behalf of our company. We intend to expand their insurance coverage against such liabilities, including by providing for coverage against liabilities under the Securities Act.
In the underwriting agreement, the form of which is filed as Exhibit 1.1 to this Registration Statement, the underwriters will agree to indemnify, under certain conditions, us, the members of our management board and persons who control our company within the meaning of the Securities Act, against certain liabilities, but only to the extent that such liabilities are caused by information relating to the underwriters furnished to us in writing expressly for use in this Registration Statement and certain other disclosure documents.
Item 7.
Recent Sales of Unregistered Securities
No unregistered securities were sold by us within the past three years.
Item 8.
Exhibits and Financial Statement Schedule
Exhibit Number | Description of Exhibit | ||
---|---|---|---|
1.1 | * | Form of Underwriting Agreement | |
3.1 | * | Articles of Association of voxeljet AG | |
3.2 | Rules of Procedure of the Supervisory Board of voxeljet AG | ||
3.3 | Rules of Procedure of the Management Board of voxeljet AG | ||
4.1 | * | Form of specimen of ordinary registered share certificate and English translation | |
4.2 | Form of Deposit Agreement | ||
4.3 | Form of American Depositary Receipt (included in Exhibit 4.2) | ||
4.4 | ** | Shareholders' Agreement among voxeljet AG and its shareholders, dated July 2, 2013 | |
5.1 | * | Opinion of Dechert LLP | |
8.1 | * | Opinion of Dechert LLP as to U.S. tax matters | |
8.2 | * | Opinion of Dechert LLP as to German tax matters | |
10.1 | ** | Lease Agreement between Deuter GmbH and voxeljet AG (formerly known as Voxeljet Technology GmbH), dated October 19, 2012 (English translation) | |
10.2 | ** | Addendum to the Lease Agreement of October 19, 2012 between Deuter GmbH and voxeljet AG (formerly known as Voxeljet Technology GmbH), dated October 19, 2012 (English translation) | |
10.3 | | Cross License Agreement between voxeljet AG (formerly known as Voxeljet Technology GmbH) and BEGO Medical GmbH, dated August 21, 2012 (English translation) | |
10.4 | | Nonexclusive Patent License and Sublicense Agreement between Z Corporation and voxeljet AG (formerly known as Voxeljet Technology GmbH), dated August 16, 2004 | |
10.5 | First Amendment to the Nonexclusive Patent License and Sublicense Agreement between Z Corporation and voxeljet AG (formerly known as Voxeljet Technology GmbH), dated March 31, 2011 |
II-1
Exhibit Number | Description of Exhibit | ||
---|---|---|---|
10.6 | | Patent and Know-How Transfer Agreement between voxeljet AG (formerly known as Generis GmbH) and The ExOne Company(formerly known as Extrude Hone GmbH) , dated June 27, 2003 | |
10.7 | | Amendment to Patent and Know-How Transfer Agreement between voxeljet AG (formerly known as Voxeljet Technology GmbH) and Prometal RCT GmbH, dated July 14, 2009 | |
23.1 | * | Consent of Dechert LLP (included in Exhibits 5.1, 8.1 and 8.2) | |
23.2 | Consent of KPMG AG Wirtschaftsprüfungsgesellschaft | ||
24.1 | ** | Powers of Attorney (included on the signature page) |
(i) For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this Registration Statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this Registration Statement as of the time it was declared effective.
(ii) For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
II-2
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Friedberg, Germany on the 7th day of October, 2013.
|
|
VOXELJET AG |
||
|
|
By: |
|
/s/ DR. INGO EDERER |
Name: | Dr. Ingo Ederer | |||
Title: | Chief Executive Officer |
Pursuant to the requirements of the United States Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
|
Signature
|
|
Date
|
|||
---|---|---|---|---|---|---|
|
|
|
|
|
|
|
/s/ DR. INGO EDERER
Dr. Ingo Ederer |
Chief Executive Officer and Member of the Management Board
(Principal Executive Officer) |
October 7, 2013 | ||||
/s/ RUDOLF FRANZ Rudolf Franz |
|
Chief Financial Officer and Member of the Management Board (Principal Financial Officer and Principal Accounting Officer) |
|
October 7, 2013 |
||
* Prof. Dr. Joachim Heinzl |
|
Member of Supervisory Board |
|
October 7, 2013 |
||
* Peter Nietzer |
|
Member of Supervisory Board |
|
October 7, 2013 |
||
* Dr. Stefan Söhn |
|
Member of Supervisory Board |
|
October 7, 2013 |
||
*By: |
|
/s/ RUDOLF FRANZ Rudolf Franz Attorney-in-fact |
|
|
|
|
II-3
SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES
Pursuant to the requirements of the United States Securities Act of 1933, as amended, the undersigned, the registrant's duly authorized representative in the United States has signed this Registration Statement in New York, New York on the 7th day of October, 2013.
LAW DEBENTURE CORPORATE SERVICES INC. | ||
|
|
/s/ AMY SEGLER Name: Amy Segler Title: Service of Process Officer |
II-4
Exhibit
Number |
Description of Exhibit | ||
---|---|---|---|
1.1 | * | Form of Underwriting Agreement | |
3.1 | * | Articles of Association of voxeljet AG | |
3.2 | Rules of Procedure of the Supervisory Board of voxeljet AG | ||
3.3 | Rules of Procedure of the Management Board of voxeljet AG | ||
4.1 | * | Form of specimen of ordinary registered share certificate and English translation | |
4.2 | Form of Deposit Agreement | ||
4.3 | Form of American Depositary Receipt (included in Exhibit 4.2) | ||
4.4 | ** | Shareholders' Agreement among voxeljet AG and its shareholders, dated July 2, 2013 | |
5.1 | * | Opinion of Dechert LLP | |
8.1 | * | Opinion of Dechert LLP as to U.S. tax matters | |
8.2 | * | Opinion of Dechert LLP as to German tax matters | |
10.1 | ** | Lease Agreement between Deuter GmbH and voxeljet AG (formerly known as Voxeljet Technology GmbH), dated October 19, 2012 (English translation) | |
10.2 | ** | Addendum to the Lease Agreement of October 19, 2012 between Deuter GmbH and voxeljet AG (formerly known as Voxeljet Technology GmbH), dated October 19, 2012 (English translation) | |
10.3 | | Cross License Agreement between voxeljet AG (formerly known as Voxeljet Technology GmbH) and BEGO Medical GmbH, dated August 21, 2012 (English translation) | |
10.4 | | Nonexclusive Patent License and Sublicense Agreement between Z Corporation and voxeljet AG (formerly known as Voxeljet Technology GmbH), dated August 16, 2004 | |
10.5 | First Amendment to the Nonexclusive Patent License and Sublicense Agreement between Z Corporation and voxeljet AG (formerly known as Voxeljet Technology GmbH), dated March 31, 2011 | ||
10.6 | | Patent and Know-How Transfer Agreement between voxeljet AG (formerly known as Generis GmbH) and The ExOne Company(formerly known as Extrude Hone GmbH) , dated June 27, 2003 | |
10.7 | | Amendment to Patent and Know-How Transfer Agreement between voxeljet AG (formerly known as Voxeljet Technology GmbH) and Prometal RCT GmbH, dated July 14, 2009 | |
23.1 | * | Consent of Dechert LLP (included in Exhibits 5.1, 8.1 and 8.2) | |
23.2 | Consent of KPMG AG Wirtschaftsprüfungsgesellschaft | ||
24.1 | ** | Powers of Attorney (included on the signature page) |
II-5
Exhibit 3.2
GESCHÄFTSORDNUNG
|
|
RULES OF PROCEDURE OF THE
|
|
|
|
Der Aufsichtsrat der voxeljet AG (vormalig firmierend unter VXLT 2013 AG) hat durch Beschluss vom 31. Juli 2013 seine Geschäftsordnung wie folgt festgestellt: |
|
By way of a resolution dated 31 July 2013, the Supervisory Board of voxeljet AG (previously named as VXLT 2013 AG) has adopted the following rules of procedure: |
|
|
|
§ 1
|
|
§ 1
|
|
|
|
1. Der Aufsichtsrat berät und überwacht den Vorstand bei der Leitung des Unternehmens. |
|
1. The Supervisory Board shall advise and supervise the Management Board in its management of the Company. |
|
|
|
2. Der Aufsichtsrat führt seine Geschäfte nach den Vorschriften der Gesetze, der Satzung der Gesellschaft, dem Deutschen Corporate Governance Kodex (soweit nicht in der Entsprechungserklärung Abweichungen veröffentlicht wurden) und dieser Geschäftsordnung. Bei der Wahrnehmung seiner Aufgaben arbeitet der Aufsichtsrat vertrauensvoll mit dem Vorstand zum Wohle des Unternehmens eng zusammen. |
|
2. The Supervisory Board shall conduct its business in accordance with applicable law, the Companys articles of association (the Articles of Association ), the German Corporate Governance Code (unless deviations have been disclosed in the applicable declaration of adherence) and these rules of procedure. In fulfilling its duties, it shall cooperate closely, in good faith, with the Management Board in pursuing the best interests of the Company. |
|
|
|
3. Der Aufsichtsrat überprüft regelmäßig, mindestens jedoch alle zwei Jahre, die Effizienz seiner Tätigkeit. |
|
3. The Supervisory Board shall review the efficiency of its activities on a regular basis, at least once every two years. |
§ 2
|
|
§ 2
|
|
|
|
1. Dem Aufsichtsrat gehören insgesamt drei Mitglieder an. |
|
1. The Supervisory Board shall be composed of three members. |
|
|
|
2. Jedes Aufsichtsratsmitglied soll über die zur ordnungsgemäßen Wahrnehmung der Aufgaben erforderlichen Kenntnisse, Fähigkeiten und fachlichen Erfahrungen verfügen und hinreichend unabhängig sein. Die Amtszeit eines Aufsichtsratsmitglieds soll nicht über dessen 75. Geburtstag hinaus fortdauern. |
|
2. Each member of the Supervisory Board shall have the required knowledge, abilities and relevant experience to fulfil his/her duties properly and shall be sufficiently independent. The tenure of a Supervisory Board member shall not be extended beyond his/her 75th birthday. |
|
|
|
3. Bei den Vorschlägen zur Wahl von Aufsichtsratsmitgliedern durch die Hauptversammlung soll auf die folgenden Grundsätze geachtet werden: |
|
3. The Supervisory Boards proposals for the election of new members of the Supervisory Board by the general shareholders meeting shall take into account the following principles: |
|
|
|
a) Kandidaten, die dem Vorstand einer anderen börsennotierten Gesellschaft angehören, dürfen nicht zum Mitglied des Aufsichtsrats gewählt werden, wenn sie mehr als zwei Aufsichtsratsmandate in börsennotierten Gesellschaften wahrnehmen, die nicht dem Konzern derjenigen Gesellschaft angehören, in der die Vorstandstätigkeit ausgeübt wird. |
|
a) Candidates who are members of the management board of another listed company shall not serve on the Supervisory Board if they hold more than two supervisory board seats at listed companies which do not belong to the group of the company at which the management board position is held. |
b) Dem Aufsichtsrat sollen nicht mehr als zwei ehemalige Mitglieder des Vorstands angehören. Aufsichtsratsmitglieder sollen keine Organfunktion oder Beratungsaufgaben bei wesentlichen Wettbewerbern des Unternehmens ausüben. |
|
b) No more than two former members of the Companys Management Board shall serve on the Supervisory Board. Members of the Supervisory Board shall not hold directorships or similar positions, or work in an advisory capacity, at major competitors of the Company. |
|
|
|
c) Die Bestellung eines ehemaligen Vorstandsmitglieds (insbesondere des Vorstandsvorsitzenden) zum Aufsichtsratsvorsitzenden oder zum Vorsitzenden eines Aufsichtsratsauschusses soll nicht die Regel sein. Wenn eine solche Bestellung vorgeschlagen wird, muss diese in der Hauptversammlung besonders begründet werden. |
|
c) A previous member of the Management Board (especially the chairman of the Management Board) should generally not be appointed as chairman of the Supervisory Board or as chairman of a Committee. If such appointment is proposed, it must be firmly justified at the general shareholders meeting. |
|
|
|
d) Dem Aufsichtsrat sollen nach seiner Einschätzung mehrheitlich unabhängige Mitglieder angehören. Ein Aufsichtsratsmitglied ist als unabhängig anzusehen, wenn es in keiner geschäftlichen oder persönlichen Beziehung zu der Gesellschaft oder deren Vorstand steht, die einen Interessenskonflikt begründen könnte. |
|
d) The majority of the Supervisory Board shall be composed of - in its own opinion independent members. A member of the Supervisory Board is independent if the member has no business or personal relationship with the Company or its Management Board which could constitute a conflict of interest. |
e) Bei den Vorschlägen zur Wahl von Aufsichtsratsmitgliedern soll auf die internationale Tätigkeit des Unternehmens sowie auf die Vielfalt ( Diversity ) geachtet werden, insbesondere durch eine angemessene Beteiligung von Frauen. |
|
e) Attention shall be paid to the international activities of the Company and diversity with regard to the proposals for the election of members of the Supervisory Board, in particular through the adequate participation of women. |
|
|
|
§ 3
|
|
§ 3
|
|
|
|
1. Die Mitglieder des Aufsichtsrats haben die gleichen Rechte und Pflichten, sofern das Gesetz, die Satzung oder diese Geschäftsordnung nichts anderes bestimmen. An Aufträge und Weisungen sind sie nicht gebunden. |
|
1. All members of the Supervisory Board shall have the same rights and duties unless otherwise determined by applicable law, the Articles of Association or these rules of procedure. They are not bound by mandates or instructions. |
|
|
|
2. Die Mitglieder des Aufsichtsrats haben über vertrauliche Angaben und Geheimnisse der Gesellschaft, insbesondere vertrauliche Berichte und Beratungen, die ihnen durch ihre Tätigkeit im Aufsichtsrat bekannt werden, Stillschweigen zu bewahren. Diese Verpflichtung gilt auch nach dem Ausscheiden aus dem Amt. Mit Beendigung der Mitgliedschaft im Aufsichtsrat sind alle im Besitz des ausscheidenden Aufsichtsratsmitglieds befindlichen vertraulichen Unterlagen an den Aufsichtsratsvorsitzenden zurückzugeben. |
|
2. The members of the Supervisory Board shall be bound to strict confidentiality with regard to confidential information and secrets of the Company (especially confidential reports and consultations) to which they gain access through their service on the Supervisory Board. This obligation continues to apply after they have left office. All confidential documents must be returned to the chairman of the Supervisory Board when a members membership of the Supervisory Board comes to an end. |
3. Jedes Mitglied des Aufsichtsrats ist dem Unternehmensinteresse verpflichtet. Es darf bei seinen Entscheidungen weder persönliche Interessen verfolgen noch Geschäftschancen, die dem Unternehmen zustehen, für sich nutzen. |
|
3. Each member of the Supervisory Board shall act in the Companys best interests. No member of the Supervisory Board may pursue personal interests in his/her decisions or personally engage business opportunities intended for the Company. |
|
|
|
4. Jedes Aufsichtsratsmitglied hat dem Aufsichtsratsvorsitzenden gegenüber jegliche Interessenkonflikte offen zu legen, insbesondere solche, die aufgrund einer Beratung oder Organfunktion bei Kunden, Lieferanten, Kreditgebern oder sonstigen Geschäftspartnern entstehen könnten. Der Aufsichtsratsvorsitzende veranlasst gegebenenfalls eine Beratung im Vergütungs- und Nominierungsausschuss des Aufsichtsrats. Der Aufsichtsratsvorsitzende hat den Aufsichtsrat oder den Vergütungsund Nominierungsausschuss über eigene Interessenkonflikte zu unterrichten. |
|
4. Each member of the Supervisory Board shall inform the chairman of the Supervisory Board of potential conflicts of interest, especially those which may arise through a consultant or directorship function with clients, suppliers, lenders or other business associates. If necessary, the chairman of the Supervisory Board will arrange for the matter to be discussed by the Compensation and Nomination Committee. The chairman of the Supervisory Board shall inform the Supervisory Board or the Compensation and Nomination Committee of his own conflicts of interest. |
|
|
|
5. Jedes Mitglied des Aufsichtsrats ist verpflichtet, den Kauf und Verkauf von Aktien der Gesellschaft sowie ihrer Tochtergesellschaften, von Optionen sowie sonstigen Derivaten auf diese unverzüglich der Gesellschaft bekannt zu geben. |
|
5. Each member of the Supervisory Board shall inform the Company without undue delay of any purchase or sale of shares in the Company or any of its subsidiaries and of any options or other derivatives in relation to such shares. |
|
|
|
6. Der Aufsichtsrat soll in seinem Bericht an die Hauptversammlung |
|
6. The Supervisory Board shall inform the annual shareholders meeting in |
über aufgetretene Interessenkonflikte und deren Behandlung informieren. Wesentliche und nicht nur vorübergehende Interessenkonflikte in der Person eines Aufsichtsratsmitglieds sollten zur Beendigung des Mandats führen. |
|
its annual report ( Bericht des Aufsichtsrates ) of any arising conflicts of interest and the handling thereof. material and lasting conflicts of interest concerning a Supervisory Board member should lead to the termination of the mandate.
|
|
|
|
7. Der Aufsichtsrat bestellt und entlässt die Mitglieder des Vorstands. Bei der Zusammensetzung des Vorstands soll der Aufsichtsrat auf Vielfalt ( Diversity ) achten. Die Amtszeit eines Vorstandsmitglieds soll nicht über dessen 65. Geburtstag hinaus fortdauern. Der Aufsichtsrat soll gemeinsam mit dem Vorstand für eine langfristige Nachfolgeplanung sorgen. Der Aufsichtsrat soll eine Wiederbestellung von Vorstandsmitgliedern früher als ein Jahr vor dem Ende der Amtsperiode unter gleichzeitiger Aufhebung der laufenden Bestellung nur bei Vorliegen besonderer Umstände vornehmen. |
|
7. The Supervisory Board appoints and dismisses the members of the Management Board. When appointing the Management Board, the Supervisory Board shall respect diversity. The tenure of a member of the Management Board shall not be extended beyond his/her 65th birthday. Together with the Management Board, it shall ensure that there is long-term succession planning. Only under special circumstances shall the Supervisory Board terminate a current appointment and reappoint members of the Management Board earlier than one year prior to the end of their current tenure. |
|
|
|
§ 4
|
|
§ 4
|
|
|
|
1. Der Aufsichtsrat wählt nach Maßgabe des Aktiengesetzes und der Satzung unter der Leitung des ältesten anwesenden Aufsichtsratsmitglieds aus seiner Mitte einen Vorsitzenden und dessen Stellvertreter. Die Wahl erfolgt jeweils für die Dauer der
|
|
1. As provided by the German Stock Corporation Act ( Aktiengesetz, AktG ) and the Articles of Association, under the direction of the oldest Supervisory Board member present, the Supervisory Board shall elect a chairman and a deputy chairman from |
Mitgliedschaft im Aufsichtsrat. |
|
among its members; elected in each case for the duration of their membership on the Supervisory Board. |
|
|
|
2. Scheidet der Aufsichtsratsvorsitzende oder sein Stellvertreter während der Amtszeit aus, so hat der Aufsichtsrat unverzüglich einen Nachfolger für die restliche Amtszeit des Ausgeschiedenen zu wählen. |
|
2. Should one of the aforementioned retire during their tenure, the Supervisory Board shall immediately elect a successor to serve during the remaining term of the retired member. |
|
|
|
3. Der Aufsichtsratsvorsitzende ist zur Abgabe jeglicher Willenerklärungen im Namen des Aufsichtsrats berechtigt, die zur Umsetzung der Aufsichtsratsbeschlüsse erforderlich sind. Der Aufsichtsratsvorsitzende ist befugt, Erklärungen für den Aufsichtsrat entgegenzunehmen. Sollte der Aufsichtsratsvorsitzende verhindert sein, hat der Stellvertreter diese Rechte und Pflichten. |
|
3. The chairman of the Supervisory Board shall be authorized, on behalf of the Supervisory Board, to make declarations necessary to implement the resolutions of the Supervisory Board. The chairman of the Supervisory Board is authorized to accept declarations addressed to the Supervisory Board. If the chairman of the Supervisory Board is incapacitated the deputy chairman shall have such authorities. |
|
|
|
§ 5
|
|
§ 5
|
|
|
|
1. Der Aufsichtsrat muss mindestens zwei Sitzungen in den ersten beiden Quartalen und mindestens zwei Sitzungen in den letzten beiden Quartalen jedes Kalenderjahres abhalten. Weitere Sitzungen werden nach Bedarf einberufen. |
|
1. The Supervisory Board shall hold at least two meetings in the first two quarters and at least two meetings in the second two quarters of each calendar year. Additional meetings shall be held if necessary. |
2. Der Aufsichtsratsvorsitzende informiert den Aufsichtsrat insbesondere über wichtige Ereignisse, die ihm vom Vorstandsvorsitzenden mitgeteilt wurden und von grundlegender Bedeutung für die Beurteilung der Lage und der Entwicklung des Unternehmens sowie für die Geschäftsleitung des Unternehmens sind, und beruft erforderlichenfalls eine außerordentliche Sitzung des Aufsichtsrats ein. |
|
2. In particular, the chairman of the Supervisory Board shall inform the Supervisory Board and, if required, convene an extraordinary meeting of the Supervisory Board if he is informed by the chairman of the Management Board of important events which are essential for the assessment of the situation and development as well as for the management of the Company. |
|
|
|
3. Der Aufsichtsratsvorsitzende oder, wenn dieser verhindert ist, dessen Stellvertreter, beruft die Sitzungen des Aufsichtsrats ein und bestimmt den Ort der Sitzung. Die Sitzungen werden in Textform (z.B. per Brief, Telefax oder Email) an die Adresse bekanntgegeben, die dem Vorstand zuletzt mitgeteilt wurde. In dringenden Fällen kann der Aufsichtsratsvorsitzende Sitzungen auch telefonisch einberufen. |
|
3. The chairman of the Supervisory Board or, if unavailable, his deputy, shall convene the meetings of the Supervisory Board and determine the venue of the meeting. Notices of the meetings shall be sent in written form (e.g. by letter, fax or e-mail) to the address last made known to the Management Board. In urgent cases, the chairman of the Supervisory Board can also call meetings by telephone. |
|
|
|
4. Die Sitzung wird mit einer Frist von 14 Tagen unter Angabe der Tagesordnung bekanntgegeben. In dringenden Fällen kann die Frist abgekürzt werden. Den Aufsichtsratmitgliedern werden zusammen mit der Bekanntgabe der Sitzung, jedenfalls aber rechtzeitig vor der Sitzung, Arbeitsdokumente zugesandt. Zum Zwecke der |
|
4. Notice of the meeting is given with 14 days notice and such notice shall state the individual items on the agenda. In urgent cases, the notice period can be shortened. Working documents are sent to the members of the Supervisory Board, together with the notice of the meeting, but in any case sufficiently in advance. The aforementioned notice period is |
Berechnung der genannten Bekanntgabefrist ist das Absenden der Mitteilung maßgeblich. |
|
calculated from the time the notice is sent. |
|
|
|
5. Jedes Mitglied des Aufsichtsrats oder des Vorstands kann unter Angabe des Zwecks und der Gründe vom Aufsichtsratsvorsitzenden die unverzügliche Einberufung des Aufsichtsrats verlangen. Wird dem Verlangen nicht entsprochen, so kann das Mitglied des Aufsichtsrats oder des Vorstands unter Angabe einer Tagesordnung selbst den Aufsichtsrat einberufen. |
|
5. Each member of the Supervisory Board or the Management Board, indicating the purpose and the reasons for the request, shall be entitled to have the chairman of the Supervisory Board convene a meeting of the Supervisory Board without delay. Should this request be denied, the member of the Supervisory Board or the Management Board may provide an agenda and convene the Supervisory Board themselves. |
|
|
|
6. Anträge einzelner Mitglieder des Aufsichtsrats oder des Vorstands, die vor Absendung der Tagesordnung eingehen, sind auf die Tagesordnung zu setzen. |
|
6. Proposals for resolutions by individual members of either the Supervisory Board or the Management Board shall be placed on the agenda if received before the agenda is circulated. |
|
|
|
7. Der Vorstand nimmt an den Sitzungen des Aufsichtsrats teil, soweit der Aufsichtsratsvorsitzende nichts anderes bestimmt. |
|
7. The Management Board shall attend the meetings of the Supervisory Board unless the chairman of the Supervisory Board decides otherwise. |
|
|
|
§ 6
|
|
§ 6
|
|
|
|
1. Der Aufsichtsratsvorsitzende leitet die Sitzungen des Aufsichtsrats. Er bestimmt die Reihenfolge der Sitzungsgegenstände sowie die Art der Abstimmung. |
|
1. The chairman of the Supervisory Board shall conduct the meetings of the Supervisory Board. He shall determine the order in which items are dealt with as well as the type of voting procedure. |
2. Der Aufsichtsratsvorsitzende bestimmt die Verhandlungssprache. Ist ein Mitglied des Aufsichtsrats der Verhandlungssprache nicht mächtig, so hat der Aufsichtsratsvorsitzende für die Herbeiziehung eines Simultandolmetschers Sorge zu tragen. |
|
2. The chairman of the Supervisory Board also determines the language in which the meeting shall be conducted. If a member of the Supervisory Board does not speak the language so determined, the chairman of the Supervisory Board shall procure a simultaneous interpreter. |
|
|
|
3. Beschlüsse des Aufsichtsrats werden grundsätzlich in Sitzungen gefasst. Außerhalb von Sitzungen können Beschlüsse mündlich, telefonisch, schriftlich, per Email oder durch jede andere übliche Form der Telekommunikation, insbesondere per Videokonferenz gefasst werden, wenn alle Aufsichtsratmitglieder an der Beschlussfassung teilnehmen oder wenn der Aufsichtsratsvorsitzende dies anordnet und kein Aufsichtsratmitglied innerhalb einer angemessenen Zeit, die der Aufsichtratsvorsitzende in seiner Anordnung bestimmt, der Beschlussfassung auf diesem Wege widerspricht. |
|
3. Resolutions of the Supervisory Board shall generally adopted in meetings. Outside of meetings, resolutions can be adopted orally, by telephone, in writing, by fax, by e-mail or by any other common means of communication, in particular by video conference, if all members of the Supervisory Board participate in the adoption of the resolution or if the chairman of the Supervisory Board orders, and no member of the Supervisory Board objects to the adoption of the resolution by any such means within a reasonable period of time determined by the chairman of the Supervisory Board and stated in his order. |
|
|
|
4. Abwesende Aufsichtsratsmitglieder können an der Beschlussfassung teilnehmen, indem sie ihre Stimmabgaben in Schriftform durch anwesende Mitglieder überreichen lassen. Die Aufsichtsratmitglieder können ihre Stimme während der Sitzung oder in einem angemessenen Zeitraum danach, den der |
|
4. Absent members of the Supervisory Board can participate in the voting by submitting their votes in written form through other members present at the meeting. They can also cast their votes during a meeting or following the meeting within a reasonable period of time to be determined by the chairman of the Supervisory |
Aufsichtsratsvorsitzende bestimmt, auch per Telefon, Telefax, Email oder durch jede andere übliche Form der Telekommunikation unter der Voraussetzung abgeben, dass kein Aufsichtsratmitglied einer derartigen Stimmabgabe widersprochen hat. |
|
Board by telephone, by fax, by e-mail or by any other common means of communication, provided that no member of the Supervisory Board objects to voting by such means. |
|
|
|
5. Die Beschlussfähigkeit des Aufsichtsrats richtet sich nach dem Gesetz und der Satzung. Beschlüsse bedürfen der Mehrheit der abgegebenen Stimmen, sofern sich aus zwingenden Gesetzesbestimmungen oder der Satzung nichts anderes ergibt. Enthält sich ein Aufsichtsratmitglied seiner Stimme, so gilt dies als Teilnahme an der Beschlussfassung. |
|
5. The quorum for the Supervisory Board shall be determined by the law and the Articles of Association. Resolutions shall be adopted by a majority of the votes cast unless otherwise provided by applicable mandatory law or the Articles of Association. A member is also deemed to have participated in the vote on the adoption of a resolution if he abstains from voting. |
|
|
|
6. Ergibt eine Abstimmung Stimmengleichheit, so steht dem Aufsichtsratsvorsitzenden das Recht zum Stichentscheid zu. Gemäß § 6 Abs. 4 dieser Geschäftsordnung kann das Recht zum Stichentscheid auch schriftlich ausgeübt werden. Sofern kein Aufsichtsratvorsitzender bestellt ist oder der Aufsichtsratsvorsitzende nicht an der Beschlussfassung teilnimmt, gilt der Beschluss im Falle einer Stimmengleichheit als abgelehnt. |
|
6. In the event of a tie, the chairman of the Supervisory Board shall have a tie-breaking vote. Pursuant to Section 6 para. 4 of these rules of procedure, this tie-breaking vote may also be submitted in written form. If no chairman of the Supervisory Board is appointed or if the chairman of the Supervisory Board does not participate in the resolution, the resolution shall be deemed rejected in case of a tie of votes. |
7. Über Gegenstände, die nicht auf der Tagesordnung stehen, darf verhandelt werden, wenn die anwesenden Aufsichtsratsmitglieder dies mit einfacher Mehrheit beschließen. Beschlüsse über solche Gegenstände dürfen nur gefasst werden, wenn in der Sitzung kein Aufsichtsratsmitglied widerspricht und alle abwesenden Mitglieder diesem Verfahren innerhalb einer vom Aufsichtsratsvorsitzenden zu bestimmenden Frist nachträglich zustimmen. |
|
7. Items not included in the agenda may be debated if the majority of the members of the Supervisory Board choose to do so. Resolutions on such items may only be adopted if no member raises an objection in the meeting and all the absent members subsequently approve this procedure within a period to be set by the chairman of the Supervisory Board. |
|
|
|
8. Der Aufsichtsratsvorsitzende bestellt einen Protokollführer und entscheidet über die Zuziehung von Sachverständigen und Auskunftspersonen zur Beratung über einzelne Gegenstände der Tagesordnung. |
|
8. The chairman of the Supervisory Board shall arrange for a person to take down the minutes and decides whether to call upon experts or other persons able to provide information for dealing with individual points on the agenda. |
|
|
|
9. Über die Sitzungen des Aufsichtsrats sind Niederschriften anzufertigen, die vom Aufsichtsratsvorsitzenden zu unterzeichnen sind. In der Niederschrift sind Ort und Tag der Sitzung, die Teilnehmer, die Gegenstände der Tagesordnung, der wesentliche Inhalt der Verhandlungen und die Beschlüsse des Aufsichtsrats anzugeben. Uber einen Beschluss, der außerhalb von Sitzungen gefasst wird, ist eine schriftliche Niederschrift anzufertigen, die unverzüglich allenAufsichtsratmitgliedern
|
|
9. Minutes are kept for each meeting of the Supervisory Board which shall be signed by the chairman of the Supervisory Board. The minutes shall state the place and the day of the meeting, those present, the items on the agenda, the essential content of what was discussed and any resolutions passed by the Supervisory Board. Any resolution adopted outside of meetings shall be recorded in writing and such minutes shall be sent to all members of the Supervisory Board immediately.
|
zugesandt wird. Die Niederschriften sind in der vom Aufsichtsratsvorsitzenden nach § 6 Abs. 2 dieser Geschäftsordnung bestimmten Sprache anzufertigen und nachfolgend in eine Sprache zu übersetzen, die von dem Aufsichtsratsmitglied bzw. den Aufsichtsratsmitgliedern gesprochen wird bzw. werden, welcher bzw. welche die Sprache, in der die Sitzung abgehalten wurde, nicht spricht bzw. sprechen. |
|
Minutes shall be kept in the language determined by the chairman of the Supervisory Board pursuant to Section 6 para. 2 of these rules of procedure and subsequently translated into a language spoken by the members of the Supervisory Board, if any, who do not speak the language in which the meeting was conducted. |
|
|
|
10. Die Niederschriften nach § 6 Abs. 9 dieser Geschäftsordnung sind allen Aufsichtsratsmitgliedern zuzusenden. Sie gelten als genehmigt, wenn kein Mitglied des Aufsichtsrats, das an der Beschlussfassung teilgenommen hat, innerhalb von vier Wochen nach Absendung der Niederschrift schriftlich beim Aufsichtsratsvorsitzenden widerspricht. |
|
10. The minutes pursuant to Section 6 para. 9 of these rules of procedure shall be sent to all members of the Supervisory Board. They shall be deemed approved if no member of the Supervisory Board who took part in the voting submits a written objection to the chairman of the Supervisory Board within four weeks of the minutes being sent. |
|
|
|
§ 7
|
|
§ 7
|
|
|
|
1. Der Aufsichtsrat bildet und besetzt aus seiner Mitte die folgenden Ausschüsse: |
|
1. From among its members, the Supervisory Board shall set up and appoint the following Committees: |
|
|
|
a) einen Nominierungs- und Vergütungsausschuss, |
|
a) a Compensation and Nomination Committee, |
|
|
|
b) einen Prüfungsausschuss. |
|
b) an Audit Committee. |
2. Der Aufsichtsrat kann aus seiner Mitte weitere Ausschüsse bilden und besetzen und ihnen, soweit gesetzlich zulässig, ebenso wie den in § 7 Abs. 1 dieser Geschäftsordnung genannten Ausschüssen, Entscheidungsbefugnisse übertragen. |
|
2. From among its members, the Supervisory Board may set up and appoint further committees and, to the extent legally possible, transfer to them decision-making powers similar to those of the committees mentioned in Section 7 para. 1 of these rules of procedure. |
|
|
|
3. Die für den Aufsichtsrat in der Satzung und dieser Geschäftsordnung getroffenen Regelungen gelten entsprechend für die innere Organisation der Ausschüsse, soweit nicht nachfolgend Abweichendes bestimmt ist. |
|
3. The regulations established for the Supervisory Board in the Articles of Association and these rules of procedure apply accordingly to the internal organization of the committees unless otherwise provided below. |
|
|
|
§ 8
|
|
§ 8
|
|
|
|
1. Die Mitglieder der Ausschüsse werden in der konstituierenden Aufsichtsratssitzung für die Dauer ihrer Amtszeit als Aufsichtsratsmitglieder bestellt. |
|
1. The members of the committees are appointed at the constituent meeting of the Supervisory Board for their entire tenure as members of the Supervisory Board. |
|
|
|
2. Die Ausschüsse sind soweit sie anstelle des Aufsichtsrats Entscheidungen treffen beschlussfähig, wenn mindestens drei ihrer Mitglieder an der Beschlussfassung teilnehmen. |
|
2. A Committee, insofar as it shall make decisions on behalf of the Supervisory Board, shall have a quorum to adopt resolutions if at least three of its members participate. |
|
|
|
3. Der jeweilige Ausschussvorsitzende berichtet regelmäßig an den Aufsichtsrat über die Tätigkeit des Ausschusses. |
|
3. Each committees chairman shall report to the Supervisory Board on the activity of the committee on a regular basis. |
§ 9
|
|
§ 9
|
|
|
|
1. Der Vergütungs- und Nominierungsausschuss besteht aus dem Vorsitzenden und zwei weiteren Mitgliedern des Aufsichtsrats. Der Aufsichtsratsvorsitzende ist zugleich Vorsitzender des Vergütungs- und Nominierungsausschusses. |
|
1. The Compensation and Nomination Committee shall be composed of the chairman and two other members of the Supervisory Board. The chairman of the Supervisory Board shall chair the Compensation and Nomination Committee. |
|
|
|
2. Der Vergütungs- und Nominierungsausschuss bereitet die Personalentscheidungen und die Sitzungen des Aufsichtsrats vor und hat die folgenden Aufgaben: |
|
2. The Compensation and Nomination Committee shall prepare the staffing decisions of the Supervisory Board and the meetings of the Supervisory Board and have the following assignments: |
|
|
|
a) Vorbereitung der Beschlüsse des Aufsichtsrats über Abschluss, Änderung und Beendigung der Anstellungsverträge mit den Vorstandsmitgliedern im Rahmen der vom Aufsichtsrat beschlossenen Struktur des Vergütungssystems; |
|
a) preparation of the resolutions of the Supervisory Board regarding the conclusion, alteration and termination of employment contracts of members of the Management Board within the framework of the compensation system adopted by the Supervisory Board; |
|
|
|
b) Vorbereitung der Beschlüsse des Aufsichtsrats über Stellung eines Antrags zur Herabsetzung der Bezüge der Vorstandsmitglieder durch das Gericht nach § 87 Abs. 2 AktG; |
|
b) preparation of the resolutions of the Supervisory Board to reduce the remuneration of the management board through the judiciary under Section 87 para. 2 AktG; |
|
|
|
c) Vorbereitung der Beschlüsse des Aufsichtsrats über Struktur des |
|
c) preparation of the resolutions of the Supervisory Board on the |
Vergütungssystems für den Vorstand einschließlich der wesentlichen Vertragselemente und der regelmäßigen Versorgung des Aufsichtsrats mit Informationen, die dieser zur Überprüfung des Vergütungssystems benötigt; |
|
framework of the compensation scheme of the Management Board, including its essential contractual elements and providing the Supervisory Board with information necessary for it to review this compensation scheme on a regular basis; |
|
|
|
d) Vertretung der Gesellschaft gegenüber ausgeschiedenen Vorstandsmitgliedern nach § 112 AktG; |
|
d) representation of the Company vis-à-vis former members of the Management Board under Section 112 AktG; |
|
|
|
e) Einwilligung zu Nebenbeschäftigungen sowie zu anderweitigen Tätigkeiten eines Vorstandsmitglieds nach § 88 AktG; |
|
e) granting consent for secondary occupations and for other activities of a Management Board member under Section 88 AktG; |
|
|
|
f) Zustimmung zu Verträgen mit Aufsichtsratsmitgliedern nach § 114 AktG; und |
|
f) approval of agreements with Supervisory Board members under Section 114 AktG; and |
|
|
|
g) der Hauptversammlung geeignete Personen zur Besetzung des Aufsichtsrats im Falle der Wahl von Aufsichtsratmitgliedern vorzuschlagen. |
|
g) proposing suitable candidates as Supervisory Board members to the general shareholders meeting in case of elections of Supervisory Board members. |
|
|
|
3. Der Vergütungs- und Nominierungsausschuss überwacht die Einhaltung der Geschäftsordnung des Vorstands. Der Vergütungs- und Nominierungsausschuss wird vom Vorstand gemäß § 9 Abs. 1 der Geschäftsordnung des Vorstands |
|
3. The Compensation and Nomination Committee monitors adherence to the rules of procedure of the Management Board. The Compensation and Nomination Committee is informed by the Management Board pursuant to Section 9 para. 1 of the rules of |
informiert. |
|
procedure of the Management Board. |
|
|
|
§ 10
|
|
§ 10
|
|
|
|
1. Dem Prüfungsausschuss gehören drei Mitglieder an. |
|
1. The Audit Committee shall be composed of three members. |
|
|
|
2. Der Prüfungsausschuss ist insbesondere zuständig für die Überprüfung der Rechnungslegung, der Effektivität der unternehmensinternen Kontrolle, des Risikomanagements und der Einhaltung und Beachtung der gesetzlichen Bestimmungen und der unternehmensinternen Richtlinien durch die Konzernunternehmen (Compliance), der erforderlichen Unabhängigkeit der Abschlussprüfer, der Erteilung des Prüfungsauftrags an die Abschlussprüfer, der Zustimmung zu zusätzlichen, durch den Prüfungsauftrag abzudeckenden Leistungen oder der Festlegung von Prüfungsschwerpunkten und der Übereinkunft über dieHonorarvereinbarung. Der Prüfungsausschuss bereitet die Beschlussfassung des Aufsichtsrats über den Konzern- und Jahresabschluss vor. Der Prüfungsausschuss ist insbesondere zuständig für die Einführung von Prozessen für (i) den Empfang, den Erhalt und die Behandlung von Beschwerden betreffend die Rechnungslegung, die interne |
|
2. The Audit Committee shall be, above all, responsible for reviewing the accounting process, the effectiveness of the internal system of control, risk management and compliance and the necessary independence of the auditors, commissioning the auditors to conduct the audit, agreeing on additional services to be provided by the auditor under the auditors commission or establishing the main points of the audit and reaching agreement upon a fee. It shall prepare the Supervisory Boards resolution on the consolidated and unconsolidated financial statements. The Audit Committee is in particular responsible for the establishment of procedures for (i) the receipt, retention and treatment of complaints, which the Company receives regarding accounting, internal accounting controls or auditing matters and (ii) the confidential, anonymous submission by the employees of concerns regarding questionable accounting or auditing matters. |
Rechnungsprüfung oder Prüfungsangelegenheiten sowie für (ii) vertrauliche und anonyme Mitteilungen von Mitarbeitern betreffend fragwürdige Rechnungs-legungs- oder Prüfungsange-legenheiten. |
|
|
|
|
|
3. Der Vorsitzende des Prüfungsausschusses wird vom Aufsichtsrat gewählt. Der Vorsitzende des Prüfungsausschusses soll über besondere Kenntnisse und Erfahrungen in der Anwendung von Rechnungslegungsgrundsätzen und internen Kontrollverfahren verfügen und soll kein ehemaliges Vorstandsmitglied der Gesellschaft sein, dessen Bestellung vor weniger als zwei Jahren vor der Bestellung als Vorsitzender des Prüfungsausschusses endete. |
|
3. The chairman of the Audit Committee shall be elected by the Supervisory Board. The chairman of the Audit Committee shall have special knowledge and experience of the application of accounting principles and internal control procedures, and shall not be a former member of the Management Board of the Company whose appointment ended less than two years prior to his appointment as chairman of the Audit Committee. |
|
|
|
§ 11
|
|
§ 11
|
|
|
|
1. Die Prüfungsberichte werden den Aufsichtsratsmitgliedern gemäß § 170 Abs. 3 AktG zur Vorbereitung auf die Aufsichtsratssitzung, zu deren Tagesordnung die Beschlussfassung über den Konzern- und Jahresabschluss gehört, ausgehändigt oder übersandt. Die Anlagen und Erläuterungsteile zu den Prüfungsberichten werden nur den Mitgliedern des Prüfungsausschusses |
|
1. The auditors reports shall be handed over or sent to the members of the Supervisory Board pursuant to Section 170 para. 3 AktG in order to prepare for the Supervisory Board meeting whose agenda includes a resolution on the consolidated and unconsolidated financial statements. The appendices and notes to the auditors reports shall be given or sent solely to the members of the |
ausgehändigt oder übersandt; alle Aufsichtsratsmitglieder können diese Unterlagen jedoch einsehen. |
|
Audit Committee; however, all members of the Supervisory Board may inspect these documents. |
|
|
|
§ 12
|
|
§ 12
|
|
|
|
1. Diese Geschäftsordnung tritt am Tag des Aufsichtsratsbeschlusses in Kraft, mit dem über sie Beschluss gefasst wird, und gilt solange, bis sie durch den Aufsichtsrat verändert oder widerrufen wird. |
|
1. The rules of procedure shall be effective as of the date of the Supervisory Board resolution by which they are implemented and shall remain in force until amended or abolished by the Supervisory Board. |
|
|
|
2. Im Zweifelsfalle hat die deutsche Fassung Vorrang. |
|
2. In cases of doubt, the German language version shall control. |
Exhibit 3.3
GESCHÄFTSORDNUNG
|
|
RULES OF PROCEDURE
|
|
|
|
Aufgrund § 8 Abs. 3 der Satzung der voxeljet AG (vormalig firmierend unter VXLT 2013 AG) und des Aufsichtsratsbeschlusses vom 2. Juli 2013 wird die folgende Geschäftsordnung für den Vorstand in Kraft gesetzt: |
|
In accordance with Section 8 para. 3 of the articles of association of voxeljet AG (previously named as VXLT 2013 AG) (the Articles of Association ) and by way of a resolution of the Supervisory Board dated 2 July 2013, the following rules of procedure of the Management Board shall apply: |
|
|
|
§ 1
|
|
§ 1
|
|
|
|
1. Der Vorstand führt die Geschäfte der voxeljet AG (fortan die Gesellschaft und zusammen mit ihren unmittelbaren und mittelbaren Tochtergesellschaften die voxeljet Group ) unabhängig. Dabei hat er im besten Interesse der Gesellschaft zu handeln. Er entwickelt die strategische Ausrichtung der Gesellschaft in Zusammenarbeit mit dem Aufsichtsrat und diskutiert den aktuellen Stand ihrer Umsetzung in regelmäßigen Abständen mit dem Aufsichtsrat. |
|
1. The Management Board shall be responsible for independently managing the business of voxeljet AG (the Company and together with its direct and indirect subsidiaries the voxeljet Group ). In doing so, it shall be obliged to act in the Companys best interest. It shall develop the Companys strategic approach in coordination with the Supervisory Board and regularly discuss the current state of its implementation with the Supervisory Board. |
|
|
|
2. Der Vorstand führt die Geschäfte der Gesellschaft in Übereinstimmung mit dem Gesetz, der Satzung der Gesellschaft, dem Deutschen Corporate Governance Kodex gemäß § 161 Abs. 1 AktG (soweit nicht Abweichungen in der gültigen Entsprechenserklärung offengelegt wurden), dieser Geschäftsordnung und den jeweiligen Anstellungsverträgen. Er arbeitet mit den |
|
2. The Management Board shall conduct the Companys business in accordance with applicable law, the Articles of Association, the German Corporate Governance Code pursuant to Section 161 para. 1 of the German Stock Corporation Act (Aktiengesetz, AktG ) (unless deviations have been disclosed in the applicable compliance statement), these rules of procedure, and relevant |
übrigen Organen der Gesellschaft zum Wohle der Gesellschaft vertrauensvoll zusammen. |
|
employment contracts. It shall cooperate with the other bodies of the Company, in good faith, in the Companys best interest. |
|
|
|
3. Der Vorstand stellt sicher, dass die Gesellschaft alle Vorschriften des geltenden Rechts ebenso wie die internen Regeln der voxeljet Group einhält und arbeitet darauf hin, dass auch die Gesellschaften der voxeljet Group diese Regeln einhalten; ferner gewährleistet der Vorstand ein angemessenes Risikomanagement und eine entsprechende Risikoüberwachung. |
|
3. The Management Board shall ensure that all provisions of applicable law and voxeljet Groups internal policies are complied with by the Company and shall work to achieve their compliance by the voxeljet Group companies; in addition, it shall ensure appropriate risk management and risk controlling. |
|
|
|
§ 2
|
|
§ 2
|
|
|
|
1. Der Vorstand besteht aus einem oder mehreren Mitgliedern. |
|
1. The Management Board shall be composed of one or more members. |
|
|
|
2. Die Mitglieder des Vorstands tragen gemeinsam die Verantwortung für die gesamte Geschäftsführung. Sie arbeiten kollegial zusammen und unterrichten sich gegenseitig über alle wichtigen Vorgänge und Maßnahmen in ihren Zuständigkeitsbereichen. |
|
2. The members of the Management Board shall bear joint responsibility for the Companys management. They shall work together collegially and shall keep one another informed about all material business transactions and measures adopted in their respective areas of responsibility. |
|
|
|
3. Unbeschadet der Gesamtverant-wortung aller Vorstandsmitglieder für die Geschäftsführung der Gesellschaft führt jedes Vorstandsmitglied die ihm ggf. durch einen Geschäftsverteilungsplan oder andere Vorstandsbeschlüsse zugewiesenen Bereiche in eigener Verantwortung. |
|
3. Notwithstanding the joint responsibility of the Management Boards members for the management of the Company, each Board member shall be individually responsible for the areas allocated to him in connection with an Organization Plan, if applicable, or other resolutions of the Management Board. |
§ 3
|
|
§ 3
|
|
|
|
1. Der Vorstand legt die Geschäftsbereiche der Gesellschaft fest und unterteilt diese in Segmente. Der Vorstand kann im Einvernehmen mit dem Aufsichtsrat die Zuweisung von Verantwortlichkeiten der verschiedenen Mitglieder des Vorstandes für die einzelnen Geschäftsbereiche beschließen, indem er einen Geschäftsverteilungsplan aufstellt. |
|
1. The Management Board shall determine the Companys business areas and combine them into segments. The Management Board can in mutual cooperation with the supervisory board determine the allocation of responsibilities for business areas and segments to the various members of the Management Board through an Organization Plan ( Geschäftsverteilungsplan ). |
|
|
|
2. Jeder Beschluss über die Verabschiedung, die Änderung oder die Aufhebung des Geschäftsverteilungsplans muss einstimmig ergehen. Wenn ein einstimmiger Beschluss des Vorstandes nicht gefasst werden kann, so hat der Aufsichtsrat die Entscheidung zu treffen. Der Aufsichtsrat ist umgehend über die Verabschiedung, die Änderung oder die Aufhebung eines Geschäftsverteilungsplans zu unterrichten. |
|
2. Any resolution on the enactment, any amendments or the revocation of the Organization Plan ( Geschäftsverteilungsplan ) shall require the approval of all members of the Management Board. If a unanimous decision of the Management Board cannot be reached, the Supervisory Board shall make the decision instead. The Supervisory Board shall be informed immediately about any Organization Plan and any amendment to it or its revocation. |
|
|
|
§ 4
|
|
§ 4
|
|
|
|
Soweit der Vorstand einen Geschäftsverteilungsplan erlässt, finden die nachfolgenden Regelungen dieses § 4 Anwendung. |
|
In case the Management Board adopts an Organization Plan this Section 4 shall apply. |
1. Die Verantwortlichkeit jedes einzelnen Vorstandsmitglieds wird durch den Geschäftsverteilungsplan festgelegt. |
|
1. The responsibilities of the individual members of the Management Board shall be determined by the Organization Plan ( Geschäftsverteilungsplan ). |
|
|
|
2. Jedes Vorstandsmitglied ist verpflichtet, bei schwerwiegenden Bedenken bezüglich einer Angelegenheit eines anderen Ressorts eine Behandlung der Angelegenheit durch den gesamten Vorstand herbeizuführen, sofern die Bedenken nicht durch eine Aussprache mit den anderen Vorstandsmitgliedern oder dem Vorstandsvorsitzenden ausgeräumt werden können. |
|
2. Each Management Board member shall be obliged, in the event serious concern regarding another business area arises, to ensure that it is discussed by the full Management Board, unless the concerns can be overcome through discussion with the other board members or the chairman of the Management Board. |
|
|
|
3. Jedes Vorstandsmitglied kann von den übrigen Vorstandsmitgliedern jederzeit Informationen über Angelegenheiten einfordern, welche in deren Verantwortungsbereich fallen. Der Vorstand ist in regelmäßigen Abständen von dem im Einzelfall verantwortlichen Vorstandsmitglied über Entwicklungen in dem jeweiligen Geschäftsbereich und Segment zu unterrichten. Soweit Maßnahmen und Geschäftsaktivitäten aus dem Verantwortungsbereich eines Vorstandsmitglieds den Verantwortungsbereich eines anderen Vorstandsmitglieds wesentlich berühren, haben sich die zuständigen Vorstandsmitglieder im Voraus abzustimmen. |
|
3. Each Management Board member shall, at any time, be entitled to demand information from the other members of the Management Board on individual matters relating to the areas for which they bear responsibility. The Management Board shall be regularly informed about developments in the individual business areas and segments by the respective board members. Insofar as the measures and business activities from the area of responsibility of one board member also substantially affect the area of responsibility of another board member, the board members in charge of these areas shall consult one another in advance. |
4. Jedes Vorstandsmitglied kann verlangen, dass Maßnahmen oder Geschäfte aus dem Verantwortungsbereich eines anderen Vorstandsmitglieds, die seinen Verantwortungsbereich wesentlich berühren, eines Vorstandsbeschlusses bedürfen. |
|
4. Each Board member whose area of responsibility is substantially affected by the measures or business activities of a member of the Board with another area of responsibility, may request a resolution by the Management Board. |
|
|
|
5. Die Vorstandsmitglieder sind gemeinschaftlich dafür verantwortlich, dass der Aufsichtsrat angemessen unterrichtet wird. Der Vorstand hat den Aufsichtsrat in regelmäßigen Abständen rechtzeitig und umfassend über alle Angelegenheiten der Gesellschaft im Zusammenhang mit der Planung, der Geschäftsentwicklung, der Risiko-situation, dem Risikomanagement und der Einhaltung von § 90 AktG zu unterrichten. Der Vorstand soll Abweichungen des Geschäfts-betriebs von den zuvor formulierten Plänen und Zielen und die Ursachen hierfür herausarbeiten sowie Vorschläge für geeignete Gegenmaßnahmen machen. |
|
5. The members of the Management Board are jointly responsible for providing sufficient information to the Supervisory Board. The Management Board shall regularly inform the Supervisory Board, comprehensively and without delay, of all material issues to the Company with regard to planning, business development, risk situation, risk management and compliance in accordance with Section 90 AktG. The Management Board shall point out deviations of the actual business development from previously formulated plans and targets, and indicate the reasons therefore and make suggestions for any counter-measures to be taken. |
|
|
|
§ 5
|
|
§ 5
|
|
|
|
Neben Geschäften, welche bereits von Gesetzes wegen, aufgrund der Satzung oder nach dieser Geschäftsordnung eines Vorstandsbeschlusses bedürfen, sind folgende Maßnahmen nur auf der Grundlage eines Beschlusses des Gesamtvorstands durchzuführen: |
|
In addition to transactions for which a resolution adopted by the Management Board is required by law, by the Articles of Association or by these rules of procedure, the following matters shall require a resolution adopted by the Management Board: |
a) die Erstellung der Berichte des Vorstands zur Information des Aufsichtsrats (§ 9 dieser Geschäftsordnung) und der viertel-und halbjährlichen Berichte, welche aufgrund des einschlägigen Kapitalmarktrechts zu erstellen sind; |
|
a) the preparation of the Management Boards reporting to inform the Supervisory Board (Section 9 of these rules of procedure) and of the quarterly and semi-annual reports as required by the applicable capital market laws; |
|
|
|
b) grundlegende Organisationsmaß nahmen wie etwa der Abschluss oder die Änderung von Unternehmens-verträgen (§§ 291 ff. AktG), Umwandlungsmaßnahmen im Sinne des Umwandlungsgesetzes, die Veräußerung oder Akquisition wesentlicher Unternehmensteile sowie Angelegenheiten der Strategie-und Geschäftsplanung im Sinne des § 90 Abs. 1 Nr. 1 AktG; |
|
b) fundamental organizational measures, such as the conclusion of or amendment to company transfer agreements (Section 291 et seqq. AktG), transformation measures within the meaning of the German Transformation of Companies Act ( Umwandlungsgesetz ), sale or acquisition of material company assets as well as issues of strategy and business planning as set out in Section 90 para. 1 no. 1 AktG; |
|
|
|
c) Maßnahmen im Zusammenhang mit der Implementierung und der Kontrolle eines Überwachungs-systems im Sinne von § 91 Abs. 2 AktG; |
|
c) measures related to the implementation and controlling of a monitoring system as described in Section 91 para. 2 AktG; |
|
|
|
d) die Abgabe der Entsprechenserklä-rung gemäß § 161 Abs. 1 AktG; |
|
d) the issuance of the compliance statement pursuant to Section 161 para. 1 AktG; |
|
|
|
e) die Aufstellung des Konzern- und Jahresabschlusses (einschließlich des Lageberichts) sowie vergleichbarer Berichte, welche die Gesellschaft freiwillig oder aufgrund kapitalmarktrechtlicher Bestimmungen veröffentlicht; |
|
e) the preparation of the consolidated and unconsolidated financial statements (including the management report on the Companys business situation) as well as comparable reports issued by the Company voluntarily or based upon capital market rules; |
|
|
|
f) Einberufungen der Hauptversamm-lung sowie Anfragen und |
|
f) convening of the general shareholders meeting and the Management Boards |
Beschlussvorschläge des Vorstands, welche in der Hauptversammlung behandelt und über welche abgestimmt werden soll; oder |
|
requests and proposals for resolutions to be dealt with and voted on therein; or |
|
|
|
g) Angelegenheiten, deren Beschluss-fassung der Vorstandsvorsitzende oder zwei Vorstandsmitglieder verlangt haben. |
|
g) matters with respect to which the Chairman or any two members of the Management Board have requested a resolution by the Management Board. |
|
|
|
§ 6
|
|
§ 6
|
|
|
|
1. Der Aufsichtsrat kann ein Mitglied des Vorstands zum Vorsitzenden ernennen. Ist ein Mitglied des Vorstands zum Vorsitzenden des Vorstands ernannt worden, finden die folgenden Regelungen in diesem § 6 Anwendung. |
|
1. The Supervisory Board can appoint one member of the management board as chairman. In case a chairman of the management board has been appointed the following rules in this Section 6 shall apply. |
|
|
|
2. Die Koordination von Segmenten mit sich überschneidenden Aufgaben-bereichen obliegt dem Vorstandsvorsitzenden. Der Vorstandsvorsitzende wirkt darauf hin, dass sich die Geschäftsführung einheitlich an den durch die Beschlussfassung des Vorstands definierten Zielen orientiert. Er ist berechtigt, von den übrigen Vorstandsmitgliedern jederzeit Informationen über die in ihren jeweiligen Verantwortlichkeitsbereich fallenden Geschäftsangelegenheiten zu verlangen; er kann auch entscheiden, dass er über bestimmte Geschäfte und bestimmte Arten von Geschäften im Voraus informiert wird. |
|
2. Coordination of segments with shared functions shall be incumbent upon the chairman of the Management Board. He shall endeavour to ensure that the conduct of the Companys business is uniformly oriented towards the objectives established by the resolutions of the Management Board. He is entitled, at any time, to demand information from the members of the Management Board on individual matters relating to the areas for which they bear responsibility and may decide that he shall be informed in advance about certain transactions and certain types of transactions. |
3. Der Vorstandsvorsitzende repräsentiert den Vorstand und die Gesellschaft in der Öffentlichkeit, speziell im Umgang mit Behörden, Vereinigungen, Wirtschaftsverbänden und den Medien in Bezug auf Angelegenheiten, welche die Gesellschaft als Ganzes oder aber verschiedene Geschäftsbereichte oder Segmente betreffen, welche in den Verantwortlichkeitsbereich eines anderen Vorstandsmitglieds fallen. Alle Presseveröffentlichungen bedürfen der vorherigen Zustimmung des Vorstandsvorsitzenden. |
|
3. The chairman of the Management Board shall represent the Board and the Company in the public sphere, especially in dealings with authorities, associations, business organizations and the media in matters which concern the Company as a whole or several business areas or segments from the area of responsibility of different Board members. All press statements require prior approval of the chairman of the Management Board. |
|
|
|
4. Der Vorstandsvorsitzende koordiniert die Zusammenarbeit zwischen Vorstand und Aufsichtsrat. Er halt stetigen Kontakt mit dem Aufsichtsrat; er ist dafür verantwortlich, dass die gegenüber dem Aufsichtsrat bestehenden Berichtspflichten erfüllt werden und informiert den Aufsichtsratsvorsitzenden umgehend über Geschäfte, die der Zustimmung des Aufsichtsrats bedürfen, speziell über Unzulänglichkeiten im Zusammenhang mit dem gem. § 91 Abs. 2 AktG zu etablierenden Risikomanagementsystem. Alle Mitglieder des Vorstandes unterstützen den Vorstandsvorsitzenden bei der Erfüllung seiner Pflichten. |
|
4. The chairman of the Management Board shall organize the Management Boards cooperation with the Supervisory Board. He shall maintain regular contact with the Supervisory Board; he shall be responsible for reporting duties towards the Supervisory Board being fulfilled and informs the chairman of the Supervisory Board promptly about transactions requiring the approval of the Supervisory Board and especially about any deficiencies arising within the risk management system to be set up by the Management Board pursuant to Section 91 para. 2 AktG. All the members of the Management Board shall support him in fulfilling his duties. |
|
|
|
§ 7
|
|
§ 7
|
|
|
|
1. Der Vorstandsvorsitzende beruft die Vorstandssitzungen ein, er stellt die Tagesordnung zusammen und sitzt den |
|
1. The chairman of the Management Board shall convene Board meetings, establish the agenda and chair the meetings of |
Vorstandssitzungen vor. Der Vorstandsvorsitzende bestimmt die Reihenfolge, in welcher die Tagesordnungspunkte behandelt werden, ebenso wie die Reihenfolge, in der abgestimmt wird. Jedes Vorstandsmitglied hat einen Anspruch darauf, dass die von ihm vorgeschlagenen Angelegenheiten auf die Tagesordnung gesetzt werden. Kann der Vorstandsvor-sitzende einer Sitzung nicht beiwohnen, so vertritt ihn das dienstälteste Vorstandsmitglied bei der Vorbereitung, Einberufung und dem Vorsitz der Vorstandssitzung. Soweit kein Mitglied des Vorstands zum Vorsitzenden des Vorstands ernannt worden ist, kann jeder Vorstand eine Vorstandssitzung einberufen. |
|
the Management Board. He shall determine the sequence in which the items on the agenda shall be dealt with, as well as the rules and sequence of voting. Each member of the Management Board shall have the right to demand that any items he may propose be put on the agenda. Should the chairman of the Management Board be unable to attend, the longest-serving member of the Management Board present shall serve as his proxy in preparing, convening and chairing Board meetings. In case no member of the management board has been appointed as chairman, each member of the management board can call a board meeting. |
|
|
|
2. Der Vorstand soll in zweiwöchigem Abstand zusammenkommen, wenigstens jedoch einmal im Monat. Vorstandssitzungen werden auf Deutsch geführt, es sei denn, die Mehrheit der anwesenden Vorstandsmitglieder entscheidet, dass die Sitzung auf Englisch durchgeführt werden soll oder die anwesenden Vorstandsmitglieder entscheiden einstimmig, dass die Sitzung in einer anderen Sprache abgehalten werden soll. Auf Verlangen eines Vorstandsmitglieds ist eine Vorstandssitzung unverzüglich einzuberufen. |
|
2. The Management Board shall meet every two weeks, and at least once each month. Board meetings shall be conducted in the German language, unless the majority of the members of the Management Board present shall decide to conduct the meeting in English or the present members of the Management Board decide unanimously to conduct the meeting in another language. Any member of the Management Board can demand the immediate convening of a Board meeting. |
|
|
|
3. Der Vorstand ist beschlussfähig, wenn all seine Mitglieder Einladungen zur Vorstandssitzung erhalten haben und |
|
3. The Management Board shall have a quorum if all its members shall have received invitations to the meeting and |
mindestens die Hälfte der Mitglieder bei der Beschlussfassung mitwirken. Abwesende Vorstandsmitglieder können an der Beschlussfassung teilnehmen, indem sie ihre Stimme schriftlich, per Telefax, telefonisch oder durch ein anderes gebräuchliches Telekommunikations-mittel übermitteln. Telefonische Stimmabgaben sind schriftlich zu bestätigen. Auch nachträgliche Stimmabgaben gelten als Teilnahme an der Beschlussfassung. Sie sind nur zulässig, wenn der Sitzungsleiter sie zulässt und eine Frist für ihre Abgabe bestimmt. |
|
at least half of its members shall participate in adopting resolutions. Absent members of the Management Board may participate in adopting resolutions by submitting their written vote to the Chairman prior to or during the Management Board meeting by fax, email, telephone, or any other customary means of telecommunication; votes cast by telephone shall be confirmed in written form. Subsequently submitted votes also count toward participation in the adoption of resolutions. They are only admissible if the person chairing the meeting allows them and sets a deadline for their submission. |
|
|
|
4 Außerhalb von Sitzungen können Beschlüsse im Umlaufverfahren oder in anderer Weise (zum Beispiel durch telefonische Stimmabgabe oder Stimmabgabe mittels sonstiger Telekommunikationsmittel, einschließlich E-Mail) gefasst werden. Soweit ein Vorstandsmitglied an solchen Beschlussfassungen nicht teilgenommen hat, ist es unverzüglich über die gefassten Beschlüsse zu unterrichten. |
|
4. Resolutions may be adopted outside meetings either by circulating the documents or in any other form (e.g., by casting of votes by telephone, via video conferencing or via other means of telecommunication (including email)). Insofar as a member of the Management Board has not participated in adopting such resolutions, he shall be informed immediately about the resolutions adopted. |
|
|
|
5. Der Vorstand hat sich bei der Beschlussfassung nach Kräften um Einstimmigkeit zu bemühen. Ist Einstimmigkeit nicht zu erzielen, so beschließt der Vorstand, soweit nicht durch Satzung oder Gesetz andere Mehrheiten vorgeschrieben sind, mit einfacher Mehrheit der an der Beschlussfassung teilnehmenden Vorstandsmitglieder. Bei |
|
5. The Management Board shall do everything in its power to ensure that its resolutions are adopted unanimously. Should unanimity not be achievable, a simple majority of the members of the Board participating in the vote may adopt resolutions, unless otherwise prescribed by the Articles of Association or by law. In the case of a tie, the chairman of the Management Board |
Stimmengleichheit gibt die Stimme des Vorstandsvorsitzenden den Ausschlag. |
|
shall have a second, tie-breaking vote. |
|
|
|
6. Über die Sitzungen des Vorstands ist Protokoll in deutscher und/oder englischer Sprache zu führen, das vom Sitzungsleiter und Protokollführer zu unterzeichnen ist. Eine Abschrift dieses Protokolls ist allen Vorstandsmitgliedern unverzüglich zuzuleiten. |
|
6. Minutes shall be kept of the meetings of the Management Board in the German and/or in the English language and signed by the chairman of the meeting and the person taking down the minutes. A copy of these minutes shall be sent immediately to all members of the Management Board. |
|
|
|
§ 8
|
|
§ 8
|
|
|
|
1. Neben Geschäften, welche bereits von Gesetzes wegen, aufgrund der Satzung oder nach dieser Geschäftsordnung der Zustimmung des Aufsichtsrates bedürfen, sind insbesondere folgende Geschäfte nur mit Zustimmung des Aufsichtsrates durchzuführen: |
|
1. Apart from transactions which must be approved by the Supervisory Board under applicable law or the Articles of Association, in particular the following transactions to be undertaken by the Company require the prior approval of the Supervisory Board: |
|
|
|
a) maßgebliche Änderungen der Geschäftsstrategie der voxeljet Group; |
|
a) any material changes to the business strategy of the voxeljet Group; |
|
|
|
b) (i) der Erwerb und die Veräußerung von Grundstücken, (ii) der Erwerb oder die Veräußerung von Gesellschaften (iii) der Erwerb, Verkauf, die Neubegründung, Ausweitung, Reduzierung oder Beendigung von Geschäftsaktivitäten, einschließlich materieller wie immaterieller Rechte, sofern der jeweilige Preis oder Wert EUR 50.000 im Einzelfall übersteigt; |
|
b) (i) the purchase or sale of real estate, (ii) the purchase or sale of legal entities or (iii) purchase, sale, creation, extension, reduction or termination of business activities, including tangible or intangible assets and joint ventures, if the relevant price or value, in each case, exceeds EUR 50,000; |
|
|
|
c) der Erwerb, Verkauf oder die Neubegründung von Joint Ventures |
|
c) the purchase, sale or creation of joint ventures, |
d) der Abschluss oder die Änderung von Vereinbarungen im Zusammenhang mit der Kreditvergabe, Kreditaufnahme, Übernahme von Garantien, Abgabe von Bürgschaftserklärungen oder mit Rechtsgeschäften, durch die ähnliche Verbindlichkeiten begründet werden, deren Höhe im Einzelfall EUR 50.000 übersteigt; |
|
d) the conclusion or amendment of an agreement for or relating to borrowing, lending, underwriting guarantees or surety ships or assuming similar liabilities of an amount exceeding EUR 50,000, in each case; |
|
|
|
e) der Abschluss oder die Abänderung von Vereinbarungen über Beratungs-oder andere Dienstleistungen, sofern die mit der einzelnen Vereinbarung für die Gesellschaft oder für die voxeljet Group verbundenen Kosten oder Verbindlichkeiten pro Jahr EUR 50.000 oder insgesamt EUR 250.000 übersteigen; |
|
e) the conclusion of, or amendment to, consulting, advisory or other service agreements, if the costs or obligations associated with the respective agreement for the Company or for voxeljet Group exceed EUR 50,000 per year or EUR 250,000 in the aggregate; |
|
|
|
f) der Abschluss oder die Abänderung von Leasing-, Pacht- und Mietverträgen in Bezug auf Grundstücke, Gebäude oder ähnliche Objekte, sofern die Verpflichtungen der Gesellschaft aus dem einzelnen Vertrag pro Jahr EUR 50.000 oder insgesamt EUR 250.000 übersteigen; |
|
f) the conclusion of, or amendment to, operating lease, land lease or rental agreements in relation to real estate, buildings or similar objects, if the obligations of the Company associated with the respective agreement exceed EUR 50,000 per year or EUR 250,000 in the aggregate; |
|
|
|
g) Aufwendungen oder Investitionen, welche im Einzelfall den Betrag von EUR 50.000 übersteigen, es sei denn, die betreffende Maßnahme fällt unter einen anderen Punkt dieses Absatzes; |
|
g) expenditure or capital investments exceeding an amount of EUR 50,000 in each case, unless the relevant measure is covered by another item of this paragraph; |
h) jede Anstellung, Kündigung oder Änderung des Anstellungsvertrages eines leitenden Angestellten, sofern die Gesamtvergütung (inklusive in bar zu leistender Boni) EUR 75.000 überschreitet; |
|
h) any hiring, dismissal or modification of an employment agreement of any executive manager provided that its aggregate cash remuneration (including cash bonuses) exceeds EUR 75,000; |
|
|
|
i) die Aufnahme neuer oder die Beendigung bereits existierender wesentlicher Geschäftsaktivitäten der voxeljet Group (insbesondere, wenn die Investitionen oder die Kosten der Maßnahme im Einzelfall EUR 50.000 überschreiten), es sei denn, die betreffende Maßnahme fällt unter einen anderen Punkt dieses Absatzes; |
|
i) the opening of new or the termination of material existing business activities of voxeljet Group (in particular, if the investment or the costs of the measure individually exceed EUR 50,000) , unless the relevant measure is covered by another item of this paragraph; |
|
|
|
j) jede wesentliche Änderung oder Ergänzung der internen Verhaltensrichtlinien sowie |
|
j) any material change or amendment to the code of conduct; and |
|
|
|
k) die Bewilligung des Budgets der voxeljet Group, einschließlich des Investitionsbudgets sowie des darauf bezogenen Finanzplans. |
|
k) the approval of voxeljet Groups budget, including the investment budget as well as the related financing plan. |
|
|
|
2. Der Zustimmung des Aufsichtsrats bedarf es auch, wenn der Vorstand in Bezug auf Tochtergesellschaften an Geschäften im Sinne von § 8 Abs. 1 dieser Geschäftsordnung teilnimmt oder diese wesentlich beeinflusst (im Wege der Erteilung von Weisungen, der Zustimmung oder der Stimmabgabe, in seiner Funktion als Vorstandsmitglied der Gesellschaft, oder in sonstiger Weise). |
|
2. The prior approval of the Supervisory Board shall also be required if the Management Board, in relation to any of its affiliates, participates in or significantly influences (by way of giving instructions, approving or voting, in its capacity as a member of the Management Board of the Company, or in any other way) transactions as those set out under Section 8 para. 1 of these rules of procedure. |
3. Der Zustimmung des Aufsichtsrats bezüglich jeder der im § 8 Abs. 1 dieser Geschäftsordnung genannten Geschäfte bedarf es nicht, wenn der Aufsichtsrat Geschäften dieser Art bereits generell oder im Einzelfall im Zusammenhang mit der Geschäftsplanung zugestimmt hat oder soweit derartige Geschäfte bereits im Budget vorgesehen sind. |
|
3. The Supervisory Boards approval in relation to any of the transactions set out above in Section 8 para. 1 of these rules of procedure is not required if the Supervisory Board has already given general approval to such transactions or approval individually in connection with business planning, or to the extent that such transactions are already included in the budget. |
|
|
|
4. Einer Zustimmung bedarf es gemäß § 8 Abs. 1 lit. b) bis h) (auch in Verbindung mit § 8 Abs. 2) dieser Geschäftsordnung nicht, wenn es sich bei allen Parteien des jeweiligen Geschäfts um Gesellschaften, deren sämtliche Anteile unmittelbar oder mittelbar von der Gesellschaft gehalten werden, oder um die Gesellschaft selbst handelt. |
|
4. No approval under Section 8 para. 1 lit. b) to h) (also in connection with Section 8 para. 2) of these rules of procedure shall be required if all parties to the respective transaction are wholly owned direct or indirect subsidiaries of the Company or the Company itself. |
|
|
|
§ 9
|
|
§ 9
|
|
|
|
1. Der Vorstand hat, ungeachtet § 90 AktG, § 4 Abs. 5 und § 6 Abs. 4 dieser Geschäftsordnung sowie Ziffer 3 des Deutschen Corporate Governance Kodex den Aufsichtsrat über folgende Angelegenheiten zu informieren: |
|
1. Notwithstanding the provisions in § 90 AktG, of Section 4 para. 5 and Section 6 para. 4 of these rules of procedure and of Section 3 of the German Corporate Governance Code, the Management Board shall inform the Supervisory Board of the following matters: |
|
|
|
a) Der Vorstand hat den Aufsichtsrat wenigstens einmal im Jahr über seine Geschäftspolitik in Bezug auf die Gesellschaft und über andere grundsätzliche Fragen im Zusammenhang mit der Unternehmensplanung (speziell die Finanz-, Investitions- und die |
|
a) At least once each year, the Management Board shall inform the Supervisory Board of its Company business policy and of other fundamental questions related to its business planning (especially financial, investment and human resources planning); in this regard, the |
Beschäftigungsplanung) zu unterrichten; in diesem Zusammenhang soll der Vorstand Abweichungen der tatsächlichen Geschäftsentwicklung von zuvor formulierten Plänen und Zielen sowie die Gründe für dieses Abweichen aufzeigen; ferner stellt der Vorstand den mittelfristigen Geschäftsplan sowie Entwürfe des Budgets und des Geschäftsplans vor; |
|
Management Board shall point out deviations of the actual business development from previously formulated plans and targets, including the reasons for such deviation; the Management Board shall present the mid term business plan and drafts of the budget and the business plan; |
|
|
|
b) Der Vorstand unterrichtet den Aufsichtsrat wenigstens einmal im Jahr (im Rahmen der Vorstandssitzung, in welcher der Beschluss über den Konzern- und Jahresabschluss gefasst wird) über die Profitabilität der Gesellschaft; |
|
b) At least once each year (in the meeting in which the resolution on the consolidated and unconsolidated financial statements is passed), the Management Board shall inform the Supervisory Board of the Companys profitability; |
|
|
|
c) Der Vorstand informiert den Aufsichtsrat wenigstens alle drei Monate über die gegenwärtige Lage der Gesellschaft, speziell über den Umsatz und die allgemeine Situation der Gesellschaft einschließlich ihrer Finanzierungssituation. Des Weiteren hat der Vorstand dem Aufsichtsrat jeweils monatlich die monatlichen betriebswirtschaftlichen Auswertun¬gen zukommen zu lassen; |
|
c) At least once every three months, the Management Board shall inform the Supervisory Board of the state of the Companys operations, especially its turnover and the Companys overall situation including status of financing. Furthermore, the Management Board shall provide the Supervisory Board each month with the monthly management accounts; |
|
|
|
d) Der Vorstand hat den Aufsichtsrat umgehend und im Voraus von solchen Geschäften zu unterrichten, die wesentliche Auswirkungen auf die Profitabilität oder die Liquidität der Gesellschaft haben können; ebenso unterrichtet der Vorstand den Aufsichtsrat, wenn die Geschäftstätigkeit der voxeljet Group wesentlich gegen |
|
d) The Management Board shall inform the Supervisory Board promptly in advance of any transactions which may have a material impact on the Companys profitability or liquidity; the Management Board shall also inform the Supervisory Board if voxeljet Groups operations do not comply with law in any material |
geltendes Recht verstößt. |
|
respect. |
|
|
|
2. Der Vorstand hat den Vorsitzenden des Aufsichtsrats ferner über sonstige wichtige Ereignisse zu unterrichten. Zu solchen Ereignissen gehört insbesondere der Umstand, dass der Vorstand Kenntnis von Geschäften unter Beteiligung einer Tochtergesellschaft erlangt hat, die einen wesentlichen Einfluss auf die Gesamtlage der Gesellschaft haben könnte. |
|
2. Moreover, the Management Board shall report any other important events to the chairman of the Supervisory Board. This includes an event in which the Management Board has become aware of a transaction involving an affiliate which may have a material impact on the Companys overall situation. |
|
|
|
3. Berichte und Informationen, die dem Aufsichtsrat nach dieser Vorschrift zu übermitteln sind, müssen rechtzeitig und grundsätzlich in schriftlicher Form übermittelt werden. |
|
3. The reports and information to be provided to the Supervisory Board hereunder shall be issued without delay and generally in written form. |
|
|
|
§ 10
|
|
§ 10
|
|
|
|
1. Die Vorstandsmitglieder unterliegen nach Maßgabe ihrer jeweiligen Anstellungsverträge, einem Wettbewerbsverbot. |
|
1. Subject to their respective service agreements, the members of the Management Board are under a non-competition obligation. |
|
|
|
2. Die Vorstandsmitglieder bedürfen zur Ausübung von Nebentätigkeiten der Zustimmung des Aufsichtsrats, insbesondere zur Übernahme von Aufsichtsrats-, Beirats- und ähnlichen Mandaten sowie zum Eintritt in die Geschäftsleitung eines anderen Unternehmens. |
|
2. The members of the Management Board require the approval of the Supervisory Board for accepting other positions or assignments, especially seats on supervisory, advisory and similar boards, as well as assuming an executive position at another company. |
|
|
|
3. Jedes Vorstandsmitglied hat Interessenkonflikte unverzüglich gegenüber dem Aufsichtsrat offenzulegen und die anderen Vorstandsmitglieder hiervon zu |
|
3. Each member of the Management Board shall disclose conflicts of interest immediately to the Supervisory Board and inform the other members of the |
informieren. |
|
Management Board. |
|
|
|
4. Jedes Geschäft, welches die Gesellschaft mit einem Vorstandsmitglied oder mit einem Vorstandsmitglied nahestehenden Personen oder Gesellschaften abschließt, muss den einschlägigen branchentypischen Standards entsprechen. Jedes dieser Geschäfte bedarf der Zustimmung des Aufsichtsrats. |
|
4. Any transaction between the Company and any member of the Management Board, as well as persons or companies associated with a member of the Management Board, must comply with standards customary in the sector. Any such transaction requires the approval of the Supervisory Board. |
|
|
|
§ 11
|
|
§ 11
|
|
|
|
1. Diese Geschäftsordnung tritt am Tag des Aufsichtsratsbeschlusses in Kraft, mit dem über sie Beschluss gefasst wird, und gilt solange, bis sie durch den Aufsichtsrat verändert oder widerrufen wird. |
|
1. The rules of procedure shall be effective as of the date of the Supervisory Board resolution by which they are implemented and shall remain in force until amended or abolished by the Supervisory Board. |
|
|
|
2. Im Zweifelsfalle hat die deutsche Fassung Vorrang. |
|
2. In cases of doubt, the German language version shall prevail. |
Exhibit 4.2
|
DEPOSIT AGREEMENT
|
by and among
VOXELJET AG
AND
CITIBANK, N.A.,
as Depositary,
AND
ALL HOLDERS AND BENEFICIAL OWNERS OF
AMERICAN DEPOSITARY SHARES
ISSUED HEREUNDER
|
Dated as of [DATE] , 2013
TABLE OF CONTENTS
ARTICLE I DEFINITIONS |
|
1 |
|
Section 1.1 |
ADS Record Date |
|
1 |
Section 1.2 |
Affiliate |
|
2 |
Section 1.3 |
American Depositary Receipt(s) , ADR(s) and Receipt(s) |
|
2 |
Section 1.4 |
American Depositary Share(s) and ADS(s) |
|
2 |
Section 1.5 |
Applicant |
|
2 |
Section 1.6 |
Articles of Association |
|
2 |
Section 1.7 |
Beneficial Owner |
|
2 |
Section 1.8 |
Certificated ADS(s) |
|
3 |
Section 1.9 |
Clearstream |
|
3 |
Section 1.10 |
Commission |
|
3 |
Section 1.11 |
Company |
|
3 |
Section 1.12 |
Custodian |
|
3 |
Section 1.13 |
Deliver and Delivery |
|
3 |
Section 1.14 |
Deposit Agreement |
|
4 |
Section 1.15 |
Depositary |
|
4 |
Section 1.16 |
Deposited Property |
|
4 |
Section 1.17 |
Deposited Securities |
|
4 |
Section 1.18 |
Dollars and $ |
|
4 |
Section 1.19 |
DTC |
|
4 |
Section 1.20 |
DTC Participant |
|
4 |
Section 1.21 |
Euro and |
|
5 |
Section 1.22 |
Exchange Act |
|
5 |
Section 1.23 |
Foreign Currency |
|
5 |
Section 1.24 |
Germany |
|
5 |
Section 1.25 |
Full Entitlement ADR(s) , Full Entitlement ADS(s) and Full Entitlement Share(s) |
|
5 |
Section 1.26 |
Holder(s) |
|
5 |
Section 1.27 |
Initial Deposit |
|
5 |
Section 1.28 |
Partial Entitlement ADR(s) , Partial Entitlement ADS(s) and Partial Entitlement Share(s) |
|
5 |
Section 1.29 |
Pre-Release Transaction |
|
5 |
Section 1.30 |
Principal Office |
|
5 |
Section 1.31 |
Registrar |
|
5 |
Section 1.32 |
Restricted Securities |
|
6 |
Section 1.33 |
Restricted ADR(s) , Restricted ADS(s) and Restricted Shares |
|
6 |
Section 1.34 |
Securities Act |
|
6 |
Section 1.35 |
Share Registrar |
|
6 |
Section 1.36 |
Shares |
|
6 |
Section 1.37 |
Uncertificated ADS(s) |
|
6 |
Section 1.38 |
Uncertificated Restricted ADS(s) |
|
6 |
Section 1.39 |
United States and U.S. |
|
6 |
ARTICLE II APPOINTMENT OF DEPOSITARY; FORM OF RECEIPTS; DEPOSIT OF SHARES; EXECUTION AND DELIVERY, TRANSFER AND SURRENDER OF RECEIPTS |
|
7 |
|
Section 2.1 |
Appointment of Depositary |
|
7 |
Section 2.2 |
Form and Transferability of ADSs |
|
7 |
Section 2.3 |
Deposit of Shares |
|
9 |
Section 2.4 |
Registration and Safekeeping of Deposited Securities |
|
10 |
Section 2.5 |
Issuance of ADSs |
|
11 |
Section 2.6 |
Transfer, Combination and Split-up of ADRs |
|
11 |
Section 2.7 |
Surrender of ADSs and Withdrawal of Deposited Securities |
|
13 |
Section 2.8 |
Limitations on Execution and Delivery, Transfer, etc. of ADSs; Suspension of Delivery, Transfer, etc . |
|
14 |
Section 2.9 |
Lost ADRs, etc . |
|
15 |
Section 2.10 |
Cancellation and Destruction of Surrendered ADRs; Maintenance of Records |
|
15 |
Section 2.11 |
Escheatment |
|
15 |
Section 2.12 |
Partial Entitlement ADSs |
|
16 |
Section 2.13 |
Certificated/Uncertificated ADSs |
|
16 |
Section 2.14 |
Restricted ADSs |
|
18 |
|
|
|
|
ARTICLE III CERTAIN OBLIGATIONS OF HOLDERS AND BENEFICIAL OWNERS OF ADSs |
|
19 |
|
Section 3.1 |
Proofs, Certificates and Other Information |
|
19 |
Section 3.2 |
Liability for Taxes and Other Charges |
|
20 |
Section 3.3 |
Representations and Warranties on Deposit of Shares |
|
20 |
Section 3.4 |
Compliance with Information Requests |
|
21 |
Section 3.5 |
Ownership Restrictions |
|
21 |
Section 3.6 |
Reporting Obligations and Regulatory Approvals |
|
21 |
|
|
|
|
ARTICLE IV THE DEPOSITED SECURITIES |
|
22 |
|
Section 4.1 |
Cash Distributions |
|
22 |
Section 4.2 |
Distribution in Shares |
|
23 |
Section 4.3 |
Elective Distributions in Cash or Shares |
|
23 |
Section 4.4 |
Distribution of Rights to Purchase Additional ADSs |
|
24 |
Section 4.5 |
Distributions Other Than Cash, Shares or Rights to Purchase Shares |
|
26 |
Section 4.6 |
Distributions with Respect to Deposited Securities in Bearer Form |
|
27 |
Section 4.7 |
Redemption |
|
27 |
Section 4.8 |
Conversion of Foreign Currency |
|
27 |
Section 4.9 |
Fixing of ADS Record Date |
|
28 |
Section 4.10 |
Voting of Deposited Securities |
|
28 |
Section 4.11 |
Changes Affecting Deposited Securities |
|
30 |
Section 4.12 |
Available Information |
|
31 |
Section 4.13 |
Reports |
|
31 |
Section 4.14 |
List of Holders |
|
31 |
Section 4.15 |
Taxation |
|
31 |
Section 4.16 |
Limitation of Rights |
|
32 |
ARTICLE V THE DEPOSITARY, THE CUSTODIAN AND THE COMPANY |
|
32 |
|
Section 5.1 |
Maintenance of Office and Transfer Books by the Registrar |
|
32 |
Section 5.2 |
Exoneration |
|
33 |
Section 5.3 |
Standard of Care |
|
34 |
Section 5.4 |
Resignation and Removal of the Depositary; Appointment of Successor Depositary |
|
35 |
Section 5.5 |
The Custodian |
|
35 |
Section 5.6 |
Notices and Reports |
|
36 |
Section 5.7 |
Issuance of Additional Shares, ADSs etc . |
|
37 |
Section 5.8 |
Indemnification |
|
38 |
Section 5.9 |
ADS Fees and Charges |
|
39 |
Section 5.10 |
Pre-Release Transactions |
|
40 |
Section 5.11 |
Restricted Securities Owners |
|
41 |
|
|
|
|
ARTICLE VI AMENDMENT AND TERMINATION |
|
41 |
|
Section 6.1 |
Amendment/Supplement |
|
41 |
Section 6.2 |
Termination |
|
42 |
|
|
|
|
ARTICLE VII MISCELLANEOUS |
|
43 |
|
Section 7.1 |
Counterparts |
|
43 |
Section 7.2 |
No Third-Party Beneficiaries |
|
43 |
Section 7.3 |
Severability |
|
43 |
Section 7.4 |
Holders and Beneficial Owners as Parties; Binding Effect |
|
43 |
Section 7.5 |
Notices |
|
44 |
Section 7.6 |
Governing Law and Jurisdiction |
|
45 |
Section 7.7 |
Assignment |
|
46 |
Section 7.8 |
Compliance with U.S. Securities Laws |
|
46 |
Section 7.9 |
Relationship between the Company and Holders and Beneficial Owners |
|
46 |
Section 7.10 |
German Law References |
|
47 |
Section 7.11 |
Titles and References |
|
47 |
|
|
|
|
EXHIBITS |
|
|
|
|
Form of ADR |
|
A-1 |
|
Fee Schedule |
|
B-1 |
DEPOSIT AGREEMENT
DEPOSIT AGREEMENT , dated as of [DATE] , 2013, by and among (i) voxeljet AG, a company organized under the laws of the Federal Republic of Germany, and its successors (the Company), (ii) CITIBANK, N.A., a national banking association organized under the laws of the United States of America acting in its capacity as depositary, and any successor depositary hereunder (the Depositary), and (iii) all Holders and Beneficial Owners of American Depositary Shares issued hereunder (all such capitalized terms as hereinafter defined).
W I T N E S S E T H T H A T :
WHEREAS , the Company desires to establish with the Depositary an ADR facility to provide, inter alia , for the deposit of the Shares (as hereinafter defined) and the creation of American Depositary Shares representing the Shares so deposited and for the execution and delivery of American Depositary Receipts (as hereinafter defined) to investors evidencing such American Depositary Shares; and
WHEREAS , the Depositary is willing to act as the Depositary for such ADR facility upon the terms set forth in the Deposit Agreement (as hereinafter defined); and
WHEREAS , any American Depositary Receipts issued pursuant to the terms of the Deposit Agreement are to be substantially in the form of Exhibit A attached hereto, with appropriate insertions, modifications and omissions, as hereinafter provided in the Deposit Agreement; and
WHEREAS , the American Depositary Shares to be issued pursuant to the terms of the Deposit Agreement are to be listed for trading on the New York Stock Exchange; and
WHEREAS , the Management Board of the Company (or an authorized committee thereof) has duly approved the establishment of an ADR facility upon the terms set forth in the Deposit Agreement, the execution and delivery of the Deposit Agreement on behalf of the Company, and the actions of the Company and the transactions contemplated herein.
NOW, THEREFORE , for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
ARTICLE I
DEFINITIONS
All capitalized terms used, but not otherwise defined, herein shall have the meanings set forth below, unless otherwise clearly indicated:
Section 1.1 ADS Record Date shall have the meaning given to such term in Section 4.9.
Section 1.2 Affiliate shall have the meaning assigned to such term by the Commission (as hereinafter defined) under Regulation C promulgated under the Securities Act (as hereinafter defined), or under any successor regulation thereto.
Section 1.3 American Depositary Receipt(s) , ADR(s) and Receipt(s) shall mean the certificate(s) issued by the Depositary to evidence the American Depositary Shares issued under the terms of the Deposit Agreement in the form of Certificated ADS(s) (as hereinafter defined), as such ADRs may be amended from time to time in accordance with the provisions of the Deposit Agreement. An ADR may evidence any number of ADSs and may, in the case of ADSs held through a central depository such as DTC, be in the form of a Balance Certificate.
Section 1.4 American Depositary Share(s) and ADS(s) shall mean the rights and interests in the Deposited Property (as hereinafter defined) granted to the Holders and Beneficial Owners pursuant to the terms and conditions of the Deposit Agreement and , if issued as Certificated ADS(s) (as hereinafter defined), the ADR(s) issued to evidence such ADSs. ADS(s) may be issued under the terms of the Deposit Agreement in the form of (a) Certificated ADS(s) (as hereinafter defined), in which case the ADS(s) are evidenced by ADR(s), or (b) Uncertificated ADS(s) (as hereinafter defined), in which case the ADS(s) are not evidenced by ADR(s) but are reflected on the direct registration system maintained by the Depositary for such purposes under the terms of Section 2.13. Unless otherwise specified in the Deposit Agreement or in any ADR, or unless the context otherwise requires, any reference to ADS(s) shall include Certificated ADS(s) and Uncertificated ADS(s), individually or collectively, as the context may require. Each ADS shall represent the right to receive, and to exercise the beneficial ownership interests in, the number of Shares specified in the form of ADR attached hereto as Exhibit A (as amended from time to time) on deposit with the Depositary and/or the Custodian, subject, in each case, to the terms and conditions of the Deposit Agreement and the applicable ADR (if issued as a Certificated ADS), until there shall occur a distribution upon Deposited Securities referred to in Section 4.2 or a change in Deposited Securities referred to in Section 4.11 with respect to which additional ADSs are not issued, and thereafter each ADS shall represent the right to receive, and to exercise the beneficial ownership interests in, the applicable Deposited Property on deposit with the Depositary and the Custodian determined in accordance with the terms of such Sections, subject, in each case, to the terms and conditions of the Deposit Agreement and the applicable ADR (if issued as a Certificated ADS).
Section 1.5 Applicant shall have the meaning given to such term in Section 5.10.
Section 1.6 Articles of Association shall mean the Articles of Association of the Company, as they may be amended from time to time.
Section 1.7 Beneficial Owner shall mean, as to any ADS, any person or entity having a beneficial interest deriving from the ownership of such ADS. Notwithstanding anything else contained in the Deposit Agreement, any ADR(s) or any other instruments or agreements relating to the ADSs and the corresponding Deposited Property, the Depositary, the Custodian and their respective nominees are intended to be, and shall at all times during the term
of the Deposit Agreement be, the record holders only of the Deposited Property represented by the ADSs for the benefit of the Holders and Beneficial Owners of the corresponding ADSs. The Depositary, on its own behalf and on behalf of the Custodian and their respective nominees, disclaims any beneficial ownership interest in the Deposited Property held on behalf of the Holders and Beneficial Owners of ADSs. The beneficial ownership interests in the Deposited Property are intended to be, and shall at all times during the term of the Deposit Agreement continue to be, vested in the Beneficial Owners of the ADSs representing the Deposited Property. The beneficial ownership interests in the Deposited Property shall, unless otherwise agreed by the Depositary, be exercisable by the Beneficial Owners of the ADSs only through the Holders of such ADSs, by the Holders of the ADSs (on behalf of the applicable Beneficial Owners) only through the Depositary, and by the Depositary (on behalf of the Holders and Beneficial Owners of the corresponding ADSs) directly, or indirectly through the Custodian or their respective nominees, in each case upon the terms of the Deposit Agreement and, if applicable, the terms of the ADR(s) evidencing the ADSs. A Beneficial Owner of ADSs may or may not be the Holder of such ADSs. A Beneficial Owner shall be able to exercise any right or receive any benefit hereunder solely through the person who is the Holder of the ADSs owned by such Beneficial Owner. Unless otherwise identified to the Depositary, a Holder shall be deemed to be the Beneficial Owner of all the ADSs registered in his/her/its name.
Section 1.8 Certificated ADS(s) shall have the meaning set forth in Section 2.13.
Section 1.9 Clearstream shall mean Clearstream Banking AG, which provides the book-entry settlement system for equity securities in Germany, or any successor entity thereto.
Section 1.10 Commission shall mean the Securities and Exchange Commission of the United States or any successor governmental agency thereto in the United States.
Section 1.11 Company shall mean voxeljet AG, a company incorporated and existing under the laws of Germany, and its successors.
Section 1.12 Custodian shall mean, as of the date hereof (i) Citigroup Global Markets Deutschland AG, a company incorporated and validly existing under the laws of Germany, having its principal office at Reuterweg 16 60323 Frankfurt Germany, as the custodian for the purposes of the Deposit Agreement, (ii) Citibank, N.A., acting as custodian of Deposited Securities pursuant to the Deposit Agreement, and (iii) any other entity that may be appointed by the Depositary pursuant to the terms of Section 5.5 as successor, substitute or additional custodian hereunder. The term Custodian shall mean any Custodian individually or all Custodians collectively, as the context requires.
Section 1.13 Deliver and Delivery shall mean (x) when used in respect of Shares and other Deposited Securities , either (i) the physical delivery of the certificate(s) representing such securities, or (ii) the book-entry transfer and recordation of such securities on the books of the Share Registrar (as hereinafter defined) or in the book-entry settlement of
Clearstream, and (y) when used in respect of ADSs , either (i) the physical delivery of ADR(s) evidencing the ADSs, or (ii) the book-entry transfer and recordation of ADSs on the books of the Depositary or any book-entry settlement system in which the ADSs are settlement-eligible.
Section 1.14 Deposit Agreement shall mean this Deposit Agreement and all exhibits hereto, as the same may be amended and supplemented from time to time in accordance with the terms of the Deposit Agreement.
Section 1.15 Depositary shall mean Citibank, N.A., a national banking association organized under the laws of the United States, in its capacity as depositary under the terms of the Deposit Agreement, and any successor depositary hereunder.
Section 1.16 Deposited Property shall mean the Deposited Securities and any cash and other property held on deposit by the Depositary and the Custodian in respect of the ADSs under the terms of the Deposit Agreement, subject, in the case of cash, to the provisions of Section 4.8. All Deposited Property shall be held by the Custodian, the Depositary and their respective nominees for the benefit of the Holders and Beneficial Owners of the ADSs representing the Deposited Property. The Deposited Property is not intended to, and shall not, constitute proprietary assets of the Depositary, the Custodian or their nominees. Beneficial ownership in the Deposited Property is intended to be, and shall at all times during the term of the Deposit Agreement continue to be, vested in the Beneficial Owners of the ADSs representing the Deposited Property. Notwithstanding the foregoing, the collateral delivered in connection with Pre-Release Transactions described in Section 5.10 shall not constitute Deposited Property.
Section 1.17 Deposited Securities shall mean the Shares and any other securities held on deposit by the Custodian from time to time in respect of the ADSs under the Deposit Agreement and constituting Deposited Property.
Section 1.18 Dollars and $ shall refer to the lawful currency of the United States.
Section 1.19 DTC shall mean The Depository Trust Company, a national clearinghouse and the central book-entry settlement system for securities traded in the United States and, as such, the custodian for the securities of DTC Participants (as hereinafter defined) maintained in DTC, and any successor thereto.
Section 1.20 DTC Participant shall mean any financial institution (or any nominee of such institution) having one or more participant accounts with DTC for receiving, holding and delivering the securities and cash held in DTC. A DTC Participant may or may not be a Beneficial Owner. If a DTC Participant is not the Beneficial Owner of the ADSs credited to its account at DTC, or of the ADSs in respect of which the DTC Participant is otherwise acting, such DTC Participant shall be deemed, for all purposes hereunder, to have all requisite authority to act on behalf of the Beneficial Owner(s) of the ADSs credited to its account at DTC or in respect of which the DTC Participant is so acting.
Section 1.21 Euro and shall refer to the lawful currency of the European Union.
Section 1.22 Exchange Act shall mean the United States Securities Exchange Act of 1934, as amended from time to time.
Section 1.23 Foreign Currency shall mean any currency other than Dollars.
Section 1.24 Germany shall mean the Federal Republic of Germany.
Section 1.25 Full Entitlement ADR(s) , Full Entitlement ADS(s) and Full Entitlement Share(s) shall have the respective meanings set forth in Section 2.12.
Section 1.26 Holder(s) shall mean the person(s) in whose name the ADSs are registered on the books of the Depositary (or the Registrar, if any) maintained for such purpose. A Holder may or may not be a Beneficial Owner. If a Holder is not the Beneficial Owner of the ADS(s) registered in its name, such person shall be deemed, for all purposes hereunder, to have all requisite authority to act on behalf of the Beneficial Owners of the ADSs registered in its name.
Section 1.27 Initial Deposit shall mean the initial deposit of Shares by the Company in connection with the offering of ADSs pursuant to the Prospectus dated [DATE] , 2013.
Section 1.28 Partial Entitlement ADR(s) , Partial Entitlement ADS(s) and Partial Entitlement Share(s) shall have the respective meanings set forth in Section 2.12.
Section 1.29 Pre-Release Transaction shall have the meaning set forth in Section 5.10.
Section 1.30 Principal Office shall mean, when used with respect to the Depositary, the principal office of the Depositary at which at any particular time its depositary receipts business shall be administered, which, at the date of the Deposit Agreement, is located at 388 Greenwich Street, New York, New York 10013, U.S.A.
Section 1.31 Registrar shall mean the Depositary or any bank or trust company having an office in the Borough of Manhattan, The City of New York, which shall be appointed by the Depositary to register issuances, transfers and cancellations of ADSs as herein provided, and shall include any co-registrar appointed by the Depositary for such purposes. Registrars (other than the Depositary) may be removed and substitutes appointed by the Depositary. Each Registrar (other than the Depositary) appointed pursuant to the Deposit Agreement shall be required to give notice in writing to the Depositary accepting such appointment and agreeing to be bound by the applicable terms of the Deposit Agreement.
Section 1.32 Restricted Securities shall mean Shares, Deposited Securities or ADSs which (i) have been acquired directly or indirectly from the Company or any of its Affiliates in a transaction or chain of transactions not involving any public offering and are subject to resale limitations under the Securities Act or the rules issued thereunder, or (ii) are held by an officer or director (or persons performing similar functions) or other Affiliate of the Company, or (iii) are subject to other restrictions on sale or deposit under the laws of the United States or Germany, or under a shareholder agreement or the Articles of Association of the Company or under the regulations of an applicable securities exchange unless, in each case, such Shares, Deposited Securities or ADSs are being transferred or sold to persons other than an Affiliate of the Company in a transaction (a) covered by an effective resale registration statement, or (b) exempt from the registration requirements of the Securities Act (as hereinafter defined), and the Shares, Deposited Securities or ADSs are not, when held by such person(s), Restricted Securities.
Section 1.33 Restricted ADR(s) , Restricted ADS(s) and Restricted Shares shall have the respective meanings set forth in Section 2.14.
Section 1.34 Securities Act shall mean the United States Securities Act of 1933, as amended from time to time.
Section 1.35 Share Registrar shall mean the share registrar appointed by the Company from time to time or any other institution organized under the laws of Germany appointed by the Company to carry out the duties of registrar for the Shares, and any successor thereto.
Section 1.36 Shares shall mean the Companys ordinary shares, 1.00 nominal value per share, validly issued and outstanding and fully paid and may, if the Depositary so agrees after consultation with the Company, include evidence of the right to receive Shares; provided that in no event shall Shares include evidence of the right to receive Shares with respect to which the full purchase price has not been paid or Shares as to which preemptive rights have theretofore not been validly waived or exercised; provided further , however , that , if there shall occur any change in nominal value, split-up, consolidation, reclassification, exchange, conversion or any other event described in Section 4.11 in respect of the Shares of the Company, the term Shares shall thereafter, to the maximum extent permitted by law, represent the successor securities resulting from such event.
Section 1.37 Uncertificated ADS(s) shall have the meaning set forth in Section 2.13.
Section 1.38 Uncertificated Restricted ADS(s) shall have the meaning set forth in Section 2.14.
Section 1.39 United States and U.S. shall have the meaning assigned to it in Regulation S as promulgated by the Commission under the Securities Act.
ARTICLE II
APPOINTMENT OF DEPOSITARY; FORM OF RECEIPTS;
DEPOSIT OF SHARES; EXECUTION AND
DELIVERY, TRANSFER AND SURRENDER OF RECEIPTS
Section 2.1 Appointment of Depositary . The Company hereby appoints the Depositary as depositary for the Deposited Property and hereby authorizes and directs the Depositary to act in accordance with the terms and conditions set forth in the Deposit Agreement and the applicable ADRs. Each Holder and each Beneficial Owner, upon acceptance of any ADSs (or any interest therein) issued in accordance with the terms and conditions of the Deposit Agreement, shall be deemed for all purposes to (a) be a party to and bound by the terms of the Deposit Agreement and the applicable ADR(s), and (b) appoint the Depositary as its attorney-in-fact, with full power to delegate, to act on its behalf and to take any and all actions contemplated in the Deposit Agreement and the applicable ADR(s), to adopt any and all procedures necessary to comply with applicable law and to take such action as the Depositary in its sole discretion may deem necessary or appropriate to carry out the purposes of the Deposit Agreement and the applicable ADR(s), the taking of such actions to be the conclusive determinant of the necessity and appropriateness thereof.
Section 2.2 Form and Transferability of ADSs .
(a) Form . Certificated ADSs shall be evidenced by definitive ADRs which shall be engraved, printed, lithographed or produced in such other manner as may be agreed upon by the Company and the Depositary. ADRs may be issued under the Deposit Agreement in denominations of any whole number of ADSs. The ADRs shall be substantially in the form set forth in Exhibit A to the Deposit Agreement, with any appropriate insertions, modifications and omissions, in each case as otherwise contemplated in the Deposit Agreement or required by law. ADRs shall be (i) dated, (ii) signed by the manual or facsimile signature of a duly-authorized signatory of the Depositary, (iii) countersigned by the manual or facsimile signature of a duly-authorized signatory of the Registrar, and (iv) registered in the books maintained by the Registrar for the registration of issuances and transfers of ADSs. No ADR and no ADS evidenced thereby shall be entitled to any benefits under the Deposit Agreement or be valid or enforceable for any purpose against the Depositary or the Company, unless such ADR shall have been so dated, signed, countersigned and registered. ADRs bearing the facsimile signature of a duly-authorized signatory of the Depositary or the Registrar, who at the time of signature was a duly-authorized signatory of the Depositary or the Registrar, as the case may be, shall bind the Depositary, notwithstanding the fact that such signatory has ceased to be so authorized prior to the delivery of such ADR by the Depositary. The ADRs shall bear a CUSIP number that is different from any CUSIP number that was, is or may be assigned to any depositary receipts previously or subsequently issued pursuant to any other arrangement between the Depositary (or any other depositary) and the Company and which are not ADRs outstanding hereunder.
(b) Legends . The ADRs may be endorsed with, or have incorporated in the text thereof, such legends or recitals not inconsistent with the provisions of the Deposit Agreement as
may be (i) necessary to enable the Depositary and the Company to perform their respective obligations hereunder, (ii) required to comply with any applicable laws or regulations, or with the rules and regulations of any securities exchange or market upon which ADSs may be traded, listed or quoted, or to conform with any usage with respect thereto, (iii) necessary to indicate any special limitations or restrictions to which any particular ADRs or ADSs are subject by reason of the date of issuance of the Deposited Securities or otherwise, or (iv) required by any book-entry system in which the ADSs are held. Holders and Beneficial Owners shall be deemed, for all purposes, to have notice of, and to be bound by, the terms and conditions of the legends set forth, in the case of Holders, on the ADR registered in the name of the applicable Holders or, in the case of Beneficial Owners, on the ADR representing the ADSs owned by such Beneficial Owners.
(c) Title . Subject to the limitations contained herein and in the ADR, title to an ADR (and to each Certificated ADS evidenced thereby) shall be transferable upon the same terms as a certificated security under the laws of the State of New York, provided that, in the case of Certificated ADSs, such ADR has been properly endorsed or is accompanied by proper instruments of transfer. Notwithstanding any notice to the contrary, the Depositary and the Company may deem and treat the Holder of an ADS (that is, the person in whose name an ADS is registered on the books of the Depositary) as the absolute owner thereof for all purposes. Neither the Depositary nor the Company shall have any obligation nor be subject to any liability under the Deposit Agreement or any ADR to any Holder or any Beneficial Owner unless, in the case of a holder of ADSs, such holder is the Holder registered on the books of the Depositary or, in the case of a Beneficial Owner, such Beneficial Owner, or the Beneficial Owners representative, is the Holder registered on the books of the Depositary.
(d) Book-Entry Systems . The Depositary shall make arrangements for the acceptance of the ADSs into DTC. All ADSs held through DTC will be registered in the name of the nominee for DTC (currently Cede & Co.). As such, the nominee for DTC will be the only Holder of all ADSs held through DTC. Unless issued by the Depositary as Uncertificated ADSs, the ADSs registered in the name of Cede & Co. will be evidenced by one or more ADR(s) in the form of a Balance Certificate, which will provide that it represents the aggregate number of ADSs from time to time indicated in the records of the Depositary as being issued hereunder and that the aggregate number of ADSs represented thereby may from time to time be increased or decreased by making adjustments on such records of the Depositary and of DTC or its nominee as hereinafter provided. Citibank, N.A. (or such other entity as is appointed by DTC or its nominee) may hold the Balance Certificate as custodian for DTC. Each Beneficial Owner of ADSs held through DTC must rely upon the procedures of DTC and the DTC Participants to exercise or be entitled to any rights attributable to such ADSs. The DTC Participants shall for all purposes be deemed to have all requisite power and authority to act on behalf of the Beneficial Owners of the ADSs held in the DTC Participants respective accounts in DTC, and the Depositary shall for all purposes be authorized to rely upon any instructions and information given to it by DTC Participants. So long as ADSs are held through DTC or unless otherwise required by law, ownership of beneficial interests in the ADSs registered in the name of the nominee for DTC will be shown on, and transfers of such ownership will be effected only through, records maintained by (i) DTC or its nominee (with respect to the interests of DTC
Participants), or (ii) DTC Participants or their nominees (with respect to the interests of clients of DTC Participants).
Section 2.3 Deposit of Shares . Subject to the terms and conditions of the Deposit Agreement and applicable law, Shares or evidence of rights to receive Shares (other than Restricted Securities) may be deposited by any person (including the Depositary in its individual capacity but subject, however, in the case of the Company or any Affiliate of the Company, to Section 5.7) at any time, whether or not the transfer books of the Company or the Share Registrar, if any, are closed, by Delivery of the Shares to the Custodian. Every deposit of Shares shall be accompanied by the following: (A) (i) in the case of Shares represented by certificates issued in registered form , appropriate instruments of transfer or endorsement, in a form reasonably satisfactory to the Custodian, (ii) in the case of Shares represented by certificates in bearer form , the requisite coupons and talons pertaining thereto, and (iii) in the case of Shares delivered by book-entry transfer and recordation , confirmation of such book-entry transfer and recordation in the books of the Share Registrar or of Clearstream, as applicable, to the Custodian or that irrevocable instructions have been given to cause such Shares to be so transferred and recorded, (B) such certifications and payments (including, without limitation, the Depositarys fees and related charges) and evidence of such payments (including, without limitation, stamping or otherwise marking such Shares by way of receipt) as may be reasonably required by the Depositary or the Custodian in accordance with the provisions of the Deposit Agreement and applicable law, (C) if the Depositary so requires, a written order directing the Depositary to issue and deliver to, or upon the written order of, the person(s) stated in such order the number of ADSs representing the Shares so deposited, (D) if the Depositary so requires, evidence reasonably satisfactory to the Depositary (which may be an opinion of counsel) that all necessary approvals have been granted by, or there has been compliance with the rules and regulations of, if any, any applicable governmental agency in Germany, and (E) if the Depositary so requires, (i) an agreement, assignment or instrument reasonably satisfactory to the Depositary or the Custodian which provides for the prompt transfer by any person in whose name the Shares are or have been recorded to the Custodian of any distribution, or right to subscribe for additional Shares or to receive other property in respect of any such deposited Shares or, in lieu thereof, such indemnity or other agreement as shall be reasonably satisfactory to the Depositary or the Custodian and (ii) if the Shares are registered in the name of the person on whose behalf they are presented for deposit, a proxy or proxies entitling the Custodian to exercise voting rights in respect of the Shares for any and all purposes until the Shares so deposited are registered in the name of the Depositary, the Custodian or any nominee.
Without limiting any other provision of the Deposit Agreement, the Depositary shall instruct the Custodian not to, and the Depositary shall not knowingly, accept for deposit (a) any Restricted Securities (except as contemplated by Section 2.14) nor (b) any fractional Shares or fractional Deposited Securities nor (c) a number of Shares or Deposited Securities which upon application of the ADS to Shares ratio would give rise to fractional ADSs. No Shares shall be accepted for deposit unless accompanied by evidence, if any is required by the Depositary, that is reasonably satisfactory to the Depositary or the Custodian that all conditions to such deposit have been satisfied by the person depositing such Shares under the laws and regulations of Germany and any necessary approval has been granted by any applicable governmental body in Germany,
if any. The Depositary may issue ADSs against evidence of rights to receive Shares from the Company, any agent of the Company or any custodian, registrar, transfer agent, clearing agency or other entity involved in ownership or transaction records in respect of the Shares. Such evidence of rights shall consist of written blanket or specific guarantees of ownership of Shares furnished by the Company or any such custodian, registrar, transfer agent, clearing agency or other entity involved in ownership or transaction records in respect of the Shares.
Without limitation of the foregoing, the Depositary shall not knowingly accept for deposit under the Deposit Agreement (A) any Shares or other securities required to be registered under the provisions of the Securities Act, unless (i) a registration statement is in effect as to such Shares or other securities or (ii) the deposit is made upon terms contemplated in Section 2.14, or (B) any Shares or other securities the deposit of which would violate any provisions of the Articles of Association of the Company. For purposes of the foregoing sentence, the Depositary shall be entitled to rely upon representations and warranties made or deemed made pursuant to the Deposit Agreement and shall not be required to make any further investigation. The Depositary will comply with written instructions of the Company (received by the Depositary reasonably in advance) not to accept for deposit hereunder any Shares identified in such instructions at such times and under such circumstances as may reasonably be specified in such instructions in order to facilitate the Companys compliance with the securities laws of the United States.
Section 2.4 Registration and Safekeeping of Deposited Securities . The Depositary shall instruct the Custodian upon each Delivery of registered Shares being deposited hereunder with the Custodian (or other Deposited Securities pursuant to Article IV hereof), together with the other documents above specified, to present such Shares, together with the appropriate instrument(s) of transfer or endorsement, duly stamped, to the Share Registrar for transfer and registration of the Shares (as soon as transfer and registration can be accomplished and at the expense of the person for whom the deposit is made) in the name of the Depositary, the Custodian or a nominee of either. Deposited Securities shall be held by the Depositary, or by a Custodian for the account and to the order of the Depositary or a nominee of the Depositary, in each case, on behalf of the Holders and Beneficial Owners, at such place(s) as the Depositary or the Custodian shall determine. Notwithstanding anything else contained in the Deposit Agreement, any ADR(s), or any other instruments or agreements relating to the ADSs and the corresponding Deposited Property, the registration of the Deposited Securities in the name of the Depositary, the Custodian or any of their respective nominees shall, to the maximum extent permitted by applicable law, vest in the Depositary, the Custodian or the applicable nominee the record ownership in the applicable Deposited Securities with the beneficial ownership rights and interests in such Deposited Securities being at all times vested with the Beneficial Owners of the ADSs representing the Deposited Securities. Notwithstanding the foregoing, the Depositary, the Custodian and the applicable nominee shall at all times be entitled to exercise the beneficial ownership rights in all Deposited Property, in each case only on behalf of the Holders and Beneficial Owners of the ADSs representing the Deposited Property, upon the terms set forth in the Deposit Agreement and, if applicable, the ADR(s) representing the ADSs. The Depositary, the Custodian and their respective nominees shall for all purposes be deemed to have all requisite power and authority to act in respect of Deposited Property on behalf of the Holders and
Beneficial Owners of ADSs representing the Deposited Property, and upon making payments to, or acting upon instructions from, or information provided by, the Depositary, the Custodian or their respective nominees, all persons shall be authorized to rely upon such power and authority.
Section 2.5 Issuance of ADSs. The Depositary has made arrangements with the Custodian for the Custodian to confirm to the Depositary upon receipt of a deposit of Shares (i) that a deposit of Shares has been made pursuant to Section 2.3, (ii) that such Deposited Securities have been recorded in the name of the Depositary, the Custodian or a nominee of either on the shareholders register maintained by or on behalf of the Company by the Share Registrar on the books of Clearstream, (iii) that all required documents have been received, and (iv) the person(s) to whom or upon whose order ADSs are deliverable in respect thereof and the number of ADSs to be so delivered. Such notification may be made by letter, cable, telex, SWIFT message or, at the risk and expense of the person making the deposit, by facsimile or other means of electronic transmission. Upon receiving such notice from the Custodian, the Depositary, subject to the terms and conditions of the Deposit Agreement and applicable law, shall issue the ADSs representing the Shares so deposited to or upon the order of the person(s) named in the notice delivered to the Depositary and, if applicable, shall execute and deliver at its Principal Office Receipt(s) registered in the name(s) requested by such person(s) and evidencing the aggregate number of ADSs to which such person(s) are entitled, but, in each case, only upon payment to the Depositary of the charges of the Depositary for accepting a deposit and issuing ADSs (as set forth in Section 5.9 and Exhibit B hereto) and all taxes and governmental charges and fees payable in connection with such deposit and the transfer of the Shares and the issuance of the ADS(s). The Depositary shall only issue ADSs in whole numbers and deliver, if applicable, ADR(s) evidencing whole numbers of ADSs. Nothing herein shall prohibit any Pre-Release Transaction upon the terms set forth in the Deposit Agreement.
Section 2.6 Transfer, Combination and Split-up of ADRs .
(a) Transfer . The Registrar shall register the transfer of ADRs (and of the ADSs represented thereby) on the books maintained for such purpose and the Depositary shall (x) cancel such ADRs and execute new ADRs evidencing the same aggregate number of ADSs as those evidenced by the ADRs canceled by the Depositary, (y) cause the Registrar to countersign such new ADRs and (z) Deliver such new ADRs to or upon the order of the person entitled thereto, if each of the following conditions has been satisfied: (i) the ADRs have been duly Delivered by the Holder (or by a duly-authorized attorney of the Holder) to the Depositary at its Principal Office for the purpose of effecting a transfer thereof, (ii) the surrendered ADRs have been properly endorsed or are accompanied by proper instruments of transfer (including signature guarantees in accordance with standard securities industry practice), (iii) the surrendered ADRs have been duly stamped (if required by the laws of the State of New York or of the United States), and (iv) all applicable fees and charges of, and expenses incurred by, the Depositary and all applicable taxes and governmental charges (as are set forth in Section 5.9 and Exhibit B hereto) have been paid, subject, however, in each case , to the terms and conditions of the applicable ADRs, of the Deposit Agreement and of applicable law, in each case as in effect at the time thereof.
(b) Combination & Split-Up . The Registrar shall register the split-up or combination of ADRs (and of the ADSs represented thereby) on the books maintained for such purpose and the Depositary shall (x) cancel such ADRs and execute new ADRs for the number of ADSs requested, but in the aggregate not exceeding the number of ADSs evidenced by the ADRs canceled by the Depositary, (y) cause the Registrar to countersign such new ADRs and (z) Deliver such new ADRs to or upon the order of the Holder thereof, if each of the following conditions has been satisfied: (i) the ADRs have been duly Delivered by the Holder (or by a duly-authorized attorney of the Holder) to the Depositary at its Principal Office for the purpose of effecting a split-up or combination thereof, and (ii) all applicable fees and charges of, and expenses incurred by, the Depositary and all applicable taxes and governmental charges (as are set forth in Section 5.9 and Exhibit B hereto) have been paid, subject, however, in each case , to the terms and conditions of the applicable ADRs, of the Deposit Agreement and of applicable law, in each case as in effect at the time thereof.
(c) Co-Transfer Agents . The Depositary may (with notice given as promptly as practicable to the Company) appoint one or more co-transfer agents for the purpose of effecting transfers, combinations and split-ups of ADRs at designated transfer offices on behalf of the Depositary. In carrying out its functions, a co-transfer agent may require evidence of authority and compliance with applicable laws and other requirements by Holders or persons entitled to such ADRs and will be entitled to protection and indemnity to the same extent as the Depositary. Such co-transfer agents may be removed and substitutes appointed by the Depositary. Each co-transfer agent appointed under this Section 2.6 (other than the Depositary) shall give notice in writing to the Depositary accepting such appointment and agreeing to be bound by the applicable terms of the Deposit Agreement.
Section 2.7 Surrender of ADSs and Withdrawal of Deposited Securities . The Holder of ADSs shall be entitled to Delivery (at the Custodians designated office) of the Deposited Securities at the time represented by the ADSs upon satisfaction of each of the following conditions: (i) the Holder (or a duly-authorized attorney of the Holder) has duly Delivered ADSs to the Depositary at its Principal Office (and if applicable, the ADRs evidencing such ADSs) for the purpose of withdrawal of the Deposited Securities represented thereby, (ii) if applicable and so required by the Depositary, the ADRs Delivered to the Depositary for such purpose have been properly endorsed in blank or are accompanied by proper instruments of transfer in blank (including signature guarantees in accordance with standard securities industry practice), (iii) if so required by the Depositary, the Holder of the ADSs has executed and delivered to the Depositary a written order directing the Depositary to cause the Deposited Securities being withdrawn to be Delivered to or upon the written order of the person(s) designated in such order, and (iv) all applicable fees and charges of, and expenses incurred by, the Depositary and all applicable taxes and governmental charges (as are set forth in Section 5.9 and Exhibit B ) have been paid, subject, however, in each case , to the terms and conditions of the ADRs evidencing the surrendered ADSs, of the Deposit Agreement, of the Companys Articles of Association and of any applicable laws and the rules of Clearstream, and to the terms and conditions of or governing the Deposited Securities, in each case as in effect at the time thereof.
Upon satisfaction of each of the conditions specified above, the Depositary (i) shall cancel the ADSs Delivered to it (and, if applicable, the ADR(s) evidencing the ADSs so Delivered), (ii) shall direct the Registrar to record the cancellation of the ADSs so Delivered on the books maintained for such purpose, and (iii) shall direct the Custodian to Deliver, or cause the Delivery of, in each case, without unreasonable delay, the Deposited Securities represented by the ADSs so canceled together with any certificate or other document of title for the Deposited Securities, or evidence of the electronic transfer thereof (if available), as the case may be, to or upon the written order of the person(s) designated in the order delivered to the Depositary for such purpose, subject however, in each case , to the terms and conditions of the Deposit Agreement, of the ADRs evidencing the ADSs so canceled, of the Articles of Association of the Company, of any applicable laws and of the rules of Clearstream, and to the terms and conditions of or governing the Deposited Securities, in each case as in effect at the time thereof.
The Depositary shall not accept for surrender ADSs representing less than one (1) Share. In the case of Delivery to it of ADSs representing a number other than a whole number of Shares, the Depositary shall cause ownership of the appropriate whole number of Shares to be Delivered in accordance with the terms hereof, and shall, at the discretion of the Depositary, either (i) return to the person surrendering such ADSs the number of ADSs representing any remaining fractional Share, or (ii) sell or cause to be sold the fractional Share represented by the ADSs so surrendered and remit the proceeds of such sale (net of (a) applicable fees and charges of, and expenses incurred by, the Depositary and (b) taxes required to be withheld as a result of such sale) to the person surrendering the ADSs.
Notwithstanding anything else contained in any ADR or the Deposit Agreement, the Depositary may make delivery at the Principal Office of the Depositary of Deposited Property consisting of (i) any cash dividends or cash distributions, or (ii) any proceeds from the sale of any non-cash distributions, which are at the time held by the Depositary in respect of the Deposited Securities represented by the ADSs surrendered for cancellation and withdrawal. At the request, risk and expense of any Holder so surrendering ADSs, and for the account of such Holder, the Depositary shall direct the Custodian to forward (to the extent permitted by law) any Deposited Property (other than Deposited Securities) held by the Custodian in respect of such ADSs to the Depositary for delivery at the Principal Office of the Depositary. Such direction shall be given by letter or, at the request, risk and expense of such Holder, by cable, telex or facsimile.
Section 2.8 Limitations on Execution and Delivery, Transfer, etc. of ADSs; Suspension of Delivery, Transfer, etc .
(a) Additional Requirements . As a condition precedent to the execution and delivery, the registration of issuance, transfer, split-up, combination or surrender, of any ADS, the delivery of any distribution thereon, or the withdrawal of any Deposited Property, the Depositary or the Custodian may require (i) payment from the depositor of Shares or presenter of ADSs or of an ADR of a sum sufficient to reimburse it for any tax or other governmental charge and any stock transfer or registration fee with respect thereto (including any such tax or charge and fee with respect to Shares being deposited or withdrawn) and payment of any applicable fees and charges of the Depositary as provided in Section 5.9 and Exhibit B , (ii) the production of proof satisfactory to it as to the identity and genuineness of any signature or any other matter contemplated by Section 3.1, and (iii) compliance with (A) any laws or governmental regulations relating to the execution and delivery of ADRs or ADSs or to the withdrawal of Deposited Securities and (B) such reasonable regulations as the Depositary and the Company may establish consistent with the provisions of the representative ADR, if applicable, the Deposit Agreement and applicable law.
(b) Additional Limitations . The issuance of ADSs against deposits of Shares generally or against deposits of particular Shares may be suspended, or the deposit of particular Shares may be refused, or the registration of transfer of ADSs in particular instances may be refused, or the registration of transfers of ADSs generally may be suspended, during any period when the transfer books of the Company, the Depositary, a Registrar or the Share Registrar are closed or if any such action is deemed necessary or advisable by the Depositary or the Company, in good faith, at any time or from time to time because of any requirement of law or regulation, any government or governmental body or commission or any securities exchange on which the ADSs or Shares are listed, or under any provision of the Deposit Agreement or the representative ADR(s), if applicable, or under any provision of, or governing, the Deposited Securities, or because of a meeting of shareholders of the Company or for any other reason, subject, in all cases, to Section 7.8.
(c) Regulatory Restrictions . Notwithstanding any provision of the Deposit Agreement or any ADR(s) to the contrary, Holders are entitled to surrender outstanding ADSs to
withdraw the Deposited Securities associated herewith at any time subject only to (i) temporary delays caused by closing the transfer books of the Depositary or the Company or the deposit of Shares in connection with voting at a shareholders meeting or the payment of dividends, (ii) the payment of fees, taxes and similar charges, (iii) compliance with any U.S. or foreign laws or governmental regulations relating to the ADSs or to the withdrawal of the Deposited Securities, and (iv) other circumstances specifically contemplated by Instruction I.A.(l) of the General Instructions to Form F-6 (as such General Instructions may be amended from time to time).
Section 2.9 Lost ADRs, etc . In case any ADR shall be mutilated, destroyed, lost, or stolen, the Depositary shall execute and deliver a new ADR of like tenor at the expense of the Holder (a) in the case of a mutilated ADR , in exchange of and substitution for such mutilated ADR upon cancellation thereof, or (b) in the case of a destroyed, lost or stolen ADR , in lieu of and in substitution for such destroyed, lost, or stolen ADR, after the Holder thereof (i) has submitted to the Depositary a written request for such exchange and substitution before the Depositary has notice that the ADR has been acquired by a bona fide purchaser, (ii) has provided such security or indemnity (including an indemnity bond) as may be required by the Depositary to save it and any of its agents harmless, and (iii) has satisfied any other reasonable requirements imposed by the Depositary, including, without limitation, evidence satisfactory to the Depositary of such destruction, loss or theft of such ADR, the authenticity thereof and the Holders ownership thereof.
Section 2.10 Cancellation and Destruction of Surrendered ADRs; Maintenance of Records . All ADRs surrendered to the Depositary shall be canceled by the Depositary. Canceled ADRs shall not be entitled to any benefits under the Deposit Agreement or be valid or enforceable against the Depositary for any purpose. The Depositary is authorized to destroy ADRs so canceled, provided the Depositary maintains a record of all destroyed ADRs. Any ADSs held in book-entry form ( i.e. , through accounts at DTC) shall be deemed canceled when the Depositary causes the number of ADSs evidenced by the Balance Certificate to be reduced by the number of ADSs surrendered (without the need to physically destroy the Balance Certificate).
Section 2.11 Escheatment . In the event any unclaimed property relating to the ADSs, for any reason, is in the possession of Depositary and has not been claimed by the Holder thereof or cannot be delivered to the Holder thereof through usual channels, the Depositary shall, upon expiration of any applicable statutory period relating to abandoned property laws, escheat such unclaimed property to the relevant authorities in accordance with the laws of each of the relevant States of the United States.
Section 2.12 Partial Entitlement ADSs . In the event any Shares are deposited which (i) entitle the holders thereof to receive a per-share distribution or other entitlement in an amount different from the Shares then on deposit or (ii) are not fully fungible (including, without limitation, as to settlement or trading) with the Shares then on deposit (the Shares then on deposit collectively, Full Entitlement Shares and the Shares with different entitlement, Partial Entitlement Shares ), the Depositary shall (i) cause the Custodian to hold Partial Entitlement Shares separate and distinct from Full Entitlement Shares, and (ii) subject to the terms of the Deposit Agreement, issue ADSs representing Partial Entitlement Shares which are separate and distinct from the ADSs representing Full Entitlement Shares, by means of separate CUSIP numbering and legending (if necessary) and, if applicable, by issuing ADRs evidencing such ADSs with applicable notations thereon ( Partial Entitlement ADSs/ADRs and Full Entitlement ADSs/ADRs , respectively). If and when Partial Entitlement Shares become Full Entitlement Shares, the Depositary shall (a) give notice thereof to Holders of Partial Entitlement ADSs and give Holders of Partial Entitlement ADRs the opportunity to exchange such Partial Entitlement ADRs for Full Entitlement ADRs, (b) cause the Custodian to transfer the Partial Entitlement Shares into the account of the Full Entitlement Shares, and (c) take such actions as are necessary to remove the distinctions between (i) the Partial Entitlement ADRs and ADSs, on the one hand, and (ii) the Full Entitlement ADRs and ADSs on the other. Holders and Beneficial Owners of Partial Entitlement ADSs shall only be entitled to the entitlements of Partial Entitlement Shares. Holders and Beneficial Owners of Full Entitlement ADSs shall be entitled only to the entitlements of Full Entitlement Shares. All provisions and conditions of the Deposit Agreement shall apply to Partial Entitlement ADRs and ADSs to the same extent as Full Entitlement ADRs and ADSs, except as contemplated by this Section 2.12. The Depositary is authorized to take any and all other actions as may be necessary (including, without limitation, making the necessary notations on ADRs) to give effect to the terms of this Section 2.12. The Company agrees to give timely written notice to the Depositary if any Shares issued or to be issued are Partial Entitlement Shares and shall assist the Depositary with the establishment of procedures enabling the identification of Partial Entitlement Shares upon Delivery to the Custodian.
Section 2.13 Certificated/Uncertificated ADSs . Notwithstanding any other provision of the Deposit Agreement, the Depositary may, at any time and from time to time, issue ADSs that are not evidenced by ADRs (such ADSs, the Uncertificated ADS(s) , and the ADS(s) evidenced by ADR(s), the Certificated ADS(s) ). When issuing and maintaining Uncertificated ADS(s) under the Deposit Agreement, the Depositary shall at all times be subject to (i) the standards applicable to registrars and transfer agents maintaining direct registration systems for equity securities in New York and issuing uncertificated securities under New York law, and (ii) the terms of New York law applicable to uncertificated equity securities. Uncertificated ADSs shall not be represented by any instruments but shall be evidenced by registration in the books of the Depositary maintained for such purpose. Holders of Uncertificated ADSs that are not subject to any registered pledges, liens, restrictions or adverse claims of which the Depositary has notice at such time shall at all times have the right to exchange the Uncertificated ADS(s) for Certificated ADS(s) of the same type and class, subject in each case to applicable laws and any rules and regulations the Depositary may have established in respect of the Uncertificated ADSs. Holders of Certificated ADSs shall, if the
Depositary maintains a direct registration system for the ADSs, have the right to exchange the Certificated ADSs for Uncertificated ADSs upon (i) the due surrender of the Certificated ADS(s) to the Depositary for such purpose and (ii) the presentation of a written request to that effect to the Depositary, subject in each case to (a) all liens and restrictions noted on the ADR evidencing the Certificated ADS(s) and all adverse claims of which the Depositary then has notice, (b) the terms of the Deposit Agreement and the rules and regulations that the Depositary may establish for such purposes hereunder, (c) applicable law, and (d) payment of the Depositary fees and expenses applicable to such exchange of Certificated ADS(s) for Uncertificated ADS(s). Uncertificated ADSs shall in all material respects be identical to Certificated ADS(s) of the same type and class, except that (i) no ADR(s) shall be, or shall need to be, issued to evidence Uncertificated ADS(s), (ii) Uncertificated ADS(s) shall, subject to the terms of the Deposit Agreement, be transferable upon the same terms and conditions as uncertificated securities under New York law, (iii) the ownership of Uncertificated ADS(s) shall be recorded on the books of the Depositary maintained for such purpose and evidence of such ownership shall be reflected in periodic statements provided by the Depositary to the Holder(s) in accordance with applicable New York law, (iv) the Depositary may from time to time, upon notice to the Holders of Uncertificated ADSs affected thereby, establish rules and regulations, and amend or supplement existing rules and regulations, as may be deemed reasonably necessary to maintain Uncertificated ADS(s) on behalf of Holders, provided that (a) such rules and regulations do not conflict with the terms of the Deposit Agreement and applicable law, and (b) the terms of such rules and regulations are readily available to Holders upon request, (v) the Uncertificated ADS(s) shall not be entitled to any benefits under the Deposit Agreement or be valid or enforceable for any purpose against the Depositary or the Company unless such Uncertificated ADS(s) is/are registered on the books of the Depositary maintained for such purpose, (vi) the Depositary may, in connection with any deposit of Shares resulting in the issuance of Uncertificated ADSs and with any transfer, pledge, release and cancellation of Uncertificated ADSs, require the prior receipt of such documentation as the Depositary may deem reasonably appropriate, and (vii) upon termination of the Deposit Agreement, the Depositary shall not require Holders of Uncertificated ADSs to affirmatively instruct the Depositary before remitting proceeds from the sale of the Deposited Property represented by such Holders Uncertificated ADSs under the terms of Section 6.2 of the Deposit Agreement. When issuing ADSs under the terms of the Deposit Agreement, including, without limitation, issuances pursuant to Sections 2.5, 4.2, 4.3, 4.4, 4.5 and 4.11, the Depositary may in its discretion determine to issue Uncertificated ADSs rather than Certificated ADSs, unless otherwise specifically instructed by the applicable Holder to issue Certificated ADSs. All provisions and conditions of the Deposit Agreement shall apply to Uncertificated ADSs to the same extent as to Certificated ADSs, except as contemplated by this Section 2.13. The Depositary is authorized and directed to take any and all actions and establish any and all procedures deemed reasonably necessary to give effect to the terms of this Section 2.13. Any references in the Deposit Agreement or any ADR(s) to the terms American Depositary Share(s) or ADS(s) shall, unless the context otherwise requires, include Certificated ADS(s) and Uncertificated ADS(s). Except as set forth in this Section 2.13 and except as required by applicable law, the Uncertificated ADSs shall be treated as ADSs issued and outstanding under the terms of the Deposit Agreement. In the event that, in determining the rights and obligations of parties hereto with respect to any Uncertificated ADSs, any conflict arises between (a) the terms of the Deposit Agreement (other than this Section 2.13) and (b) the
terms of this Section 2.13, the terms and conditions set forth in this Section 2.13 shall be controlling and shall govern the rights and obligations of the parties to the Deposit Agreement pertaining to the Uncertificated ADSs.
Section 2.14 Restricted ADSs . The Depositary shall, at the request and expense of the Company, establish procedures enabling the deposit hereunder of Shares that are Restricted Securities in order to enable the holder of such Shares to hold its ownership interests in such Restricted Shares in the form of ADSs issued under the terms hereof (such Shares, Restricted Shares ). Upon receipt of a written request from the Company to accept Restricted Shares for deposit hereunder, the Depositary agrees to establish procedures permitting the deposit of such Restricted Shares and the issuance of ADSs representing the right to receive, subject to the terms of the Deposit Agreement and the applicable ADR (if issued as a Certificated ADS), such deposited Restricted Shares (such ADSs, the Restricted ADSs , and the ADRs evidencing such Restricted ADSs, the Restricted ADRs ). Notwithstanding anything contained in this Section 2.14, the Depositary and the Company may, to the extent not prohibited by law, agree to issue the Restricted ADSs in uncertificated form ( Uncertificated Restricted ADSs ) upon such terms and conditions as the Company and the Depositary may deem necessary and appropriate. The Company shall assist the Depositary in the establishment of such procedures and agrees that it shall take all steps necessary and satisfactory to the Depositary to ensure that the establishment of such procedures does not violate the provisions of the Securities Act or any other applicable laws. The depositors of such Restricted Shares and the Holders of the Restricted ADSs may be required prior to the deposit of such Restricted Shares, the transfer of the Restricted ADRs and Restricted ADSs or the withdrawal of the Restricted Shares represented by Restricted ADSs to provide such written certifications or agreements as the Depositary or the Company may reasonably require. The Company shall provide to the Depositary in writing the legend(s) to be affixed to the Restricted ADRs (if the Restricted ADSs are to be issued as Certificated ADSs ) , or to be included in the statements issued from time to time to Holders of Uncertificated ADSs (if issued as Uncertificated Restricted ADSs), which legends shall (i) be in a form reasonably satisfactory to the Depositary and (ii) contain the specific circumstances under which the Restricted ADSs and, if applicable, the Restricted ADRs evidencing the Restricted ADSs may be transferred or the Restricted Shares withdrawn. The Restricted ADSs issued upon the deposit of Restricted Shares shall be separately identified on the books of the Depositary and the Restricted Shares so deposited shall, to the extent required by law, be held separate and distinct from the other Deposited Securities held hereunder. The Restricted Shares and the Restricted ADSs shall not be eligible for Pre-Release Transactions. The Restricted ADSs shall not be eligible for inclusion in any book-entry settlement system, including, without limitation, DTC, and shall not in any way be fungible with the ADSs issued under the terms hereof that are not Restricted ADSs. The Restricted ADSs and, if applicable, the Restricted ADRs evidencing the Restricted ADSs shall be transferable only by the Holder thereof upon delivery to the Depositary of (i) all documentation otherwise contemplated by the Deposit Agreement and (ii) an opinion of counsel reasonably satisfactory to the Depositary setting forth, inter alia , the conditions upon which the Restricted ADSs presented, and, if applicable, the Restricted ADRs evidencing the Restricted ADSs, are transferable by the Holder thereof under applicable securities laws and the transfer restrictions contained in the legend applicable to the Restricted ADSs presented for transfer. Except as set forth in this Section 2.14 and except as required by
applicable law, the Restricted ADSs and the Restricted ADRs evidencing Restricted ADSs shall be treated as ADSs and ADRs issued and outstanding under the terms of the Deposit Agreement. In the event that, in determining the rights and obligations of parties hereto with respect to any Restricted ADSs, any conflict arises between (a) the terms of the Deposit Agreement (other than this Section 2.14) and (b) the terms of (i) this Section 2.14 or (ii) the applicable Restricted ADR, the terms and conditions set forth in this Section 2.14 and of the Restricted ADR shall be controlling and shall govern the rights and obligations of the parties to the Deposit Agreement pertaining to the deposited Restricted Shares, the Restricted ADSs and Restricted ADRs.
If the Restricted ADRs, the Restricted ADSs and the Restricted Shares cease to be Restricted Securities, the Depositary, upon receipt of (x) an opinion of counsel reasonably satisfactory to the Depositary setting forth, inter alia , that the Restricted ADRs, the Restricted ADSs and the Restricted Shares are not as of such time Restricted Securities, and (y) instructions from the Company to remove the restrictions applicable to the Restricted ADRs, the Restricted ADSs and the Restricted Shares, shall (i) eliminate the distinctions and separations that may have been established between the applicable Restricted Shares held on deposit under this Section 2.14 and the other Shares held on deposit under the terms of the Deposit Agreement that are not Restricted Shares, (ii) treat the newly unrestricted ADRs and ADSs on the same terms as, and fully fungible with, the other ADRs and ADSs issued and outstanding under the terms of the Deposit Agreement that are not Restricted ADRs or Restricted ADSs, and (iii) take all actions necessary to remove any distinctions, limitations and restrictions previously existing under this Section 2.14 between the applicable Restricted ADRs and Restricted ADSs, respectively, on the one hand, and the other ADRs and ADSs that are not Restricted ADRs or Restricted ADSs, respectively, on the other hand, including, without limitation, by making the newly-unrestricted ADSs eligible for Pre-Release Transactions and for inclusion in the applicable book-entry settlement systems.
ARTICLE III
CERTAIN OBLIGATIONS OF HOLDERS
AND BENEFICIAL OWNERS OF ADSs
Section 3.1 Proofs, Certificates and Other Information . Any person presenting Shares for deposit, any Holder and any Beneficial Owner may be required, and every Holder and Beneficial Owner agrees, from time to time to provide to the Depositary and the Custodian such proof of citizenship or residence, taxpayer status, payment of all applicable taxes or other governmental charges relating to that person, exchange control approval, legal or beneficial ownership of ADSs and Deposited Property, compliance with applicable laws, the terms of the Deposit Agreement or the ADR(s) evidencing the ADSs and the provisions of, or governing, the Deposited Property, to execute such certifications and to make such representations and warranties, and to provide such other information and documentation (or, in the case of Shares in registered form presented for deposit, such information relating to the registration on the books of the Company or of the Share Registrar) as the Depositary or the Custodian may deem necessary or proper or as the Company may reasonably require by written request to the Depositary consistent with its obligations under the Deposit Agreement and the
applicable ADR(s). The Depositary and the Registrar, as applicable, may, and at the reasonable written request of the Company, shall, to the extent practicable, withhold the execution or delivery or registration of transfer of any ADR or ADS or the distribution or sale of any dividend or distribution of rights or of the proceeds thereof or, to the extent not limited by the terms of Section 7.8, the delivery of any Deposited Property until such proof or other information is filed or such certifications are executed, or such representations and warranties are made, or such other documentation or information provided, in each case to the Depositarys, the Registrars and the Companys satisfaction. The Depositary shall provide the Company, in a timely manner, with copies or originals if necessary and appropriate of (i) any such proofs of citizenship or residence, taxpayer status, or exchange control approval or copies of written representations and warranties which it receives from Holders and Beneficial Owners, and (ii) any other information or documents which the Company may reasonably request and which the Depositary shall request and receive from any Holder or Beneficial Owner or any person presenting Shares for deposit or ADSs for cancellation, transfer or withdrawal. Nothing herein shall obligate the Depositary to (i) obtain any information for the Company if not provided by the Holders or Beneficial Owners, or (ii) verify or vouch for the accuracy of the information so provided by the Holders or Beneficial Owners.
Section 3.2 Liability for Taxes and Other Charges . Any tax or other governmental charge payable by the Custodian or by the Depositary with respect to any Deposited Property, ADSs or ADRs shall be payable by the Holders and Beneficial Owners to the Depositary. The Company, the Custodian and/or the Depositary may withhold or deduct from any distributions made in respect of Deposited Property, and may sell for the account of a Holder and/or Beneficial Owner any or all of the Deposited Property and apply such distributions and sale proceeds in payment of, any taxes (including applicable interest and penalties) or charges that are payable by Holders or Beneficial Owners in respect of the ADSs, Deposited Property and ADRs, the Holder and the Beneficial Owner remaining liable for any deficiency. The Custodian may refuse the deposit of Shares and the Depositary may refuse to issue ADSs, deliver ADRs, register the transfer of ADSs, register the split-up or combination of ADRs and (subject to Section 7.8) the withdrawal of Deposited Property until payment in full of such tax, charge, penalty or interest is received. Every Holder and Beneficial Owner agrees to indemnify the Depositary, the Company, the Custodian, and any of their agents, officers, employees and Affiliates for, and to hold each of them harmless from, any claims with respect to taxes (including applicable interest and penalties thereon) arising from any tax benefit obtained by such Holder and/or Beneficial Owner.
Section 3.3 Representations and Warranties on Deposit of Shares . Each person depositing Shares under the Deposit Agreement shall be deemed thereby to represent and warrant that, pursuant to applicable German laws, (i) such Shares and the certificates therefor are duly authorized, validly issued, fully paid, non-assessable and legally obtained by such person, (ii) all preemptive (and similar) rights, if any, with respect to such Shares have been validly waived or exercised, (iii) the person making such deposit is duly authorized so to do, (iv) the Shares presented for deposit are free and clear of any lien, encumbrance, security interest, charge, mortgage or adverse claim, (v) the Shares presented for deposit are not, and the ADSs issuable upon such deposit will not be, Restricted Securities
(except as contemplated in Section 2.14) , and (vi) the Shares presented for deposit have not been stripped of any rights or entitlements. Such representations and warranties shall survive the deposit and withdrawal of Shares, the issuance and cancellation of ADSs in respect thereof and the transfer of such ADSs. If any such representations or warranties are false in any way, the Company and the Depositary shall be authorized, at the cost and expense of the person depositing Shares, to take any and all actions necessary to correct the consequences thereof.
Section 3.4 Compliance with Information Requests . Notwithstanding any other provision of the Deposit Agreement or any ADR(s), each Holder and Beneficial Owner agrees to comply with requests from the Company pursuant to applicable law, the rules and requirements of the New York Stock Exchange and any other stock exchange on which the Shares or ADSs are, or will be, registered, traded or listed or the Articles of Association of the Company, which are made to provide information, inter alia , as to the capacity in which such Holder or Beneficial Owner owns ADSs (and the Shares represented by such ADSs as the case may be) and regarding the identity of any other person(s) interested in such ADSs (and the Shares represented by such ADSs as the case may be) and the nature of such interest and various other matters, whether or not they are Holders and/or Beneficial Owners at the time of such request. The Depositary agrees to use its reasonable efforts to forward, upon the request of the Company and at the Companys expense, any such request from the Company to the Holders and to forward to the Company, as promptly as practicable, any such responses to such requests received by the Depositary.
Section 3.5 Ownership Restrictions . Notwithstanding any other provision in the Deposit Agreement or any ADR, the Company may restrict transfers of the Shares where such transfer might result in ownership of Shares exceeding limits imposed by applicable law or the Articles of Association of the Company. The Company may also restrict, in such manner as it deems appropriate, transfers of the ADSs where such transfer may result in the total number of Shares represented by the ADSs owned by a single Holder or Beneficial Owner to exceed any such limits. The Company may, in its sole discretion but subject to applicable law, instruct the Depositary to take action with respect to the ownership interest of any Holder or Beneficial Owner in excess of the limits set forth in the preceding sentence, including, but not limited to, the imposition of restrictions on the transfer of ADSs, the removal or limitation of voting rights or the mandatory sale or disposition on behalf of a Holder or Beneficial Owner of the Shares represented by the ADSs held by such Holder or Beneficial Owner in excess of such limitations, if and to the extent such disposition is permitted by applicable law and the Articles of Association of the Company. Nothing herein shall be interpreted as obligating the Depositary or the Company to ensure compliance with the ownership restrictions described in this Section 3.5.
Section 3.6 Reporting Obligations and Regulatory Approvals . Applicable laws and regulations may require holders and beneficial owners of Shares, including the Holders and Beneficial Owners of ADSs, to satisfy reporting requirements and obtain regulatory approvals in certain circumstances. Holders and Beneficial Owners of ADSs are solely responsible for determining and complying with such reporting requirements and obtaining such approvals. Each Holder and each Beneficial Owner hereby agrees to make such
determination, file such reports, and obtain such approvals to the extent and in the form required by applicable laws and regulations as in effect from time to time. Neither the Depositary, the Custodian, the Company or any of their respective agents or affiliates shall be required to take any actions whatsoever on behalf of Holders or Beneficial Owners to determine or satisfy such reporting requirements or obtain such regulatory approvals under applicable laws and regulations.
ARTICLE IV
THE DEPOSITED SECURITIES
Section 4.1 Cash Distributions . Whenever the Company intends to make a distribution of a cash dividend or other cash distribution in respect of any Deposited Securities, the Company shall give notice thereof to the Depositary at least twenty (20) days prior to the proposed distribution specifying, inter alia , the record date applicable for determining the holders of Deposited Securities entitled to receive such distribution. Upon the timely receipt of such notice, the Depositary shall establish an ADS Record Date upon the terms described in Section 4.9. Upon receipt of confirmation from the Custodian of the receipt of any cash dividend or other cash distribution on any Deposited Securities, or upon receipt of proceeds from the sale of any Deposited Property held in respect of the ADSs under the terms hereof, the Depositary will (i) if at the time of receipt thereof any amounts received in a Foreign Currency can, in the judgment of the Depositary (pursuant to Section 4.8), be converted on a practicable basis into Dollars transferable to the United States, promptly convert or cause to be converted such cash dividend, distribution or proceeds into Dollars (on the terms described in Section 4.8), (ii) if applicable and unless previously established, establish the ADS Record Date upon the terms described in Section 4.9, and (iii) distribute promptly the amount thus received (net of (a) the applicable fees and charges of, and expenses incurred by, the Depositary and (b) taxes required to be withheld as a result of the distribution) to the Holders entitled thereto as of the ADS Record Date in proportion to the number of ADSs held as of the ADS Record Date. The Depositary shall distribute only such amount, however, as can be distributed without attributing to any Holder a fraction of one cent, and any balance not so distributed shall be held by the Depositary (without liability for interest thereon) and shall be added to and become part of the next sum received by the Depositary for distribution to Holders of ADSs outstanding at the time of the next distribution. If the Company, the Custodian or the Depositary is required to withhold and does withhold from any cash dividend or other cash distribution in respect of any Deposited Securities, or from any cash proceeds from the sales of Deposited Property, an amount on account of taxes, duties or other governmental charges, the amount distributed to Holders on the ADSs shall be reduced accordingly. Such withheld amounts shall be forwarded by the Company, the Custodian or the Depositary to the relevant governmental authority. Evidence of payment thereof by the Company shall be forwarded by the Company to the Depositary upon request. The Depositary will hold any cash amounts it is unable to distribute in a non-interest bearing account for the benefit of the applicable Holders and Beneficial Owners of ADSs until the distribution can be effected or the funds that the Depositary holds must be escheated as unclaimed property in accordance with the laws of the relevant states of the United States.
Section 4.2 Distribution in Shares . Whenever the Company intends to make a distribution that consists of a dividend in, or free distribution of, Shares, the Company shall give notice thereof to the Depositary at least twenty (20) days prior to the proposed distribution, specifying, inter alia , the record date applicable to holders of Deposited Securities entitled to receive such distribution. Upon the timely receipt of such notice from the Company, the Depositary shall establish the ADS Record Date upon the terms described in Section 4.9. Upon receipt of confirmation from the Custodian of the receipt of the Shares so distributed by the Company, the Depositary shall either (i) subject to Section 5.9, distribute to the Holders as of the ADS Record Date in proportion to the number of ADSs held as of the ADS Record Date, additional ADSs, which represent in the aggregate the number of Shares received as such dividend, or free distribution, subject to the other terms of the Deposit Agreement (including, without limitation, (a) the applicable fees and charges of, and expenses incurred by, the Depositary and (b) applicable taxes), or (ii) if additional ADSs are not so distributed, take all actions necessary so that each ADS issued and outstanding after the ADS Record Date shall, to the extent permissible by law, thenceforth also represent rights and interests in the additional integral number of Shares distributed upon the Deposited Securities represented thereby (net of (a) the applicable fees and charges of, and expenses incurred by, the Depositary and (b) applicable taxes). In lieu of delivering fractional ADSs, the Depositary shall sell the number of Shares or ADSs, as the case may be, represented by the aggregate of such fractions and distribute the net proceeds upon the terms described in Section 4.1. In the event that the Depositary determines that any distribution in property (including Shares) is subject to any tax or other governmental charges which the Depositary is obligated to withhold, or if the Company, in the fulfillment of its obligations under Section 5.7, has furnished an opinion of U.S. counsel determining that Shares must be registered under the Securities Act or other laws in order to be distributed to Holders (and no such registration statement has been declared effective), the Depositary may dispose of all or a portion of such property (including Shares and rights to subscribe therefor) in such amounts and in such manner, including by public or private sale, as the Depositary deems necessary and practicable, and the Depositary shall distribute the net proceeds of any such sale (after deduction of applicable (a) taxes and (b) fees and charges of, and expenses incurred by, the Depositary) to Holders entitled thereto upon the terms described in Section 4.1. The Depositary shall hold and/or distribute any unsold balance of such property in accordance with the provisions of the Deposit Agreement.
Section 4.3 Elective Distributions in Cash or Shares . Whenever the Company intends to make a distribution payable at the election of the holders of Deposited Securities in cash or in additional Shares, the Company shall give timely notice thereof to the Depositary prior to the proposed distribution specifying, inter alia , the record date applicable to holders of Deposited Securities entitled to receive such elective distribution and whether or not it wishes such elective distribution to be made available to Holders of ADSs. Upon the timely receipt of a notice indicating that the Company wishes such elective distribution to be made available to Holders of ADSs, the Depositary shall consult with the Company to determine, and the Company shall assist the Depositary in its determination, whether it is lawful and reasonably practicable to make such elective distribution available to the Holders of ADSs. The Depositary shall make such elective distribution available to Holders only if (i) the Company shall have timely requested that the elective distribution be made available to Holders, (ii) the Depositary
shall have determined that such distribution is reasonably practicable and (iii) the Depositary shall have received satisfactory documentation within the terms of Section 5.7. If the above conditions are not satisfied, the Depositary shall establish an ADS Record Date on the terms described in Section 4.9 and, to the extent permitted by law, distribute to the Holders, on the basis of the same determination as is made in Germany in respect of the Shares for which no election is made, either (X) cash upon the terms described in Section 4.1 or (Y) additional ADSs representing such additional Shares upon the terms described in Section 4.2. If the above conditions are satisfied, the Depositary shall establish an ADS Record Date on the terms described in Section 4.9 and establish procedures to enable Holders to elect the receipt of the proposed distribution in cash or in additional ADSs. The Company shall assist the Depositary in establishing such procedures to the extent necessary. If a Holder elects to receive the proposed distribution in cash, then the distribution shall be made upon the terms described in Section 4.1. If a Holder elects to receive the proposed distribution in ADSs, then the distribution shall be made upon the terms described in Section 4.2. Nothing herein shall obligate the Depositary to make available to Holders a method to receive the elective distribution in Shares (rather than ADSs). There can be no assurance that Holders generally, or any Holder in particular, will be given the opportunity to receive elective distributions on the same terms and conditions as the holders of Shares.
Section 4.4 Distribution of Rights to Purchase Additional ADSs .
(a) Distribution to ADS Holders . Whenever the Company intends to distribute to the holders of the Deposited Securities rights to subscribe for additional Shares, the Company shall give notice thereof to the Depositary at least sixty (60) days prior to the proposed distribution specifying, inter alia , the record date applicable to holders of Deposited Securities entitled to receive such distribution and whether or not it wishes such rights to be made available to Holders of ADSs. Upon the timely receipt of a notice indicating that the Company wishes such rights to be made available to Holders of ADSs, the Depositary shall consult with the Company to determine, and the Company shall assist the Depositary in its determination, whether it is lawful and reasonably practicable to make such rights available to the Holders. The Depositary shall make such rights available to Holders only if (i) the Company shall have timely requested that such rights be made available to Holders, (ii) the Depositary shall have received satisfactory documentation within the terms of Section 5.7, and (iii) the Depositary shall have determined that such distribution of rights is reasonably practicable. In the event any of the conditions set forth above are not satisfied or if the Company requests that the rights not be made available to Holders of ADSs, the Depositary shall proceed with the sale of the rights as contemplated in Section 4.4(b) below. In the event all conditions set forth above are satisfied, the Depositary shall establish an ADS Record Date (upon the terms described in Section 4.9) and establish procedures (x) to distribute rights to purchase additional ADSs (by means of warrants or otherwise), (y) to enable the Holders to exercise such rights (upon payment of the subscription price and of the applicable (a) fees and charges of, and expenses incurred by, the Depositary and (b) taxes), and (z) to deliver ADSs upon the valid exercise of such rights. The Company shall assist the Depositary to the extent necessary in establishing such procedures. Nothing herein shall obligate the Depositary to make available to the Holders a method to exercise rights to subscribe for Shares (rather than ADSs).
(b) Sale of Rights . If (i) the Company does not timely request the Depositary to make the rights available to Holders or requests that the rights not be made available to Holders, (ii) the Depositary fails to receive satisfactory documentation within the terms of Section 5.7 or determines it is not reasonably practicable to make the rights available to Holders, or (iii) any rights made available are not exercised and appear to be about to lapse, the Depositary shall determine whether it is lawful and reasonably practicable to sell such rights, in a riskless principal capacity, at such place and upon such terms (including public or private sale) as it may deem practicable. The Company shall assist the Depositary to the extent necessary to determine such legality and practicability. The Depositary shall, upon such sale, convert and distribute proceeds of such sale (net of applicable (a) fees and charges of, and expenses incurred by, the Depositary and (b) taxes) upon the terms set forth in Section 4.1.
(c) Lapse of Rights . If the Depositary is unable to make any rights available to Holders upon the terms described in Section 4.4(a) or to arrange for the sale of the rights upon the terms described in Section 4.4(b), the Depositary shall allow such rights to lapse.
The Depositary shall not be responsible for (i) any failure to determine that it may be lawful or practicable to make such rights available to Holders in general or any Holders in particular, (ii) any foreign exchange exposure or loss incurred in connection with such sale or exercise, or (iii) the content of any materials forwarded to the Holders on behalf of the Company in connection with the rights distribution.
Notwithstanding anything to the contrary in this Section 4.4, if registration (under the Securities Act or any other applicable law) of the rights or the securities to which any rights relate may be required in order for the Company to offer such rights or such securities to Holders and to sell the securities represented by such rights, the Depositary will not distribute such rights to the Holders (i) unless and until a registration statement under the Securities Act (or other applicable law) covering such offering is in effect or (ii) unless the Company furnishes the Depositary opinion(s) of counsel for the Company in the United States and counsel to the Company in any other applicable country in which rights would be distributed, in each case reasonably satisfactory to the Depositary, to the effect that the offering and sale of such securities to Holders and Beneficial Owners are exempt from, or do not require registration under, the provisions of the Securities Act or any other applicable laws.
In the event that the Company, the Depositary or the Custodian shall be required to withhold and does withhold from any distribution of Deposited Property (including rights) an amount on account of taxes or other governmental charges, the amount distributed to the Holders of ADSs shall be reduced accordingly. In the event that any distribution of Deposited Property (including Shares and rights to subscribe therefor) is subject to any tax or other governmental charges which the Depositary is obligated to withhold, the Depositary may dispose of all or a portion of such Deposited Property (including Shares and rights to subscribe therefor) in such amounts and in such manner, including by public or private sale, as the Depositary deems necessary and practicable to pay any such taxes or charges.
Section 4.5 Distributions Other Than Cash, Shares or Rights to Purchase Shares .
(a) Whenever the Company intends to distribute to the holders of Deposited Securities property other than cash, Shares or rights to purchase additional Shares, the Company shall give timely notice thereof to the Depositary and shall indicate whether or not it wishes such distribution to be made to Holders of ADSs. Upon receipt of a notice indicating that the Company wishes such distribution be made to Holders of ADSs, the Depositary shall consult with the Company, and the Company shall assist the Depositary, to determine whether such distribution to Holders is lawful and reasonably practicable. The Depositary shall not make such distribution unless (i) the Company shall have requested the Depositary to make such distribution to Holders, (ii) the Depositary shall have received satisfactory documentation within the terms of Section 5.7, and (iii) the Depositary shall have determined that such distribution is reasonably practicable.
(b) Upon receipt of satisfactory documentation and the request of the Company to distribute property to Holders of ADSs and after making the requisite determinations set forth in (a) above, the Depositary shall distribute the property so received to the Holders of record, as of the ADS Record Date, in proportion to the number of ADSs held by them respectively and in such manner as the Depositary may deem practicable for accomplishing such distribution (i) upon receipt of payment or net of the applicable fees and charges of, and expenses incurred by, the Depositary, and (ii) net of any taxes required to be withheld. The Depositary may dispose of all or a portion of the property so distributed and deposited, in such amounts and in such manner (including public or private sale) as the Depositary may deem practicable or necessary to satisfy any taxes (including applicable interest and penalties) or other governmental charges applicable to the distribution.
(c) If (i) the Company does not request the Depositary to make such distribution to Holders or requests not to make such distribution to Holders, (ii) the Depositary does not receive satisfactory documentation within the terms of Section 5.7, or (iii) the Depositary determines that all or a portion of such distribution is not reasonably practicable, the Depositary shall sell or cause such property to be sold in a public or private sale, at such place or places and upon such terms as it may deem practicable and shall (i) cause the proceeds of such sale, if any, to be converted into Dollars and (ii) distribute the proceeds of such conversion received by the Depositary (net of applicable (a) fees and charges of, and expenses incurred by, the Depositary and (b) taxes) to the Holders as of the ADS Record Date upon the terms of Section 4.1. If the Depositary is unable to sell such property, the Depositary may dispose of such property for the account of the Holders in any way it deems reasonably practicable under the circumstances.
Section 4.6 Distributions with Respect to Deposited Securities in Bearer Form . Subject to the terms of this Article IV, distributions in respect of Deposited Securities that are held by the Depositary in bearer form shall be made to the Depositary for the account of the respective Holders of ADS(s) with respect to which any such distribution is made upon due presentation by the Depositary or the Custodian to the Company of any relevant coupons, talons, or certificates. The Company shall promptly notify the Depositary of such distributions. The Depositary or the Custodian shall promptly present such coupons, talons or certificates, as the case may be, in connection with any such distribution.
Section 4.7 Redemption . If the Company intends to exercise any right of redemption in respect of any of the Deposited Securities, the Company shall give timely notice thereof to the Depositary prior to the intended date of redemption which notice shall set forth the particulars of the proposed redemption. Upon timely receipt of (i) such notice and (ii) satisfactory documentation given by the Company to the Depositary within the terms of Section 5.7, and only if, after consultation between the Depositary and the Company, the Depositary shall have determined that such proposed redemption is practicable, the Depositary shall provide to each Holder a notice setting forth the intended exercise by the Company of the redemption rights and any other particulars set forth in the Companys notice to the Depositary. The Depositary shall instruct the Custodian to present to the Company the Deposited Securities in respect of which redemption rights are being exercised against payment of the applicable redemption price. Upon receipt of confirmation from the Custodian that the redemption has taken place and that funds representing the redemption price have been received, the Depositary shall convert, transfer, and distribute the proceeds (net of applicable (a) fees and charges of, and the expenses incurred by, the Depositary, and (b) taxes), retire ADSs and cancel ADRs, if applicable, upon delivery of such ADSs by Holders thereof and the terms set forth in Sections 4.1 and 6.2. If less than all outstanding Deposited Securities are redeemed, the ADSs to be retired will be accepted on a pro rata basis. The redemption price per ADS shall be the dollar equivalent of the per share amount received by the Depositary (adjusted to reflect the ADS(s)-to-Share(s) ratio) upon the redemption of the Deposited Securities represented by ADSs (subject to the terms of Section 4.8 and the applicable fees and charges of, and expenses incurred by, the Depositary, and applicable taxes) multiplied by the number of Deposited Securities represented by each ADS redeemed.
Section 4.8 Conversion of Foreign Currency . Whenever the Depositary or the Custodian shall receive Foreign Currency, by way of dividends or other distributions or the net proceeds from the sale of Deposited Property, which in the judgment of the Depositary can at such time be converted on a practicable basis, by sale or in any other manner that it may determine in accordance with applicable law, into Dollars transferable to the United States and distributable to the Holders entitled thereto, the Depositary shall convert or cause to be converted, by sale or in any other manner that it may determine, such Foreign Currency into Dollars, and shall distribute such Dollars (net of any applicable fees, any reasonable and customary expenses incurred in such conversion and any expenses incurred on behalf of the Holders in complying with currency exchange control or other governmental requirements) in accordance with the terms of the applicable sections of the Deposit Agreement. If the Depositary shall have distributed warrants or other instruments that entitle the holders thereof to such
Dollars, the Depositary shall distribute such Dollars to the holders of such warrants and/or instruments upon surrender thereof for cancellation, in either case without liability for interest thereon. Such distribution may be made upon an averaged or other practicable basis without regard to any distinctions among Holders on account of any application of exchange restrictions or otherwise.
If such conversion or distribution generally or with regard to a particular Holder can be effected only with the approval or license of any government or agency thereof, the Depositary shall have authority to file such application for approval or license, if any, as it may deem desirable. In no event, however, shall the Depositary be obligated to make such a filing.
If at any time the Depositary shall determine that in its judgment the conversion of any Foreign Currency and the transfer and distribution of proceeds of such conversion received by the Depositary is not practicable or lawful, or if any approval or license of any governmental authority or agency thereof that is required for such conversion, transfer and distribution is denied or, in the opinion of the Depositary, not obtainable at a reasonable cost or within a reasonable period, the Depositary may, in its reasonable discretion, (i) make such conversion and distribution in Dollars to the Holders for whom such conversion, transfer and distribution is lawful and practicable, (ii) distribute the Foreign Currency (or an appropriate document evidencing the right to receive such Foreign Currency) to Holders for whom this is lawful and practicable, or (iii) hold (or cause the Custodian to hold) such Foreign Currency (without liability for interest thereon) for the respective accounts of the Holders entitled to receive the same.
Section 4.9 Fixing of ADS Record Date . Whenever the Depositary shall receive notice of the fixing of a record date by the Company for the determination of holders of Deposited Securities entitled to receive any distribution (whether in cash, Shares, rights, or other property), or whenever for any reason the Depositary causes a change in the number of Shares that are represented by each ADS, or whenever the Depositary shall receive notice of any meeting of, or solicitation of consents or proxies of, holders of Shares or other Deposited Securities, or whenever the Depositary shall find it necessary or convenient in connection with the giving of any notice, solicitation of any consent or any other matter, the Depositary shall fix a record date (the ADS Record Date ) for the determination of the Holders of ADS(s) who shall be entitled to receive such distribution, to give instructions for the exercise of voting rights at any such meeting, to give or withhold such consent, to receive such notice or solicitation or to otherwise take action, or to exercise the rights of Holders with respect to such changed number of Shares represented by each ADS. The Depositary shall make reasonable efforts to establish the ADS Record Date as closely as possible to the applicable record date for the Deposited Securities (if any) set by the Company in Germany. Subject to applicable law and the provisions of Section 4.1 through 4.8 and to the other terms and conditions of the Deposit Agreement, only the Holders of ADSs at the close of business in New York on such ADS Record Date shall be entitled to receive such distribution, to give such voting instructions, to receive such notice or solicitation, or otherwise take action.
Section 4.10 Voting of Deposited Securities . As soon as practicable after receipt of notice of any meeting at which the holders of Deposited Securities are entitled to vote,
or of solicitation of consents or proxies from holders of Deposited Securities, the Depositary shall fix the ADS Record Date in respect of such meeting or solicitation of consent or proxy in accordance with Section 4.9. The Depositary shall, if requested by the Company in writing in a timely manner (the Depositary having no obligation to take any further action if the request shall not have been received by the Depositary at least thirty (30) days prior to the date of such vote or meeting), at the Companys expense and provided no U.S. legal prohibitions exist, distribute as soon as practicable after receipt thereof to Holders as of the ADS Record Date: (a) such notice of meeting or solicitation of consent or proxy, (b) a statement that the Holders at the close of business on the ADS Record Date will be entitled, subject to any applicable law, the provisions of the Deposit Agreement, the Articles of Association of the Company and the provisions of or governing the Deposited Securities (which provisions, if any, shall be summarized in pertinent part by the Company), to instruct the Depositary as to the exercise of the voting rights, if any, pertaining to the Deposited Securities represented by such Holders ADSs, and (c) a brief statement as to the manner in which such voting instructions may be given.
Notwithstanding anything contained in the Deposit Agreement or any ADR, with the Companys prior written consent, the Depositary may, to the extent not prohibited by law or regulations, or by the requirements of the stock exchange on which the ADSs are listed, in lieu of distribution of the materials provided to the Depositary in connection with any meeting of, or solicitation of consents or proxies from, holders of Deposited Securities, distribute to the Holders a notice that provides Holders with, or otherwise publicizes to Holders, instructions on how to retrieve such materials or receive such materials upon request ( i.e. , by reference to a website containing the materials for retrieval or a contact for requesting copies of the materials).
Voting instructions may be given only in respect of a number of ADSs representing an integral number of Deposited Securities. Upon the timely receipt of voting instructions from a Holder of ADSs as of the ADS Record Date of voting instructions in the manner specified by the Depositary, the Depositary shall endeavor, insofar as practicable and permitted under applicable law, the provisions of the Deposit Agreement, the Articles of Association of the Company and the provisions of the Deposited Securities, to vote, or cause the Custodian to vote, the Deposited Securities (in person or by proxy) represented by such Holders ADSs in accordance with such voting instructions.
Neither the Depositary nor the Custodian shall under any circumstances exercise any discretion as to voting, and neither the Depositary nor the Custodian shall vote, attempt to exercise the right to vote, or in any way make use of, for purposes of establishing a quorum or otherwise, the Deposited Securities represented by ADSs, except pursuant to and in accordance with the voting instructions timely received from Holders or as otherwise contemplated herein. If the Depositary timely receives voting instructions from a Holder which fail to specify the manner in which the Depositary is to vote the Deposited Securities represented by such Holders ADSs, the Depositary will deem such Holder (unless otherwise specified in the notice distributed to Holders) to have instructed the Depositary to vote in favor of the items set forth in such voting instructions. Deposited Securities represented by ADSs for which no timely voting instructions are received by the Depositary from the Holder shall not be voted. Notwithstanding anything else contained herein, the Depositary shall, if so requested in writing by the Company, represent
all Deposited Securities (whether or not voting instructions have been received in respect of such Deposited Securities from Holders as of the ADS Record Date) for the sole purpose of establishing quorum at a meeting of shareholders .
Notwithstanding anything else contained in the Deposit Agreement or any ADR, the Depositary shall not have any obligation to take any action with respect to any meeting, or solicitation of consents or proxies, of holders of Deposited Securities if the taking of such action would violate U.S. laws. The Company agrees to take any and all actions reasonably necessary and as permitted by the laws of Germany to enable Holders and Beneficial Owners to indirectly exercise the voting rights accruing to the Deposited Securities through the Depositary and to deliver to the Depositary an opinion of U.S. counsel addressing any actions requested to be taken if so requested by the Depositary.
There can be no assurance that Holders generally or any Holder in particular will receive the notice described above with sufficient time to enable the Holder to return voting instructions to the Depositary in a timely manner.
Section 4.11 Changes Affecting Deposited Securities . Upon any change in nominal or par value, split-up, cancellation, consolidation or any other reclassification of Deposited Securities, or upon any recapitalization, reorganization, merger, consolidation or sale of assets affecting the Company or to which it is a party, any property which shall be received by the Depositary or the Custodian in exchange for, or in conversion of, or replacement of, or otherwise in respect of, such Deposited Securities shall, to the extent permitted by law, be treated as new Deposited Property under the Deposit Agreement, and the ADRs shall, subject to the provisions of the Deposit Agreement and applicable law, evidence ADSs representing the right to receive such additional or replacement Deposited Property. In giving effect to such change, split-up, cancellation, consolidation or other reclassification of Deposited Securities, recapitalization, reorganization, merger, consolidation or sale of assets, the Depositary may, with the Companys approval, and shall, if the Company shall so request, subject to the terms of the Deposit Agreement and receipt of an opinion of counsel to the Company reasonably satisfactory to the Depositary that such actions are not in violation of any applicable laws or regulations, (i) issue and deliver additional ADSs as in the case of a stock dividend on the Shares, (ii) amend the Deposit Agreement and the applicable ADRs, (iii) amend the applicable Registration Statement(s) on Form F-6 as filed with the Commission in respect of the ADSs, (iv) call for the surrender of outstanding ADRs to be exchanged for new ADRs, and (v) take such other actions as are appropriate to reflect the transaction with respect to the ADSs. The Company agrees to, jointly with the Depositary, amend the Registration Statement on Form F-6 as filed with the Commission to permit the issuance of such new form of ADRs. Notwithstanding the foregoing, in the event that any Deposited Property so received may not be lawfully distributed to some or all Holders, the Depositary may, with the Companys approval, and shall, if the Company requests, subject to receipt of an opinion of Companys counsel reasonably satisfactory to the Depositary that such action is not in violation of any applicable laws or regulations, sell such Deposited Property at public or private sale, at such place or places and upon such terms as it may deem proper and may allocate the net proceeds of such sales (net of (a) fees and charges of, and expenses incurred by, the Depositary and (b) applicable taxes) for the account of the Holders
otherwise entitled to such Deposited Property upon an averaged or other practicable basis without regard to any distinctions among such Holders and distribute the net proceeds so allocated to the extent practicable as in the case of a distribution received in cash pursuant to Section 4.1. The Depositary shall not be responsible for (i) any failure to determine that it may be lawful or practicable to make such Deposited Property available to Holders in general or to any Holder in particular, (ii) any foreign exchange exposure or loss incurred in connection with such sale, or (iii) any liability to the purchaser of such Deposited Property.
Section 4.12 Available Information . The Company is subject to the periodic reporting requirements of the Exchange Act and, accordingly, is required to file or furnish certain reports with the Commission. These reports can be retrieved from the Commissions website (www.sec.gov) and can be inspected and copied at the public reference facilities maintained by the Commission located (as of the date of the Deposit Agreement) at 100 F Street, N.E., Washington D.C. 20549.
Section 4.13 Reports . The Depositary shall make available for inspection by Holders at its Principal Office, as promptly as practicable after receipt thereof, any reports and communications, including any proxy soliciting materials, received from the Company which are both (a) received by the Depositary, the Custodian, or the nominee of either of them as the holder of the Deposited Property and (b) made generally available to the holders of such Deposited Property by the Company. The Depositary shall also provide or make available to Holders copies of such reports when furnished by the Company pursuant to Section 5.6.
Section 4.14 List of Holders . Promptly upon written request by the Company, the Depositary shall furnish to it a list, as of a recent date, of the names, addresses and holdings of ADSs of all Holders.
Section 4.15 Taxation . The Depositary will, and will instruct the Custodian to, forward to the Company or its agents such information from its records as the Company may reasonably request to enable the Company or its agents to file the necessary tax reports with governmental authorities or agencies. The Depositary, the Custodian or the Company and its agents may file such reports as are necessary to reduce or eliminate applicable taxes on dividends and on other distributions in respect of Deposited Property under applicable tax treaties or laws for the Holders and Beneficial Owners. In accordance with instructions from the Company and to the extent practicable, the Depositary or the Custodian will take reasonable administrative actions to obtain tax refunds, reduced withholding of tax at source on dividends and other benefits under applicable tax treaties or laws with respect to dividends and other distributions on the Deposited Property. As a condition to receiving such benefits, Holders and Beneficial Owners of ADSs may be required from time to time, and in a timely manner, to file such proof of taxpayer status, residence and beneficial ownership (as applicable), to execute such certificates and to make such representations and warranties, or to provide any other information or documents, as the Depositary or the Custodian may deem necessary or proper to fulfill the Depositarys or the Custodians obligations under applicable law. The Holders and Beneficial Owners shall indemnify the Depositary, the Company, the Custodian and any of their respective directors, employees, agents and Affiliates against, and hold each of them harmless from, any
claims by any governmental authority with respect to taxes, additions to tax, penalties or interest arising out of any refund of taxes, reduced rate of withholding at source or other tax benefit obtained.
If the Company (or any of its agents) withholds from any distribution any amount on account of taxes or governmental charges, or pays any other tax in respect of such distribution ( i.e. , stamp duty tax, capital gains or other similar tax), the Company shall (and shall cause such agent to) remit promptly to the Depositary information about such taxes or governmental charges withheld or paid, and, if so requested, the tax receipt (or other proof of payment to the applicable governmental authority) therefor, in each case, in a form reasonably satisfactory to the Depositary. The Depositary shall, to the extent required by U.S. law, report to Holders any taxes withheld by it or the Custodian and, if such information is provided to it by the Company, any taxes withheld by the Company. The Depositary and the Custodian shall not be required to provide the Holders with any evidence of the remittance by the Company (or its agents) of any taxes withheld, or of the payment of taxes by the Company, except to the extent the evidence is provided by the Company to the Depositary or the Custodian, as applicable. Neither the Depositary nor the Custodian shall be liable for the failure by any Holder or Beneficial Owner to obtain the benefits of credits on the basis of non-U.S. tax paid against such Holders or Beneficial Owners income tax liability.
The Depositary is under no obligation to provide the Holders and Beneficial Owners with any information about the tax status of the Company, except to the extent the Company provides such information to the Depositary for distribution to the Holders and Beneficial Owners. The Depositary shall not incur any liability for any tax consequences that may be incurred by Holders and Beneficial Owners on account of their ownership of the ADSs, including, without limitation, tax consequences resulting from the Company (or any of its subsidiaries) being treated as a Passive Foreign Investment Company (in each case as defined in the U.S. Internal Revenue Code and the regulations issued thereunder) or otherwise.
Section 4.16 Limitation of Rights . Holders generally, or any Holder in particular, will not be given the opportunity to receive any rights or distributions pursuant to this Article IV on the same terms and conditions as the holders of Shares, or at all, unless the Company explicitly agrees to provide such rights or distributions to such Holder or Holders. Nothing contained in this Deposit Agreement shall obligate the Company to file any registration statement in respect of any rights, Shares or other securities distributed pursuant to this Article IV or any Shares or other securities to be acquired upon the exercise of rights distributed pursuant to this Article IV.
ARTICLE V
THE DEPOSITARY, THE CUSTODIAN AND THE COMPANY
Section 5.1 Maintenance of Office and Transfer Books by the Registrar . Until termination of the Deposit Agreement in accordance with its terms, the Registrar shall maintain in the Borough of Manhattan, the City of New York, an office and facilities for the issuance and delivery of ADSs, the acceptance for surrender of ADS(s) for the
purpose of withdrawal of Deposited Securities, the registration of issuances, cancellations, transfers, combinations and split-ups of ADS(s) and, if applicable, to countersign ADRs evidencing the ADSs so issued, transferred, combined or split-up, in each case in accordance with the provisions of the Deposit Agreement.
The Registrar shall keep books for the registration of ADSs which at all reasonable times shall be open for inspection by the Company and by the Holders of such ADSs, provided that such inspection shall not be, to the Registrars knowledge, for the purpose of communicating with Holders of such ADSs in the interest of a business or object other than the business of the Company or other than a matter related to the Deposit Agreement or the ADSs.
The Registrar may close the transfer books with respect to the ADSs, at any time or from time to time, when deemed necessary or advisable by it in good faith in connection with the performance of its duties hereunder, or at the reasonable written request of the Company subject, in all cases, to Section 7.8.
If any ADSs are listed on one or more stock exchanges or automated quotation systems in the United States, the Depositary shall act as Registrar or, with written advance notice given as promptly as practicable to the Company, appoint a Registrar or one or more co-registrars for registration of issuances, cancellations, transfers, combinations and split-ups of ADSs and, if applicable, to countersign ADRs evidencing the ADSs so issued, transferred, combined or split-up, in accordance with any requirements of such exchanges or systems. Such Registrar or co-registrars may be removed and a substitute or substitutes appointed by the Depositary.
Section 5.2 Exoneration . Neither the Depositary nor the Company shall be obligated to do or perform any act which is inconsistent with the provisions of the Deposit Agreement or incur any liability (i) if the Depositary or the Company shall be prevented or forbidden from, or delayed in, doing or performing any act or thing required by the terms of the Deposit Agreement, by reason of any provision of any present or future law or regulation of the United States, Germany, or any other country, or of any other governmental authority or regulatory authority or stock exchange, or on account of potential criminal or civil penalties or restraints, or by reason of any provision, present or future, of the Articles of Association of the Company or any provision of or governing any Deposited Securities, or by reason of any act of God or war or other circumstances beyond its control (including, without limitation, nationalization, expropriation, currency restrictions, work stoppage, strikes, civil unrest, acts of terrorism, revolutions, rebellions, explosions and computer failure), (ii) by reason of any exercise of, or failure to exercise, any discretion provided for in the Deposit Agreement or in the Articles of Association of the Company or provisions of or governing Deposited Securities, (iii) for any action or inaction in reliance upon the advice of or information from legal counsel, accountants, any person presenting Shares for deposit, any Holder, any Beneficial Owner or authorized representative thereof, or any other person believed by it in good faith to be competent to give such advice or information, (iv) for the inability by a Holder or Beneficial Owner to benefit from any distribution, offering, right or other benefit which is made available to holders of Deposited Securities but is not, under the terms of the Deposit Agreement, made available to Holders of
ADSs, or (v) for any consequential or punitive damages for any breach of the terms of the Deposit Agreement.
The Depositary, its controlling persons, its agents, any Custodian and the Company, its controlling persons and its agents may rely and shall be protected in acting upon any written notice, request or other document reasonably believed by it to be genuine and to have been signed or presented by the proper party or parties.
No disclaimer of liability under the Securities Act is intended by any provision of the Deposit Agreement.
Section 5.3 Standard of Care . The Company, the Depositary and their respective directors, officers, employees and agents assume no obligation and shall not be subject to any liability under the Deposit Agreement or any ADRs to any Holder(s) or Beneficial Owner(s), except that the Company and the Depositary agree to perform their respective obligations specifically set forth in the Deposit Agreement or the applicable ADRs without negligence or bad faith.
Without limitation of the foregoing, neither the Depositary, nor the Company, nor any of their respective controlling persons, directors, officers, employees, or agents, shall be under any obligation to appear in, prosecute or defend any action, suit or other proceeding in respect of any Deposited Property or in respect of the ADSs, which in its reasonable opinion may involve it in expense or liability, unless indemnity satisfactory to it against all expense (including fees and disbursements of counsel) and liability be furnished as often as may be required (and no Custodian shall be under any obligation whatsoever with respect to such proceedings, the responsibility of the Custodian being solely to the Depositary).
The Depositary and its agents shall not be liable for any failure to carry out any instructions to vote any of the Deposited Securities, or for the manner in which any vote is cast or the effect of any vote, provided that any such action or omission is in good faith and in accordance with the terms of the Deposit Agreement. The Depositary shall not incur any liability for any failure to determine that any distribution or action may be lawful or reasonably practicable, for the content of any information submitted to it by the Company for distribution to the Holders or for any inaccuracy of any translation thereof, for any investment risk associated with acquiring an interest in the Deposited Property, for the validity or worth of the Deposited Property or for any tax consequences that may result from the ownership of ADSs, Shares or other Deposited Property, for the credit-worthiness of any third party, for allowing any rights to lapse upon the terms of the Deposit Agreement, for the failure or timeliness of any notice from the Company, or for any action of or failure to act by, or any information provided or not provided by, DTC or any DTC Participant.
The Depositary shall not be liable for any acts or omissions made by a successor depositary whether in connection with a previous act or omission of the Depositary or in connection with any matter arising wholly after the removal or resignation of the Depositary, provided that in connection with the issue out of which such potential liability arises the
Depositary performed its obligations without negligence or bad faith while it acted as Depositary.
Section 5.4 Resignation and Removal of the Depositary; Appointment of Successor Depositary . The Depositary may at any time resign as Depositary hereunder by written notice of resignation delivered to the Company, such resignation to be effective on the earlier of (i) the 90th day after delivery thereof to the Company (whereupon the Depositary shall be entitled to take the actions contemplated in Section 6.2), or (ii) the appointment by the Company of a successor depositary and its acceptance of such appointment as hereinafter provided.
The Depositary may at any time be removed by the Company by written notice of such removal, which removal shall be effective on the later of (i) the 90th day after delivery thereof to the Depositary (whereupon the Depositary shall be entitled to take the actions contemplated in Section 6.2), or (ii) upon the appointment by the Company of a successor depositary and its acceptance of such appointment as hereinafter provided.
In case at any time the Depositary acting hereunder shall resign or be removed, the Company shall use reasonable efforts to appoint a successor depositary, which shall be a bank or trust company having an office in the Borough of Manhattan, the City of New York. Every successor depositary shall be required by the Company to execute and deliver to its predecessor and to the Company an instrument in writing accepting its appointment hereunder, and thereupon such successor depositary, without any further act or deed (except as required by applicable law), shall become fully vested with all the rights, powers, duties and obligations of its predecessor (other than as contemplated in Sections 5.8 and 5.9). The predecessor depositary, upon payment of all sums due it and on the written request of the Company, shall, (i) execute and deliver an instrument transferring to such successor all rights and powers of such predecessor hereunder (other than as contemplated in Sections 5.8 and 5.9), (ii) duly assign, transfer and deliver all of the Depositarys right, title and interest to the Deposited Property to such successor, and (iii) deliver to such successor a list of the Holders of all outstanding ADSs and such other information relating to ADSs and Holders thereof as the successor may reasonably request. Any such successor depositary shall promptly provide notice of its appointment to such Holders.
Any entity into or with which the Depositary may be merged or consolidated shall be the successor of the Depositary without the execution or filing of any document or any further act.
Section 5.5 The Custodian . The Depositary has initially appointed Citigroup Global Markets Deutschland AG as Custodian for the purpose of the Deposit Agreement. The Custodian or its successors in acting hereunder shall be subject at all times and in all respects to the direction of the Depositary for the Deposited Property for which the Custodian acts as custodian and shall be responsible solely to it. If any Custodian resigns or is discharged from its duties hereunder with respect to any Deposited Property and no other Custodian has previously been appointed hereunder, the Depositary shall promptly appoint a substitute custodian. The Depositary shall require such resigning or discharged Custodian to Deliver, or cause the Delivery of, the Deposited Property held by it, together with all such records maintained by it as Custodian with respect to such Deposited Property as the Depositary
may request, to the Custodian designated by the Depositary. Whenever the Depositary determines, in its discretion, that it is appropriate to do so, it may appoint an additional custodian with respect to any Deposited Property, or discharge the Custodian with respect to any Deposited Property and appoint a substitute custodian, which shall thereafter be Custodian hereunder with respect to the Deposited Property. Immediately upon any such change, the Depositary shall give notice thereof in writing to all Holders of ADSs, each other Custodian and the Company.
Citibank, N.A. may at any time act as Custodian of the Deposited Property pursuant to the Deposit Agreement, in which case any reference to Custodian shall mean Citibank, N.A. solely in its capacity as Custodian pursuant to the Deposit Agreement. Notwithstanding anything contained in the Deposit Agreement or any ADR, the Depositary shall not be obligated to give notice to the Company, any Holders of ADSs or any other Custodian of its acting as Custodian pursuant to the Deposit Agreement.
Upon the appointment of any successor depositary, any Custodian then acting hereunder shall, unless otherwise instructed by the Depositary, continue to be the Custodian of the Deposited Property without any further act or writing and shall be subject to the direction of the successor depositary. The successor depositary so appointed shall, nevertheless, on the written request of any Custodian, execute and deliver to such Custodian all such instruments as may be proper to give to such Custodian full and complete power and authority to act on the direction of such successor depositary.
Section 5.6 Notices and Reports . On or before the first date on which the Company gives notice, by publication or otherwise, of any meeting of holders of Shares or other Deposited Securities, or of any adjourned meeting of such holders, or of the taking of any action by such holders other than at a meeting, or of the taking of any action in respect of any cash or other distributions or the offering of any rights in respect of Deposited Securities, the Company shall transmit to the Depositary and the Custodian a copy of the notice thereof in the English language but otherwise in the form given or to be given to holders of Shares or other Deposited Securities. The Company shall also furnish to the Custodian and the Depositary a summary, in English, of any applicable provisions or proposed provisions of the Articles of Association of the Company that may be relevant or pertain to such notice of meeting or be the subject of a vote thereat.
The Company will also transmit to the Depositary (a) an English-language version of the other notices, reports and communications which are made generally available by the Company to holders of its Shares or other Deposited Securities and (b) the English-language versions of the Companys annual reports prepared in accordance with the applicable requirements of the Commission, provided that the requirement in clause (b) shall be deemed completed if the Company files such annual report with the Commission on the Electronic Data-Gathering, Analysis, and Retrieval (EDGAR) system. The Depositary shall arrange, at the request of the Company and at the Companys expense, to provide copies thereof to all Holders or make such notices, reports and other communications available to all Holders on a basis similar to that for holders of Shares or other Deposited Securities or on such other basis as the Company may advise the Depositary or as may be required by any applicable law, regulation or stock exchange
requirement. The Company has delivered to the Depositary and the Custodian a copy of the Companys Articles of Association, and, promptly upon any amendment thereto or change therein, the Company shall deliver to the Depositary and the Custodian a copy of such amendment thereto or change therein. The Depositary may rely upon such copy for all purposes of the Deposit Agreement.
The Depositary will, at the expense of the Company, make available a copy of any such notices, reports or communications issued by the Company and delivered to the Depositary for inspection by the Holders of the ADSs at the Depositarys Principal Office, at the office of the Custodian and at any other designated transfer office.
Section 5.7 Issuance of Additional Shares, ADSs etc . The Company agrees that in the event it or any of its Affiliates proposes (i) an issuance, sale or distribution of additional Shares, (ii) an offering of rights to subscribe for Shares or other Deposited Securities, (iii) an issuance or assumption of securities convertible into or exchangeable for Shares, (iv) an issuance of rights to subscribe for securities convertible into or exchangeable for Shares, (v) an elective dividend of cash or Shares, (vi) a redemption of Deposited Securities, (vii) a meeting of holders of Deposited Securities, or a solicitation of consents or proxies, relating to any reclassification of securities, merger or consolidation or transfer of assets, (viii) any assumption, reclassification, recapitalization, reorganization, merger, consolidation or sale of assets which affects the Deposited Securities, or (ix) a distribution of securities other than Shares, it will obtain U.S. legal advice and take all steps necessary to ensure that the proposed transaction does not violate the registration provisions of the Securities Act, or any other applicable laws (including, without limitation, the Investment Company Act of 1940, as amended, the Exchange Act and the securities laws of the states of the United States). In support of the foregoing, the Company will furnish to the Depositary (a) a written opinion of U.S. counsel (reasonably satisfactory to the Depositary) stating whether such transaction (1) requires a registration statement under the Securities Act to be in effect or (2) is exempt from the registration requirements of the Securities Act and (b) an opinion of German counsel stating that (1) making the transaction available to Holders and Beneficial Owners does not violate the laws or regulations of Germany and (2) all requisite regulatory consents and approvals have been obtained in Germany. If the filing of a registration statement is required, the Depositary shall not have any obligation to proceed with the transaction unless it shall have received evidence reasonably satisfactory to it that such registration statement has been declared effective. If, being advised by counsel, the Company determines that a transaction is required to be registered under the Securities Act, the Company will either (i) register such transaction to the extent necessary, (ii) alter the terms of the transaction to avoid the registration requirements of the Securities Act or (iii) direct the Depositary to take specific measures, in each case as contemplated in the Deposit Agreement, to prevent such transaction from violating the registration requirements of the Securities Act. The Company agrees with the Depositary that neither the Company nor any of its Affiliates will at any time (i) deposit any Shares or other Deposited Securities, either upon original issuance or upon a sale of Shares or other Deposited Securities previously issued and reacquired by the Company or by any such Affiliate, or (ii) issue additional Shares, rights to subscribe for such Shares, securities convertible into or exchangeable for Shares or rights to subscribe for such securities or distribute securities other than Shares, unless such transaction
and the securities issuable in such transaction do not violate the registration provisions of the Securities Act, or any other applicable laws (including, without limitation, the Investment Company Act of 1940, as amended, the Exchange Act and the securities laws of the states of the United States).
Notwithstanding anything else contained in the Deposit Agreement, nothing in the Deposit Agreement shall be deemed to obligate the Company to file any registration statement in respect of any proposed transaction.
Section 5.8 Indemnification . The Depositary agrees to indemnify the Company and its directors, officers, employees, agents and Affiliates against, and hold each of them harmless from, any direct loss, liability, tax, charge or expense of any kind whatsoever (including, but not limited to, the reasonable fees and expenses of counsel) which may arise out of acts performed or omitted by the Depositary under the terms hereof due to the negligence or bad faith of the Depositary.
The Company agrees to indemnify the Depositary, the Custodian and any of their respective directors, officers, employees, agents and Affiliates against, and hold each of them harmless from, any direct loss, liability, tax, charge or expense of any kind whatsoever (including, but not limited to, the reasonable fees and expenses of counsel) that are required to be paid by the relevant person (a) out of, or in connection with, any offer, issuance, sale, resale, transfer, deposit or withdrawal of ADRs, ADSs, the Shares, or other Deposited Securities, as the case may be, (b) out of, or as a result of, any offering documents in respect thereof or (c) out of acts performed or omitted, including, but not limited to, any delivery by the Depositary on behalf of the Company of information regarding the Company in connection with the Deposit Agreement, the ADRs, the ADSs, the Shares, or any Deposited Property, in any such case (i) by the Depositary, the Custodian or any of their respective directors, officers, employees, agents and Affiliates, except to the extent such loss, liability, tax, charge or expense is due to the negligence or bad faith of any of them, or (ii) by the Company or any of its directors, officers, employees, agents and Affiliates, provided, however, that the Company shall not be liable for any fees, charges or expenses payable by Holders or Beneficial Owners under this Deposit Agreement. The Company shall not indemnify the Depositary or the Custodian against any liability or expense arising out of information relating to the Depositary or such Custodian, as the case may be, furnished in a signed writing to the Company, executed by the Depositary or such Custodian expressly for use in any registration statement, prospectus or preliminary prospectus relating to any Deposited Securities represented by the ADSs. The indemnities contained in this paragraph shall not extend to any liability or expense that may arise solely and exclusively out of any Pre-Release Transaction (as defined in Section 5.10), other than a Pre-Release Transaction entered into at the request of the Company.
The obligations set forth in this Section shall survive the termination of the Deposit Agreement and the succession or substitution of any party hereto.
Any person seeking indemnification hereunder (an indemnified person) shall notify the person from whom it is seeking indemnification (the indemnifying person) of the commencement of any indemnifiable action or claim promptly after such indemnified person
becomes aware of such commencement (provided that the failure to make such notification shall not affect such indemnified persons rights to seek indemnification except to the extent the indemnifying person is materially prejudiced by such failure) and shall consult in good faith with the indemnifying person as to the conduct of the defense of such action or claim that may give rise to an indemnity hereunder, which defense shall be reasonable in the circumstances. No indemnified person shall compromise or settle any action or claim that may give rise to an indemnity hereunder without the consent of the indemnifying person, which consent shall not be unreasonably withheld.
Section 5.9 ADS Fees and Charges . The Company, the Holders, the Beneficial Owners, and persons depositing Shares for issuance of ADSs or surrendering ADSs for cancellation and withdrawal of Deposited Securities shall be required to pay the ADS fees and charges identified as payable by them respectively in the Fee Schedule attached hereto as Exhibit B. All ADS fees and charges so payable may be deducted from distributions or must be remitted to the Depositary, or its designee, and may, at any time and from time to time, be changed by agreement between the Depositary and the Company, but, in the case of ADS fees and charges payable by Holders and Beneficial Owners, only in the manner contemplated in Section 6.1. The Depositary shall provide, without charge, a copy of its latest fee schedule to anyone upon request.
ADS fees and charges payable upon (i) deposit of Shares against issuance of ADSs and (ii) surrender of ADSs for cancellation and withdrawal of Deposited Securities will be payable by the person to whom the ADSs so issued are delivered by the Depositary (in the case of ADS issuances) and by the person who delivers the ADSs for cancellation to the Depositary (in the case of ADS cancellations). In the case of ADSs issued by the Depositary into DTC or presented to the Depositary via DTC, the ADS issuance and cancellation fees and charges will be payable by the DTC Participant(s) receiving the ADSs from the Depositary or the DTC Participant(s) surrendering the ADSs to the Depositary for cancellation, as the case may be, on behalf of the Beneficial Owner(s) and will be charged by the DTC Participant(s) to the account(s) of the applicable Beneficial Owner(s) in accordance with the procedures and practices of the DTC Participant(s) as in effect at the time. ADS fees and charges in respect of distributions and the ADS service fee are payable by Holders as of the applicable ADS Record Date established by the Depositary. In the case of distributions of cash, the amount of the applicable ADS fees and charges is deducted from the funds being distributed. In the case of (i) distributions other than cash and (ii) the ADS service fee, the applicable Holders as of the ADS Record Date established by the Depositary will be invoiced for the amount of the ADS fees and charges. For ADSs held through DTC, the ADS fees and charges for distributions other than cash and the ADS service fee are charged to the DTC Participants in accordance with the procedures and practices prescribed by DTC from time to time and the DTC Participants in turn charge the amount of such ADS fees and charges to the Beneficial Owners for whom they hold ADSs.
The Depositary may reimburse the Company for certain expenses incurred by the Company in respect of the ADR program established pursuant to the Deposit Agreement, by making available a portion of the ADS fees charged in respect of the ADR program or otherwise, upon such terms and conditions as the Company and the Depositary agree from time to time.
The Company shall pay to the Depositary such fees and charges, and reimburse the Depositary for such out-of-pocket expenses, as the Depositary and the Company may agree from time to time. Responsibility for payment of such fees, charges and reimbursements may from time to time be changed by agreement between the Company and the Depositary. Unless otherwise agreed, the Depositary shall present its statement for such fees, charges and reimbursements to the Company once every three months. The charges and expenses of the Custodian are for the sole account of the Depositary.
The obligation of Holders and Beneficial Owners to pay ADS fees and charges shall survive the termination of the Deposit Agreement. As to any Depositary, upon the resignation or removal of such Depositary as described in Section 5.4, the right to collect ADS fees and charges shall extend for those ADS fees and charges incurred prior to the effectiveness of such resignation or removal.
Section 5.10 Pre-Release Transactions . Subject to the further terms and provisions of this Section 5.10, the Depositary, its Affiliates and their agents, on their own behalf, may own and deal in any class of securities of the Company and its Affiliates and in ADSs. In its capacity as Depositary, the Depositary shall not lend Shares or ADSs; provided, however, that the Depositary may (i) issue ADSs prior to the receipt of Shares pursuant to Section 2.3 and (ii) deliver Shares prior to the receipt of ADSs for withdrawal of Deposited Securities pursuant to Section 2.7, including ADSs which were issued under (i) above but for which Shares may not have been received (each such transaction a Pre-Release Transaction ). The Depositary may receive ADSs in lieu of Shares under (i) above and receive Shares in lieu of ADSs under (ii) above. Each such Pre-Release Transaction will be (a) subject to a written agreement whereby the person or entity (the Applicant ) to whom ADSs or Shares are to be delivered (w) represents that at the time of the Pre-Release Transaction the Applicant or its customer owns the Shares or ADSs that are to be delivered by the Applicant under such Pre-Release Transaction, (x) agrees to indicate the Depositary as owner of such Shares or ADSs in its records and to hold such Shares or ADSs in trust for the Depositary until such Shares or ADSs are delivered to the Depositary or the Custodian, (y) unconditionally guarantees to deliver to the Depositary or the Custodian, as applicable, such Shares or ADSs, and (z) agrees to any additional restrictions or requirements that the Depositary deems appropriate, (b) at all times fully collateralized with cash, U.S. government securities or such other collateral as the Depositary deems appropriate, (c) terminable by the Depositary on not more than five (5) business days notice and (d) subject to such further indemnities and credit regulations as the Depositary deems appropriate. The Depositary will normally limit the number of ADSs and Shares involved in such Pre-Release Transactions at any one time to thirty percent (30%) of the ADSs outstanding (without giving effect to ADSs outstanding under (i) above), provided, however, that the Depositary reserves the right to change or disregard such limit from time to time as it deems appropriate.
The Depositary may also set limits with respect to the number of ADSs and Shares involved in Pre-Release Transactions with any one person on a case-by-case basis as it deems appropriate. The Depositary may retain for its own account any compensation received by it in
conjunction with the foregoing. Collateral provided pursuant to (b) above, but not the earnings thereon, shall be held for the benefit of the Holders (other than the Applicant).
Section 5.11 Restricted Securities Owners . The Company agrees to advise in writing each of the persons or entities who, to the knowledge of the Company, holds Restricted Securities that such Restricted Securities are ineligible for deposit hereunder (except under the circumstances contemplated in Section 2.14) and, to the extent practicable, shall require each of such persons to represent in writing that such person will not deposit Restricted Securities hereunder (except under the circumstances contemplated in Section 2.14).
ARTICLE VI
AMENDMENT AND TERMINATION
Section 6.1 Amendment/Supplement . Subject to the terms and conditions of this Section 6.1 and applicable law, (a) the ADRs outstanding at any time, (b) the provisions of the Deposit Agreement and (c) the form of ADR attached hereto and to be issued under the terms hereof may at any time and from time to time be amended or supplemented by written agreement between the Company and the Depositary in any respect which they may deem necessary or desirable without the prior written consent of the Holders or Beneficial Owners. Any amendment or supplement which shall impose or increase any fees or charges (other than charges in connection with foreign exchange control regulations, and taxes and other governmental charges, delivery and other such expenses), or which shall otherwise materially prejudice any substantial existing right of Holders or Beneficial Owners, shall not, however, become effective as to outstanding ADSs until the expiration of thirty (30) days after notice of such amendment or supplement shall have been given to the Holders of outstanding ADSs. Notice of any amendment to the Deposit Agreement or any ADR shall not need to describe in detail the specific amendments effectuated thereby, and failure to describe the specific amendments in any such notice shall not render such notice invalid, provided , however , that, in each such case, the notice given to the Holders identifies a means for Holders and Beneficial Owners to retrieve or receive the text of such amendment ( i.e. , upon retrieval from the Commissions, the Depositarys or the Companys website or upon request from the Depositary). The parties hereto agree that any amendments or supplements which (i) are reasonably necessary (as agreed by the Company and the Depositary) in order for (a) the ADSs to be registered on Form F-6 under the Securities Act or (b) the ADSs to be settled solely in electronic book-entry form and (ii) do not in either such case impose or increase any fees or charges to be borne by Holders, shall be deemed not to materially prejudice any substantial rights of Holders or Beneficial Owners. Every Holder and Beneficial Owner at the time any amendment or supplement so becomes effective shall be deemed, by continuing to hold such ADSs, to consent and agree to such amendment or supplement and to be bound by the Deposit Agreement and the ADR, if applicable, as amended or supplemented thereby. In no event shall any amendment or supplement impair the right of the Holder to surrender such ADS and receive therefor the Deposited Securities represented thereby, except in order to comply with mandatory provisions of applicable law. Notwithstanding the foregoing, if any governmental body should adopt new laws, rules or regulations which would require an amendment of, or supplement to, the Deposit
Agreement to ensure compliance therewith, the Company and the Depositary may amend or supplement the Deposit Agreement and any ADRs at any time in accordance with such changed laws, rules or regulations. Such amendment or supplement to the Deposit Agreement and any ADRs in such circumstances may become effective before a notice of such amendment or supplement is given to Holders or within any other period of time as required for compliance with such laws, rules or regulations.
Section 6.2 Termination . The Depositary shall, at any time at the written direction of the Company, terminate the Deposit Agreement by distributing notice of such termination to the Holders of all ADSs then outstanding at least thirty (30) days prior to the date fixed in such notice for such termination. If ninety (90) days shall have expired after (i) the Depositary shall have delivered to the Company a written notice of its election to resign, or (ii) the Company shall have delivered to the Depositary a written notice of the removal of the Depositary, and, in either case, a successor depositary shall not have been appointed and accepted its appointment as provided in Section 5.4 of the Deposit Agreement, the Depositary may terminate the Deposit Agreement by distributing notice of such termination to the Holders of all ADSs then outstanding at least thirty (30) days prior to the date fixed in such notice for such termination. The date so fixed for termination of the Deposit Agreement in any termination notice so distributed by the Depositary to the Holders of ADSs is referred to as the Termination Date . Until the Termination Date, the Depositary shall continue to perform all of its obligations under the Deposit Agreement, and the Holders and Beneficial Owners will be entitled to all of their rights under the Deposit Agreement.
If any ADSs shall remain outstanding after the Termination Date, the Registrar and the Depositary shall not, after the Termination Date, have any obligation to perform any further acts under the Deposit Agreement, except that the Depositary shall, subject, in each case, to the terms and conditions of the Deposit Agreement, continue to (i) collect dividends and other distributions pertaining to Deposited Securities, (ii) sell Deposited Property received in respect of Deposited Securities, (iii) deliver Deposited Securities, together with any dividends or other distributions received with respect thereto and the net proceeds of the sale of any other Deposited Property, in exchange for ADSs surrendered to the Depositary (after deducting, or charging, as the case may be, in each case, the fees and charges of, and expenses incurred by, the Depositary, and all applicable taxes or governmental charges for the account of the Holders and Beneficial Owners, in each case upon the terms set forth in Section 5.9 of the Deposit Agreement), and (iv) take such actions as may be required under applicable law in connection with its role as Depositary under the Deposit Agreement.
At any time after the Termination Date, the Depositary may sell the Deposited Property then held under the Deposit Agreement and shall after such sale hold un-invested the net proceeds of such sale, together with any other cash then held by it under the Deposit Agreement, in an un-segregated account and without liability for interest, for the pro rata benefit of the Holders whose ADSs have not theretofore been surrendered. After making such sale, the Depositary shall be discharged from all obligations under the Deposit Agreement except (i) to account for such net proceeds and other cash (after deducting, or charging, as the case may be, in each case, the fees and charges of, and expenses incurred by, the Depositary, and all applicable
taxes or governmental charges for the account of the Holders and Beneficial Owners, in each case upon the terms set forth in Section 5.9 of the Deposit Agreement), and (ii) as may be required at law in connection with the termination of the Deposit Agreement. After the Termination Date, the Company shall be discharged from all obligations under the Deposit Agreement, except for its obligations to the Depositary under Sections 5.8, 5.9 and 7.6 of the Deposit Agreement. The obligations under the terms of the Deposit Agreement of Holders and Beneficial Owners of ADSs outstanding as of the Termination Date shall survive the Termination Date and shall be discharged only when the applicable ADSs are presented by their Holders to the Depositary for cancellation under the terms of the Deposit Agreement.
ARTICLE VII
MISCELLANEOUS
Section 7.1 Counterparts . The Deposit Agreement may be executed (including by facsimile transmission or by e-mail of a .pdf attachment) in any number of counterparts, each of which shall be deemed an original and all of such counterparts together shall constitute one and the same agreement. Copies of the Deposit Agreement shall be maintained with the Depositary and shall be open to inspection by any Holder during business hours.
Section 7.2 No Third-Party Beneficiaries . Notwithstanding any rights and obligations the Custodian will have hereunder and which may be set forth in a separate agreement, the Deposit Agreement is for the exclusive benefit of the parties hereto (and their successors) and shall not be deemed to give any legal or equitable right, remedy or claim whatsoever to any other person, except to the extent specifically set forth in the Deposit Agreement. Nothing in the Deposit Agreement shall be deemed to give rise to a partnership or joint venture among the parties nor establish a fiduciary or similar relationship among the parties. The parties hereto acknowledge and agree that (i) the Depositary and its Affiliates may at any time have multiple banking relationships with the Company and its Affiliates, (ii) the Depositary and its Affiliates may be engaged at any time in transactions in which parties adverse to the Company or the Holders or Beneficial Owners may have interests and (iii) nothing contained in the Deposit Agreement shall (a) preclude the Depositary or any of its Affiliates from engaging in such transactions or establishing or maintaining such relationships, and (b) obligate the Depositary or any of its Affiliates to disclose such transactions or relationships or to account for any profit made or payment received in such transactions or relationships.
Section 7.3 Severability . In case any one or more of the provisions contained in the Deposit Agreement or in the ADRs should be or become invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein or therein shall in no way be affected, prejudiced or disturbed thereby.
Section 7.4 Holders and Beneficial Owners as Parties; Binding Effect . The Holders and Beneficial Owners from time to time of ADSs issued hereunder shall be parties to the Deposit Agreement and shall be bound by all of the terms and conditions hereof and of any ADR evidencing their ADSs by acceptance thereof or any beneficial interest therein.
Section 7.5 Notices . Any and all notices to be given to the Company shall be deemed to have been duly given if personally delivered or sent by mail, air courier or cable, telex or facsimile or other electronic transmission, confirmed by letter personally delivered or sent by mail or air courier, addressed to voxeljet AG, Paul-Lenz-Straße 1, 86316 Friedberg, Germany, Attention : Rudolf Franz, or to any other address which the Company may specify in writing to the Depositary.
Any and all notices to be given to the Depositary shall be deemed to have been duly given if personally delivered or sent by mail, air courier or cable, telex or facsimile, confirmed by letter personally delivered or sent by mail or air courier, addressed to Citibank, N.A., 388 Greenwich Street, New York, New York 10013, U.S.A., Attention : Depositary Receipts Department, or to any other address which the Depositary may specify in writing to the Company.
Any and all notices to be given to any Holder shall be deemed to have been duly given if (a) personally delivered or sent by mail or cable, telex or facsimile transmission, confirmed by letter, addressed to such Holder at the address of such Holder as it appears on the books of the Depositary or, if such Holder shall have filed with the Depositary a request that notices intended for such Holder be mailed to some other address, at the address specified in such request, or (b) if a Holder shall have designated such means of notification as an acceptable means of notification under the terms of the Deposit Agreement, by means of electronic messaging addressed for delivery to the e-mail address designated by the Holder for such purpose. Notice to Holders shall be deemed to be notice to Beneficial Owners for all purposes of the Deposit Agreement. Failure to notify a Holder or any defect in the notification to a Holder shall not affect the sufficiency of notification to other Holders or to the Beneficial Owners of ADSs held by such other Holders.
Delivery of a notice sent by mail, air courier or cable, telex, facsimile or email transmissions (provided that, in the event the Depositary is to be the recipient of such email transmission, such email transmission is in a form acceptable to the Depositary as determined at its sole discretion) shall be deemed to be effective at the time when a duly addressed letter containing the same ((or a confirmation thereof in the case of a cable, telex, facsimile or email transmission (provided that, in the event the Depositary is to be the recipient of such email transmission, such email transmission is in a form acceptable to the Depositary as determined at its sole discretion)) is deposited, postage prepaid, in a post-office letter box or delivered to an air courier service, without regard for the actual receipt or time of actual receipt thereof by a Holder. The Depositary or the Company may, however, act upon any cable, telex, facsimile or email transmission (provided that, in the event the Depositary is to be the recipient of such email transmission, such email transmission is in a form acceptable to the Depositary as determined at its sole discretion) received by it from any Holder, the Custodian, the Depositary, or the Company, notwithstanding that such cable, telex, facsimile or email transmission (provided that, in the event the Depositary is to be the recipient of such email transmission, such email transmission is in a form acceptable to the Depositary as determined at its sole discretion) shall not be subsequently confirmed by letter.
Delivery of a notice by means of electronic messaging shall be deemed to be effective at the time of the initiation of the transmission by the sender (as shown on the senders records), notwithstanding that the intended recipient retrieves the message at a later date, fails to retrieve such message, or fails to receive such notice on account of its failure to maintain the designated e-mail address, its failure to designate a substitute e-mail address or for any other reason.
Section 7.6 Governing Law and Jurisdiction . The Deposit Agreement and the ADRs shall be interpreted in accordance with, and all rights hereunder and thereunder and provisions hereof and thereof shall be governed by, the laws of the State of New York applicable to contracts made and to be wholly performed in that State. Notwithstanding anything contained in the Deposit Agreement, any ADR or any present or future provisions of the laws of the State of New York, the rights of holders of Shares and of any other Deposited Securities and the obligations and duties of the Company in respect of the holders of Shares and other Deposited Securities, as such, shall be governed by the laws of Germany (or, if applicable, such other laws as may govern the Deposited Securities).
Except as set forth in the following paragraph of this Section 7.6, the Company and the Depositary agree that the federal or state courts in the City of New York shall have jurisdiction to hear and determine any suit, action or proceeding and to settle any dispute between them that may arise out of or in connection with the Deposit Agreement and, for such purposes, each irrevocably submits to the non-exclusive jurisdiction of such courts. The Company hereby designates, appoints and empowers Corporation Service Company (the Agent ) now at 1090 Vermont Avenue N.W., Washington, DC 20005 as its authorized agent to receive and accept for and on its behalf, and on behalf of its properties, assets and revenues, service by mail of any and all legal process, summons, notices and documents that may be served in any suit, action or proceeding brought against the Company in any federal or state court as described in the preceding sentence or in the next paragraph of this Section 7.6. The Company may replace the Agent at its election at any time, but agrees to immediately designate a new agent and promptly notify the Depositary in writing of the name and address of such new agent. If for any reason the Agent or any successor shall cease to be available to act as such, the Company agrees to designate a new agent in New York on the terms and for the purposes of this Section 7.6 reasonably satisfactory to the Depositary. The Company further hereby irrevocably consents and agrees to the service of any and all legal process, summons, notices and documents in any suit, action or proceeding against the Company, by service by mail of a copy thereof upon the Agent (whether or not the appointment of such Agent shall for any reason prove to be ineffective or such Agent shall fail to accept or acknowledge such service), with a copy mailed to the Company by registered or certified air mail, postage prepaid, to its address provided in Section 7.5. The Company agrees that the failure of the Agent to give any notice of such service to it shall not impair or affect in any way the validity of such service or any judgment rendered in any action or proceeding based thereon.
Notwithstanding the foregoing, the Depositary and the Company unconditionally agree that in the event that a Holder or Beneficial Owner brings a suit, action or proceeding against (a) the Company, (b) the Depositary in its capacity as Depositary under the Deposit Agreement or (c) against both the Company and the Depositary, in any such case, in any state or federal court
of the United States, and the Depositary or the Company have any claim, for indemnification or otherwise, against each other arising out of the subject matter of such suit, action or proceeding, then the Company and the Depositary may pursue such claim against each other in the state or federal court in the United States in which such suit, action, or proceeding is pending and, for such purposes, the Company and the Depositary irrevocably submit to the non-exclusive jurisdiction of such courts. The Company agrees that service of process upon the Agent in the manner set forth in the preceding paragraph shall be effective service upon it for any suit, action or proceeding brought against it as described in this paragraph.
The Company irrevocably and unconditionally waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of venue of any actions, suits or proceedings brought in any court as provided in this Section 7.6, and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such action, suit or proceeding brought in any such court has been brought in an inconvenient forum.
The Company irrevocably and unconditionally waives, to the fullest extent permitted by law, and agrees not to plead or claim, any right of immunity from legal action, suit or proceeding, from setoff or counterclaim, from the jurisdiction of any court, from service of process, from attachment upon or prior to judgment, from attachment in aid of execution or judgment, from execution of judgment, or from any other legal process or proceeding for the giving of any relief or for the enforcement of any judgment, and consents to such relief and enforcement against it, its assets and its revenues in any jurisdiction, in each case with respect to any matter arising out of, or in connection with, the Deposit Agreement, any ADR or the Deposited Property.
No disclaimer of liability under the Securities Act is intended by any provision of the Deposit Agreement. The provisions of this Section 7.6 shall survive any termination of the Deposit Agreement, in whole or in part.
Section 7.7 Assignment . Subject to the provisions of Section 5.4, the Deposit Agreement may not be assigned by either the Company or the Depositary.
Section 7.8 Compliance with U.S. Securities Laws . Notwithstanding anything in the Deposit Agreement to the contrary, the withdrawal or delivery of Deposited Securities will not be suspended by the Company or the Depositary except as would be permitted by Instruction I.A.(1) of the General Instructions to Form F-6 Registration Statement, as amended from time to time, under the Securities Act.
Section 7.9 Relationship between the Company and Holders and Beneficial Owners . Notwithstanding any provision in this Deposit Agreement to the contrary, Holders and Beneficial Owners, in their capacity as such, have no claims or rights against or in relation to the Company to the extent that such claims or rights are conferred through ownership of the Shares, unless and until such Holders and Beneficial Owners convert their ADSs into Shares (either permanently or temporarily).
Section 7.10 German Law References . Any summary of German laws and regulations and of the terms of the Companys Articles of Association set forth in the Deposit Agreement have been provided by the Company solely for the convenience of Holders, Beneficial Owners and the Depositary. While such summaries are believed by the Company to be accurate as of the date of the Deposit Agreement, (i) they are summaries and as such may not include all aspects of the materials summarized applicable to a Holder or Beneficial Owner, and (ii) these laws and regulations and the Companys Articles of Association may change after the date of the Deposit Agreement. Neither the Depositary nor the Company has any obligation under the terms of the Deposit Agreement to update any such summaries.
Section 7.11 Titles and References .
(a) Deposit Agreement . All references in the Deposit Agreement to exhibits, articles, sections, subsections, and other subdivisions refer to the exhibits, articles, sections, subsections and other subdivisions of the Deposit Agreement unless expressly provided otherwise. The words the Deposit Agreement, herein, hereof, hereby, hereunder, and words of similar import refer to the Deposit Agreement as a whole as in effect at the relevant time between the Company, the Depositary and the Holders and Beneficial Owners of ADSs and not to any particular subdivision unless expressly so limited. Pronouns in masculine, feminine and neuter gender shall be construed to include any other gender, and words in the singular form shall be construed to include the plural and vice versa unless the context otherwise requires. Titles to sections of the Deposit Agreement are included for convenience only and shall be disregarded in construing the language contained in the Deposit Agreement. References to applicable laws and regulations shall refer to laws and regulations applicable to ADRs, ADSs or Deposited Property as in effect at the relevant time of determination, unless otherwise required by law or regulation.
(b) ADRs . All references in any ADR(s) to paragraphs, exhibits, articles, sections, subsections, and other subdivisions refer to the paragraphs, exhibits, articles, sections, subsections and other subdivisions of the ADR(s) in question unless expressly provided otherwise. The words the Receipt, the ADR, herein, hereof, hereby, hereunder, and words of similar import used in any ADR refer to the ADR as a whole and as in effect at the relevant time, and not to any particular subdivision unless expressly so limited. Pronouns in masculine, feminine and neuter gender in any ADR shall be construed to include any other gender, and words in the singular form shall be construed to include the plural and vice versa unless the context otherwise requires. Titles to paragraphs of any ADR are included for convenience only and shall be disregarded in construing the language contained in the ADR. References to applicable laws and regulations shall refer to laws and regulations applicable to ADRs, ADSs or Deposited Property as in effect at the relevant time of determination, unless otherwise required by law or regulation.
IN WITNESS WHEREOF, VOXELJET AG and CITIBANK, N.A. have duly executed the Deposit Agreement as of the day and year first above set forth and all Holders and Beneficial Owners shall become parties hereto upon acceptance by them of ADSs issued in accordance with the terms hereof, or upon acquisition of any beneficial interest therein.
|
VOXELJET AG |
||
|
|
||
|
|
||
|
By: |
|
|
|
|
Name: |
Rudolf Franz |
|
|
Title: |
Chief Financial Officer |
|
|
||
|
CITIBANK, N.A. |
||
|
|
||
|
|
||
|
By: |
|
|
|
|
Name: |
|
|
|
Title: |
EXHIBIT A
[FORM OF ADR]
Number |
CUSIP NUMBER: |
American Depositary Shares (each American Depositary Share representing the right to receive [number of shares] fully paid ordinary shares)
AMERICAN DEPOSITARY RECEIPT
FOR
AMERICAN DEPOSITARY SHARES
representing
DEPOSITED ORDINARY SHARES
of
VOXELJET AG
(Incorporated under the laws of the Federal Republic of Germany)
CITIBANK, N.A., a national banking association organized and existing under the laws of the United States of America, as depositary (the Depositary), hereby certifies that is the owner of American Depositary Shares (hereinafter ADS) representing deposited ordinary shares, including evidence of rights to receive such ordinary shares (the Shares), of voxeljet AG, a corporation incorporated under the laws of the Federal Republic of Germany (the Company). As of the date of the Deposit Agreement (as hereinafter defined), each ADS represents the right to receive [number of shares] Shares deposited under the Deposit Agreement with the Custodian, which at the date of execution of the Deposit Agreement is Citigroup Global Markets Deutschland AG (the Custodian). The ADS(s)-to-Share(s) ratio is subject to amendment as provided in Articles IV and VI of the
Deposit Agreement. The Depositarys Principal Office is located at 388 Greenwich Street, New York, New York 10013, U.S.A.
(1) The Deposit Agreement . This American Depositary Receipt is one of an issue of American Depositary Receipts (ADRs), all issued and to be issued upon the terms and conditions set forth in the Deposit Agreement, dated as of [date] , 2013 (as amended and supplemented from time to time, the Deposit Agreement), by and among the Company, the Depositary, and all Holders and Beneficial Owners from time to time of ADSs issued thereunder. The Deposit Agreement sets forth the rights and obligations of Holders and Beneficial Owners of ADSs and the rights and duties of the Depositary in respect of the Shares deposited thereunder and any and all Deposited Property from time to time received and held on deposit in respect of the ADSs. Copies of the Deposit Agreement are on file at the Principal Office of the Depositary and with the Custodian. Each Holder and each Beneficial Owner, upon acceptance of any ADSs (or any interest therein) issued in accordance with the terms and conditions of the Deposit Agreement, shall be deemed for all purposes to (a) be a party to and bound by the terms of the Deposit Agreement and the applicable ADR(s), and (b) appoint the Depositary its attorney-in-fact, with full power to delegate, to act on its behalf and to take any and all actions contemplated in the Deposit Agreement and the applicable ADR(s), to adopt any and all procedures necessary to comply with applicable law and to take such action as the Depositary in its sole discretion may deem necessary or appropriate to carry out the purposes of the Deposit Agreement and the applicable ADR(s), the taking of such actions to be the conclusive determinant of the necessity and appropriateness thereof.
The statements made on the face and reverse of this ADR are summaries of certain provisions of the Deposit Agreement and the Articles of Association of the Company (as in effect on the date of the signing of the Deposit Agreement) and are qualified by and subject to the detailed provisions of the Deposit Agreement and the Articles of Association of the Company, to which reference is hereby made.
All capitalized terms not defined herein shall have the meanings ascribed thereto in the Deposit Agreement.
The Depositary makes no representation or warranty as to the validity or worth of the Deposited Property. The Depositary has made arrangements for the acceptance of the ADSs into DTC. Each Beneficial Owner of ADSs held through DTC must rely on the procedures of DTC and the DTC Participants to exercise and be entitled to any rights attributable to such ADSs. The Depositary may issue Uncertificated ADSs subject, however, to the terms and conditions of Section 2.13 of the Deposit Agreement.
(2) Surrender of ADSs and Withdrawal of Deposited Securities . The Holder of this ADR (and of the ADSs evidenced hereby) shall be entitled to Delivery (at the Custodians designated
office) of the Deposited Securities at the time represented by the ADSs evidenced hereby upon satisfaction of each of the following conditions: (i) the Holder (or a duly-authorized attorney of the Holder) has duly Delivered ADSs to the Depositary at its Principal Office the ADSs evidenced hereby (and, if applicable, this ADR evidencing such ADSs) for the purpose of withdrawal of the Deposited Securities represented thereby, (ii) if applicable and so required by the Depositary, this ADR Delivered to the Depositary for such purpose has been properly endorsed in blank or is accompanied by proper instruments of transfer in blank (including signature guarantees in accordance with standard securities industry practice), (iii) if so required by the Depositary, the Holder of the ADSs has executed and delivered to the Depositary a written order directing the Depositary to cause the Deposited Securities being withdrawn to be Delivered to or upon the written order of the person(s) designated in such order, and (iv) all applicable fees and charges of, and expenses incurred by, the Depositary and all applicable taxes and governmental charges (as are set forth in Section 5.9 of, and Exhibit B to, the Deposit Agreement) have been paid, subject, however, in each case , to the terms and conditions of this ADR evidencing the surrendered ADSs, of the Deposit Agreement, of the Articles of Association of the Company, of any applicable laws and the rules of Clearstream, and to the terms and conditions of or governing the Deposited Securities, in each case as in effect at the time thereof.
Upon satisfaction of each of the conditions specified above, the Depositary (i) shall cancel the ADSs Delivered to it (and, if applicable, this ADR(s) evidencing the ADSs so Delivered), (ii) shall direct the Registrar to record the cancellation of the ADSs so Delivered on the books maintained for such purpose, and (iii) shall direct the Custodian to Deliver, or cause the Delivery of, in each case, without unreasonable delay, the Deposited Securities represented by the ADSs so canceled together with any certificate or other document of title for the Deposited Securities, or evidence of the electronic transfer thereof (if available), as the case may be, to or upon the written order of the person(s) designated in the order delivered to the Depositary for such purpose, subject however, in each case , to the terms and conditions of the Deposit Agreement, of this ADR evidencing the ADS so canceled, of the Articles of Association of the Company, of any applicable laws and of the rules of Clearstream, and to the terms and conditions of or governing the Deposited Securities, in each case as in effect at the time thereof.
The Depositary shall not accept for surrender ADSs representing less than one (1) Share. In the case of Delivery to it of ADSs representing a number other than a whole number of Shares, the Depositary shall cause ownership of the appropriate whole number of Shares to be Delivered in accordance with the terms hereof, and shall, at the discretion of the Depositary, either (i) return to the person surrendering such ADSs the number of ADSs representing any remaining fractional Share, or (ii) sell or cause to be sold the fractional Share represented by the ADSs so surrendered and remit the proceeds of such sale (net of (a) applicable fees and charges of, and expenses incurred by, the Depositary and (b) taxes required to be withheld as a result of such sale) to the person surrendering the ADSs.
Notwithstanding anything else contained in this ADR or the Deposit Agreement, the Depositary may make delivery at the Principal Office of the Depositary of Deposited Property consisting of (i) any cash dividends or cash distributions, or (ii) any proceeds from the sale of any non-cash distributions, which are at the time held by the Depositary in respect of the Deposited Securities represented by the ADSs surrendered for cancellation and withdrawal. At the request, risk and expense of any Holder so surrendering ADSs represented by this ADR, and for the account of such Holder, the Depositary shall direct the Custodian to forward (to the extent permitted by law) any Deposited Property (other than Deposited Securities) held by the Custodian in respect of such ADSs to the Depositary for delivery at the Principal Office of the Depositary. Such direction shall be given by letter or, at the request, risk and expense of such Holder, by cable, telex or facsimile transmission.
(3) Transfer, Combination and Split-up of ADRs . The Registrar shall register the transfer of this ADR (and of the ADSs represented hereby) on the books maintained for such purpose and the Depositary shall (x) cancel this ADR and execute new ADRs evidencing the same aggregate number of ADSs as those evidenced by this ADR canceled by the Depositary, (y) cause the Registrar to countersign such new ADRs, and (z) Deliver such new ADRs to or upon the order of the person entitled thereto, if each of the following conditions has been satisfied: (i) this ADR has been duly Delivered by the Holder (or by a duly-authorized attorney of the Holder) to the Depositary at its Principal Office for the purpose of effecting a transfer thereof, (ii) this surrendered ADR has been properly endorsed or is accompanied by proper instruments of transfer (including signature guarantees in accordance with standard securities industry practice), (iii) this surrendered ADR has been duly stamped (if required by the laws of the State of New York or of the United States), and (iv) all applicable fees and charges of, and expenses incurred by, the Depositary and all applicable taxes and governmental charges (as are set forth in Section 5.9 of, and Exhibit B to, the Deposit Agreement) have been paid, subject, however, in each case, to the terms and conditions of this ADR, of the Deposit Agreement and of applicable law, in each case as in effect at the time thereof.
The Registrar shall register the split-up or combination of this ADR (and of the ADSs represented hereby) on the books maintained for such purpose and the Depositary shall (x) cancel this ADR and execute new ADRs for the number of ADSs requested, but in the aggregate not exceeding the number of ADSs evidenced by this ADR canceled by the Depositary, (y) cause the Registrar to countersign such new ADRs, and (z) Deliver such new ADRs to or upon the order of the Holder thereof, if each of the following conditions has been satisfied: (i) this ADR has been duly Delivered by the Holder (or by a duly-authorized attorney of the Holder) to the Depositary at its Principal Office for the purpose of effecting a split-up or combination hereof, and (ii) all applicable fees and charges of, and expenses incurred by, the Depositary and all applicable taxes and governmental charges (as are set forth in Section 5.9 of, and Exhibit B to, the Deposit Agreement) have been paid, subject, however, in each case , to the
terms and conditions of this ADR, of the Deposit Agreement and of applicable law, in each case as in effect at the time thereof.
The Depositary may (with notice given as promptly as practicable to the Company) appoint one or more co-transfer agents for the purpose of effecting transfers, combinations and split-ups of ADRs at designated transfer offices on behalf of the Depositary. In carrying out its functions, a co-transfer agent may require evidence of authority and compliance with applicable laws and other requirements by Holders or persons entitled to such ADRs and will be entitled to protection and indemnity to the same extent as the Depositary. Such co-transfer agents may be removed and substitutes appointed by the Depositary. Each co-transfer agent appointed under Section 2.6 of the Deposit Agreement (other than the Depositary) shall give notice in writing to the Depositary accepting such appointment and agreeing to be bound by the applicable terms of the Deposit Agreement.
(4) Pre-Conditions to Registration, Transfer, Etc . As a condition precedent to the execution and delivery, the registration of issuance, transfer, split-up, combination or surrender, of any ADS, the delivery of any distribution thereon, or the withdrawal of any Deposited Property, the Depositary or the Custodian may require (i) payment from the depositor of Shares or presenter of ADSs or of this ADR of a sum sufficient to reimburse it for any tax or other governmental charge and any stock transfer or registration fee with respect thereto (including any such tax or charge and fee with respect to Shares being deposited or withdrawn) and payment of any applicable fees and charges of the Depositary as provided in Section 5.9 and Exhibit B to the Deposit Agreement and in this ADR, (ii) the production of proof satisfactory to it as to the identity and genuineness of any signature or any other matter contemplated by Section 3.1 of the Deposit Agreement, and (iii) compliance with (A) any laws or governmental regulations relating to the execution and delivery of this ADR or ADSs or to the withdrawal of Deposited Securities and (B) such reasonable regulations as the Depositary and the Company may establish consistent with the provisions of this ADR, the Deposit Agreement and applicable law.
The issuance of ADSs against deposits of Shares generally or against deposits of particular Shares may be suspended, or the deposit of particular Shares may be refused, or the registration of transfer of ADSs in particular instances may be refused, or the registration of transfer of ADSs generally may be suspended, during any period when the transfer books of the Company, the Depositary, a Registrar or the Share Registrar are closed or if any such action is deemed necessary or advisable by the Depositary or the Company, in good faith, at any time or from time to time because of any requirement of law or regulation, any government or governmental body or commission or any securities exchange on which the ADSs or Shares are listed, or under any provision of the Deposit Agreement or this ADR, or under any provision of, or governing, the Deposited Securities, or because of a meeting of shareholders of the Company or for any other reason, subject, in all cases to paragraph (25) of this ADR. Notwithstanding any
provision of the Deposit Agreement or this ADR to the contrary, Holders are entitled to surrender outstanding ADSs to withdraw the Deposited Securities associated therewith at any time subject only to (i) temporary delays caused by closing the transfer books of the Depositary or the Company or the deposit of Shares in connection with voting at a shareholders meeting or the payment of dividends, (ii) the payment of fees, taxes and similar charges, (iii) compliance with any U.S. or foreign laws or governmental regulations relating to the ADSs or to the withdrawal of the Deposited Securities, and (iv) other circumstances specifically contemplated by Instruction I.A.(l) of the General Instructions to Form F-6 (as such General Instructions may be amended from time to time).
(5) Compliance With Information Requests . Notwithstanding any other provision of the Deposit Agreement or this ADR, each Holder and Beneficial Owner of the ADSs represented hereby agrees to comply with requests from the Company pursuant to applicable law, the rules and requirements of the New York Stock Exchange, and any other stock exchange on which the Shares or ADSs are, or will be, registered, traded or listed, or the Articles of Association of the Company, which are made to provide information, inter alia , as to the capacity in which such Holder or Beneficial Owner owns ADSs (and the Shares represented by such ADSs as the case may be) and regarding the identity of any other person(s) interested in such ADSs (and the Shares represented by such ADSs as the case may be) and the nature of such interest and various other matters, whether or not they are Holders and/or Beneficial Owners at the time of such request. The Depositary agrees to use its reasonable efforts to forward, upon the request of the Company and at the Companys expense, any such request from the Company to the Holders and to forward to the Company, as promptly as practicable, any such responses to such requests received by the Depositary.
(6) Ownership Restrictions . Notwithstanding any other provision of this ADR or of the Deposit Agreement, the Company may restrict transfers of the Shares where such transfer might result in ownership of Shares exceeding limits imposed by applicable law or the Articles of Association of the Company. The Company may also restrict, in such manner as it deems appropriate, transfers of the ADSs where such transfer may result in the total number of Shares represented by the ADSs owned by a single Holder or Beneficial Owner to exceed any such limits. The Company may, in its sole discretion but subject to applicable law, instruct the Depositary to take action with respect to the ownership interest of any Holder or Beneficial Owner in excess of the limits set forth in the preceding sentence, including but not limited to, the imposition of restrictions on the transfer of ADSs, the removal or limitation of voting rights or the mandatory sale or disposition on behalf of a Holder or Beneficial Owner of the Shares represented by the ADSs held by such Holder or Beneficial Owner in excess of such limitations, if and to the extent such disposition is permitted by applicable law and the Articles of Association of the Company. Nothing herein or in the Deposit Agreement shall be interpreted as obligating the Depositary or the Company to ensure compliance with the ownership restrictions described herein or in Section 3.5 of the Deposit Agreement.
(7) Reporting Obligations and Regulatory Approvals . Applicable laws and regulations may require holders and beneficial owners of Shares, including the Holders and Beneficial Owners of ADSs, to satisfy reporting requirements and obtain regulatory approvals in certain circumstances. Holders and Beneficial Owners of ADSs are solely responsible for determining and complying with such reporting requirements and obtaining such approvals. Each Holder and each Beneficial Owner hereby agrees to make such determination, file such reports, and obtain such approvals to the extent and in the form required by applicable laws and regulations as in effect from time to time. Neither the Depositary, the Custodian, the Company or any of their respective agents or affiliates shall be required to take any actions whatsoever on behalf of Holders or Beneficial Owners to determine or satisfy such reporting requirements or obtain such regulatory approvals under applicable laws and regulations.
(8) Liability for Taxes and Other Charges . Any tax or other governmental charge payable by the Custodian or by the Depositary with respect to any Deposited Property, ADSs or this ADR shall be payable by the Holders and Beneficial Owners to the Depositary. The Company, the Custodian and/or the Depositary may withhold or deduct from any distributions made in respect of Deposited Property, and may sell for the account of a Holder and/or Beneficial Owner any or all of the Deposited Property and apply such distributions and sale proceeds in payment of, any taxes (including applicable interest and penalties) or charges that are payable by Holders or Beneficial Owners in respect of the ADSs, Deposited Property and this ADR, the Holder and the Beneficial Owner hereof remaining liable for any deficiency. The Custodian may refuse the deposit of Shares and the Depositary may refuse to issue ADSs, deliver ADRs, register the transfer of ADSs, register the split-up or combination of ADRs and (subject to paragraph (25) of this ADR and Section 7.8 of the Deposit Agreement) the withdrawal of Deposited Property until payment in full of such tax, charge, penalty or interest is received. Every Holder and Beneficial Owner agrees to indemnify the Depositary, the Company, the Custodian, and any of their agents, officers, employees and Affiliates for, and to hold each of them harmless from, any claims with respect to taxes (including applicable interest and penalties thereon) arising from any tax benefit obtained by such Holder and/or Beneficial Owner.
(9) Representations and Warranties of Depositors . Each person depositing Shares under the Deposit Agreement shall be deemed thereby to represent and warrant that, pursuant to applicable German laws, (i) such Shares and the certificates therefor are duly authorized, validly issued, fully paid, non-assessable and legally obtained by such person, (ii) all preemptive (and similar) rights, if any, with respect to such Shares have been validly waived or exercised, (iii) the person making such deposit is duly authorized so to do, (iv) the Shares presented for deposit are free and clear of any lien, encumbrance, security interest, charge, mortgage or adverse claim, (v) the Shares presented for deposit are not, and the ADSs issuable upon such deposit will not be, Restricted Securities ( except as contemplated in Section 2.14 of the Deposit Agreement), and (vi) the Shares presented for deposit have not been stripped of any rights or entitlements. Such representations and warranties shall survive the deposit and withdrawal of Shares, the issuance
and cancellation of ADSs in respect thereof and the transfer of such ADSs. If any such representations or warranties are false in any way, the Company and the Depositary shall be authorized, at the cost and expense of the person depositing Shares, to take any and all actions necessary to correct the consequences thereof.
(10) Proofs, Certificates and Other Information . Any person presenting Shares for deposit, any Holder and any Beneficial Owner may be required, and every Holder and Beneficial Owner agrees, from time to time to provide to the Depositary and the Custodian such proof of citizenship or residence, taxpayer status, payment of all applicable taxes or other governmental charges relating to that person, exchange control approval, legal or beneficial ownership of ADSs and Deposited Property, compliance with applicable laws, the terms of the Deposit Agreement or this ADR evidencing the ADSs and the provisions of, or governing, the Deposited Property, to execute such certifications and to make such representations and warranties, and to provide such other information and documentation (or, in the case of Shares in registered form presented for deposit, such information relating to the registration on the books of the Company or of the Share Registrar) as the Depositary or the Custodian may deem necessary or proper or as the Company may reasonably require by written request to the Depositary consistent with its obligations under the Deposit Agreement and this ADR. The Depositary and the Registrar, as applicable, may, and at the reasonable written request of the Company, shall, to the extent practicable, withhold the execution or delivery or registration of transfer of any ADR or ADS or the distribution or sale of any dividend or distribution of rights or of the proceeds thereof or, to the extent not limited by paragraph (25) and Section 7.8 of the Deposit Agreement, the delivery of any Deposited Property until such proof or other information is filed or such certifications are executed, or such representations and warranties are made, or such other documentation or information provided, in each case to the Depositarys, the Registrars and the Companys satisfaction. The Depositary shall provide the Company, in a timely manner, with copies or originals if necessary and appropriate of (i) any such proofs of citizenship or residence, taxpayer status, or exchange control approval or copies of written representations and warranties which it receives from Holders and Beneficial Owners, and (ii) any other information or documents which the Company may reasonably request and which the Depositary shall request and receive from any Holder or Beneficial Owner or any person presenting Shares for deposit or ADSs for cancellation, transfer or withdrawal. Nothing herein shall obligate the Depositary to (i) obtain any information for the Company if not provided by the Holders or Beneficial Owners, or (ii) verify or vouch for the accuracy of the information so provided by the Holders or Beneficial Owners.
(11) ADS Fees and Charges . The following ADS fees are payable under the terms of the Deposit Agreement:
(i) ADS Issuance Fee : by any person depositing Shares or to whom ADSs are issued upon the deposit of Shares (excluding issuances as a result of
distributions described in paragraph (iv) below), a fee not in excess of U.S. $5.00 per 100 ADSs (or fraction thereof) so issued under the terms of the Deposit Agreement;
(ii) ADS Cancellation Fee : by any person surrendering ADSs for cancellation and withdrawal of Deposited Securities or by any person to whom Deposited Securities are delivered, a fee not in excess of U.S. $5.00 per 100 ADSs (or fraction thereof) surrendered;
(iii) Cash Distribution Fee : by any Holder of ADSs, a fee not in excess of U.S. $5.00 per 100 ADSs (or fraction thereof) held for the distribution of cash dividends or other cash distributions ( i.e. , sale of rights and other entitlements);
(iv) Stock Distribution /Rights Exercise Fee : by any Holder of ADS(s), a fee not in excess of U.S. $5.00 per 100 ADSs (or fraction thereof) held for (i) stock dividends or other free stock distributions or (ii) exercise of rights to purchase additional ADSs;
(v) Other Distribution Fee : by any Holder of ADS(s), a fee not in excess of U.S. $5.00 per 100 ADSs (or fraction thereof) held for the distribution of securities other than ADSs or rights to purchase additional ADSs ( i.e. , spin-off shares); and
(vi) Depositary Services Fee : by any Holder of ADS(s), a fee not in excess of U.S. $5.00 per 100 ADSs (or fraction thereof) held on the applicable record date(s) established by the Depositary.
The Company, Holders, Beneficial Owners, persons depositing Shares, and persons surrendering ADSs for cancellation and for the purpose of withdrawing Deposited Securities shall be responsible for the following ADS charges under the terms of the Deposit Agreement:
(a) taxes (including applicable interest and penalties) and other governmental charges;
(b) such registration fees as may from time to time be in effect for the registration of Shares or other Deposited Securities on the share register and applicable to transfers of Shares or other Deposited Securities to or from the name of the Custodian, the Depositary or any nominees upon the making of deposits and withdrawals, respectively;
(c) such cable, telex and facsimile transmission and delivery expenses as are expressly provided in the Deposit Agreement to be at the expense of the person depositing Shares or withdrawing Deposited Securities or of the Holders and Beneficial Owners of ADSs;
(d) the expenses and charges incurred by the Depositary in the conversion of foreign currency;
(e) such fees and expenses as are incurred by the Depositary in connection with compliance with exchange control regulations and other regulatory requirements applicable to Shares, Deposited Securities, ADSs and ADRs; and
(f) the fees and expenses incurred by the Depositary, the Custodian, or any nominee in connection with the delivery or servicing of Deposited Property.
All ADS fees and charges may, at any time and from time to time, be changed by agreement between the Depositary and Company but, in the case of ADS fees and charges payable by Holders and Beneficial Owners, only in the manner contemplated by paragraph (23) of this ADR and as contemplated in Section 6.1 of the Deposit Agreement. The Depositary shall provide, without charge, a copy of its latest fee schedule to anyone upon request.
ADS fees and charges payable upon (i) deposit of Shares against issuance of ADSs and (ii) surrender of ADSs for cancellation and withdrawal of Deposited Securities will be payable by the person to whom the ADSs so issued are delivered by the Depositary (in the case of ADS issuances) and by the person who delivers the ADSs for cancellation to the Depositary (in the case of ADS cancellations). In the case of ADSs issued by the Depositary into DTC or presented to the Depositary via DTC, the ADS issuance and cancellation fees and charges will be payable by the DTC Participant(s) receiving the ADSs from the Depositary or the DTC Participant(s) surrendering the ADSs to the Depositary for cancellation, as the case may be, on behalf of the Beneficial Owner(s) and will be charged by the DTC Participant(s) to the account(s) of the applicable Beneficial Owner(s) in accordance with the procedures and practices of the DTC Participant(s) as in effect at the time. ADS fees and charges in respect of distributions and the ADS service fee are payable by Holders as of the applicable ADS Record Date established by the Depositary. In the case of distributions of cash, the amount of the applicable ADS fees and charges is deducted from the funds being distributed. In the case of (i) distributions other than cash and (ii) the ADS service fee, the applicable Holders as of the ADS Record Date established by the Depositary will be invoiced for the amount of the ADS fees and charges. For ADSs held through DTC, the ADS fees and charges for distributions other than cash and the ADS service fee are charged to the DTC Participants in accordance with the procedures and practices
prescribed by DTC from time to time and the DTC Participants in turn charge the amount of such ADS fees and charges to the Beneficial Owners for whom they hold ADSs.
The Depositary may reimburse the Company for certain expenses incurred by the Company in respect of the ADR program established pursuant to the Deposit Agreement, by making available a portion of the ADS fees charged in respect of the ADR program or otherwise, upon such terms and conditions as the Company and the Depositary agree from time to time. The Company shall pay to the Depositary such fees and charges, and reimburse the Depositary for such out-of-pocket expenses, as the Depositary and the Company may agree from time to time. Responsibility for payment of such fees, charges and reimbursements may from time to time be changed by agreement between the Company and the Depositary. Unless otherwise agreed, the Depositary shall present its statement for such fees, charges and reimbursements to the Company once every three months. The charges and expenses of the Custodian are for the sole account of the Depositary.
The obligation of Holders and Beneficial Owners to pay ADS fees and charges shall survive the termination of the Deposit Agreement. As to any Depositary, upon the resignation or removal of such Depositary as described in Section 5.4 of the Deposit Agreement, the right to collect ADS fees and charges shall extend for those ADS fees and charges incurred prior to the effectiveness of such resignation or removal.
(12) Title to ADRs . Subject to the limitations contained in the Deposit Agreement and in this ADR, it is a condition of this ADR, and every successive Holder of this ADR by accepting or holding the same consents and agrees, that title to this ADR (and to each Certificated ADS evidenced hereby) shall be transferable upon the same terms as a certificated security under the laws of the State of New York, provided that, in the case of Certificated ADSs, this ADR has been properly endorsed or is accompanied by proper instruments of transfer. Notwithstanding any notice to the contrary, the Depositary and the Company may deem and treat the Holder of this ADR (that is, the person in whose name this ADR is registered on the books of the Depositary) as the absolute owner thereof for all purposes. Neither the Depositary nor the Company shall have any obligation nor be subject to any liability under the Deposit Agreement or this ADR to any holder of this ADR or any Beneficial Owner unless, in the case of a holder of ADSs, such holder is the Holder of this ADR registered on the books of the Depositary or, in the case of a Beneficial Owner, such Beneficial Owner, or the Beneficial Owners representative, is the Holder registered on the books of the Depositary.
(13) Validity of ADR . The Holder(s) of this ADR (and the ADSs represented hereby) shall not be entitled to any benefits under the Deposit Agreement or be valid or enforceable for any purpose against the Depositary or the Company unless this ADR has been (i) dated, (ii) signed by the manual or facsimile signature of a duly-authorized signatory of the Depositary, (iii) countersigned by the manual or facsimile signature of a duly-authorized signatory of the
Registrar, and (iv) registered in the books maintained by the Registrar for the registration of issuances and transfers of ADRs. An ADR bearing the facsimile signature of a duly-authorized signatory of the Depositary or the Registrar, who at the time of signature was a duly-authorized signatory of the Depositary or the Registrar, as the case may be, shall bind the Depositary, notwithstanding the fact that such signatory has ceased to be so authorized prior to the delivery of such ADR by the Depositary.
(14) Available Information; Reports; Inspection of Transfer Books .
The Company is subject to the periodic reporting requirements of the Exchange Act and, accordingly, is required to file or furnish certain reports with the Commission. These reports can be retrieved from the Commissions website (www.sec.gov) and can be inspected and copied at the public reference facilities maintained by the Commission located (as of the date of the Deposit Agreement) at 100 F Street, N.E., Washington D.C. 20549. The Depositary shall make available for inspection by Holders at its Principal Office, as promptly as practicable after receipt thereof, any reports and communications, including any proxy soliciting materials, received from the Company which are both (a) received by the Depositary, the Custodian, or the nominee of either of them as the holder of the Deposited Property and (b) made generally available to the holders of such Deposited Property by the Company. The Depositary shall also provide or make available to Holders copies of such reports when furnished by the Company pursuant to Section 5.6 of the Deposit Agreement.
The Registrar shall keep books for the registration of ADSs which at all reasonable times shall be open for inspection by the Company and by the Holders of such ADSs, provided that such inspection shall not be, to the Registrars knowledge, for the purpose of communicating with Holders of such ADSs in the interest of a business or object other than the business of the Company or other than a matter related to the Deposit Agreement or the ADSs.
The Registrar may close the transfer books with respect to the ADSs, at any time or from time to time, when deemed necessary or advisable by it in good faith in connection with the performance of its duties hereunder, or at the reasonable written request of the Company subject, in all cases, to paragraph (25) and Section 7.8 of the Deposit Agreement.
Dated:
CITIBANK, N.A. |
CITIBANK, N.A. |
|||
Transfer Agent and Registrar |
as Depositary |
|||
|
|
|||
|
|
|||
By: |
|
|
By: |
|
Authorized Signatory |
Authorized Signatory |
The address of the Principal Office of the Depositary is 388 Greenwich Street, New York, New York 10013, U.S.A.
[FORM OF REVERSE OF ADR]
SUMMARY OF CERTAIN ADDITIONAL PROVISIONS
OF THE DEPOSIT AGREEMENT
(15) Dividends and Distributions in Cash, Shares, etc . Whenever the Company intends to make a distribution of a cash dividend or other cash distribution in respect of any Deposited Securities, the Company shall give notice thereof to the Depositary at least twenty (20) days prior to the proposed distribution specifying, inter alia , the record date applicable for determining the holders of Deposited Securities entitled to receive such distribution. Upon the timely receipt of such notice, the Depositary shall establish an ADS Record Date upon the terms described in Section 4.9 of the Deposit Agreement. Upon receipt of confirmation from the Custodian of the receipt of any cash dividend or other cash distribution on any Deposited Securities, or upon receipt of proceeds from the sale of any Deposited Property held in respect of the ADSs under the terms of the Deposit Agreement, the Depositary will (i) if at the time of receipt thereof any amounts received in a Foreign Currency can, in the judgment of the Depositary (pursuant to Section 4.8 of the Deposit Agreement), be converted on a practicable basis into Dollars transferable to the United States, promptly convert or cause to be converted such cash dividend, distribution or proceeds into Dollars (on the terms described in Section 4.8 of the Deposit Agreement), (ii) if applicable and unless previously established, establish the ADS Record Date upon the terms described in Section 4.9 of the Deposit Agreement, and (iii) distribute promptly the amount thus received (net of (a) the applicable fees and charges of, and expenses incurred by, the Depositary and (b) taxes required to be withheld as a result of the distribution) to the Holders entitled thereto as of the ADS Record Date in proportion to the number of ADSs held as of the ADS Record Date. The Depositary shall distribute only such amount, however, as can be distributed without attributing to any Holder a fraction of one cent, and any balance not so distributed shall be held by the Depositary (without liability for interest thereon) and shall be added to and become part of the next sum received by the Depositary for distribution to Holders of ADSs outstanding at the time of the next distribution. If the Company, the Custodian or the Depositary is required to withhold and does withhold from any cash dividend or other cash distribution in respect of any Deposited Securities, or from any cash proceeds from the sales of Deposited Property, an amount on account of taxes, duties or other governmental charges, the amount distributed to Holders on the ADSs shall be reduced accordingly. Such withheld amounts shall be forwarded by the Company, the Custodian or the Depositary to the relevant governmental authority. Evidence of payment thereof by the Company shall be forwarded by the Company to the Depositary upon request. The Depositary will hold any cash amounts it is unable to distribute in a non-interest bearing account for the benefit of the applicable Holders and Beneficial Owners of ADSs until the distribution can be
effected or the funds that the Depositary holds must be escheated as unclaimed property in accordance with the laws of the relevant states of the United States.
Whenever the Company intends to make a distribution that consists of a dividend in, or free distribution of, Shares, the Company shall give notice thereof to the Depositary at least twenty (20) days prior to the proposed distribution, specifying, inter alia , the record date applicable to holders of Deposited Securities entitled to receive such distribution. Upon the timely receipt of such notice from the Company, the Depositary shall establish the ADS Record Date upon the terms described in Section 4.9 of the Deposit Agreement. Upon receipt of confirmation from the Custodian of the receipt of the Shares so distributed by the Company, the Depositary shall either (i) subject to Section 5.9 of the Deposit Agreement, distribute to the Holders as of the ADS Record Date in proportion to the number of ADSs held as of the ADS Record Date, additional ADSs, which represent in the aggregate the number of Shares received as such dividend, or free distribution, subject to the other terms of the Deposit Agreement (including, without limitation, (a) the applicable fees and charges of, and expenses incurred by, the Depositary and (b) applicable taxes), or (ii) if additional ADSs are not so distributed, take all actions necessary so that each ADS issued and outstanding after the ADS Record Date shall, to the extent permissible by law, thenceforth also represent rights and interests in the additional integral number of Shares distributed upon the Deposited Securities represented thereby (net of (a) the applicable fees and charges of, and expenses incurred by, the Depositary and (b) applicable taxes). In lieu of delivering fractional ADSs, the Depositary shall sell the number of Shares or ADSs, as the case may be, represented by the aggregate of such fractions and distribute the net proceeds upon the terms described in Section 4.1 of the Deposit Agreement. In the event that the Depositary determines that any distribution in property (including Shares) is subject to any tax or other governmental charges which the Depositary is obligated to withhold, or if the Company, in the fulfillment of its obligations under Section 5.7 of the Deposit Agreement, has furnished an opinion of U.S. counsel determining that Shares must be registered under the Securities Act or other laws in order to be distributed to Holders (and no such registration statement has been declared effective), the Depositary may dispose of all or a portion of such property (including Shares and rights to subscribe therefor) in such amounts and in such manner, including by public or private sale, as the Depositary deems necessary and practicable, and the Depositary shall distribute the net proceeds of any such sale (after deduction of applicable (a) taxes and (b) fees and charges of, and expenses incurred by, the Depositary) to Holders entitled thereto upon the terms described in Section 4.1 of the Deposit Agreement. The Depositary shall hold and/or distribute any unsold balance of such property in accordance with the provisions of the Deposit Agreement.
Whenever the Company intends to make a distribution payable at the election of the holders of Deposited Securities in cash or in additional Shares, the Company shall give timely notice thereof to the Depositary prior to the proposed distribution specifying, inter alia , the record date applicable to holders of Deposited Securities entitled to receive such elective
distribution and whether or not it wishes such elective distribution to be made available to Holders of ADSs. Upon the timely receipt of a notice indicating that the Company wishes such elective distribution to be made available to Holders of ADSs, the Depositary shall consult with the Company to determine, and the Company shall assist the Depositary in its determination, whether it is lawful and reasonably practicable to make such elective distribution available to the Holders of ADSs. The Depositary shall make such elective distribution available to Holders only if (i) the Company shall have timely requested that the elective distribution be made available to Holders, (ii) the Depositary shall have determined that such distribution is reasonably practicable and (iii) the Depositary shall have received satisfactory documentation within the terms of Section 5.7 of the Deposit Agreement. If the above conditions are not satisfied, the Depositary shall establish an ADS Record Date on the terms described in Section 4.9 of the Deposit Agreement and, to the extent permitted by law, distribute to the Holders, on the basis of the same determination as is made in Germany in respect of the Shares for which no election is made, either (X) cash upon the terms described in Section 4.1 of the Deposit Agreement or (Y) additional ADSs representing such additional Shares upon the terms described in Section 4.2 of the Deposit Agreement. If the above conditions are satisfied, the Depositary shall establish an ADS Record Date on the terms described in Section 4.9 of the Deposit Agreement and establish procedures to enable Holders to elect the receipt of the proposed distribution in cash or in additional ADSs. The Company shall assist the Depositary in establishing such procedures to the extent necessary. If a Holder elects to receive the proposed distribution in cash, then the distribution shall be made upon the terms described in Section 4.1 of the Deposit Agreement. If a Holder elects to receive the proposed distribution in ADSs, then the distribution shall be made upon the terms described in Section 4.2 of the Deposit Agreement. Nothing herein shall obligate the Depositary to make available to Holders a method to receive the elective distribution in Shares (rather than ADSs). There can be no assurance that Holders generally, or any Holder in particular, will be given the opportunity to receive elective distributions on the same terms and conditions as the holders of Shares.
Whenever the Company intends to distribute to the holders of the Deposited Securities rights to subscribe for additional Shares, the Company shall give notice thereof to the Depositary at least sixty (60) days prior to the proposed distribution specifying, inter alia , the record date applicable to holders of Deposited Securities entitled to receive such distribution and whether or not it wishes such rights to be made available to Holders of ADSs. Upon the timely receipt of a notice indicating that the Company wishes such rights to be made available to Holders of ADSs, the Depositary shall consult with the Company to determine, and the Company shall assist the Depositary in its determination, whether it is lawful and reasonably practicable to make such rights available to the Holders. The Depositary shall make such rights available to Holders only if (i) the Company shall have timely requested that such rights be made available to Holders, (ii) the Depositary shall have received satisfactory documentation within the terms of Section 5.7 of the Deposit Agreement, and (iii) the Depositary shall have determined that such distribution of
rights is reasonably practicable. In the event any of the conditions set forth above are not satisfied or if the Company requests that the rights not be made available to Holders of ADSs, the Depositary shall proceed with the sale of the rights as contemplated in Section 4.4(b) of the Deposit Agreement. In the event all conditions set forth above are satisfied, the Depositary shall establish an ADS Record Date (upon the terms described in Section 4.9 of the Deposit Agreement) and establish procedures (x) to distribute rights to purchase additional ADSs (by means of warrants or otherwise), (y) to enable the Holders to exercise such rights (upon payment of the subscription price and of the applicable (a) fees and charges of, and expenses incurred by, the Depositary and (b) taxes), and (z) to deliver ADSs upon the valid exercise of such rights. The Company shall assist the Depositary to the extent necessary in establishing such procedures. Nothing herein shall obligate the Depositary to make available to the Holders a method to exercise rights to subscribe for Shares (rather than ADSs).
If (i) the Company does not timely request the Depositary to make the rights available to Holders or requests that the rights not be made available to Holders, (ii) the Depositary fails to receive satisfactory documentation within the terms of Section 5.7 of the Deposit Agreement or determines it is not reasonably practicable to make the rights available to Holders, or (iii) any rights made available are not exercised and appear to be about to lapse, the Depositary shall determine whether it is lawful and reasonably practicable to sell such rights, in a riskless principal capacity, at such place and upon such terms (including public or private sale) as it may deem practicable. The Company shall assist the Depositary to the extent necessary to determine such legality and practicability. The Depositary shall, upon such sale, convert and distribute proceeds of such sale (net of applicable (a) fees and charges of, and expenses incurred by, the Depositary and (b) taxes) upon the terms set forth in Section 4.1 of the Deposit Agreement.
If the Depositary is unable to make any rights available to Holders upon the terms described in Section 4.4(a) of the Deposit Agreement or to arrange for the sale of the rights upon the terms described in Section 4.4(b) of the Deposit Agreement, the Depositary shall allow such rights to lapse.
The Depositary shall not be responsible for (i) any failure to determine that it may be lawful or practicable to make such rights available to Holders in general or any Holders in particular, (ii) any foreign exchange exposure or loss incurred in connection with such sale or exercise, or (iii) the content of any materials forwarded to the Holders on behalf of the Company in connection with the rights distribution.
Notwithstanding anything to the contrary in Section 4.4 of the Deposit Agreement, if registration (under the Securities Act or any other applicable law) of the rights or the securities to which any rights relate may be required in order for the Company to offer such rights or such securities to Holders and to sell the securities represented by such rights, the Depositary will not distribute such rights to the Holders (i) unless and until a registration statement under the
Securities Act (or other applicable law) covering such offering is in effect or (ii) unless the Company furnishes the Depositary opinion(s) of counsel for the Company in the United States and counsel to the Company in any other applicable country in which rights would be distributed, in each case reasonably satisfactory to the Depositary, to the effect that the offering and sale of such securities to Holders and Beneficial Owners are exempt from, or do not require registration under, the provisions of the Securities Act or any other applicable laws.
In the event that the Company, the Depositary or the Custodian shall be required to withhold and does withhold from any distribution of Deposited Property (including rights) an amount on account of taxes or other governmental charges, the amount distributed to the Holders of ADSs shall be reduced accordingly. In the event that any distribution of Deposited Property (including Shares and rights to subscribe therefor) is subject to any tax or other governmental charges which the Depositary is obligated to withhold, the Depositary may dispose of all or a portion of such Deposited Property (including Shares and rights to subscribe therefor) in such amounts and in such manner, including by public or private sale, as the Depositary deems necessary and practicable to pay any such taxes or charges.
Whenever the Company intends to distribute to the holders of Deposited Securities property other than cash, Shares or rights to purchase additional Shares, the Company shall give timely notice thereof to the Depositary and shall indicate whether or not it wishes such distribution to be made to Holders of ADSs. Upon receipt of a notice indicating that the Company wishes such distribution be made to Holders of ADSs, the Depositary shall consult with the Company, and the Company shall assist the Depositary, to determine whether such distribution to Holders is lawful and reasonably practicable. The Depositary shall not make such distribution unless (i) the Company shall have requested the Depositary to make such distribution to Holders, (ii) the Depositary shall have received satisfactory documentation within the terms of Section 5.7 of the Deposit Agreement, and (iii) the Depositary shall have determined that such distribution is reasonably practicable.
Upon receipt of satisfactory documentation and the request of the Company to distribute property to Holders of ADSs and after making the requisite determinations set forth in (a) above, the Depositary shall distribute the property so received to the Holders of record, as of the ADS Record Date, in proportion to the number of ADSs held by them respectively and in such manner as the Depositary may deem practicable for accomplishing such distribution (i) upon receipt of payment or net of the applicable fees and charges of, and expenses incurred by, the Depositary, and (ii) net of any taxes required to be withheld. The Depositary may dispose of all or a portion of the property so distributed and deposited, in such amounts and in such manner (including public or private sale) as the Depositary may deem practicable or necessary to satisfy any taxes (including applicable interest and penalties) or other governmental charges applicable to the distribution.
If (i) the Company does not request the Depositary to make such distribution to Holders or requests not to make such distribution to Holders, (ii) the Depositary does not receive satisfactory documentation within the terms of Section 5.7 of the Deposit Agreement, or (iii) the Depositary determines that all or a portion of such distribution is not reasonably practicable, the Depositary shall sell or cause such property to be sold in a public or private sale, at such place or places and upon such terms as it may deem practicable and shall (i) cause the proceeds of such sale, if any, to be converted into Dollars and (ii) distribute the proceeds of such conversion received by the Depositary (net of applicable (a) fees and charges of, and expenses incurred by, the Depositary and (b) taxes) to the Holders as of the ADS Record Date upon the terms of Section 4.1 of the Deposit Agreement. If the Depositary is unable to sell such property, the Depositary may dispose of such property for the account of the Holders in any way it deems reasonably practicable under the circumstances.
Holders generally, or any Holder in particular, will not be given the opportunity to receive any rights or distributions pursuant to this ADR or Article IV of the Deposit Agreement on the same terms and conditions as the holders of Shares, or at all, unless the Company explicitly agrees to provide such rights or distributions to such Holder or Holders. Nothing contained in this ADR or the Deposit Agreement shall obligate the Company to file any registration statement in respect of any rights, Shares or other securities distributed pursuant to this ADR or Article IV of the Deposit Agreement or any Shares or other securities to be acquired upon the exercise of rights distributed pursuant to this ADR or Article IV of the Deposit Agreement.
(16) Redemption . Upon timely receipt of notice from the Company that it intends to exercise its right of redemption in respect of any of the Deposited Securities, and satisfactory documentation, and upon determining that such proposed redemption is practicable, the Depositary shall provide to each Holder a notice setting forth the Companys intention to exercise the redemption rights and any other particulars set forth in the Companys notice to the Depositary. The Depositary shall instruct the Custodian to present to the Company the Deposited Securities in respect of which redemption rights are being exercised against payment of the applicable redemption price. Upon receipt of confirmation from the Custodian that the redemption has taken place and that funds representing the redemption price have been received, the Depositary shall convert, transfer, and distribute the proceeds (net of applicable (a) fees and charges of, and the expenses incurred by, the Depositary, and (b) taxes), retire ADSs and cancel ADRs, if applicable, upon delivery of such ADSs by Holders thereof and the terms set forth in Sections 4.1 and 6.2 of the Deposit Agreement. If less than all outstanding Deposited Securities are redeemed, the ADSs to be retired will be accepted on a pro rata basis. The redemption price per ADS shall be the dollar equivalent of the per share amount received by the Depositary (adjusted to reflect the ADS(s)-to-Share(s) ratio) upon the redemption of the Deposited Securities represented by ADSs (subject to the terms of Section 4.8 of the Deposit Agreement
and the applicable fees and charges of, and expenses incurred by, the Depositary, and applicable taxes) multiplied by the number of Deposited Securities represented by each ADS redeemed.
(17) Fixing of ADS Record Date . Whenever the Depositary shall receive notice of the fixing of a record date by the Company for the determination of holders of Deposited Securities entitled to receive any distribution (whether in cash, Shares, rights or other property), or whenever for any reason the Depositary causes a change in the number of Shares that are represented by each ADS, or whenever the Depositary shall receive notice of any meeting of, or solicitation of consents or proxies of, holders of Shares or other Deposited Securities, or whenever the Depositary shall find it necessary or convenient in connection with the giving of any notice, solicitation of any consent or any other matter, the Depositary shall fix a record date (the ADS Record Date ) for the determination of the Holders of ADS(s) who shall be entitled to receive such distribution, to give instructions for the exercise of voting rights at any such meeting, to give or withhold such consent, to receive such notice or solicitation or to otherwise take action, or to exercise the rights of Holders with respect to such changed number of Shares represented by each ADS. The Depositary shall make reasonable efforts to establish the ADS Record Date as closely as possible to the applicable record date for the Deposited Securities (if any) set by the Company in Germany. Subject to applicable law, the terms and conditions of this ADR and Sections 4.1 through 4.8 of the Deposit Agreement, only the Holders of ADSs at the close of business in New York on such ADS Record Date shall be entitled to receive such distribution, to give such voting instructions, to receive such notice or solicitation, or otherwise take action.
(18) Voting of Deposited Securities . As soon as practicable after receipt of notice of any meeting at which the holders of Deposited Securities are entitled to vote, or of solicitation of consents or proxies from holders of Deposited Securities, the Depositary shall fix the ADS Record Date in respect of such meeting or solicitation of consent or proxy in accordance with Section 4.9 of the Deposit Agreement. The Depositary shall, if requested by the Company in writing in a timely manner (the Depositary having no obligation to take any further action if the request shall not have been received by the Depositary at least thirty (30) days prior to the date of such vote or meeting), at the Companys expense and provided no U.S. legal prohibitions exist, distribute as soon as practicable after receipt thereof to Holders as of the ADS Record Date: (a) such notice of meeting or solicitation of consent or proxy, (b) a statement that the Holders at the close of business on the ADS Record Date will be entitled, subject to any applicable law, the provisions of the Deposit Agreement, the Articles of Association of the Company and the provisions of or governing the Deposited Securities (which provisions, if any, shall be summarized in pertinent part by the Company), to instruct the Depositary as to the exercise of the voting rights, if any, pertaining to the Deposited Securities represented by such Holders ADSs and (c) a brief statement as to the manner in which such voting instructions may be given.
Notwithstanding anything contained in the Deposit Agreement or any ADR, with the Companys prior written consent, the Depositary may, to the extent not prohibited by law or regulations, or by the requirements of the stock exchange on which the ADSs are listed, in lieu of distribution of the materials provided to the Depositary in connection with any meeting of, or solicitation of consents or proxies from, holders of Deposited Securities, distribute to the Holders a notice that provides Holders with, or otherwise publicizes to Holders, instructions on how to retrieve such materials or receive such materials upon request ( i.e. , by reference to a website containing the materials for retrieval or a contact for requesting copies of the materials).
Voting instructions may be given only in respect of a number of ADSs representing an integral number of Deposited Securities. Upon the timely receipt of voting instructions from a Holder of ADSs as of the ADS Record Date of voting instructions in the manner specified by the Depositary, the Depositary shall endeavor, insofar as practicable and permitted under applicable law, the provisions of the Deposit Agreement, the Articles of Association of the Company and the provisions of the Deposited Securities, to vote, or cause the Custodian to vote, the Deposited Securities (in person or by proxy) represented by such Holders ADSs in accordance with such voting instructions.
Neither the Depositary nor the Custodian shall under any circumstances exercise any discretion as to voting, and neither the Depositary nor the Custodian shall vote, attempt to exercise the right to vote, or in any way make use of, for purposes of establishing a quorum or otherwise, the Deposited Securities represented by ADSs, except pursuant to and in accordance with the voting instructions timely received from Holders or as otherwise contemplated in the Deposit Agreement or herein. If the Depositary timely receives voting instructions from a Holder which fail to specify the manner in which the Depositary is to vote the Deposited Securities represented by such Holders ADSs, the Depositary will deem such Holder (unless otherwise specified in the notice distributed to Holders) to have instructed the Depositary to vote in favor of the items set forth in such voting instructions. Deposited Securities represented by ADSs for which no timely voting instructions are received by the Depositary from the Holder shall not be voted. Notwithstanding anything else contained herein, the Depositary shall, if so requested in writing by the Company, represent all Deposited Securities (whether or not voting instructions have been received in respect of such Deposited Securities from Holders as of the ADS Record Date) for the sole purpose of establishing quorum at a meeting of shareholders.
Notwithstanding anything else contained in the Deposit Agreement or this ADR, the Depositary shall not have any obligation to take any action with respect to any meeting, or solicitation of consents or proxies, of holders of Deposited Securities if the taking of such action would violate U.S. laws. The Company agrees to take any and all actions reasonably necessary and as permitted by the laws of Germany to enable Holders and Beneficial Owners to indirectly exercise the voting rights accruing to the Deposited Securities through the Depositary and to deliver to the Depositary an opinion of U.S. counsel addressing any actions requested to be taken
if so requested by the Depositary. There can be no assurance that Holders generally or any Holder in particular will receive the notic e described above with sufficient time to enable the Holder to return voting instructions to the Depositary in a timely manner.
(19) Changes Affecting Deposited Securities . Upon any change in nominal or par value, split-up, cancellation, consolidation or any other reclassification of Deposited Securities, or upon any recapitalization, reorganization, merger, consolidation or sale of assets affecting the Company or to which it is a party, any property which shall be received by the Depositary or the Custodian in exchange for, or in conversion of, or replacement of, or otherwise in respect of, such Deposited Securities shall, to the extent permitted by law, be treated as new Deposited Property under the Deposit Agreement, and this ADR shall, subject to the provisions of the Deposit Agreement, this ADR and applicable law, evidence ADSs representing the right to receive such additional or replacement Deposited Property. In giving effect to such change, split-up, cancellation, consolidation or other reclassification of Deposited Securities, recapitalization, reorganization, merger, consolidation or sale of assets, the Depositary may, with the Companys approval, and shall, if the Company shall so request, subject to the terms of the Deposit Agreement and receipt of an opinion of counsel to the Company reasonably satisfactory to the Depositary that such actions are not in violation of any applicable laws or regulations, (i) issue and deliver additional ADSs as in the case of a stock dividend on the Shares, (ii) amend the Deposit Agreement and the applicable ADRs, (iii) amend the applicable Registration Statement(s) on Form F-6 as filed with the Commission in respect of the ADSs, (iv) call for the surrender of outstanding ADRs to be exchanged for new ADRs, and (v) take such other actions as are appropriate to reflect the transaction with respect to the ADSs. The Company agrees to, jointly with the Depositary, amend the Registration Statement on Form F-6 as filed with the Commission to permit the issuance of such new form of ADRs. Notwithstanding the foregoing, in the event that any Deposited Property so received may not be lawfully distributed to some or all Holders, the Depositary may, with the Companys approval, and shall, if the Company requests, subject to receipt of an opinion of Companys counsel reasonably satisfactory to the Depositary that such action is not in violation of any applicable laws or regulations, sell such Deposited Property at public or private sale, at such place or places and upon such terms as it may deem proper and may allocate the net proceeds of such sales (net of (a) fees and charges of, and expenses incurred by, the Depositary and (b) applicable taxes) for the account of the Holders otherwise entitled to such Deposited Property upon an averaged or other practicable basis without regard to any distinctions among such Holders and distribute the net proceeds so allocated to the extent practicable as in the case of a distribution received in cash pursuant to Section 4.1 of the Deposit Agreement. The Depositary shall not be responsible for (i) any failure to determine that it may be lawful or practicable to make such Deposited Property available to Holders in general or to any Holder in particular, (ii) any foreign exchange exposure or loss incurred in connection with such sale, or (iii) any liability to the purchaser of such Deposited Property.
(20) Exoneration . Neither the Depositary nor the Company shall be obligated to do or perform any act which is inconsistent with the provisions of the Deposit Agreement or incur any liability (i) if the Depositary or the Company shall be prevented or forbidden from, or delayed in, doing or performing any act or thing required by the terms of the Deposit Agreement and this ADR, by reason of any provision of any present or future law or regulation of the United States, Germany or any other country, or of any other governmental authority or regulatory authority or stock exchange, or on account of potential criminal or civil penalties or restraint, or by reason of any provision, present or future, of the Articles of Association of the Company or any provision of or governing any Deposited Securities, or by reason of any act of God or war or other circumstances beyond its control (including, without limitation, nationalization, expropriation, currency restrictions, work stoppage, strikes, civil unrest, acts of terrorism, revolutions, rebellions, explosions and computer failure), (ii) by reason of any exercise of, or failure to exercise, any discretion provided for in the Deposit Agreement or in the Articles of Association of the Company or provisions of or governing Deposited Securities, (iii) for any action or inaction in reliance upon the advice of or information from legal counsel, accountants, any person presenting Shares for deposit, any Holder, any Beneficial Owner or authorized representative thereof, or any other person believed by it in good faith to be competent to give such advice or information, (iv) for the inability by a Holder or Beneficial Owner to benefit from any distribution, offering, right or other benefit which is made available to holders of Deposited Securities but is not, under the terms of the Deposit Agreement, made available to Holders of ADSs, or (v) for any consequential or punitive damages for any breach of the terms of the Deposit Agreement. The Depositary, its controlling persons, its agents, any Custodian and the Company, its controlling persons and its agents may rely and shall be protected in acting upon any written notice, request or other document believed by it to be genuine and to have been signed or presented by the proper party or parties. No disclaimer of liability under the Securities Act is intended by any provision of the Deposit Agreement or this ADR.
(21) Standard of Care . The Company, the Depositary and their respective directors, officers, employees and agents assume no obligation and shall not be subject to any liability under the Deposit Agreement or this ADR to any Holder(s) or Beneficial Owner(s), except that the Company and the Depositary agree to perform their respective obligations specifically set forth in the Deposit Agreement or this ADR without negligence or bad faith. Without limitation of the foregoing, neither the Depositary, nor the Company, nor any of their respective controlling persons, directors, officers, employees or agents, shall be under any obligation to appear in, prosecute or defend any action, suit or other proceeding in respect of any Deposited Property or in respect of the ADSs, which in its opinion may involve it in expense or liability, unless indemnity satisfactory to it against all expense (including fees and disbursements of counsel) and liability be furnished as often as may be required (and no Custodian shall be under any obligation whatsoever with respect to such proceedings, the responsibility of the Custodian being solely to the Depositary).
The Depositary and its agents shall not be liable for any failure to carry out any instructions to vote any of the Deposited Securities, or for the manner in which any vote is cast or the effect of any vote, provided that any such action or omission is in good faith and in accordance with the terms of the Deposit Agreement. The Depositary shall not incur any liability for any failure to determine that any distribution or action may be lawful or reasonably practicable, for the content of any information submitted to it by the Company for distribution to the Holders or for any inaccuracy of any translation thereof, for any investment risk associated with acquiring an interest in the Deposited Property, for the validity or worth of the Deposited Property or for any tax consequences that may result from the ownership of ADSs, Shares or other Deposited Property, for the credit-worthiness of any third party, for allowing any rights to lapse upon the terms of the Deposit Agreement, for the failure or timeliness of any notice from the Company, or for any action of or failure to act by, or any information provided or not provided by, DTC or any DTC Participant.
The Depositary shall not be liable for any acts or omissions made by a successor depositary whether in connection with a previous act or omission of the Depositary or in connection with any matter arising wholly after the removal or resignation of the Depositary, provided that in connection with the issue out of which such potential liability arises the Depositary performed its obligations without negligence or bad faith while it acted as Depositary.
(22) Resignation and Removal of the Depositary; Appointment of Successor Depositary . The Depositary may at any time resign as Depositary under the Deposit Agreement by written notice of resignation delivered to the Company, such resignation to be effective on the earlier of (i) the 90th day after delivery thereof to the Company (whereupon the Depositary shall be entitled to take the actions contemplated in Section 6.2 of the Deposit Agreement), or (ii) the appointment by the Company of a successor depositary and its acceptance of such appointment as provided in the Deposit Agreement. The Depositary may at any time be removed by the Company by written notice of such removal, which removal shall be effective on the later of (i) the 90th day after delivery thereof to the Depositary (whereupon the Depositary shall be entitled to take the actions contemplated in Section 6.2 of the Deposit Agreement), or (ii) upon the appointment by the Company of a successor depositary and its acceptance of such appointment as provided in the Deposit Agreement. In case at any time the Depositary acting hereunder shall resign or be removed, the Company shall use reasonable efforts to appoint a successor depositary, which shall be a bank or trust company having an office in the Borough of Manhattan, the City of New York. Every successor depositary shall be required by the Company to execute and deliver to its predecessor and to the Company an instrument in writing accepting its appointment hereunder, and thereupon such successor depositary, without any further act or deed (except as required by applicable law), shall become fully vested with all the rights, powers, duties and obligations of its predecessor (other than as contemplated in Sections 5.8 and 5.9 of the Deposit Agreement). The predecessor depositary, upon payment of all sums due it and on
the written request of the Company, shall (i) execute and deliver an instrument transferring to such successor all rights and powers of such predecessor hereunder (other than as contemplated in Sections 5.8 and 5.9 of the Deposit Agreement), (ii) duly assign, transfer and deliver all of the Depositarys right, title and interest to the Deposited Property to such successor, and (iii) deliver to such successor a list of the Holders of all outstanding ADSs and such other information relating to ADSs and Holders thereof as the successor may reasonably request. Any such successor depositary shall promptly provide notice of its appointment to such Holders. Any entity into or with which the Depositary may be merged or consolidated shall be the successor of the Depositary without the execution or filing of any document or any further act.
(23) Amendment/Supplement . Subject to the terms and conditions of this paragraph 23 and Section 6.1 of the Deposit Agreement and applicable law, this ADR and the provisions of the Deposit Agreement may at any time and from time to time be amended or supplemented by written agreement between the Company and the Depositary in any respect which they may deem necessary or desirable without the prior written consent of the Holders or Beneficial Owners. Any amendment or supplement which shall impose or increase any fees or charges (other than charges in connection with foreign exchange control regulations, and taxes and other governmental charges, delivery and other such expenses), or which shall otherwise materially prejudice any substantial existing right of Holders or Beneficial Owners, shall not, however, become effective as to outstanding ADSs until the expiration of thirty (30) days after notice of such amendment or supplement shall have been given to the Holders of outstanding ADSs. Notice of any amendment to the Deposit Agreement or any ADR shall not need to describe in detail the specific amendments effectuated thereby, and failure to describe the specific amendments in any such notice shall not render such notice invalid, provided , however , that, in each such case, the notice given to the Holders identifies a means for Holders and Beneficial Owners to retrieve or receive the text of such amendment ( i.e. , upon retrieval from the Commissions, the Depositarys or the Companys website or upon request from the Depositary). The parties hereto agree that any amendments or supplements which (i) are reasonably necessary (as agreed by the Company and the Depositary) in order for (a) the ADSs to be registered on Form F-6 under the Securities Act or (b) the ADSs to be settled solely in electronic book-entry form and (ii) do not in either such case impose or increase any fees or charges to be borne by Holders, shall be deemed not to materially prejudice any substantial rights of Holders or Beneficial Owners. Every Holder and Beneficial Owner at the time any amendment or supplement so becomes effective shall be deemed, by continuing to hold such ADSs, to consent and agree to such amendment or supplement and to be bound by the Deposit Agreement and this ADR, as amended or supplemented thereby. In no event shall any amendment or supplement impair the right of the Holder to surrender such ADS and receive therefor the Deposited Securities represented thereby, except in order to comply with mandatory provisions of applicable law. Notwithstanding the foregoing, if any governmental body should adopt new laws, rules or regulations which would require an amendment of, or supplement to, the Deposit
Agreement to ensure compliance therewith, the Company and the Depositary may amend or supplement the Deposit Agreement and this ADR at any time in accordance with such changed laws, rules or regulations. Such amendment or supplement to the Deposit Agreement and this ADR in such circumstances may become effective before a notice of such amendment or supplement is given to Holders or within any other period of time as required for compliance with such laws, rules or regulations.
(24) Termination . The Depositary shall, at any time at the written direction of the Company, terminate the Deposit Agreement by distributing notice of such termination to the Holders of all ADSs then outstanding at least thirty (30) days prior to the date fixed in such notice for such termination. If ninety (90) days shall have expired after (i) the Depositary shall have delivered to the Company a written notice of its election to resign, or (ii) the Company shall have delivered to the Depositary a written notice of the removal of the Depositary, and, in either case, a successor depositary shall not have been appointed and accepted its appointment as provided in Section 5.4 of the Deposit Agreement, the Depositary may terminate the Deposit Agreement by distributing notice of such termination to the Holders of all ADSs then outstanding at least thirty (30) days prior to the date fixed in such notice for such termination. The date so fixed for termination of the Deposit Agreement in any termination notice so distributed by the Depositary to the Holders of ADSs is referred to as the Termination Date . Until the Termination Date, the Depositary shall continue to perform all of its obligations under the Deposit Agreement, and the Holders and Beneficial Owners will be entitled to all of their rights under the Deposit Agreement. If any ADSs shall remain outstanding after the Termination Date, the Registrar and the Depositary shall not, after the Termination Date, have any obligation to perform any further acts under the Deposit Agreement, except that the Depositary shall, subject, in each case, to the terms and conditions of the Deposit Agreement, continue to (i) collect dividends and other distributions pertaining to Deposited Securities, (ii) sell Deposited Property received in respect of Deposited Securities, (iii) deliver Deposited Securities, together with any dividends or other distributions received with respect thereto and the net proceeds of the sale of any other Deposited Property, in exchange for ADSs surrendered to the Depositary (after deducting, or charging, as the case may be, in each case, the fees and charges of, and expenses incurred by, the Depositary, and all applicable taxes or governmental charges for the account of the Holders and Beneficial Owners, in each case upon the terms set forth in Section 5.9 of the Deposit Agreement), and (iv) take such actions as may be required under applicable law in connection with its role as Depositary under the Deposit Agreement. At any time after the Termination Date, the Depositary may sell the Deposited Property then held under the Deposit Agreement and shall after such sale hold un-invested the net proceeds of such sale, together with any other cash then held by it under the Deposit Agreement, in an un-segregated account and without liability for interest, for the pro rata benefit of the Holders whose ADSs have not theretofore been surrendered. After making such sale, the Depositary shall be discharged from all obligations under the Deposit Agreement except (i) to account for such net proceeds and other
cash (after deducting, or charging, as the case may be, in each case, the fees and charges of, and expenses incurred by, the Depositary, and all applicable taxes or governmental charges for the account of the Holders and Beneficial Owners, in each case upon the terms set forth in Section 5.9 of the Deposit Agreement), and (ii) as may be required at law in connection with the termination of the Deposit Agreement. After the Termination Date, the Company shall be discharged from all obligations under the Deposit Agreement, except for its obligations to the Depositary under Sections 5.8, 5.9 and 7.6 of the Deposit Agreement. The obligations under the terms of the Deposit Agreement of Holders and Beneficial Owners of ADSs outstanding as of the Termination Date shall survive the Termination Date and shall be discharged only when the applicable ADSs are presented by their Holders to the Depositary for cancellation under the terms of the Deposit Agreement.
(25) Compliance with U.S. Securities Laws . Notwithstanding any provisions in this ADR or the Deposit Agreement to the contrary, the withdrawal or delivery of Deposited Securities will not be suspended by the Company or the Depositary except as would be permitted by Instruction I.A.(1) of the General Instructions to the Form F-6 Registration Statement, as amended from time to time, under the Securities Act.
(26) Certain Rights of the Depositary; Limitations . Subject to the further terms and provisions of this paragraph (26) and Section 5.10 of the Deposit Agreement, the Depositary, its Affiliates and their agents, on their own behalf, may own and deal in any class of securities of the Company and its Affiliates and in ADSs. In its capacity as Depositary, the Depositary shall not lend Shares or ADSs; provided , however , that the Depositary may (i) issue ADSs prior to the receipt of Shares pursuant to Section 2.3 of the Deposit Agreement and (ii) deliver Shares prior to the receipt of ADSs for withdrawal of Deposited Securities pursuant to Section 2.7 of the Deposit Agreement, including ADSs which were issued under (i) above but for which Shares may not have been received (each such transaction a Pre-Release Transaction ). The Depositary may receive ADSs in lieu of Shares under (i) above and receive Shares in lieu of ADSs under (ii) above. Each such Pre-Release Transaction will be (a) subject to a written agreement whereby the person or entity (the Applicant ) to whom ADSs or Shares are to be delivered (w) represents that at the time of the Pre-Release Transaction the Applicant or its customer owns the Shares or ADSs that are to be delivered by the Applicant under such Pre-Release Transaction, (x) agrees to indicate the Depositary as owner of such Shares or ADSs in its records and to hold such Shares or ADSs in trust for the Depositary until such Shares or ADSs are delivered to the Depositary or the Custodian, (y) unconditionally guarantees to deliver to the Depositary or the Custodian, as applicable, such Shares or ADSs and (z) agrees to any additional restrictions or requirements that the Depositary deems appropriate, (b) at all times fully collateralized with cash, U.S. government securities or such other collateral as the Depositary deems appropriate, (c) terminable by the Depositary on not more than five (5) business days notice and (d) subject to such further indemnities and credit regulations as the Depositary deems appropriate. The Depositary will normally limit the number of ADSs and Shares involved in
such Pre-Release Transactions at any one time to thirty percent (30%) of the ADSs outstanding (without giving effect to ADSs outstanding under (i) above), provided , however , that the Depositary reserves the right to change or disregard such limit from time to time as it deems appropriate. The Depositary may also set limits with respect to the number of ADSs and Shares involved in Pre-Release Transactions with any one person on a case-by-case basis as it deems appropriate. The Depositary may retain for its own account any compensation received by it in conjunction with the foregoing. Collateral provided pursuant to (b) above, but not the earnings thereon, shall be held for the benefit of the Holders (other than the Applicant).
(ASSIGNMENT AND TRANSFER SIGNATURE LINES)
FOR VALUE RECEIVED, the undersigned Holder hereby sell(s), assign(s) and transfer(s) unto whose taxpayer identification number is and whose address including postal zip code is , the within ADR and all rights thereunder, hereby irrevocably constituting and appointing attorney-in-fact to transfer said ADR on the books of the Depositary with full power of substitution in the premises.
Dated: |
Name: |
|
|
|
By: |
|
|
Title: |
|
NOTICE: The signature of the Holder to this assignment must correspond with the name as written upon the face of the within instrument in every particular, without alteration or enlargement or any change whatsoever. |
|
|
|
|
|
If the endorsement be executed by an attorney, executor, administrator, trustee or guardian, the person executing the endorsement must give his/her full title in such capacity and proper evidence of authority to act in such capacity, if not on file with the Depositary, must be forwarded with this ADR. |
|
|
|
|
SIGNATURE GUARANTEED |
|
|
|
|
|
|
All endorsements or assignments of ADRs must be guaranteed by a member of a Medallion Signature Program approved by the Securities Transfer Association, Inc. |
|
EXHIBIT B
FEE SCHEDULE
DEPOSITARY FEES AND RELATED CHARGES
All capitalized terms used but not otherwise defined herein shall have the meaning given to such terms in the Deposit Agreement.
I. ADS Fees
The following ADS fees are payable under the terms of the Deposit Agreement:
Service |
|
Rate |
|
By Whom Paid |
(1) Issuance of ADSs upon deposit of Shares (excluding issuances as a result of distributions described in paragraph (4) below). |
|
Up to U.S. $5.00 per 100 ADSs (or fraction thereof) issued. |
|
Person depositing Shares or person receiving ADSs. |
(2) Delivery of Deposited Securities against surrender of ADSs. |
|
Up to U.S. $5.00 per 100 ADSs (or fraction thereof) surrendered. |
|
Person surrendering ADSs for the purpose of withdrawal of Deposited Securities or person to whom Deposited Securities are delivered. |
(3) Distribution of cash dividends or other cash distributions ( i.e. , sale of rights and other entitlements). |
|
Up to U.S. $5.00 per 100 ADSs (or fraction thereof) held. |
|
Person to whom distribution is made. |
(4) Distribution of ADSs pursuant to (i) stock dividends or other free stock distributions, or (ii) exercise of rights to purchase additional ADSs. |
|
Up to U.S. $5.00 per 100 ADSs (or fraction thereof) held. |
|
Person to whom distribution is made. |
(5) Distribution of securities other than ADSs or rights to purchase additional ADSs ( i.e. , spin-off shares). |
|
Up to U.S. $5.00 per 100 ADSs (or fraction thereof) held. |
|
Person to whom distribution is made. |
6) ADS Services. |
|
Up to U.S. $5.00 per 100 ADSs (or fraction thereof) held on the applicable record date(s) established by the Depositary. |
|
Person holding ADSs on the applicable record date(s) established by the Depositary. |
II. Charges
The Company, Holders, Beneficial Owners, persons depositing Shares and persons surrendering ADSs for cancellation and for the purpose of withdrawing Deposited Securities shall be responsible for the following ADS charges under the terms of the Deposit Agreement:
(i) taxes (including applicable interest and penalties) and other governmental charges;
(ii) such registration fees as may from time to time be in effect for the registration of Shares or other Deposited Securities on the share register and applicable to transfers of Shares or other Deposited Securities to or from the name of the Custodian, the Depositary or any nominees upon the making of deposits and withdrawals, respectively;
(iii) such cable, telex and facsimile transmission and delivery expenses as are expressly provided in the Deposit Agreement to be at the expense of the person depositing Shares or withdrawing Deposited Securities or of the Holders and Beneficial Owners of ADSs;
(iv) the expenses and charges incurred by the Depositary in the conversion of foreign currency;
(v) such fees and expenses as are incurred by the Depositary in connection with compliance with exchange control regulations and other regulatory requirements applicable to Shares, Deposited Securities, ADSs and ADRs; and
(vi) the fees and expenses incurred by the Depositary, the Custodian, or any nominee in connection with the servicing or delivery of Deposited Property.
Exhibit 10.3
PATENT CROSS-LICENSING AGREEMENT
between
BEGO Medical GmbH
Technologiepark Universität,
Wilhelm-Herbst-Straße 1, 28359 Bremen,
- hereinafter referred to as BEGO -
and
VOXELJET technology GmbH
Paul-Lenz-Strasse 1, 86316 Friedberg
- hereinafter referred to as VOXELJET -
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
PREAMBLE
Whereas BEGO is a manufacturer of customised and industrially made Prosthetic Dentistry centrally in Bremen and distributes it to dental engineering labs. Whereas BEGO is applying a globally unique rapid prototyping method for making Prosthetic Dentistry from biocompatible metallic alloys. Whereas BEGO MEDICAL is an affiliate company of BEGO DENTAL which for 120 years has successfully been making dental engineering products in Bremen and distributing them throughout the world.
Whereas VOXELJET is active in the field of development, manufacturing and distribution of industrial 3D Printers for tool-less and fully automated manufacturing of components made of plastic and moulding sand. Whereas VOXELJET furthermore operates a service centre with such 3D Printers for on-demand manufacturing of moulding sand for metal cast as well as plastic moulding and functional models made of plastic.
Whereas VOXELJET is interested in obtaining from BEGO a licence with respect to certain industrial property rights defined in more detail below.
Whereas BEGO in turn is interested in obtaining from VOXELJET a licence with respect to certain property rights also defined in more detail below.
Whereas BEGO furthermore is interested in exploiting its patents as well as licenced VOXELJET patent rights by awarding licences to Third Parties (Licensing Scheme).
Whereas VOXELJET is interested in this Licensing Scheme not limiting and restricting marketing of VOXELJET products and services as well as its customer relationships and unless the Licensing Scheme would conflict with the interests of VOXELJET, in particular by immediate competitors of VOXELJET being given an opportunity of circumvention.
Whereas it is explicitly understood by the Parties that this licensing agreement shall neither directly nor indirectly constitute an implicit licence with respect to property rights of the Parties other than those explicitly mentioned thereon granted to the respective contracting Party or Third Parties. Now, therefore, BEGO and VOXELJET herewith enter into the following Patent Licensing Agreement.
Section 1 DEFINED TERMS
For the purposes of this Agreement, the following terms shall be defined as follows:
1.1 Field of Application means
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
· relative to VOXELJET the development, manufacturing, marketing, sale and other type of use of the Contractual Products and the Contractual Processes for the operation of the Contractual Products according to the principle of 3D Printing, however, not for use and/or distribution to customers in the field of Dental Applications (VOXELJET Field of Application) as well as
· relative to BEGO the development, manufacturing, sale and other use of the Contractual Products and Contractual Processes for additive manufacturing in the field of Dental Applications and for additive manufacturing with the exception of additive manufacturing under the 3D Printing principle for any other applications (BEGO Field of Application).
1.2 Dental Application is defined as manufacturing of Prosthetic Dentistry, Dental Auxiliary Parts or Dental Casts as well as Drill Jigs.
1.3 Prosthetic Dentistry: restoring of closed row of teeth and thus restoring of chewing ability to original state by inserting artificial dental crowns (crown prosthetic dentistry), bridge prosthetic dentistry or a dental prosthesis. The term of Fixed Prosthetic Dentistry comprises crown prosthetic dentistry and bridge prosthetic dentistry made of metal or ceramics which by means of dental cement is cemented on the ground tooth stumps or on dental implants. This includes but is not limited to the following: crown prosthetic dentistry, bridge prosthetic dentistry, post crowns, veneer crowns and abutments. A Prosthesis ranges from (i) a model cast denture with a cast retaining and support element to (ii) a comfortable version like a telescopic denture seated on crowned teeth.
1.4 Dental Auxiliary Parts are required for tooth preservation in restorative dentistry. This includes but is not limited to fillings and cast fillings including inlays and various other versions like on-lays and over-lays.
1.5 Dental Casts are casts of the jaw and/or the teeth and reflect the shape and arrangement of the teeth in the patients mouth without three-dimensional variance. Dental Casts serve as a planning aid for dentists and as a basis of the dental engineers work. Dental Casts are defined in particular as but are not limited to diagnostic casts, original dies, functional models, repair models, counterbite models, master dies, saw-cut models or die models.
1.6 Drill Jigs are positioning aids for implants and are used by the dentist for the purpose of navigated implantation of dental implants. The jigs are designed on the basis of (3D) X-ray data and grafted on the existing bone, mucous membrane or residual tooth. With the help of the guides integrated in the Drill Jig, the drill and implant are guided to the pre-defined position.
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
1.7 The term Third Party comprises every individual or legal entity with the exception of the party concerned and its Affiliated Companies.
1.8 The Effective Date of this Agreement is the date on which this Agreement has been signed by the duly authorised representatives of both Parties. If the Agreement has not been signed by both Parties on the same day, the Effective Date is the later of the two dates of execution.
1.9 Licenced BEGO Patent Rights are patents, utility models as well as applications for them, issuing thereof, their substitutes, renewal, confirmation and reissue as well as the patents applied for or issued internationally based on the priority of these patent or utility model applications listed in Annex 1 as well as divisional applications based thereon or derivations from them.
1.10 Licenced VOXELJET Patent Rights are patents, utility models as well as applications for them, issuing thereof, their substitutes, renewal, confirmation and reissue as well as the patents applied for or issued internationally based on the priority of these patent or utility model applications listed in Annex 2 as well as divisional applications based thereon or derivations from them.
1.11 Net Selling Price is the amount that a Third Party is invoiced for the acquisition of a Contractual Product or the amount that is invoiced by an Affiliated Company, sub-licensee or distributor.
Use for own purposes or Acquisition by an Affiliated Company must be based on an amount that has been defined at arms length.
For the purposes of paragraph 4.3, paragraph 1.9 shall apply mutatis mutandis relative to Consumables.
The term Acquisition shall also include renting in terms of precarium for a limited time which directly or indirectly serves the purpose of acquisition.
The following items shall be deducted from the amount thus determined to the extent such discount is actually granted or separately allocated to the Contractual Product by the seller in application of generally accepted accounting standards; for an exemplary calculation see Annex 3.
(i) Value-added tax and excise duty paid by the seller, customs and other public charges that are levied on the manufacturing, import, usage or sale of the Contractual Products;
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
(ii) customary quantity and cash discounts, customary commissions and dealer compensation or discount granted for buying the Contractual Product;
(iii) credit notes issued to customers for Contractual Products returned or for price reductions with subsequent effect concerning the Contractual Products;
(iv) costs of transportation, transport insurance and packaging if they are an integral part of the purchasing price of a Contractual Product invoiced to the Third Party on condition that the discount does not exceed the difference between the purchasing price invoiced to the Third Party and the average purchasing price that Third Parties pay excluding transport, insurance and packaging costs in the respective country.
1.12 Consumables are all materials that are processed or finished in application of the Contractual Processes.
1.13 Party/Parties, depending on the respective context, are either BEGO or VOXELJET or BEGO and VOXELJET together.
1.14 Patent claim is defined as any claim from an issued and not yet expired licenced patent right or utility model which has not been revoked, withdrawn or declared nil and void in part or as a whole by a court or an authority entitled to do so by way of a decision against which no legal redress i.e. appeal has been lodged or may be lodged and concerning which no waiver was declared.
1.15 Improvement Inventions is defined as any inventions, adaptations and amendments of the licenced patent rights that relate to the Contractual Products which
(i) improve the effect or effectiveness of the Contractual Products;
(ii) minimise side effects or any other negative consequential effects of the Contractual Products; or
(iii) reduce costs and/or enhance efficiency or improve manufacturing in manufacturing and the manufacturing process of the Contractual Products.
1.16 Affiliated Companies with respect to each and every contractual party are defined as any person, company, corporation and any other association
(i) in which one of the Parties directly or indirectly holds at least fifty per cent (50%) of the voting shares,
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
(ii) which directly or indirectly holds at least fifty per cent (50%) of the voting shares in one of the Parties,
(iii) if at least fifty per cent (50%) of the voting stock is held directly or indirectly by a person, company, corporation or any other association which in turn directly or indirectly holds at least fifty per cent (50%) of the voting stock of a Party.
For the purposes of paragraph 1.13, relative to BEGO, the controlling shareholders shall be the contracting party.
1.17 Agreement is defined as this Patent Licensing Agreement as well as any annexes thereto.
1.18 Territory is defined as any countries in which BEGO is allowed to use the Licenced VOXELJET Patent Rights and/or VOXELJET is allowed to use the Licenced BEGO Patent Rights. These are the countries in which the Licenced BEGO Patent Rights and the Licenced VOXELJET Patent Rights exist.
1.19 Production Site is defined as the place where the respective Party is allowed to manufacture the Contractual Products, namely
· relative to VOXELJET 86316 Friedberg; and
· relative to BEGO 28359 Bremen
as well as any future production sites located within the Territory. Changes in the Production Site to outside the Territory shall be subject to the respective other Partys consent.
1.20 Contractual Products are the products for which BEGO is allowed to use the Licenced VOXELJET Patent Rights or for which VOXELJET is allowed to use the Licenced BEGO Patent Rights in equivalent form and/or in an indirect way, namely every machine or part of a machine, in particular but not limited to the VOXELJET VX Concept plant.
1.21 Contractual Process means the application of the processes that form the subject-matter of the Licenced BEGO Patent Rights and the Licenced VOXELJET Patent Rights respectively.
1.22 Confidential Information is defined as know-how, all the data and information of the Parties including development data that is not in the public domain and relates to the Contractual Products, the Field of Application, the company, the research and development activities and results, the financial situation, contractual relationships or the
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
business of the Parties. The term Confidential Information also includes the existence as well as the terms and conditions of this Agreement.
1.23 3D Printing describes an additive manufacturing process in the context of which first in a process room a particle material is applied as a thin, homogeneous layer and a bonding material is subsequently selectively released to pre-defined areas of the homogeneous layer in the process room by means of a printer head which areas conform to the cross-section of a product in the respective layer for the purpose of solidifying these pre-defined areas of the layer. A description of this process, for instance, is included in the German patent application DE 10 2010 015 451 Al.
Section 2 Licence
2.1 BEGO herewith grants VOXELJET the exclusive right to use the Licenced BEGO Patent Rights for the development, manufacturing at the Production Site, marketing, sale and other type of usage of Contractual Products in application of the Contractual Processes in the VOXELJET Field of Application and in the Territory subject to the provisions and limitations of this Agreement.
2.2 VOXELJET herewith grants BEGO the exclusive right to use the Licenced VOXELJET Patent Rights for the development, manufacturing at the Production Site, marketing, sale and other type of usage of Contractual Products in application of the Contractual Processes in the BEGO Field of Application and in the Territory subject to the provisions and limitations of this Agreement.
2.3 An exclusive right within the meaning of paragraphs 2.1 and 2.2 is defined as a Party and its Affiliated Companies reserving the right to use own patent rights themselves in their own field of application for the purposes of development, manufacturing, marketing, sale and any other type of use of Contractual Products. Otherwise the Parties shall not use or sub-licence their respective patent rights outside the fields of application allocated to them.
2.4 VOXELJET has the right to grant sub-licences to an Affiliated Company all the Licenced BEGO Patent Rights under this Agreement in line with paragraph 2.1 and with respect to manufacturing, usage, marketing and sale of the Contractual Products in application of the Contractual Processes to grant sub-licences to any Third Party.
2.5 BEGO has the right to grant sub-licences to an Affiliated Company all the Licenced VOXELJET Patent Rights under this Agreement in line with paragraph 2.2 and with respect to manufacturing, usage, marketing and sale of the Contractual Products in
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
application of the Contractual Processes to grant sub-licences all the Licenced VOXELJET Patent Rights to any Third Party.
Section 3 Rights With Respect to Improvements
3.1 BEGO is the owner of any Improvement Inventions developed by it and VOXELJET shall not obtain any rights and licences with respect to the Improvement Inventions except the powers listed in the following.
3.2 Should BEGO, its Affiliated Companies or sub-licensees during the term of this Agreement make Improvement Inventions relating to the usage of the Contractual Products in the Field of Application, BEGO agrees to notify VOXELJET of the Improvement Inventions in due time in writing and place at VOXELJETs disposal a data package that in BEGOs opinion comprises all the information, know-how and other data that is required by VOXELJET for being able to use the Improvement Inventions for development, manufacturing, marketing, sale and/or any other use of products without prejudice to BEGOs licences under this Agreement. BEGO herewith grants VOXELJET a non-exclusive, perpetual, gratuitous licence to use the Improvement Inventions and any information, know-how and other data that relate to the Improvement Inventions and that were placed at VOXELJETs disposal by BEGO and grant sub-licences thereto in line with paragraph 2.4. This shall be without prejudice to BEGOs undertaking in the event of awarding licences in the VOXELJET Field of Application in or the disposal of Improvement Inventions to Third Parties prior to conclusion of contract with the Third Party to notify VOXELJET in writing of the conditions for the respective legal transaction as well as to submit to VOXELJET an offer to enter into a licensing and purchasing agreement with VOXELJET subject to the same conditions. BEGO agrees to allow VOXELJET a period of six weeks to accept this offer; the offer must be accepted in writing (Pre-emptive Right).
3.3 VOXELJET is the owner of any Improvement Inventions developed by it and BEGO shall not obtain any rights and licences with respect to the Improvement Inventions except the powers listed in the following.
3.4 Should VOXELJET, its Affiliated Companies or sub-licensees during the term of this Agreement make Improvement Inventions relating to the usage of the Contractual Products in the Field of Application, VOXELJET agrees to notify BEGO of the Improvement Inventions in due time in writing and place at BEGOs disposal a data package that in VOXELJETs opinion comprises all the information, know-how and other data that is required by BEGO for being able to use the Improvement Inventions for development, manufacturing, marketing, sale and/or any other use of products without prejudice to VOXELJETs licences under this Agreement. VOXELJET herewith grants
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
BEGO a non-exclusive, perpetual, gratuitous licence to use the Improvement Inventions and any information, know-how and other data that relate to the Improvement Inventions and that were placed at BEGOs disposal by VOXELJET and grant sub-licences thereto in line with paragraph 2.5. This shall be without prejudice to VOXELJETs undertaking in the event of awarding licences in the BEGO Field of Application in or the disposal of Improvement Inventions to Third Parties prior to conclusion of contract with the Third Party to notify BEGO in writing of the conditions for the respective legal transaction as well as to submit to BEGO an offer to enter into a licensing and purchasing agreement with BEGO subject to the same conditions. VOXELJET agrees to allow BEGO a period of six weeks to accept this offer; the offer must be accepted in writing (Pre-emptive Right).
Section 4 Remuneration
4.1 In consideration of granting of the Licenced BEGO Patent Rights under this Agreement, VOXELJET shall pay to BEGO within thirty (30) days of conclusion of contract a non-redeemable and non-offsettable advance payment totalling [***].
4.2 Without prejudice to paragraph 4.3, VOXELJET shall furthermore pay a turnover-related licence fee totalling [***] of the Net Selling Price of the Contractual Products to the extent a licenced BEGO patent right is being used in consideration of granting of the Licenced BEGO Patent Rights under this Agreement.
4.3 VOXELJET shall furthermore pay to BEGO a licence fee that is calculated depending on the quantity of Consumables used totalling [***] of the Net Selling Price of Consumables in consideration of the products manufactured in application of the Contractual Processes, to the extent a licenced BEGO patent right is being used. The licence fee according to paragraph 4.3 shall be incurred if and to the extent VOXELJET or a company affiliated with VOXELJET supplies a Third Party who uses a Contractual Product in application of Contractual Processes with Consumables. After payment of the licence fee according to paragraphs 4.2 and 4.3, Third Parties and thus VOXELJET shall not incur any additional licence fee payments with respect to the Contractual Processes that are performed on such a Contractual Product by a Third Party; this means that BEGO to this extent waives its right to assert the Licenced BEGO Patent Rights against Third Parties who acquired Contractual Products from VOXELJET and are using Contractual Processes.
4.4 No fees according to paragraphs 4.2 and 4.3 shall be incurred for Contractual Products that are manufactured for BEGO or companies affiliated with BEGO.
4.5 In the event of sub-licences, this does explicitly not include user licences to Third Parties for the use of the Contractual Products and Contractual Processes according to paragraph
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
4.3 that are performed on these Contractual Products by these Third Parties, VOXELJET shall pay to BEGO a share of [***] of any licence fees that VOXELJET receives for granting the sub-licence, however only to the extent that the VOXELJET patent rights have not been issued with final and absolute effect or have been revoked or eliminated.
Section 5 Payment Terms
5.1 Licence fees shall be paid to the accounts to be indicated by the Parties in euros plus the statutory rate of value-added tax, as amended, incurred on it.
5.2 As per the 31st day of the month of December in each calendar year, VOXELJET shall draw up a statement of accounts for the previous calendar year. The first statement of account will comprise all the relevant cases from 1 January 2012 onwards. The invoice shall be sent within four weeks of expiry of the calendar year concerned.
5.3 VOXELJET shall keep books and draw up statements of account for any data that is required for correct and complete accounts. Once every year during VOXELJETs normal business hours BEGO has the right upon reasonable prior announcement to have VOXELJETs accounts with respect to the previous calendar year inspected by an independent auditor who is under a professional secrecy obligation. VOXELJET agrees to assume the costs of the auditor should the difference between the statements of account and the auditors findings amount to five per cent (5%) or more to BEGOs detriment. Differential amounts shall be payable and due immediately.
5.4 The licence fees shall be payable by VOXELJET within thirty days of the date of invoice. Reciprocal payments shall be offset against each other. Payment shall be made to the account indicated on the invoice.
5.5 After occurrence of the maturity, every amount shall incur five (5) percentage points interest on top of the applicable base rate.
Section 6 Obtaining and Maintaining the Licenced Patent Rights
6.1 The Parties have the obligation to pursue the process of issuance for the application for the respective Licenced VOXELJET Patent Rights and/or the Licenced BEGO Patent Rights without time delay and in a proper way and to maintain the Licenced VOXELJET Patent Rights and/or the Licenced BEGO Patent Rights during the term of this Agreement. The Parties agree to take any action that is deemed to be economically reasonable and necessary for issuing or maintaining the Licenced VOXELJET Patent Rights and Licenced BEGO Patent Rights respectively.
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
6.2 Should VOXELJET decide to discontinue the issuing process or prematurely drop or sell a licenced VOXELJET patent already issued, VOXELJET has the duty to notify BEGO in writing of its corresponding intention at least thirty (30) days prior to expiry of the pertinent periods like disclosure periods or time allowed to pay maintenance fees and to submit to BEGO a written offer to take on the licenced VOXELJET patent right concerned free of charge. Should BEGO accept the offer to take on the licenced VOXELJET patent right within thirty (30) days of receipt of this offer, VOXELJET agrees to take any action that is necessary for the transfer of the licenced VOXELJET patent in the patent register. The licence fees relating to the licenced VOXELJET patent taken on by BEGO shall remain unchanged as a result of take-over which means that BEGO shall not increase the licence fees even if the licenced VOXELJET patent was included in the calculation of the licence fee. Should BEGO allow the period of thirty (30) days to pass without accepting the offer to take on the patent, VOXELJET may at its discretion drop the licenced VOXELJET patent concerned. In this case VOXELJET shall not have any claims for damages against BEGO. At VOXELJETs request BEGO shall grant VOXELJET a non-exclusive gratuitous right to use the licenced VOXELJET patent taken on.
6.3 Should BEGO decide to discontinue the issuing process or prematurely drop or sell a licenced BEGO patent already issued, BEGO has the duty to notify VOXELJET in writing of its corresponding intention at least thirty (30) days prior to expiry of the pertinent periods like disclosure periods or time allowed to pay maintenance fees and to submit to VOXELJET a written offer to take on the licenced BEGO patent right concerned free of charge. Should VOXELJET accept the offer to take on the licenced BEGO patent right within thirty (30) days of receipt of this offer, BEGO agrees to take any action that is necessary for the transfer of the licenced BEGO patent in the patent register. The licence fees relating to the licenced BEGO patent taken on by VOXELJET shall remain unchanged as a result of take-over which means that VOXELJET shall not increase the licence fees even if the licenced BEGO patent was included in the calculation of the licence fee. Should VOXELJET allow the period of thirty (30) days to pass without accepting the offer to take on the patent, BEGO may at its discretion drop the licenced BEGO patent concerned. In this case BEGO shall not have any claims for damages against VOXELJET. VOXELJET shall at BEGOs request grant BEGO a non-exclusive gratuitous right to use the licenced BEGO patent taken on.
6.4 Every Party has the right to apply for registration of the licence to the licenced patent that was granted in the German patent register or its equivalent abroad at its own expense. The other Party agrees to support the registration and at request shall take any action that may be required to achieve it.
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Section 7 Defending the Licenced Rights Against Infringement by Third Parties
7.1 The Parties agree to reciprocally notify each other in writing of any infringement of licenced rights of the respective other Party that they may become aware of during the term of this Agreement.
7.2 The Parties may at their discretion enforce claims for infringement by Third Parties. Should either of the Parties decide to enforce infringement claims, the other Party agrees to make the corresponding declarations to enable such enforcement. A German and English version of the corresponding licence acknowledgement and assignment declaration was annexed to this Agreement as Annex 4.
Section 8 Warranties
8.1 The Parties reciprocally represent and warrant as follows
(i) I am the owner or authorised licensor of the licenced patents concerned.
(ii) I have the right to enter into this Agreement and to grant the licences therein granted.
(iii) I am not aware of the existence of any circumstances which could render the licenced rights concerned invalid or according to which use of such licenced rights could infringe upon Third Party patent rights.
8.2 The Parties do not assume a warranty as to the technical feasibility, technical suitability, commercial marketability, the fitness for production, profitability of production and/or the competitiveness of the licenced rights concerned. The Parties in particular shall not assume neither an express nor an implied warranty or representation as to the success of development and marketing of the Contractual Products. Moreover, the Parties shall not warrant to each other that a patent may be obtained for the licenced rights concerned.
8.3 Warranty claims, if any, shall become statute-barred within one (1) year of the statutory commencement date of the limitation period.
Section 9 Confidentiality
9.1 Any Confidential Information that a Party (Notifying Party) notifies the other Party of (Receiving Party) or discloses to it in any other way on the basis of or in connection with this Agreement may only be used by the Receiving Party for the purposes of this Agreement. The Receiving Party shall not use the Confidential Information received from the Notifying Party for any purposes other than those relating to the Agreement and may
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
not forward the Confidential Information to Third Parties or make it available to them in any other way without the Notifying Partys consent.
9.2 The Receiving Party further undertakes to take any reasonable steps and take any precautions that may be necessary for preventing unauthorised use or disclosure of the Confidential Information received from the notifying party. The Receiving Party shall exclusively make the Confidential Information available to its staff, vicarious agents ( Erfüllungsgehilfen ), consultants, licensees, future licensees and financial investors who need to have knowledge of the Confidential Information received from the Notifying Party so as to enable the Receiving Party to comply with its rights and obligations under this Agreement and it shall only disclose them if and to the extent the staff, vicarious agents, consultants, licensees, future licensees and financial investors concerned have assumed vis-à-vis the Receiving Party an adequate confidentiality undertaking which corresponds to and comprises comparable terms and conditions to this Agreement that prohibit unauthorised use and disclosure of the Confidential Information received from the Notifying Party. The Receiving Party agrees to promptly notify the Notifying Party in writing if and once it has become aware of unauthorised use or disclosure of the Confidential Information received from the Notifying Party and it shall at the Notifying Partys request take any appropriate action that is required for preventing further unauthorised use or disclosure of the Confidential Information received from the Notifying Party.
9.3 The aforementioned obligations of the Receiving Party under paragraphs 9.1 and 9.2 above shall not apply with respect to information with respect to which the Receiving Party may prove by presenting written documents that such information:
(i) at the time of notification by the Notifying Party had already been in the public domain or had subsequently become public knowledge without the Receiving Partys fault;
(ii) at the time of notification by the Notifying Party had already been in the Receiving Partys possession;
(iii) had been made available to the Receiving Party by a Third Party without a confidentiality obligation and duty to refrain from using it being imposed;
(iv) based on a statutory provision or court order needs to be disclosed to public authorities; the Receiving Party, however, shall have the obligation to notify the Notifying Party thereof in due time in writing so as to give the Notifying Party an opportunity to initiate reasonable steps at its discretion so as to prevent the Confidential Information received from becoming generally available; or
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
(v) have been developed by the Receiving Party independently from and without breaching this Agreement.
9.4 After termination of this Agreement for whatever reason the Receiving Party agrees to return to the Notifying Party any copies of documents and any other material that comprises the Confidential Information received from the Notifying Party or destroy it after having been requested by the Notifying Party to do so. This only excludes copies the Receiving Party is required to keep by law or has the right to keep on the basis of this Agreement. Within thirty (30) days of termination of this Agreement, the Receiving Party shall send to the Notifying Party a written confirmation as to compliance with this paragraph 9.4.
9.5 All the obligations of the Receiving Party under paragraphs 9.1 and 9.2 with respect to the protection of Confidential Information received from the Notifying Party shall also survive termination of this Agreement, whatever the reason for termination.
Section 10 Term and Termination
10.1 This Agreement shall come into force upon the Effective Date and the term of the Agreement shall go on for as long as a Contractual Product is still governed by a licenced VOXELJET patent right or licenced BEGO patent right in any country within the Territory. Any Contractual Products manufactured and supplied by the Parties and paid for by the customer prior to the commencement date of the Agreement that are governed by a licenced patent claim shall be deemed to have been settled and shall not trigger payment of a licence fee according to paragraphs 4 and 5.
10.2 Should one of the Parties (Party In Breach) breach a contractual duty which is of the essence of the Agreement or be in delay with performance of one of its obligations under this Agreement, the other Party (Party Not In Breach) shall notify the Party In Breach in writing of the breach of contract and/or the delay in the performance of an obligation and request that the breach of contract and/or delay in performance of an obligation be cured without undue delay. Should the Party In Breach fail to cure the breach of contract or delay in the performance of an obligation within thirty (30) days of receipt of the written notice from the Party Not In Breach, the Party Not In Breach has the right to give to the Party In Breach written notice of termination of this Agreement as a whole or for individual countries located within the Territory or for individual fields of application. Termination of this Agreement shall not affect the right of the Party Not In Breach to assert against the Party In Breach damages as well as any other claims that may be incurred by the Party Not In Breach due to the breach of contract or delay in the performance of the obligation and the resulting premature termination of the Agreement.
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
A breach of a provision which is of the essence of the Agreement which shall give the respective other Party the right to terminate this Agreement for cause shall exist in particular in the following circumstances:
(i) delay with drawing up a statement of account for and/or payment of licence fees,
(ii) a Party challenging the other Partys property rights.
10.3 Furthermore and in supplement to the extraordinary right of termination, every Party has the right to terminate this Agreement for cause i.e. with immediate effect by sending the respective other Party a written termination notice should the assets of the other Party be subjected to bankruptcy or insolvency proceedings.
Section 11 Legal Consequences of Termination of Agreement
11.1 In the event of termination of this Agreement the licence to the contractual patents entered into under this Agreement shall expire.
11.2 Unless otherwise agreed upon, the Party concerned agrees in the event of termination of this Agreement, for whatever reason, to discontinue without undue delay further manufacturing, production, distribution, marketing and disposal of Contractual Products on the basis of this Agreement. Should the licensing agreement be terminated for reasons which are not attributable to the other Party, the Party concerned shall continue to have the right to deplete and sell off its stocks of Contractual Products within a period of no more than one hundred and twenty (120) days following termination of this Agreement without prejudice to the obligation to pay to BEGO turnover-related licence fees for such sell-off of Contractual Products.
11.3 Termination of this Agreement for whatever reason shall not release the Party concerned from its obligations of paying any licence fees and other fees which have been incurred during the term of the Agreement but remain unpaid upon termination of Agreement and/or are only incurred after the Agreement was terminated.
Section 12 Final Provisions
12.1 No Party has the right to assign its rights or the performance of its obligations under this Agreement without the other Partys prior written consent; a Party, however, may only refuse to consent for good cause; no prior written consent must be obtained from the other Party for assignment of rights or performance of obligations under this Agreement to an Affiliated Company or in the context of disposal of all material assets of the Party concerned. As a result of permissible assignment, this Party shall not be released from its
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
obligations under this Agreement including the obligation to pay licence fees for any Net Selling Prices that the buyer or sub-licensee may generate from the sale of the Contractual Products.
12.2 This Agreement shall be governed by the laws of the Federal Republic of Germany excluding the UN Sales Convention (CISG).
12.3 In case of disputes arising from or in connection with this Agreement or concerning its validity, a final and binding decision will be taken under the arbitration rules of the German Institute of Arbitration (Deutsche Institution für Schiedsgerichtsbarkeit e. V., DIS) and ordinary legal redress shall be excluded. Hamburg shall be the venue of arbitration proceedings. The arbitration tribunal shall be made up of three arbitrators. German law shall be the governing substantive law. German shall be the language relevant for arbitration proceedings.
12.4 The Parties are aware of the risk of one or several of the provisions of this Agreement becoming invalid or nil and void in contrast to what is currently envisaged by the Parties. Also in this case the Parties are willing to exclude every doubt about the validity of this Agreement. Should one or several provisions of this Agreement including this clause be or become invalid or nil and void in part or as a whole or should it turn out that there is a loophole in this Agreement, the Agreement shall therefore in derogation of section 139 German Civil Code (BGB) not only remain valid if in doubt but instead always. The contracting parties agree to replace the invalid or missing provisions by provisions that most closely correspond to the intended commercial purpose of the Agreement.
12.5 In derogation of section 9 the Parties shall make a press release coordinated between them regarding cooperation under this Agreement by which the public will be informed of the fact that the Parties have entered into this licensing agreement - without mentioning any details of the individual terms and conditions.
12.6 This Agreement including its annexes constitutes the overall agreement between the Parties with respect to the subject-matter of the Agreement. This Agreement shall supersede any previous written and verbal agreements that may have been made between the Parties with respect to the subject-matter of agreement. Changes in and amendments of this Agreement shall only be valid and effective if made in writing. This rule shall also apply to a waiver of the written form requirement.
/s/ Thomas Kosin |
|
/s/ Ingo Ederer |
BEGO Medical GmbH |
|
VOXELJET technology GmbH |
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Annexes :
Annex 1: List of Licenced BEGO Patents
· EP 2289462 Al: continuous, generative manufacturing process and device
· DE 20 2011 003 443: device for generative production of three-dimensional components
· WO 2012 076205 Al: device and process for generative production of three-dimentional components
Annex 2: List of Licenced VOXELJET Patents
· DE 102010015451 Al: process and device for producing three-dimensional objects
· WO 2011 127897 A2: process and device for producing three-dimensional models
Annex 3: Sample Net Selling Price Invoice
· Licence fee: [***] of Net Selling Price
List price incl. special fees |
|
[***] |
Minus quantity and cash discount |
|
[***] |
Minus transport costs |
|
[***] |
Minus value-added tax and excise duty |
|
[***] |
Net Selling Price |
|
[***] |
Licence fee payable |
|
[***] |
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
BEGO Medical GmbH Postfach -28353 Bremen
voxeljet technology GmbH
Attn.: Dr. Ingo Ederer
Paul-Lenz-Straße 1
86
316 Friedberg
Unser Zeichen: Lizenzvertrag |
Tel.: +49 (0) 421 20 28-110 |
24. September 2012 |
kosin@bego.com |
Fax: +49 (0) 421 20 28-44110 |
|
Confirmation of licence for VOXELJET technology GmbH
Dear Dr. Ederer,
The undersigned company is the proprietor of the following patents:
· EP 2289462 Al: Vorrichtung und Verfahren zur kontinuierlichen, generativen Fertigung
· DE 20 2011 003 443: Vorrichtung zur generativen Herstellung dreidimensionaler Bauteile
· WO 2012 076205 Al: Vorrichtung und Verfahren zur generativen Herstellung dreidimensionaler Bauteile (Patents)
According to the licence agreement dated August 21st, 2012 the Friedberg-based firm of VOXELJET technology GmbH [and its Associated Companies] has been granted an exclusive licence in the so-called VOXELJET Field of Use for all those countries in which the Patents have been registered (Contractual Territories).
VOXELJET technology GmbH and its Associated Company have the right, therefore, to grant sub-licences in its own name to third-parties anywhere within the Contractual Territories.
VOXELJET technology GmbH is also entitled to assert any rights deriving from these patents, in its own name and to its own account. Any claims to damages that may have arisen due to infringements of these patents prior to August 21st, 2012 have been assigned to VOXELJET technology GmbH. This assignment of rights is repeated here as a precautionary measure.
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Bremen, 24.09.12 |
|
|
(Place), (date) |
|
|
|
|
|
|
|
|
/s/ Thomas Kosin |
|
|
BEGO Medical GmbH |
|
|
VOXELJET technology GmbH expressly accepts the above assignment a second time.
Friedberg, |
26.09.12 /s/ Ingo Ederer |
|
|
Signature of managing director |
|
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
BEGO Medical GmbH
Mr Christoph Weiss
Wilhelm-Herbst-Stra
ß
e 1
28359 Bremen
September 27, 2012
Confirmation of licence for BEGO Medical GmbH
Dear Mr Weiss,
The undersigned company is the proprietor of the following patents:
· DE 102010015451 Al : Verfahren und Vorrichtung zum Herstellen dreidimensionaler Objekte (Patents)
· WO 2011 127897 A2: Verfahren und Vorrichtung zum Herstellen dreidimensionaler Modelle
According to the licence agreement dated August 21 st , 2012 the Bremen-based firm of BEGO Medical GmbH [and its Associated Companies] has been granted an exclusive licence for all those countries in which the Patents have been registered (Contractual Territories).
BEGO Medical GmbH and its Associated Company have the right, therefore, to grant sub-licences in its own name to third-parties anywhere within the Contractual Territories.
{BEGO Medical GmbH is also entitled to assert any rights deriving from these patents, in its own name and to its own account. Any claims to damages that may have arisen due to infringements of these patents prior to August 21 st , 2012 have been assigned to BEGO Medical GmbH. This assignment of rights is repeated here as a precautionary measure.}
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Page 2 of our letter dated September 27, 2012
Augsburg, 27.09.2012 |
|
|
|
|
|
(Place), (date) |
|
|
|
|
|
|
|
|
/s/ Ingo Ederer |
|
|
VOXELJET technology GmbH |
|
|
BEGO Medial GmbH expressly accepts the above assignment a second time.
Bremen, |
/s/ Thomas Kosin |
|
|
Signature of managing director |
|
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Exhibit 10.4
Z CORPORATION
NONEXCLUSIVE PATENT LICENSE AND SUBLICENSE AGREEMENT
WITH VOXELJET
This Agreement, effective as of the date set forth above the signatures of the parties below (the Effective Date), is between Z Corporation (Z Corp.), a Massachusetts corporation, with a principal office at 20 North Avenue, Burlington, MA 01803 and Voxeljet Technology GmbH (Voxeljet), a corporation registered in Amtsgericht Augsburg (#HRB 17081), with a principal place of business at Am Mittleren Moos 15, 86167 Augsburg, Germany.
RECITALS
WHEREAS, The Massachusetts Institute of Technology (M.I.T.) and Z Corp. have previously entered into a Patent License Agreement dated as of December 21, 1994, as amended to date (the M.I.T. License), pursuant to which M.I.T. granted to Z Corp. a license to its Three Dimensional Printing patent portfolio (the M.I.T. Patents, listed in Appendix A);
WHEREAS, Z Corp. has filed its own patents, some of which are of interest to Voxeljet (Z Corporation Patents, listed in Appendix A);
WHEREAS, Z Corp. is willing to grant to Voxeljet a non-exclusive sublicense to the M.I.T. Patents and a license to the Z Corporation Patents (collectively referred to as Licensed Patents) solely for the manufacturing, sale and operation of three dimensional printing equipment for the fabrication of plastic parts subject to specified conditions, and Voxeljet is willing to accept the grant of the license and sublicense subject to such conditions; and
WHEREAS, Z Corp. and Voxeljet desire to enter into a license and sublicense agreement upon the terms and conditions hereinafter set forth.
NOW, THEREFORE, Z Corp. and Voxeljet hereby agree as follows:
1. Definitions.
1.1 Field shall means the manufacture, sale and operation of three dimensional printing equipment solely for the fabrication of plastic parts having a polymer matrix phase that is prepared utilizing a powder that contains at least 90% synthetic organic polymeric powder in a process that does not require post-processing other than liquid infiltration of printed parts.
1.2 Licensed Product shall mean any product or part thereof that:
(a) absent the license or sublicense granted hereunder, would infringe one or more claims of the Licensed Patents; or
(b) is manufactured by using a Licensed Process or that, when used, practices a Licensed Process.
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
1.3 Licensed Process shall mean any process that, absent the license or sublicense granted hereunder, would infringe one or more claims of the Licensed Patents or which uses a Licensed Product.
1.4 Licensed Patents shall mean those patents listed in Appendix A to this Agreement together with
(a) any divisionals, continuations, continuation-in-part applications, and continued prosecution applications (and their relevant international equivalents) of the Licensed Patents to the extent the claims of such applications are directed to subject matter specifically described in the resulting patents; and
(b) any patents resulting from reissues, reexaminations, or extensions (and their relevant international equivalents) of the patents described in (a) above.
1.5 Net Sales shall mean the total amount of all consideration received by Voxeljet from unaffiliated third parties in arms length transactions (whether such transaction takes the form of a sale, lease or other use) for Licensed Products and Licensed Processes, less the following:
(a) discounts allowed in amounts customary in the trade for quantity purchases, cash payments, prompt payments, wholesalers and distributors;
(b) sales, use and excise taxes, tariffs and/or duties directly imposed on any sale of a Licensed Product or Licensed Process;
(c) outbound transportation prepaid or allowed; and
(d) amounts allowed or credited on returns.
1.6 Net Royalty Sales shall mean Net Sales for which Voxeljet pays the royalty as a percentage (ie, [***]), as described in Section 4.2 (a)-first paragraph, but shall not include Net Sales for which Voxeljet pays the minimum fixed royalty (ie, [***] per machine) as described in Sections 4.2 (a)-last paragraph, (b) and (c).
1.7 Term shall mean the term of this Agreement, which shall commence on the Effective Date and shall remain in effect until the earlier of (i) as to the M.I.T. Patents, the termination of the license to the M.I.T. Patents by Z Corporation or (ii) as to all Licensed Patents, the expiration or abandonment of all issued patents and filed patent applications within the Licensed Patents, unless earlier terminated in accordance with the provisions of this Agreement.
2. Grant of Rights.
2.1 License Grants. Subject to the terms of this Agreement, Z Corp. hereby grants to Voxeljet for the Term a worldwide, nonexclusive license or sublicense under the Licensed Patents to develop, make, have made, use, sell, lease, offer to sell, offer to lease, and import
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Licensed Products in the Field and to develop and perform Licensed Processes in the Field. Voxeljet shall not have the right to sublicense the Licensed Patents.
2.2 No Additional Rights. Nothing in this Agreement shall be construed to confer any rights upon Voxeljet by implication, estoppel, or otherwise as to any technology or patent rights of Z Corp. or M.I.T. or any other entity other than the Licensed Patents, regardless of whether such technology or patent rights shall be dominant or subordinate to any of the Licensed Patents.
3. Voxeljet Diligence Obligations.
3.1 Voxeljet agrees to demonstrate reasonable efforts to commercialize the technology represented by the Licensed Patents in the Field.
3.2 Voxeljet agrees to insert the following use restriction language verbatim in all of its Quotations, Acceptance of Purchase Orders, and all other equivalent documentation in connection with any sale or lease of the equipment by Voxeljet to its customers:
USE OF EQUIPMENT
The Equipment (including any use of the Equipment), is subject to limitations imposed under a Nonexclusive Patent Sublicense Agreement between Voxeljet and Z Corporation, and is to be used solely for the fabrication of plastic parts having a polymer matrix phase that is prepared utilizing a powder that contains at least 90% synthetic organic polymeric powder in a process that does not require post-processing other than liquid infiltration of printed parts. Other uses of the Equipment are strictly prohibited and may expose the user to liability for patent infringement.
4. Fees and Payment Terms.
For the rights, privileges and license and sublicense granted hereby, Voxeljet shall pay the following amounts to Z Corp. in the manner hereinafter provided until the earlier of the expiration or termination of the last of the Licensed Patents or until the end of the Term:
4.1 Initial License Fee. Voxeljet shall pay to Z Corp. a one-time license/sublicense fee of [***], which shall be paid as follows: [***] within ten (10) days of the Effective Date; [***] within thirty (30) days of the Effective Date; [***] within sixty (60) days of the Effective Date; and [***] within ninety (90) days of the Effective Date.
4.2 Royalties. Voxeljet shall pay to Z Corp. a running royalty in an amount equal to
(a) [***] of the first [***] in Net Royalty Sales; [***] of the next [***] in Net Royalty Sales; and [***] of all cumulative Net Royalty Sales over [***],
Subject in each instance to a minimum royalty of [***] for each 3D printer that is a Licensed Product. For sales made after December 31, 2006, such minimum royalty shall be [***] for each 3D printer that is a Licensed Product.
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
(b) If Voxeljet uses a 3D printer that is a Licensed Product, other than a 3D printer purchased from Z Corp., for making parts for internal use or for sale to third parties, Voxeljet shall pay to Z Corp. a royalty of [***], which amount will be credited against the royalty due under subsection 4.2(a) above if the Licensed Product is subsequently sold by Voxeljet. For a 3D printer that is a Licensed Product, other than a 3D printer purchased from Z Corp., put into use after December 31, 2006 for making parts for internal use or for sale to third parties, such royalty shall instead be [***]. No further royalty shall be payable by Voxeljet to Z Corp. upon use and sale of parts made by a 3D printer that is a Licensed Product beyond the royalty described above.
(c) If Voxeljet purchases a three dimensional printer that is a Licensed Product or related equipment from Z Corp. and modifies it for sale in the Field, Voxeljet shall pay to Z Corp., in addition to the purchase price for the equipment, a royalty of [***]. No further royalty shall be payable by Voxeljet to Z Corp. upon any subsequent sale of the equipment or sale of products made from the equipment to a third party. Z Corp. shall not be obligated to provide any warranty or service agreement with respect to any three dimensional printer or related equipment, parts or accessories which are purchased, modified or re-sold by Voxeljet.
5. Reports and Records.
5.1 Voxeljet shall keep full, true and accurate books of account containing all particulars that may be necessary for the purpose of showing the amounts payable to Z Corp. under this Agreement. Said books of account shall be kept at Voxeljets principal place of business. Said books of account and the supporting data shall be open at all reasonable times for five (5) years following the end of the calendar year to which they pertain to the confidential inspection, upon at least one week written notice, by a designated representative of Z Corp. for the purpose of verifying Voxeljets royalty statement or compliance in other respects with this Agreement. Should any such inspection result in the discovery of a greater than Ten Percent (10%) discrepancy to Z Corp.s detriment, as verified by a designated independent auditor of Z Corp., Voxeljet shall be required to pay the full cost of such inspection. Z Corp. shall also have the right, upon at least 48 hours written notice, during normal business hours to inspect the operations and records of Voxeljet to ensure that it remains in compliance with the provisions of this Agreement.
5.2 Voxeljet shall deliver to Z Corp. no later than thirty (30) days following the end of each calendar quarter during the Term, commencing with the calendar quarter ending September 30, 2004, true and accurate reports showing all Net Sales that occurred during the quarter in question. The reports shall include at a minimum:
(a) the number of Licensed Products manufactured, leased or sold by Voxeljet during such quarter, as well as the customer name, location and intended use;
(b) the total Net Sales, Net Royalty Sales and Cumulative Net Royalty Sales, during such quarter, noting the applicable deductions provided in Section 1.5;
(c) running royalties due under Sections 4.2 (a) and (b); and
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
(d) total royalties due under this Agreement with respect to such calendar quarter.
5.3 With each such report, Voxeljet shall pay to Z Corp. the royalties due and payable under this Agreement. If no royalties shall be due, Voxeljet shall so report. Any royalty payable under Section 4.2(c) shall be payable at the time such three dimensional printer or other equipment is purchased from Z Corp.
5.4 All payments under this Agreement should be made payable to Z Corporation and sent to the address identified in Section 14.1. Each payment should reference this Agreement and identify the obligation under this Agreement that the payment satisfies. All payments due under this Agreement shall be payable in United States dollars. Any payments by Voxeljet that are not paid on or before the date such payments are due under this Agreement shall bear interest until payment is made, to the extent permitted by law, at the rate of two percentage points above the Prime Rate of interest as reported in the Wall Street Journal on the date payment is due. The payment of such interest shall not prevent Z Corp. from pursuing any other remedy it may have as the result of any late payment made by Voxeljet.
6. Patent Prosecution.
6.1 Responsibility for M.I.T. Patents. Voxeljet acknowledges that M.I.T. shall have sole discretion to apply for, seek issuance of, maintain, or abandon the M.I.T. Patents during the term of this Agreement.
6.2 Responsibility for Z Corporation Patents. Voxeljet acknowledges that Z Corporation shall have sole discretion to apply for, seek issuance of, maintain, or abandon the Z Corporation Patents during the term of this Agreement.
6.3 Payment of Expenses. Payment of all fees and costs, including attorneys fees, incurred by M.I.T. relating to the prosecution and maintenance of the M.I.T. Patents are the responsibility of M.I.T. and licensees of the M.I.T. Patents as they exist from time to time. Voxeljet shall be responsible for [***] of such expenses, which represents significantly less than Voxeljets pro-rata share of such expenses, to be paid as follows: [***] within ninety (90) days of the Effective Date; and [***] within one hundred and twenty (120) days of the Effective Date. No further amount relating to payment of patent expenses shall be due or owing by Voxeljet during the term of this Agreement.
7. Infringement.
7.1 Notification of Infringement. If it becomes so aware, Voxeljet shall inform Z Corp. and M.I.T. promptly in writing of any alleged infringement of the Licensed Patents by a third party and of any available evidence thereof.
7.2 Right to Prosecute. Voxeljet acknowledges that Z Corp. and M.I.T. shall have the right, but shall not be obligated, to prosecute at their own expense all infringements of the M.I.T.
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Patents. Z Corp. shall have the right, but shall not be obligated, to prosecute at its own expense all infringements of the Z Corporation Patents.
7.3 Cooperation. In any infringement suit which M.I.T. or Z Corporation may institute to enforce the M.I.T. or Z Corporation Patents, Voxeljet shall, at Z Corp.s expense, cooperate in all respects and, to the extent reasonably possible, have its then existing employees testify, and help locate former employees, when requested and make available relevant records, papers, information, samples, specimens, and the like, to the extent that they still exist.
8. Indemnification and Insurance.
8.1 Indemnification.
(a) Indemnity. Voxeljet shall indemnify, defend, and hold harmless M.I.T. and Z Corp. and their trustees, directors, officers, faculty, students, employees, and agents and their respective successors, heirs and assigns (the Indemnitees), against any liability, damage, loss, or expense (including reasonable attorneys fees and expenses) incurred by or imposed upon any of the Indemnitees in connection with any claims, suits, actions, demands or judgments arising out of any theory of liability (including without limitation actions in the form of tort, warranty, or strict liability and regardless of whether such action has any factual basis) concerning any product, process, or service that is made, used, sold, imported, or performed pursuant to any right or license or sublicense granted under this Agreement.
(b) Procedures. The Indemnitees agree to provide Voxeljet with prompt written notice of any claim, suit, action, demand, or judgment for which indemnification is sought under this Agreement. Voxeljet agrees, at its own expense, to provide attorneys reasonably acceptable to M.I.T. and Z Corp. to defend against any such claim. The Indemnitees shall cooperate fully with Voxeljet in such defense and will permit Voxeljet to conduct and control such defense and the disposition of such claim, suit, or action (including all decisions relative to litigation, appeal, and settlement); provided, however, that any Indemnitee shall have the right to retain its own counsel, at the expense of Voxeljet, if representation of such Indemnitee by the counsel retained by Voxeljet would be inappropriate because of actual or potential differences in the interests of such Indemnitee and any other party represented by such counsel. Voxeljet agrees to keep M.I.T. and Z Corp. informed of the progress in the defense and disposition of such claim and to consult with M.I.T. and Z Corp. with regard to any proposed settlement.
8.2 Insurance. Voxeljet shall obtain and carry in full force and effect commercial general liability insurance, including product liability and errors and omissions insurance which shall protect Voxeljet and Indemnitees with respect to events covered by Section 8.1(a) above. Such insurance (i) shall be issued by an insurer licensed to practice in Germany, (ii) shall be endorsed to include product liability coverage, and (iii) shall require thirty (30) days written notice to be given to M.I.T. and Z Corp. prior to any cancellation or material change thereof. The limits of such insurance shall not be less than One Million Dollars ($1,000,000) per occurrence with an aggregate of Three Million Dollars ($3,000,000) for bodily injury including death; One Million Dollars ($1,000,000) per occurrence with an aggregate of Three Million Dollars ($3,000,000) for
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
property damage; and One Million Dollars ($1,000,000) per occurrence with an aggregate of Three Million Dollars ($3,000,000) for errors and omissions. Voxeljet shall provide M.I.T. and Z Corp. with Certificates of Insurance evidencing compliance with this Section. Voxeljet shall continue to maintain such insurance or self-insurance after the expiration or termination of this Agreement during any period in which Voxeljet continues (i) to make, use, or sell a product that was a Licensed Product under this Agreement or (ii) to perform a service that was a Licensed Process under this Agreement, and thereafter for a period of five (5) years.
9. No Representations or Warranties.
NEITHER M.I.T. NOR Z CORP. MAKES ANY REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE PATENT RIGHTS, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, VALIDITY OF PATENT RIGHTS CLAIMS, WHETHER ISSUED OR PENDING, AND THE ABSENCE OF LATENT OR OTHER DEFECTS, WHETHER OR NOT DISCOVERABLE. Specifically, and not to limit the foregoing, M.I.T. and Z Corp. make no warranty or representation (i) regarding the validity or scope of the M.I.T. Patents, and (ii) that the exploitation of the M.I.T. Patents or any Licensed Product or Licensed Process will not infringe any patents or other intellectual property rights.
IN NO EVENT SHALL M.I.T., Z CORP., OR VOXELJET (EXCEPT AS PROVIDED IN SECTION 8.1), THEIR TRUSTEES, DIRECTORS, OFFICERS, EMPLOYEES AND AFFILIATES, BE LIABLE FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES OF ANY KIND, INCLUDING ECONOMIC DAMAGES OR INJURY TO PROPERTY AND LOST PROFITS, REGARDLESS OF WHETHER M.I.T., Z CORP., OR VOXELJET SHALL BE ADVISED, SHALL HAVE OTHER REASON TO KNOW, OR IN FACT SHALL KNOW OF THE POSSIBILITY OF THE FOREGOING.
10. Assignment.
This Agreement is personal to Voxeljet and no rights or obligations may be assigned or otherwise transferred by Voxeljet without the prior written consent of Z Corp., which consent may be denied in Z Corp.s absolute discretion. Z Corp. acknowledges that Voxeljet may wish to assign this Agreement in the event of an Acquisition (as such term is defined below) of Voxeljet. Z Corp. has no conceptual problem with such assignment as long as it is not counter to Z Corp.s own business interests. Because it is impossible to foresee every possible situation, Z Corp. shall have the right to terminate this Agreement by written notice to Voxeljet upon any Acquisition of Voxeljet, but, before taking such action, agrees to consider Voxeljets interests as well as its own in making the decision whether to terminate this Agreement. Ultimately, Z Corp. shall make the decision based on its own business interests. For purposes of this Section 10, the term Acquisition means (a) a sale, merger or consolidation in a single transaction or series of related transactions in which securities possessing more than 50% of the total combined voting power of Voxeljets outstanding securities are transferred to a person or persons different from the persons who held those securities immediately prior to such transaction, or (b) the sale,
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
transfer, or other disposition of all or substantially all of Voxeljets assets to one or more persons (other than any wholly owned subsidiary of Voxeljet) in a single transaction or series of related transactions.
11. General Compliance with Laws.
11.1 Compliance with Laws. Voxeljet shall use reasonable commercial efforts to comply with all commercially material local, state, federal, and international laws and regulations relating to the development, manufacture, use, and sale of Licensed Products and Licensed Processes.
11.2 Export Control. Voxeljet shall comply with all applicable laws and regulations controlling the export of certain commodities and technical data, including without limitation all U.S. Export Administration Regulations of the United States Department of Commerce. Among other things, these laws and regulations prohibit or require a license for the export of certain types of commodities and technical data to specified countries. Voxeljet hereby gives written assurance that it will comply with all United States export control laws and regulations, that it bears sole responsibility for its violations of such laws and regulations and that it will indemnify, defend, and hold Z Corp. and M.I.T. harmless (in accordance with Section 8.1) for the consequences of any such violation.
11.3 Non-Use of Z Corp. or M.I.T. Name. Voxeljet shall not use the name of Z Corporation, Massachusetts Institute of Technology, Lincoln Laboratory or any variation, adaptation, or abbreviation thereof, or of any of their respective officers, directors, trustees, faculty, students, employees, or agents, or any trademark owned by Z Corp. or M.I.T., or any terms of this Agreement in any promotional material or other public announcement or disclosure without the prior written consent of Z Corp. and M.I.T. The foregoing notwithstanding, without the consent of Z Corp. and M.I.T., Voxeljet may state that it is nonexclusively licensed or sublicensed by Z Corp. under one or more of the patents and/or patent applications comprising the M.I.T. or Z Corporation Patents.
11.4 Marking of Licensed Products. To the extent commercially feasible and consistent with prevailing business practices, Voxeljet shall mark all Licensed Products that are manufactured or sold under this Agreement or literature that accompanies the Licensed Products with the number of each issued patent under the Licensed Patents that applies to such Licensed Product.
12. Termination.
12.1 Voluntary Termination by Voxeljet. Voxeljet shall have the right to terminate this Agreement, for any reason, (i) upon at least six (6) months prior written notice to Z Corp., such notice to state the date at least six (6) months in the future upon which termination is to be effective, and (ii) upon payment of all amounts due to Z Corp. through such termination effective date.
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
12.2 Cessation of Business. If Voxeljet ceases to carry on its business related to this Agreement, Z Corp. shall have the right to terminate this Agreement immediately upon written notice to Voxeljet.
12.3 Termination for Default.
(a) Nonpayment. In the event Voxeljet fails to pay any amounts due and payable to Z Corp. hereunder, and fails to make such payments within thirty (30) days after receiving written notice of such failure, in addition to all other rights and remedies available to Z Corp. under applicable law or this Agreement, Z Corp. may terminate this Agreement immediately upon written notice to Voxeljet.
(b) Material Breach. In the event Voxeljet commits a material breach of its obligations under this Agreement, except for breach as described in Section 12.3(a), and fails to cure that breach within thirty (30) days after receiving written notice thereof, in addition to all other rights and remedies available to Z Corp. under applicable law or this Agreement, Z Corp. may terminate this Agreement immediately upon written notice to Voxeljet.
(c) Liquidated Damages. In the event Voxeljet (or any third party who directly or indirectly acquires the Licensed Product or the rights to manufacture, use, sell or lease the Licensed Product or the Licensed Process from Voxeljet) sells, leases or uses any Licensed Product or Licensed Process outside the Field, Voxeljet shall immediately pay to Z Corp. as liquidated damages and not as a penalty, a payment of [***] with respect to each such Licensed Product.
(d) Late Charge. If Voxeljet fails to pay when due any royalty or other amount or charge which Voxeljet is obligated to pay under the terms of this Agreement, then Voxeljet shall pay Z Corp. a late charge equal to [***] of the royalty or other payment calculated from the due date. Voxeljet acknowledges that any late payment under this Agreement will cause Z Corp. to lose the use of that money and incur costs and expenses not contemplated under this Agreement including, without limitation, administrative costs and processing and accounting expenses, the exact amount of which is extremely difficult to ascertain. Voxeljet and Z Corp. agree that this late charge represents a reasonable estimate of such costs and expenses and is fair compensation to Z Corp. for the loss suffered as a result of such late payment by Voxeljet. The late charge is not intended to cover Z Corps attorneys fees and costs relating to delinquent payments. Acceptance of any late charge shall not constitute a waiver of Voxeljet s default with respect to such late payment by nor prevent Z Corp. from exercising any other rights or remedies available to Z Corp. under this Agreement. In no event shall this provision for the imposition of a late charge be deemed to grant to Voxeljet a grace period or an extension of time within which to pay any amount due hereunder or prevent Z Corp. from exercising any right or remedy available to Z Corp. upon Voxeljets failure to pay such amount when due.
12.4 Effect of Termination.
(a) Survival. The following provisions shall survive the expiration or termination of this Agreement: Articles 1, 5, 8, 9, 11, 12, 13 and 14.
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
(b) Pre-termination Obligations. In no event shall termination of this Agreement release Voxeljet from the obligation to pay any amounts that became due under this Agreement on or before the effective date of termination.
13. Dispute Resolution.
13.1 Mandatory Procedures. The parties agree that any dispute arising out of or relating to this Agreement shall be resolved solely by means of the procedures set forth in this Article, and that such procedures constitute legally binding obligations that are an essential provision of this Agreement. If either party fails to observe the procedures of this Article, as may be modified by their written agreement, the other party may bring an action for specific performance of these procedures in any court of competent jurisdiction.
13.2 Equitable Remedies. Although the procedures specified in this Article are the sole and exclusive procedures for the resolution of disputes arising out of or relating to this Agreement, either party may seek a preliminary injunction or other provisional equitable relief if, in its reasonable judgment, such action is necessary to avoid irreparable harm to itself or to preserve its rights under this Agreement.
13.3 Dispute Resolution Procedures.
(a) Mediation. In the event any dispute, whether arising out of or relating to this Agreement remains unresolved within sixty (60) days from the date the affected party informed the other party of such dispute, either party may initiate mediation upon written notice to the other party (Notice Date), whereupon both parties shall be obligated to engage in a mediation proceeding under the then current Center for Public Resources (CPR) Model Procedure for Mediation of Business Disputes (http://www.cpradr.org), except that specific provisions of this Article shall override inconsistent provisions of the CPR Model Procedure. The mediator will be a Registered United States Patent Attorney selected from the CPR Panels of Neutrals. If the parties cannot agree upon the selection of a mediator within fifteen (15) business days after the Notice Date, then upon the request of either party, the CPR shall appoint the mediator. The parties shall attempt to resolve the dispute through mediation until the first of the following occurs: (i) the parties reach a written settlement; (ii) the mediator notifies the parties in writing that they have reached an impasse; (iii) the parties agree in writing that they have reached an impasse; or (iv) the parties have not reached a settlement within sixty (60) days after the Notice Date.
(b) Trial Without Jury. If the parties fail to resolve the dispute through mediation, or if neither party elects to initiate mediation, each party shall have the right to pursue any other remedies legally available to resolve the dispute, provided, however, that the parties expressly waive any right to a jury trial in any legal proceeding under this Article.
13.4 Performance to Continue. Each party shall continue to perform its undisputed obligations under this Agreement pending final resolution of any dispute arising out of or relating to this Agreement; provided, however, that a party may suspend performance of its undisputed obligations during any period in which the other party fails or refuses to perform its undisputed
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
obligations. Nothing in this Article is intended to relieve Voxeljet from its obligation to make undisputed payments pursuant to this Agreement.
13.5 Statute of Limitations. The parties agree that all applicable statutes of limitation and time-based defenses (such as estoppel and laches) shall be tolled while the procedures set forth in Sections 12.3(a) are pending. The parties shall cooperate in taking any actions necessary to achieve this result.
14. Miscellaneous.
14.1 Notice. Any notices required or permitted under this Agreement shall be in writing, shall specifically refer to this Agreement, and shall be sent by hand, recognized national overnight courier, confirmed facsimile transmission, electronic mail with confirmation statement from the other side, or registered or certified mail, postage prepaid, return receipt requested, to the following addresses or facsimile numbers of the parties:
If to Z Corp: |
|
Z Corporation |
|
|
20 North Avenue |
|
|
Burlington, MA 01803 |
|
|
Attention: CEO |
|
|
Tel: (781) 852-5005 |
|
|
Fax: (781) 852-5100 |
|
|
|
If to M.I.T.: |
|
Technology Licensing Office, Room NE25-230 |
|
|
Massachusetts Institute of Technology |
|
|
77 Massachusetts Avenue |
|
|
Cambridge, MA 02139-4307 |
|
|
Attention: Director |
|
|
Tel: (617) 253-6966 |
|
|
Fax: (617) 258-6790 |
|
|
|
If to Voxeljet: |
|
Voxeljet Technology GmbH |
|
|
Am Mittleren Moos 15 |
|
|
86167 Augsburg |
|
|
Germany |
|
|
Attention: CEO |
|
|
Tel: +49 (0) 821 74 83 100 |
|
|
Fax: +49 (0) 821 74 83 111 |
All notices under this Agreement shall be deemed effective upon receipt. A party may change its contact information immediately upon written notice to the other party in the manner provided in this Section.
14.2 Governing Law; Consent to Jurisdiction. This Agreement and all disputes arising out of or related to this Agreement, or the performance, enforcement, breach or termination hereof, and
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
any remedies relating thereto, shall be construed, governed, interpreted and applied in accordance with the laws of the Commonwealth of Massachusetts, U.S.A., without regard to conflict of laws principles, except that questions affecting the construction and effect of any patent shall be determined by the law of the country in which the patent shall have been granted. Any dispute which may arise out of or in connection with this Agreement shall be adjudicated before a court located in Boston, Massachusetts and the parties hereby submit to the exclusive jurisdiction of the courts of the Commonwealth of Massachusetts located in Boston, Massachusetts and of the federal courts in Boston, Massachusetts with respect to any action or legal proceeding commenced by any party, and irrevocably waive any objection they now or hereafter may have respecting the venue of any such action or proceeding brought in such a court or respecting the fact that such court is an inconvenient forum, relating to or arising out of this Agreement, and the undersigned each consents to the service of process in any such action or legal proceeding by means of express courier and facsimile transfer, return receipt requested, in care of the address set forth below or such other address as each shall furnish in writing to the other parties hereto. In the event any such action is brought, whether at law or in equity, then the prevailing party shall be paid its reasonable attorneys fees, expenses and disbursements arising out of such action.
14.3 Force Majeure. Neither party will be responsible for delays resulting from causes beyond the reasonable control of such party, including without limitation fire, explosion, flood, war, strike, or riot, provided that the nonperforming party uses commercially reasonable efforts to avoid or remove such causes of nonperformance and continues performance under this Agreement with reasonable dispatch whenever such causes are removed; provided, however, that force majeure shall never excuse any delay by Voxeljet in making all payments under this Agreement in a timely manner.
14.4 Amendment and Waiver. This Agreement may be amended, supplemented, or otherwise modified only by means of a written instrument signed by both parties. Any waiver of any rights or failure to act in a specific instance shall relate only to such instance and shall not be construed as an agreement to waive any rights or fail to act in any other instance, whether or not similar.
14.5 Severability. In the event that any provision of this Agreement shall be held invalid or unenforceable for any reason, such invalidity or unenforceability shall not affect any other provision of this Agreement, and the parties shall negotiate in good faith to modify the Agreement to preserve (to the extent possible) their original intent.
14.6 Binding Effect. This Agreement shall be binding upon and inure to the benefit of the parties and their respective permitted successors and assigns.
14.7 Headings. All headings are for convenience only and shall not affect the meaning of any provision of this Agreement.
14.8 Entire Agreement. This Agreement constitutes the entire agreement between the parties with respect to its subject matter and supersedes all prior agreements or understandings between the parties relating to its subject matter.
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their duly authorized representatives.
The EFFECTIVE DATE of this Agreement is August 16, 2004.
Z Corporation |
Voxeljet Technology GmbH |
|||
|
|
|||
By: |
/s/ Marina Hatsopoulos |
|
By: |
/s/ Ingo Ederer |
Name: |
Marina Hatsopoulos |
|
Name: |
Ingo Ederer |
Title: |
CEO |
|
Title: |
CEO |
|
|
|||
Approved as of the Effective Date: |
|
|||
The Massachusetts Institute of Technology |
|
|||
By: |
/s/ John H. Turner, Jr. |
|
|
|
Name: |
John H. Turner, Jr. |
|
|
|
Title: |
Associate Director |
|
|
|
|
Technology Licensing Office |
|
|
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Appendix A
Licensed Patents
M.I.T. Patents
1) M.I.T. Case No. 4972
Canada Patent No. 2031562, Issued November 22, 1994
European Patent Convention Patent No. 0431924, Issued January 31, 1996
France Patent No. 0431924, Issued January 31, 1996
Germany Patent No. P69025147.5, Issued January 31, 1996
Italy Patent No. 0431924, Issued January 31, 1996
Japan Patent No. 2729110, Issued December 12, 1997
Sweden Patent No. 0431924, Issued January 31, 1996
United Kingdom Patent No. 0431924, Issued January 31, 1996
United States of America Patent No, 5204055, Issued April 20, 1993
United States of America Patent No. 5340656, Issued August 23, 1994
Three-Dimensional Printing Techniques
by Michael J. Cima, John S. Haggerty, Emanuel M. Sachs and Paul A. Williams
2) M.I.T. Case No. 5567
Canada Patent No. 2136748, Issued August 14, 2001
European Patent Convention Patent No. 0644809, Issued July 25, 2001
European Patent Convention Serial No. 00204516.9, Filed June 4, 1993
France Patent No. 0644809, Issued July 25, 2001
Germany Patent No. 0644809, Issued July 25, 2001
Japan Patent No. 2862674, Issued December 11, 1998
United Kingdom Patent No. 0644809, Issued July 25, 2001
United States of America Patent No. 5387380, Issued February 7, 1995
Three-Dimensional Printing Techniques
by David Brancazio, James F. Bredt, Michael J. Cima, Alain Curodeau, Tailin Fan, Satbir Khanuja, Alan J. Lauder, Sang-Joon J. Lee, Steven P. Michaels, Emanuel M. Sachs and Harald Tuerck
Z Corporation Patents
1) US 5,902,441
Method of Three-Dimensional Printing
2) US 6,007,318
Method and Apparatus for Prototyping a Three-Dimensional Object
3) US 6,416,850
Three-Dimensional Printing Materials System
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
4) WO 2001/34371 (Z Corp. Reference: Materials 8)
Material System and Methods of Three-Dimensional Printing
5) WO 2001/78969 (Z Corp. Reference: Materials 10)
Compositions for Three-Dimensional Printing of Solid Objects
US 2001/0050031
Compositions for Three-Dimensional Printing of Solid Objects
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Exhibit 10.5
FIRST AMENDMENT TO THE
NONEXCLUSIVE PATENT LICENSE AGREEMENT
WITH VOXELJET
This First Amendment is entered into this 31stth day of March, 2011 (the Effective Date) and amends the License Agreement dated August 16, 2004, as amended to date, by and between the Z CORPORATION, a corporation duly organized under the laws of the Commonwealth of Massachusetts and having its principal office at 32 Second Avenue, Burlington, Massachusetts 01803, U.S.A. (hereinafter referred to as Z Corp) and Voxeljet Technology GmbH (Voxeljet), a corporation registered in Amtsgericht Augsburg (#HRB 17081), with a principal place of business at Paul-Lenze-Strasse 1 86316 Friedberg, Germany. (hereinafter referred to as LICENSEE).
WHEREAS, Z CORP and LICENSEE wish to amend the License Agreement dated August 16, 2004 (the Agreement);
NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein, the parties agree as follows:
1. Amend and restate Recitals:
WHEREAS, Z Corp. is willing to grant to Voxeljet a non-exclusive license to the Z Corp Patents (referred to as Licensed Patents) subject to specified conditions, and Voxeljet is willing to accept the grant of the license subject to such conditions; and
2. Amend and restate Section 1. Definitions as follows:
Field of Use 1 shall mean the manufacture, sale and operation of three dimensional printing equipment solely for the fabrication of plastic parts having a polymer matrix phase that is prepared utilizing a powder that contains at least 90% synthetic organic polymeric powder in a process that does not require post-processing other than liquid infiltration of printed parts.
Field of Use 2 shall mean the manufacture, sale and operation of three dimensional printing equipment solely for the fabrication of molds for metal casting or direct manufacture of parts utilizing at least 90% inorganic powder in a process that does not require post-processing other than oven baking parts or liquid infiltration. It is understood that license to practice Field of Use 2 is limited to the extent allowable through license of Z Corporation patents and not through sub-license of MIT patents still in force.
Restrictions:
Z Corp is willing to grant to Voxeljet a non-exclusive license to the Z Corp Patents (referred to as Licensed Patents) with the following restrictions:
· Materials developed and manufactured by Voxeljet that utilize patents referred to in Appendix A as Materials 19 shall be limited to use with Voxeljet equipment only.
· The manufacture, sale and operation of three dimensional printing equipment shall only be developed and used in one-color (monochrome) configuration.
· The manufacture, sale and operation of three dimensional printing equipment using a powder having a calcium sulfate hemihydrate content of no more than 30%.
3. Amend and restate Section 14.1 with the following:
If to Z Corp: |
|
Z Corporation |
|
|
32 Second Avenue |
|
|
Burlington, MA 01803 |
|
|
Attention: CEO |
|
|
Tel: (781) 852-5005 |
|
|
Fax: (781) 852-5100 |
4. Amend and restate Appendix A:
ORIGINAL:
(1) US 5,902,441
Method of Three-Dimensional Printing
2) US 6,007,318
Method and Apparatus for Prototyping a Three-Dimensional Object
3) US 6,416,850
Three-Dimensional Printing Materials System
4) WO 2001/34371 (Z Corp. Reference: Materials 8)
Material System and Methods of Three-Dimensional Printing
5) WO 2001/78969 (Z Corp. Reference: Materials 10)
Compositions for Three-Dimensional Printing of Solid Objects
US 2001/0050031
Compositions for Three-Dimensional Printing of Solid Objects
NEW: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Z Corp Reference |
08/707,693 |
|
US5,902,441 |
|
HK1019866
|
|
Materials 1 |
60/197,526 |
|
US 7550518 (B2) |
|
US 2005197431 (A1) |
|
Materials 10 |
60/197,118 |
|
W00178969 (A2) |
|
W00178969 (A3)
|
|
Materials 10 |
60/164,000 |
|
EP1415792 (A2) |
|
CA2388046 (A1);
|
|
Materials 8 |
60/472,221 |
|
US 7569273 (B2) |
|
W02004113042 (A2)
|
|
Materials 12 |
10/255,139 |
|
US2004056378 (A1) |
|
US7087109 (B2)
|
|
Materials 11 |
60/873,730 |
|
US 2008138515 (A1); 7,905,951 |
|
W02008073297 (A2)
|
|
Materials 19 |
08/771,009 |
|
US 6,007,318 |
|
US 7,686,995; EP 1621311
|
|
Machine 1 |
60/808,721 |
|
|
|
W02007139938 (A2)
|
|
Machine 10 |
Except as specifically modified or amended hereby, this First Amendment along with the Agreement shall remain in full force and effect and, as modified or amended, is hereby ratified, confirmed, and approved. No provision of this Amendment or the Agreement may be modified or amended except expressly in a writing signed by both parties nor shall any terms be waived except expressly in a writing signed by the party charged therewith. This Amendment as well as the Agreement shall be governed in accordance with the laws of the Commonwealth of Massachusetts.
IN WITNESS WHEREOF, the parties have duly executed this Amendment the day and year set forth below.
Z CORPORATION |
VOXELJET |
|||
|
|
|||
By |
/s/ John Kawola |
|
By |
/s/ Ingo Ederer |
|
|
|
|
|
Name |
John Kawola |
|
Name |
Ingo Ederer |
|
|
|
|
|
Title |
CEO |
|
Title |
CEO |
|
|
|
|
|
Date |
3/31/11 |
|
Date |
31 March 2011 |
Exhibit 10.6
PATENT AND KNOW-HOW TRANSFER AGREEMENT
Between
GENERIS GMBH
AM MITTLEREN MOOS 15
D-86167 AUGSBURG
(IN THE FOLLOWING GENERIS)
AND
EXTRUDE HONE GMBH
BERGHAUSER STR. 62
D-42859 REMSCHEID
(IN THE FOLLOWING EH)
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Preamble
GENERIS has developed a CAD based ink jet technology for the production of molds, cores and other components which is particularly useful for sand casting applications (GENERIS SAND TECHNOLOGY) which is covered by patents/patent applications (GENERIS SAND PATENTS) and secret know-how (GENERIS SAND KNOW-HOW) of GENERIS (collectively GENERIS SAND IP). The GENERIS SAND TECHNOLOGY consists in certain equipment and processes, especially, but not linked to the GS 1500 system.
GENERIS has pledged the GENERIS SAND IP to Anton Hafner Bankgeschaft in Augsburg / Germany and granted a non-exclusive license to Soligen Inc., USA. GENERIS has rescinded ( angefochten ) and terminated ( gekündigt ) the non-exclusive license agreement with Soligen Inc. Soligen Inc., however, contests such rescission and termination.
Startkapital-Fonds Augsburg GmbH and Technologie Beteiligungsfonds Bayern GmbH & Co KG have entered into partnership agreements with GENERIS.
EH is interested in the use of GENERIS SAND IP and is willing to purchase co-ownership shares (Miteigentum) in GENERIS SAND IP. GENERIS is willing to transfer GENERIS SAND IP shares to EH.
EH intends to establish, a new company (NewCo) in the Land of Bavaria for the manufacture and sale of equipment based on GENERIS SAND TECHNOLOGY. EH intends to offer Mr. Ederer and Mr. Höchsmann each a [***] share in NewCo. The NewCo shall be established by 31 August 2003 at the latest. EH shall offer to the NewCo the co-ownership shares in GENERIS SAND PATENTS acquired by EH under the present Agreement. Thereby the NewCo shall be offered - according to the parties intention - EHs co-owner rights and obligations to the GENERIS SAND PATENTS EH acquires under this present Agreement.
In consideration thereof, the parties agree as follows:
§ 1 Transfer of GENERIS SAND IP to EH
1. GENERIS herewith sells and transfers a share (Miteigentum) of 40% in GENERIS SAND IP to EH.
GENERIS SAND PATENTS comprise the patents and patent applications listed in exhibit 1 hereto and any further applications covering inventions made by GENERIS and/or its key employees/personnel, Mr. Ederer or Mr. Höchsmann, through 31 August 2003 in the field of GENERIS SAND TECHNOLOGY, including any applications related thereto and branch offs, divisionals etc. thereof.
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
GENERIS SAND KNOW-HOW comprises the technical Know-How necessary to use the GENERIS SAND TECHNOLOGY, especially the documents and drawings listed in exhibit 2 hereto.
2. GENERIS shall hand over to EH within one week after signature of the present Agreement by both parties the documents and drawings listed in exhibit 2 pertaining to the GENERIS SAND KNOW-HOW.
3. GENERIS herewith grants to EH a right of first refusal ( Vorkaufsrecht ) regarding the purchase of the GENERIS Wax patents listed in exhibit 3 hereto.
§ 2 Warranty
1. GENERIS warrants that it is the sole owner of GENERIS SAND IP and has sufficient right and title to sell and transfer ownership in GENERIS SAND IP as provided under this Agreement. GENERIS further warrants that no third party has any right whatsoever with respect to GENERIS SAND IP except
· Anton Hafner Bankgeschäft under the pledge agreement;
· Soligen Inc. potentially under any still valid rights that may remain related to the non-exclusive license agreement dated 12 February 2003;
· the silent partnership agreements with Startkapital-Fonds Augsburg GmbH and Technologie Beteiligungsfonds Bayern GmbH & Co KG.
GENERIS declares that legal defects in the GENERIS SAND PATENTS and technical defects in the invention are not known to it. To the extent that GENERIS SAND PATENTS are legally defective or the invention is technically defective,
· a liability for freedom of defects, particularly dependency of the invention is not undertaken;
· all rights of warranty or rescission by EH are excluded.
2. GENERIS warrants that it has acquired with legal effect all patents from its shareholders Mr. Ederer and Mr. Höchsmann, if any, related to the GENERIS SAND TECHNOLOGY.
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
§ 3 Purchase Price
1. In consideration of the sale and transfer of the GENERIS SAND IP as well as the right of first refusal according to §1.3., EH shall pay to GENERIS a total purchase price of [***],-, plus VAT.
2. GENERIS acknowledges to have obtained an advance payment of [***],-, including VAT; the remaining portion of the purchase price in the amount of [***] plus VAT shall be paid to GENERIS within four business days after EH has obtained the documents and drawings according to § 1.2 of the present Agreement.
§ 4 Relationship between co-owners
1. EH shall be entitled to use the GENERIS SAND IP without any restriction and more particularly shall be entitled to manufacture and distribute GENERIS SAND TECHNOLOGY and grant in its own name non-exclusive licenses at fair market value to companies in which Extrude Hone Corporation (directly or indirectly) holds a majority share or is entitled to vote the majority shares (Affiliated Companies). License fees related to licenses granted by EH shall be attributed to 40% to EH and to 60% to GENERIS.
2. GENERIS shall only be entitled to use the GENERIS SAND IP for the use of machines containing GENERIS SAND TECHNOLOGY and rendering services related to GENERIS SAND TECHNOLOGY without the obligation to pay any license fee to EH.
GENERIS may be entitled to manufacture or sell machines containing GENERIS SAND TECHNOLOGY only with prior written consent of EH. EH shall provide such consent so long as GENERISs manufacture and sale of such machines does not compete with any products then engineered manufactured or sold by EH or Affiliated Companies, and so long as such manufacture or sale by GENERIS does not violate any settlement agreement it may have made with MIT (Massachusetts Institute of Technology) with regard to patents under which EH or Affiliated Companies are licensed by MIT. In case of such manufacture or sale by GENERIS of such machines, GENERIS shall pay to EH a fee at fair market value.
3. In case of use of valid GENERIS SAND PATENTS by EH directly, EH shall pay to GENERIS the following fees in addition to the upfront payment under § 3 above based on (i) the net sales price of sand casting machines and (ii) the proportionate net sales price of parts or equipment used in other machines or products of EH in case of use of valid GENERIS SAND PATENTS which proportionate net sales price shall be calculated according to the proportion of the value of such part or equipment to the value of the machine or product sold:
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
business
|
|
2003 |
|
2004 |
|
2005 |
|
2006 |
|
2007 |
|
2008 |
fee |
|
[***] |
|
[***] |
|
[***] |
|
[***] |
|
[***] |
|
[***] |
Prior to the year end of 2008, the fees for the years after the year 2008 shall be negotiated between the parties in good faith based taking into account the fee level of the year 2008.
4. GENERIS shall be responsible for prosecution and maintenance of GENERIS SAND PATENTS and shall inform EH immediately of any deadline or of any event affecting the scope of protection or the validity of GENERIS SAND PATENTS. Both parties shall bear the maintenance and prosecution costs as well as necessary attorney fees according to their respective co-ownership share. In case that one of the co-owners should not be willing to pay costs of maintenance or prosecution, the respective other co-owner shall have an option to acquire full ownership in the relevant patent and be solely liable for maintenance and prosecution costs as well as necessary attorney fees, without, however, additional payments to the co-owner from which the shares are acquired.
5. The parties agree that any transfer of ownership in GENERIS SAND IP to third parties might substantially harm the interest of the respective other co-owner. In case that one of the co-owners shall have the intention to the sell its shares in GENERIS SAND IP or in part thereof, the respective other party shall be immediately informed of such intention by written notice. The respective other party shall have an option to purchase the shares against payment of a purchase price at fair market value within one month from such notice. The same shall apply in case of insolvency of one of the co-owners.
6. GENERIS shall offer future developments and improvements of GENERIS SAND IP made and owned by GENERIS after 31 August 2003 for use by EH under reasonable conditions to be negotiated by the parties and EH shall have a right of first refusal regarding the purchase of such developments and improvements or of parts thereof.
§ 5 Transfer of GENERIS SAND PATENTS to NewCo
1. Within ten business days after the NewCo has been established, i.e. registered with the competent commercial supplier, EH will make an offer to the NewCo to transfer the co-ownership shares in GENERIS SAND PATENTS to NewCo, with all rights and obligations as defined under § 4 above. Furthermore, EH will make an offer to NewCo to grant to NewCo the royalty-free right to use EHs co-ownership shares in GENERIS SAND KNOW-HOW.
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
For the avoidance of doubt, EHs co-ownership shares in GENERIS SAND KNOW-HOW shall not be affected either by the offer to transfer, or a transfer of co-ownership shares in GENERIS SAND PATENTS to NewCo or by the offer to grant, or a grant of, the royalty-free right to NewCo to use EHs co-ownership shares in GENERIS SAND KNOW-HOW. This ownership in GENERIS SAND KNOW-HOW shall stay with EH.
2. The offer to be made by EH to NewCo shall be subject to a license back to EH conferring EH a non-exclusive license under the GENERIS SAND PATENTS to make, have made, sell, have sold GENERIS SAND TECHNOLOGY and use the GENERIS SAND PATENTS without any restriction, with the right to grant sublicenses to Affiliated Companies. The license to EH shall end with the expiration of the last of the GENERIS SAND PATENTS.
3. As far as GENERIS would request the consent to use GENERIS SAND TECHNOLOGY according to § 4.2 above from NewCo, NewCo shall not be entitled to give such consent without having obtained prior consent from EH, to be decided by EH in accordance with § 4.2 above.
4. The offer to be made to NewCo shall contain the following license fees based on (1) the net sales price of sand casting machines to be paid by EH in case of use of valid GENERIS SAND PATENTS under the license back and (2) the proportionate net sales price of parts or equipment used in other machines or products of EH in case of use of valid GENERIS SAND PATENTS which proportionate net sales price shall he calculated according to the proportion of the value of such part or equipment to the value of the machine or product sold:
business
|
|
2003 |
|
2004 |
|
2005 |
|
2006 |
|
2007 |
|
2008 |
license fee |
|
[***] |
|
[***] |
|
[***] |
|
[***] |
|
[***] |
|
[***] |
Prior to the year end of 2008, the fees for the years after the year 2008 shall be negotiated in good faith based on the fee level of the year 2008.
For the avoidance of doubt, any such license fees shall, after receipt by NewCo, be attributed to the co-owners of the GENERIS SAND PATENTS in relation to their co-ownership share, i.e. 40 % shall be attributed to the NewCo and 60% to GENERIS.
5. The license back to EH shall include the unlimited and royalty-free right of use by EHs and Affiliated Companies customers who acquired products containing GENERIS SAND TECHNOLOGY.
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
§ 6 Salvatorian Clause
Should any provision of this Agreement be invalid or unenforceable or should the Agreement contain an omission, the remaining provisions shall be valid, instead of an invalid provision or an omission, a valid provision is presumed to be agreed upon by the parties, which comes economically closest to be one actually agreed upon.
§ 7 Jurisdiction and Applicable Law
For all disputes arising out of or in connection with this Agreement the patent court of the District Court Düsseldorf shall have exclusive jurisdiction. This Agreement shall be governed and construed according to German law.
For Extrude Hone GmbH |
|
For Generis GmbH |
||
|
|
|
||
By |
/s/ Peter Gosger |
|
By |
/s/ Ingo Ederer |
|
|
|
|
|
Name Peter Gosger |
|
Name Ingo Ederer |
||
|
|
|
||
Title Geschäftsführer |
|
Title Geschäftsführer |
||
|
|
|
||
Date 27.6.2003 |
|
Date 27.6.2003 |
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Exhibit 1
Generis Patents
DE 0019723892
|
|
Method for manufacturing of parts by a deposition technique |
|
|
|
DE0019853834 |
|
Verfahren zum Herstellen von Bauteilen durch Auftragstechnik |
|
|
|
W02001068336 |
|
Method for manufacturing a structural part by a deposition technique |
|
|
|
W02001072502
|
|
Method for manufacturing a structural part by a deposition technique |
|
|
|
DE0010025740 |
|
Vorrichtung zum Erzeugen eines Sprays |
|
|
|
W02002026419
|
|
Method for manufacturing a part by a deposition technique |
|
|
|
|
Interchangeable container |
|
|
|
|
DE0010047614
|
|
Device for manufacturing models layer by layer |
|
|
|
DE0010049043
|
|
Method for unpacking shaped bodies |
|
|
|
DE0010053826 |
|
Vorrichtung zum Auftragen von zerstäubten Fluiden |
|
|
|
DE0010117875
|
|
Method and device for applying fluids |
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Exhibit 2
Generis Know-How
In transferring know-how from Generis to ExtrudeHone the following is an itemized list of items that must be transferred to comply with this agreement.
Note: All listed documents will be the most recently revised ones, at the time this agreement is put into effect.
[***]
· [***]
· [***]
· [***]
· [***]
· [***]
· [***]
· [***]
· [***]
[***]
[***]
i. [***]
ii. [***]
iii. [***]
iv. [***]
[***]
[***]
[***]
[***]
[***]
[***]
[***]
· [***]
· [***]
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
· [***]
· [***]
· [***]
· [***]
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Exhibit 3
Generis Patents
[***] |
[***] |
[***] |
|
[***] |
|
[***] |
|
|
|
[***] |
[***] |
[***] |
|
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Exhibit 10.7
Amendment to Transfer Agreement dated June 27, 2003
Between
voxeljet technology GmbH
Am Mittleren Moos 15
D 86167 Augsburg
(Formerly known as Generis GmbH)
And
Prometal RCT GmbH
Am Mittleren Moos 41
D 86167 Augsburg
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Preamble
Voxeljet GmbH and Extrude Hone GmbH are parties to a Patent and Know How Transfer Agreement dated June 27, 2003 whereby Extrude Hone Germany obtained the rights in certain patents and other intellectual properties of Generis (collectively the Generis Sand IP) which were subsequently transferred to Prometal RCT GmbH.
According to §4.2 of this agreement voxeljet requires the prior written consent of Prometal RCT to sell machines containing Generis Sand Technology.
On April 3rd 2007 a verbal understanding was reached containing the following basic points:
License for Voxeljet
Voxeljet will be granted a license on Prometals share in Generis Sand IP to build 3D printing machines for plastic forms and parts.
The license fee is based on §5.4 of the Patent and Know How Transfer agreement. The start point is the business year 2005.
The license fee will be calculated from the net sales price of the voxeljet plastic printing machines:
Business year |
|
2005 |
|
2006 |
|
2007 |
|
2008 |
|
2009 |
|
2010 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[***] |
|
[***] |
|
[***] |
|
[***] |
|
[***] |
|
[***] |
|
Sales of Voxeljet plastic printing equipment
Voxeljet agrees to use the EX ONE LLC Company (parent company to Prometal RCT) and its affiliates as a preferred partner to sell and market the plastic printing machines in international Markets especially in North America and Japan.
License fee on job shop machine
The calculation base for the license fee on internally used job shop machines is [***] of the List price of the respective machine. This calculation method applies to all machines used within voxeljet and the EX ONE group and coveres RCT sand printing machines as well as voxeljet plastic printing machines.
License Fee for consecutive years
Starting with deliveries of licensed goods in 2009 the license fee from Prometal to voxeljet will be calculated from the net sales price of the sand printing machines at a rate of [***].
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Starting with deliveries of licensed goods in 2010 the license fee from voxeljet to Prometal will be calculated from the net sales price of the plastic printing machines at a rate of [***].
The obligation to pay license fees in both directions ends with expiration of the last issued patent falling under the Generis Sand IP.
Reports and payment
The license fee shall be calculated on an annual basis not later than 28th of February of the consecutive year.
The corresponding report shall list at least the type of machine, its serial number, the customer, date of delivery and sales price.
License fees are due 30 days after filing the report.
Augsburg, July 14, 2009 |
|
14.07.2009 |
|
|
|
|
|
|
/s/ Rainer Höchsmann |
|
/s/ Ingo Ederer |
Rainer Höchsmann |
|
Dr. Ingo Ederer |
Prometal RCT GmbH |
|
Voxeljet technology GmbH |
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Consent of Independent Registered Public Accounting Firm
The
Board of Directors
voxeljet AG:
We consent to the use of our report dated August 7, 2013 with respect to the statements of financial position of voxeljet technology GmbH as of December 31, 2012, 2011, 2010 and January 1, 2010, and the related statements of comprehensive income (loss), changes in equity, and cash flows for each of the years in the three-year period ended December 31, 2012 included herein and to the reference to our firm under the heading "Experts" in the prospectus.
/s/ KPMG AG Wirtschaftsprüfungsgesellschaft
Munich, Germany
October 4, 2013